Tuesday, 6 December 2011 - World Allergy Organization

Transcription

Final Program
A World Federation of Allergy, Asthma
& Clinical Immunology Societies
www.worldallergy.org
XXII WORLD ALLERGY CONGRESS
WAC 2011 4-8 December Cancún, México
Table of Contents
Welcome from the WAC 2011 Organizing Committees.......1
Committee and Council Meetings..................................................20
WAO Board of Directors 2010-2011...................................................1
Travel Grants..................................................................................................22
Welcome from Partner Societies.........................................................2
Scientific Session Descriptions................................................... 24-25
Welcome from the Governor of Quintana Roo..........................3
Program-at-a-Glance........................................................................ 26-33
Welcome to Cancún....................................................................................4
Scientific Program............................................................................35-110
WAC 2011 Committees..............................................................................5
Posters..................................................................................................112-154
About WAO..................................................................................................6-7
Exhibit Hall Floor Plan & Hours........................................................155
WAO Member Societies.............................................................................8
Exhibitors Directory......................................................................156-160
WAO Awards.....................................................................................................9
WAO Member Society Village Floor Plan & Hours...............162
WAO Presidential Recognition & Collaboration Awards....10
WAO Member Society Village Directory..........................163-166
Countries Represented at WAC 2011.............................................10
Hotels Map..................................................................................................168
Cancún Center Floor Plan.....................................................................11
Hotels in Cancún.....................................................................................169
Fiesta Americana Grand Coral Beach Hotel (FAGCB)............11
Activities in Cancún...............................................................................169
Congress Information, A-Z............................................................ 12-18
Speaker, Author and Chairperson Index.........................171-189
Business Meetings.....................................................................................19
Media Partners..........................................................................................190
ABOUT WAO
The World Allergy Organization (WAO) is an international
alliance of 89 regional and national allergy, asthma and
clinical immunology societies. Through collaboration
with the Member Societies, WAO provides a wide range
of educational and outreach programs, symposia and
lectureships to allergists/immunologists around the
globe and conducts initiatives relating to clinical practice,
service provision, and physician training in order to
better understand and address the challenges facing
allergists/immunologists worldwide. WAO helps expand
the knowledge, expertise and skills of young physicians
establishing careers in allergy through Research Fellowships
with international placements at renowned allergy centers.
MISSION
WAO’s mission is to be a global resource and advocate
in the field of allergy, asthma and clinical immunology
advancing excellence in clinical care through education,
research and training as a worldwide alliance of allergy,
asthma and clinical immunology societies.
CONGRESS SECRETARIAT
World Allergy Organization
555 E. Wells St., Suite 1100
Milwaukee, WI 53202 USA
Phone: +1 414 276 1791
Fax: +1 414 276 3349
Email: [email protected]
CONGRESS WEBSITE
www.worldallergy.org/wac2011
Welcome from the WAC 2011
Organizing Committees
Dear Colleagues and Friends,
Welcome to Cancún and the XXII World Allergy Congress (WAC 2011)!
On behalf of the World Allergy Organization (WAO) Board of Directors and the Organizing Committees of the WAC 2011,
we warmly welcome you to Cancún, México. It has been a most rewarding experience organizing and developing the
WAC scientific and social programs. We hope that you, the participant, will enjoy the venue and Congress.
Delegates may count on a stimulating and varied scientific program that is highly relevant to both the theory and practice
of allergy and clinical immunology. It is hoped that each of you, as practitioners, educators, and researchers, will take away
from this Congress valuable information about the most recent advances in the specialty.
As a global alliance of national and regional allergy, asthma and clinical immunology societies, WAO proudly partners with
its member societies to host its biennial Congress. In 2011, the World Allergy Congress of WAO also serves as the annual
meeting of the Mexican College of Pediatric Allergists and Clinical Immunologists (COMPEDIA) and the Mexican College
of Clinical Immunology and Allergy (CMICA). Thanks, CMICA and COMPEDIA, for collaborating with WAO. We also want
to take this opportunity to thank the exceptionally skilled and committed 247 faculty members, a truly international and
versatile group.
Cancún, what more can be said? Beaches, Mayan monuments, turquoise water, clear skies, and the exquisite cuisine of
the Yucatán and the Palace of Chichen Itza frame our experience as all of us learn, network and absorb the rich mixture of
indigenous and western cultures common to México.
Thank you for attending the XXII World Allergy Congress. May your time in Cancún, Mexico, be a chance to learn, network,
and relax with friends and colleagues.
Welcome to Cancún!
Richard F. Lockey
WAO President
Congress President
Thomas B. Casale
Vice-Chair
Scientific Program
Committee
Noel Rodríguez-Perez
Chair
Local Organizing
Committee
WAO Board of Directors 2010-2011
Richard F. Lockey, President, United States
Mario Sánchez-Borges, Treasurer, Venezuela
Lanny J. Rosenwasser, Secretary-General, United States
Ruby Pawankar, President-Elect, Japan
G. Walter Canonica, Past-President, Italy
Michael A. Kaliner, Historian, United States
Ignacio Ansotegui, Spain
Michael Blaiss, United States
Thomas B. Casale, United States
Motohiro Ebisawa, Japan
Yehia El-Gamal, Egypt
Sandra González-Díaz, México
Tari Haahtela, Finland
Stephen T. Holgate, United Kingdom
Juan Carlos Ivancevich, Argentina
Marek L. Kowalski, Poland
Hae-Sim Park, South Korea
Paul C. Potter, South Africa
Tatiana Slavyanskaya, Russia
Myron Zitt, United States
1
Final Program
Welcome from Partner Societies
It is my sincere pleasure to warmly welcome all of you to the XXII World Allergy Congress
(WAC 2011) which will be held from 4 – 8 December 2011 in Cancún, México, at the Cancún
Center Conventions and Exhibitions. This knowledge-building event beautifully framed by
the Mexican Caribbean Coast will be a forum for allergy experts from throughout the world to
share experiences, as we expand our awareness of allergic and immunologic diseases for the
benefit of our patients. The emphasis on timely subjects presented by leaders in the field will build upon the momentum
of achievements from previous Congresses held around the world to continually increase awareness of allergic diseases
and equip clinicians with knowledge and resources for improved patient care.
México is committed to ensuring that WAC 2011 ultimately benefits our patients. I am particularly pleased by the
opportunity the Congress will offer to interact with delegates from 89 Member Societies that constitute the World Allergy
Organization (WAO). The increasing alignment of technology with the needs of Allergy and Immunology professionals
not only gives added impetus to scientific development, but also helps to build new frontiers in modern medicine. At
the same time, the synergies and insights that occur when we meet each other in person give impetus to our ongoing
individual efforts as well as collaborations.
As the President of the Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology (COMPEDIA), I
am pleased to work with the Mexican College of Immunology and Allergy (CMICA) and the World Allergy Organization
to make WAC 2011 a resounding success and to welcome to our beautiful country all delegates from WAO Member
Societies, speakers, exhibitors, students, trainees and all the distinguished physicians interested in the field of allergy and
immunology. In support of the meeting, the Congress will also serve as the 2011 COMPEDIA Annual Meeting.
I trust you will find time to enjoy our historic monuments, beautiful beaches, Mayan culture centers, museums and the
famous Mexican hospitality.
¡Bienvenidos! Welcome!
Dr. José Antonio Ortega Martell
President of the Mexican College of Pediatricians
Specialized in Allergy and Clinical Immunology (COMPEDIA)
Dear Delegates:
The Mexican College of Clinical Immunology and Allergy (CMICA) and The Mexican College of
Pediatricians Specialized in Allergy and Clinical Immunology (COMPEDIA) are pleased to partner
with the World Allergy Organization to bring to you the XXII World Allergy Congress (WAC 2011).
We are honored to co-host the XXII World Allergy Congress on 4-8 December at the Cancún Center
Conventions & Exhibitions, and the Fiesta Americana Hotel in Cancún, México. We are pleased
that the Congress also serves as the 2011 Annual Meeting for CMICA. A compelling scientific program was developed
under the direction of Richard F. Lockey, MD, President, World Allergy Organization, and Thomas B. Casale, MD, Vice
Chair, Scientific Program Committee. Together with the Scientific Program Committee, and with the help of invaluable
comments and suggestions received from WAO Member Societies, we have designed world-class learning in the form
of scientific sessions for specialists, general practitioners and allied health professionals. These will include Breakfast
Symposia, Debates, Collaborating Partner Sessions, New Horizon Sessions, Abstract and Poster Sessions, Plenary Sessions,
Sister Society Sessions, University Training Program, Allied Health Sessions and Workshops.
The value of this international meeting is further enhanced by the spectacular Cancún beaches and comfortable climate.
With plenty of recreational activities in the city, your family can enjoy this wonderful venue during the Congress.
Welcome to Cancún and México!
Dra. María Isabel Rojo Gutiérrez
President of the Mexican College of Clinical
Immunology and Allergy (CMICA)
2
Final Program
Welcome from the Governor of Quintana Roo
Cancún, Quintana Roo
December 2011
Dear World Allergy Congress Delegates,
In the name of the State of Quintana Roo, I am pleased to welcome
you warmly to Cancún, the Jewel of the Mexican Caribbean, which
receives you with open arms for the celebration of the XXII World Allergy
Congress of the World Allergy Organization, which will be carried out
from 4 to 8 December, 2011. As your host, we feel honored with your
distinguished presence.
The Mexican Caribbean greets and invites you to discover its many
attractions. Nature has endowed our State with an incomparable natural
beauty making this place a unique site to be explored and enjoyed.
Cancún offers to its visitors a wide variety of services and activities for all
tastes and budgets; enjoy its exquisite cuisine, its vibrant nightlife and
the best shopping; visit its delightful surroundings and let our people
pamper you with their warm hospitality.
We are sure you will find here all the necessary elements to facilitate and enhance this great scientific event and we wish it
will be an enriching opportunity to provide you with continuous worldwide learning and expand the science and practice of
allergy and clinical immunology. We also hope you enjoy very much your stay in our beautiful State and look forward to your
visit in the near future.
Yours sincerely,
Hon. Roberto Borge Angulo
Governor, State of Quintana Roo
Cancún, Quintana Roo;
Diciembre, 2011.
Estimado Congreso Mundial de Alergia delegados:
A nombre del Estado de Quintana Roo, me complace darle la más cordial bienvenida a Cancún, la Joya del Caribe
Mexicano, que lo recibe con los brazos abiertos para celebrar, Congreso Mundial de Alergia de la Organización
Mundial de Alergia. Como su anfitrión nos sentimos honrados con su distinguida presencia.
El Caribe Mexicano les saluda y les invita a descubrir sus muchos atractivos. La naturaleza ha dotado a nuestro estado
con una belleza natural incomparable haciendo de este hermoso lugar un sitio único para ser explorado y disfrutado.
Cancún ofrece a sus visitantes una gran variedad de servicios y actividades para todos los gustos y presupuestos;
disfruten de su exquisita gastronomía, su vibrante vida nocturna y las mejores compras; visiten sus maravillosos
alrededores y déjense consentir por la cálida hospitalidad de su gente.
Estamos seguros de que, como siempre, aquí encontrarán todos los elementos necesarios para la exitosa realización
del Congreso Mundial de la Organización Mundial de Alergia, y deseamos que el evento sea para ustedes,
profesionistas dedicados al sector estratégico de la salud, una enriquecedora oportunidad de intercambio de
experiencias. Así mismo, esperamos que su estancia en Cancún resulte grata y que en un futuro próximo nos honre
nuevamente con su visita.
Afectuosamente,
Hon. Roberto Borge Angulo
Gobierno del Estado de Quintana Roo
3
Final Program
Welcome to Cancún
CANCÚN - A NATURAL AND CULTURAL TREASURE OF MÉXICO
Cancún, México, a city on the northeast coast of the state of Quintana Roo, is considered one of México’s premier
destinations because of its great natural beauty.
Significant archeological sites, such as Tulum, Chichen Itza and nature reserves, such as Xcaret and Xel-Ha are near the city.
Fast Facts about México
International Visitors
to México in 2010:.....................22 million
Population......................................112 million
Official Language......................Spanish
Government.................................Federal Presidential
Constitutional Republic
President.........................................Felipe Calderón Hinojosa
Area....................................................1,964,375 km²
Currency..........................................Peso (MXN)
Time zone.......................................(UTC−8 to −6)
Country Dialing Code.............+52
Fast Facts about Cancún
International Visitors
to Cancún in 2010:....................3 million
Population......................................628,306
Language........................................Spanish; and English is also
widely spoken
Governor.........................................Roberto Borge Angulo
Climate.............................................Tropical
Temperature.................................79°F / 26°C annual average
Area....................................................1,664 km2
Telephone Area Code.............998
Nearest Destinations...............Chetumal, Cozumel, Isla Mujeres,
Playa del Carmen, Campeche
CURRENCY
The official currency of the World Allergy Congress is US
Dollars. The official currency in Cancún is the Mexican
Peso, but American Dollars are also widely accepted. Banks
are open Monday-Friday from 9:00 - 16:00 and there are
exchange houses that are open much later.
Exchange rates, as of November 2011:
$1.00 = MXN 13.1056
€1.00 = MXN 18.5628
£1.00 = MXN 21.1367
4
Final Program
WAC 2011 Committees
CONGRESS PRESIDENT
Richard F. Lockey, United States
CONGRESS ORGANIZING COMMITTEE
Richard F. Lockey, Chair, United States
Noel Rodríguez-Perez, Co-Chair, México
G. Walter Canonica, Italy
Helen Chan, Hong Kong
Michael A. Kaliner, United States
José Antonio Ortega Martell, México
Ruby Pawankar, Japan
Paul C. Potter, South Africa
María Isabel Rojo Gutiérrez, México
Lanny J. Rosenwasser, United States
SCIENTIFIC PROGRAM COMMITTEE
Thomas B. Casale, Vice Chair, United States
Cezmi Akdis, Switzerland
Carlos E. Baena-Cagnani, Argentina
Mark Ballow, United States
Marek Kowalski, Poland
Shyam Mohapatra, United States
Mario Morias de Almeida, Portugal
Johannes Ring, Germany
Noel Rodríguez-Perez, México
Nelson Rosário, Brazil
Hirohisa Saito, Japan
Mario Sánchez-Borges, Venezuela
LOCAL ORGANIZING COMMITTEE
Noel Rodríguez-Perez, Chair, México
Héctor Stone Aguilar, Vice Chair, México
Joel Oyoqui, Vice Chair, México
Alfredo Arias, México
Carlos Báez Loyola, México
Blanca Del Rio, México
Alberto Escalante, México
Alejandro Escobar, México
Rodolfo Espinosa Vizcaino, México
Maria de Jesus Ambriz, México
José Antonio Ortega Martell, México
Martin Penagos, México
María Isabel Rojo Gutiérrez, México
Juan J.L. Sienra, México
5
Final Program
About WAO
The World Allergy Organization (WAO) is an international
alliance of 89 regional and national allergy, asthma and
clinical immunology societies. Through collaboration
with the Member Societies, WAO provides a wide range
of educational and outreach programs, symposia and
lectureships to allergists/immunologists around the
globe and conducts initiatives relating to clinical practice,
service provision, and physician training in order to
better understand and address the challenges facing
allergists/immunologists worldwide. WAO helps expand
the knowledge, expertise and skills of young physicians
establishing careers in allergy through Research Fellowships
with international placements at renowned allergy centers.
MISSION OF THE
WORLD ALLERGY ORGANIZATION
WAO’s mission is to be a global resource and advocate in
the field of allergy, advancing excellence in clinical care
through education, research and training as a world-wide
alliance of allergy asthma and clinical immunology societies.
WAO MEETINGS
World Allergy Congress™ (WAC)
WAO hosts the World Allergy Congress ™ (WAC) – its main
scientific meeting – biennially in different regions of the
world. Please join us in Milan, Italy in 2013 and Seoul, South
Korea in 2015.
WAO International Scientific Conference (WISC)
In 2010, WAO launched its theme-based scientific
conferences alternating with and complementing
WAO’s biennial World Allergy Congresses. The 2nd WAO
International Scientific Conference on Severe Allergies, Severe
Asthma: New Strategies for Optimal Treatment and Prevention
will be held in Hyderabad, India, 6-9 December 2012. The
2012 Conference will provide a forum for the most useful
combination of the latest research, review of current theory
and practice, and hands-on, problem-based learning. For
more information, visit www.worldallergy.org/wisc2012.
JOURNAL
The World Allergy Organization Journal (WAO Journal)
provides a global forum for the exchange of research and
information on allergy, asthma, and clinical immunology.
The journal supports this scientific interaction among
members of the World Allergy Organization, an alliance
of 89 societies worldwide, through publication of
original research, clinical reviews, position papers, and
epidemiological studies that contribute to current
knowledge in patient care. Articles cover diagnosis,
therapeutic options, crisis management, and treatment
efficacy. Authors and reviewers represent all geographic
regions, providing a truly global perspective. Published
monthly online, with access on computers and mobile
devices, the journal ensures the widest availability of
practice-relevant science at the point of care. In 2010, the
WAO Journal launched a new feature, Chief Editor Podcasts,
consisting of audio downloads of interviews with authors
of recently published articles on the latest research.
www.waojournal.org
WAO ONLINE RESOURCES
As a leading global online destination for allergy, asthma
and clinical immunology the WAO website supports
and enhances WAO educational activities and provides
materials specifically designed for continued medical
training.
Popular resources include:
• Specially commissioned educational synopses on major
topics posted in the Allergic Diseases Resource Center
• Interactive case studies that challenge allergists to
diagnose unusual cases
• Online learning programs including the Immunology
Online Lecture Series, Asthma and Allergic Rhinitis Online
Lecture Series, and the interactive learning modules with
CME on Food Allergy and Drug Allergy
• An archive of webinars recorded at major meetings
• Audio recordings of interviews with key opinion leaders
around the world
• A special section, Defining the Specialty, which provides
easy access to WAO publications and other resources that
help to define the specialty of allergy and immunology
including the WAO White Book on Allergy
• Disease-specific sections of the website including the
Allergic Rhinitis Working Group, Small Airways Working
Group, and HAE Alliance.
The WAO website is HONcode certified.
WAO PROGRAMS FOR EDUCATION,
RESEARCH AND PATIENT CARE
Global Resources in Allergy ™ (GLORIA)
GLORIA promotes best practices in the management
of allergic disease through programs developed by
international advisory expert panels. Modules are created
from established guidelines and recommendations to
address different aspects of allergy-related patent care.
GLORIA is presented at national and regional allergy society
meetings throughout the world and also at regional, state
and local society meetings within the United States. All
current GLORIA modules are available for free download at
www.worldallergy.org/gloria.
World Allergy Forum® (WAF)
The World Allergy Forum® (WAF) program brings cutting
edge symposia to major allergy meetings throughout the
world. Developed by international expert advisory panels,
the symposia provide up-to-the minute presentations on
scientific and clinical developments in the field of allergic
disease. WAF is the longest running educational program
6
Final Program
About WAO
series sponsored by WAO and currently provides two or
three placements a year with up to 1, 000 attendees at each
program. WAF is supported by an unrestricted educational
grant from Novartis. View presentations for free at
www.worldallergy.org/waf.
Emerging Societies Program (ESP)
In order to advance the WAO mission of supporting
developments that will enable allergists to better serve
patients now and in the future, the Emerging Societies
Program (ESP) aims to disseminate information on and
share experiences about new treatments for allergic disease
and about new indications for available therapies. As a
response to an area of need identified by ESP Delegates,
the ESP has also started to offer World Allergy Training
Schools (WATS) in various regions of the world. All ESP
meetings and training schools are conducted with the
help and support of WAO Member Societies and held in
conjunction with a Member Society’s annual meeting
and in partnership with the American College of Allergy,
Asthma and Immunology (ACAAI). View all ESP activities at
www.worldallergy.org/.
WAO PUBLICATIONS
WAO papers support and promote the specialty of allergy
and help set standards for clinical practice and training.
A full bibliography is available at www.worldallergy.org/
publications/.
WORLD ALLERGY WEEK
In 2011, based on feedback from WAO Member Societies
over recent years, WAO inaugurated the first annual World
Allergy Week as a way for WAO Member Societies to
collaborate in a global effort to disseminate information
of worldwide importance about allergic and immunologic
diseases and asthma. Participation covered a wide
spectrum of activities including promotions through
websites and social media avenues, patient information
sessions, and interviews for radio and television programs.
The next World Allergy Week will be held from 16 to 22
April 2011. Watch for updates and view last year’s activities
at www.worldallergy.org/worldallergyweek/.
HISTORY OF THE
60th Anniversary
The seeds of the World Allergy Organization were sown
in 1951 when leaders in allergy from all over the world
came together to form the International Association of
Allergology and Clinical Immunology (IAACI). To celebrate
the 60-year Diamond Anniversary of this vibrant and
global organization, the World Allergy Organization Journal
is publishing a series of articles written by WAO’s past and
present leaders. A full bibliography is available at: http://
www.worldallergy.org/wao_societies/history_project.php.
Visit the WAO History Exhibit in the Cancún Center, 1st Floor
to browse photos and read personal recollections.
555 E. Wells St., Suite 1100
Milwaukee, WI 53202-3823 USA
Phone: +1 414 276 1791
Fax: +1 414 276 3349
E-mail: [email protected]
7
Final Program
WAO Member Societies
The World Allergy Organization (WAO) is an international umbrella organization whose members consist of 89 regional
and national allergology and clinical immunology societies from around the world.
All active members of dues-paying Member Societies are Individual Members of the World Allergy Organization (WAO).
Albanian Society of Allergology and Clinical Immunology
American Academy of Allergy, Asthma and Immunology
American College of Allergy, Asthma and Immunology
Argentine Association of Allergy and Immunology
Argentine Society of Allergy and Immunopathology
Australasian Society of Clinical Immunology and Allergy
Austrian Society of Allergology and Immunology
Azerbaijan Society for Asthma, Allergy and Clinical Immunology
Bangladesh Society of Allergy and Immunology
Belgian Society for Allergy and Clinical Immunology
Brazilian Society of Allergy and Immunopathology
British Society for Allergy and Clinical Immunology
Bulgarian Society of Allergology
Canadian Society of Allergy and Clinical Immunology
Chilean Society of Allergy and Immunology
Chinese Society of Allergology
Colombian Allergy, Asthma, and Immunology Association
Croatian Society of Allergology and Clinical Immunology
Cuban Society of Allergology
Czech Society of Allergology and Clinical Immunology
Danish Society of Allergology
Egyptian Society of Allergy and Clinical Immunology
Egyptian Society of Pediatric Allergy and Immunology
Finnish Society of Allergology and Clinical Immunology
French Society of Allergology
Georgian Association of Allergology and Clinical Immunology
German Society for Allergology and Clinical Immunology
Hellenic Society of Allergology and Clinical Immunology
Honduran Society of Allergy and Clinical Immunology
Hong Kong Institute of Allergy
Hungarian Society of Allergology and Clinical Immunology
Icelandic Society of Allergy and Immunology
Indian College of Allergy, Asthma and Applied Immunology
Indonesian Society for Allergy and Immunology
Israel Association of Allergy and Clinical Immunology
Italian Association of Territorial and Hospital Allergists
Italian Society of Allergy and Clinical Immunology
Japanese Society of Allergology
Korean Academy of Allergy, Asthma and Clinical Immunology
Latvian Association of Allergists
Lebanese Society of Allergy and Immunology
Malaysian Society of Allergy and Immunology
Mexican College of Clinical Immunology and Allergy
Mexican College of Pediatricians Specialized in Allergy and Clinical
Immunology
Mongolian Society of Allergology
Netherlands Society of Allergology
Norwegian Society of Allergology and Immunopathology
Panamanian Association of Allergology and Clinical Immunology
Paraguayan Society of Immunology and Allergy
Peruvian Society of Allergy and Immunology
Philippine Society of Allergy, Asthma and Immunology
Polish Society of Allergology
Portuguese Society of Allergology and Clinical Immunology
Romanian Society of Allergology and Clinical Immunology
Russian Association of Allergology and Clinical Immunology
Allergy and Clinical Immunology Society (Singapore)
Serbian Association of Allergologists and Clinical Immunologists
Slovenian Association for Allergology and Clinical Immunology
Allergy Society of South Africa
Spanish Society of Allergology and Clinical Immunology
Allergy & Immunology Society of Sri Lanka
Swiss Society for Allergology and Immunology
Allergy, Asthma and Immunology Society of Thailand
Turkish National Society of Allergy and Clinical Immunology
Ukrainian Association of Allergologists and Clinical Immunologists
Uruguayan Society of Allergology
Venezuelan Society of Allergy and Immunology
Vietnam Association of Allergy, Asthma and Clinical Immunology
Zimbabwe Allergy Society
ASSOCIATE MEMBER SOCIETIES
REGIONAL ORGANIZATIONS
National Association for Private Algerian Allergists
Belarus Association of Allergology & Clinical Immunology
Ecuadorian Society of Allergy and Immunology
Ecuadorian Society of Allergology and Affiliated Sciences
Iranian Society of Asthma and Allergy
Jordanian Society for Allergy and Clinical Immunology
Kuwait Society of Allergy and Clinical Immunology
Moldavian Society of Allergology and Immunology
Moroccan Society of Allergology and Clinical Immunology
Swedish Association for Allergology
Tunisian Society of Respiratory Diseases and Allergology
Asia Pacific Association of Allergy, Asthma and Clinical
Immunology
Commonwealth of Independent States Society of
Immunology and Allergology
European Academy of Allergy and Clinical Immunology
Latin American Society of Allergy, Asthma and
Immunology
AFFILIATE ORGANIZATIONS
British Society for Immunology
GA²LEN (Global Allergy and Asthma European Network)
International Association of Asthmology
International Primary Care Respiratory Group (IPCRG)
Southern European Allergy Societies (SEAS)
Apply for your National Allergy Society to become a WAO Member Society at
www.worldallergy.org/wao_societies/apply.php
8
Final Program
WAO Awards
The World Allergy Organization (WAO) is pleased to announce the WAO Award recipients:
Scientific Achievement Award
Rebecca H. Buckley, United States
Stephen J. Galli, United States
Special Recognition Award
James P. Kiley, United States
Erkka Valovirta, Finland
Outstanding Clinician Award
Bee Wah Lee, Singapore
James M. Oleske, United States
Pakit Vichyanond, Thailand
Distinguished Service Award
Cassim Motala, South Africa
Awards will be presented at the Opening
Ceremony on 4 December at 17:30 in the
Gran Cancún Room, 3rd Floor, Cancún
Center.
2010-2011 WAO Awards Committee
Allen P. Kaplan, United States
Charles Naspitz, Brazil
S. Gunnar O. Johansson, Sweden
Gold Medal Award
AWARDS HISTORY, 1973 - 2009
1973
Alfred W. Frankland, United Kingdom
E. Brum Negreiros, Brazil
Mario Ricci, Italy
Bernard Halpern, France
Fernando Lahoz, Spain
Henry Hyde Salter Clinical Award
Francis Rackemann, United States
M. Murray Peshkin, United States
Guido Ruiz-Moreno, Argentina
Kimishige Ishizaka, Japan
Teruko Ishizaka, Japan
F. MacFarlane Burnet, Australia
1976
Bram Rose, Canada
Max Samter, United States
Umberto Serafini, Italy
Bernard Halpern, France
1979
Alain L. de Weck, Switzerland
Lowell L. Henderson, United States
Tiuzi Sindo, Japan
Samuel C. Bukantz, United States
Francis C. Lowell, United States
Wilhelmus J. Quarles van Ufford,
Netherlands
Merrill W. Chase, United States
Robert P. Orange, Canada
1982
Israel Glazer, Israel
Joseph Jamar, Belgium
Bengt Samuelsson, Sweden
Cesar Milstein, Argentina
Georges Kohler, Germany
1985
Jack Pepys, United Kingdom
Henry Hyde Salter Clinical Awards
George Blumstein, United States
Leo Criep, United States
Luis Tuft, United States
Zoltan Ovary, United States
1988
Ernesto Mendes, Brazil
Sheldon G. Cohen, United States
Gilbert D. Barkin, United States
Robert A. Goldstein, United States
Erich Fuchs, Germany
John Morrison-Smith, United Kingdom
John Salvaggio, United States
Andre Capron, France
Tomio Tada, Japan
K. Frank Austen, United States
1991
Takumi Kishimoto, Japan
Lawrence M. Lichtenstein, United States
A. Barry Kay, United Kingdom
Sergio Romagnani, Italy
Jacques Charpin, France
Albert L. Sheffer, United States
Max Samter, United States
1994
K. Frank Austen, United States
Raif Geha, United States
Teruko Ishizaka, Japan
Terumasa Miyamoto, Japan
Albert K. Oehling, Spain
Alain L. de Weck, Switzerland
1997
S. Gunner O. Johansson, Sweeden
Philip Norman, United States
Francois B. Michel, France
Allen Kaplan, United States
Oscar L. Frick, United States
2000
John Bienenstock, Canada
William Busse, United States
Jean Bousquet, France
Frederick Hargreave, Canada
Mario Ricci, Italy
2003
Donald Y. Leung, United States
Jean Bousquet, France
Patrick G. Holt, Australia
Charles Naspitz, Brazil
Charles Reed, United States
Ulrich Wahn, Germany
S. Gunner O. Johansson, Sweden
9
2005
Thomas A.E. Platts-Mills, United States
Dietrich Kraft, Austria
Philip Lieberman, United States
Felicidad Cua-Lim, Philippines
Leonardo Greiding, Argentina
Recognition of Service
Albert K. Oehling, Spain
2007
WAO Gold Medal Award
Connie H. Katelaris, Australia
Malcolm Greaves, United Kingdom
F. Estelle Simons, Canada
You-Young Kim, South Korea
Harold Nelson, United States
Paul Van Cauwenberge, Belgium
Carlos Crisci, Argentina
WAO Special Recognition Award
Nikolai Khaltaev, Switzerland
Nan-San Zhong, China
2009
WAO Gold Medal Award
Allen P. Kaplan, United States
Anthony Fauci, United States
Holger Schunemann, Canada
Sohei Makino, Japan
Giovanni Passalacqua, Italy
Stanley Szefler, United States
WAO Special Recognition Award
Alvaro A. Cruz, Brazil
WAO Distinguished Service Award
Carlos E. Baena-Cagnani, Argentina
Final Program
WAO Presidential Recognition &
Collaboration Awards
Congratulations to the Recipients of the 2011 WAO Presidential Recognition & Collaboration Awards!
The 2011 WAO Presidential Recognition & Collaboration Awards recipients were selected based on their contributions to
WAO, which have advanced WAO’s mission as a global resource and advocate in the field of allergy.
Virginia Bellido Linares, Spain
Matteo Bonini, Italy
Jan Brozek, Canada
Sergio Del Giacco, Italy
Pascal Demoly, France
Veselin Dimov, United States
Dalia El-Ghoneimy, Egypt
Alessandro Fiocchi, Italy
Stuart Friedman, United States
Claudia Gallego Corella, México
Liliane Gendreau-Reid, Canada
Georgy Gudima, Russia
Kamal Maurice Hanna, Egypt
Juan Carlos Ivancevich, Argentina
Connie H. Katelaris, Australia
Krzysztof Kowal, Poland
Bob Lanier, United States
Dennis Ledford, United States
Phil Lieberman, United States
Carlos Nunes, Portugal
Giovanni Passalacqua, Italy
Barbara Rogala, Poland
Nelson Rosário Filho, Brazil
Hirohisa Saito, Japan
Anna Sala Cunill, Spain
Silvia Sánchez García, Spain
Glenis Scadding, United Kingdom
Holger Schünemann, Canada
Revaz Sepiashvili, Russia
F. Estelle R. Simons, Canada
Countries Represented at WAC 2011
WAC 2011 is pleased to welcome attendees from 85 countries from around the world!
Algeria
Argentina
Australia
Austria
Bahamas
Barbados
Belgium
Bermuda
Bolivia
Brazil
Bulgaria
Canada
Cayman Islands
Chile
China
Colombia
Costa Rica
Croatia
Cuba
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
El Salvador
Finland
France
Gambia
Germany
Ghana
Greece
Guatemala
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Israel
Italy
Japan
Kenya
Korea (South)
Kuwait
Latvia
Lebanon
Lithuania
Macedonia
Malaysia
Martinique
México
Moldova
Netherlands
New Zealand
Nigeria
Norway
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Republic of the Congo
Romania
10
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
United Arab Emirates
United Kingdom
United States
Uruguay
Venezuela
As of 18 November 2011
Final Program
Cancún Center Floor Plan
1st Floor
CONTACTOS
CONTACTOS
Ground Floor
E
A/A
E
A/A
CONTACTOS
ELECTRICIDAD
E
TELEFONIA
AIRE
ACONDICIONADO
ELECTRICIDAD
E
CONTACTOS
CONTACTOS
AIRE
ACONDICIONADO
ELECTRICIDAD
CONTACTOS
CONTACTOS
A/A
AIRE
ACONDICIONADO
ELECTRICIDAD
E
CONTACTOS
ELECTRICIDAD
E
A/A
AIRE
ACONDICIONADO
ELECTRICIDAD
ELECTRICIDAD
E
ELECTRICIDAD
E
CONTACTOS
TELEFONIA
TELEFONIA
ABC
a
an
a C ce
nt ran
Pu Ent
EXTINTOR
1206
1207
3m
1308
CONTACTOS
E
TELEFONIA
CONTACTOS
1309
CONTACTOS
ELECTRICIDAD
E
CONTACTOS
ABC
EXTINTOR
CONTACTOS
ELECTRICIDAD
E
CONTACTOS
CONTACTOS
CONTACTOS
E
FIR
PUL
L
tra
En
E
FIR
PUL
L
ENCIA
e
nc
EMERG
WAO Booth and
History Dislplay
Auditorium
2nd Floor
Akumal Terrace
Costa Maya
ENCIA
SUBE
LLEGA
SUBE
CONTACTOS
EMERG
WAO Member Society Village
E
ELECTRICIDAD
Registration Bag
Pick-Up
E
1603
1601
1307
ELECTRICIDAD
CONTACTOS
ELECTRICIDAD
L4
CONTACTOS
L2
L3
1604
CONTACTOS
CONTACTOS
CONTACTOS
CONTACTOS
CONTACTOS
TELEFONIA
CONTACTOS
E
1306
G4
E
CONTACTOS
TELEFONIA
1305
G3
CONTACTOS
CONTACTOS
ELECTRICIDAD
E
CONTACTOS
CONTACTOS
TELEFONIA
ELECTRICIDAD
BE
SU
CONTACTOS
CONTACTOS
ELECTRICIDAD
E
CONTACTOS
Registration
1304
L1
1605
6m
ELECTRICIDAD
1303
K4
E
1302
Allergy A4
A3
Therapeutics
K2
K3
CONTACTOS
6m
6m
1301
G2
CONTACTOS
TELEFONIA
G1
RMEI
Internet
Cafe
K1
1602
1470
ABC
EXTINTOR
5.2m
3m
6m
Coffee Area
Internet
Cafe
Nycomed
SanofiAventis
Poster Hall
General
Information
CONTACTOS
I4
1606
TELEFONIA
I3
1607
CONTACTOS
ABC
EXTINTOR
5.2m
1
3m
Pending
3m
1460
1410
2
I2
1440
6m
3
D4
6m
I1
1608
Pending
3m
Exhibit
Hall
D3
ABC
EXTINTOR
Peprotech
1101
D2
CONTACTOS
ABC
Uriach
6m
1102
D1
MSD
1420
1103
Bedfont
Scientific
Nestle Nutrition and
Nestle Nutrition Institute
TELEFONIA
1450
6m
1510
E3
LL
EG
A
Aerosol
Medical Systems
EXTINTOR
ABC
EXTINTOR
CONTACTOS
TELEFONIA
E
E
ELECTRICIDAD
CONTACTOS
ELECTRICIDAD
CONTACTOS
ABC
1430
HAE: Learn about
it, Talk about it
1104
TELEFONIA
EXTINTOR
Coffee Area
1105
Omega
Diagnostics
TELEFONIA
nSpire
Health
3m
Kohunlich
Press Room
3m
CONTACTOS
1106
Bacalar
1205
16
Shire
ELECTRICIDAD
15
14
CONTACTOS
13
A/A
1204
AIRE
ACONDICIONADO
1203
MicroLife
Mexico
EMERGENCIA
9
HAL
Allergy
CONTACTOS
1202
1201
3rd Floor
Tulum
3
1
4
Isla Mujeres
Gran Cancún
2
5
Coba
Speaker Ready Room
Xcaret
Cozumel
Fiesta Americana Grand Coral Beach Hotel (FAGCB)
The FAGCB is located across the street from the Punta Cana
entrance of the Cancún Center. Delegates will enter the
FAGCB on the Ground Floor.
The FAGCB is the venue for the Allied Health Sessions,
Breakfast Symposia and Workshops.
Room Floor
Coral Gallery Ground
Coral Gallery 1
Ground
Coral Gallery 2
Ground
Coral Gallery 3
Ground
Coral Island Lobby
Coral Sea Lobby
Coral Kingdom 1 1st
Coral Kingdom 2 1st
Coral Kingdom 3 1st
Coral Garden 1 1st
Coral Garden 2 1st
Coral Garden 3 1st
11
Final Program
Congress Information, A-Z
ABSTRACTS
Accepted abstracts that were submitted for the 2011
World Allergy Congress have been placed in Oral Abstract
Sessions, Poster Symposia and Poster Sessions during the
lunch hour on 5, 6 and 7 December. Abstract numbers are
listed to the left of the abstract title in this Final Program.
This number can be used to view, download or print the
abstracts that interest you using the Handout Kiosks.
Handout Kiosks are located on the 1st and 2nd Floors of
the Cancún Center and on the Ground Floor of the Fiesta
Americana.
BADGES
Each participant will receive a name badge upon check-in
at the Registration Desk. The badge is the official Congress
document and should be worn at all times in order to gain
entry to the Congress session rooms and social events.
Please note that access to any of the Congress areas or
events will not be possible without an official name badge.
In order to comply with security requirements, participants
are expected to wear their name badges at all times in all
areas. If you lose your badge, a new one can be purchased
at the Registration Assistance Desk for $50 USD with photo
identification.
CERTIFICATE OF ATTENDANCE
Each delegate will receive a Certificate of Attendance in the
Congress registration bag.
CONTINUING MEDICAL EDUCATION
(CME) AND CONTINUING EDUCATION
(CE) CREDITS
The 2011 World Allergy Congress is accredited by the
European Accreditation Council for Continuing Medical
Education (EACCME), Mexican National Board of Clinical
Immunology and Allergy (CONICA) and the American
Academy of Allergy, Asthma, & Immunology (AAAAI) for
Continuing Education (CE) Credits .
European Accreditation Council for
Continuing Medical Education (EACCME)
The 2011 World Allergy Congress is
accredited by the European Accreditation
Council for Continuing Medical Education
(EACCME) to provide the following CME
activity for medical specialists. The EACCME
is an institution of the European Union of
Medical Specialists (UEMS), www.uems.net.
Division of Credits
Sunday, 4 December......................................................................6 hours
Monday, 5 December ...................................................................6 hours
Tuesday, 6 December ...................................................................6 hours
Wednesday, 7 December ...........................................................6 hours
Thursday, 8 December .................................................................3 hours
EACCME credits are recognized by the American Medical
Association towards the Physician’s Recognition Award
(PRA). To convert EACCME credit to AMA PRA category
1 credit, contact the AMA, telephone 1-800-621-8335 or
1-312-464-4941. US doctors do not automatically earn CME
credits unless they contact the AMA.
To Receive EACCME Certificates
To receive your EACCME Certificate, please visit the selfserve CME Kiosks in the Registration Area on the Ground
Floor of the Cancún Center beginning on Tuesday, 6
December. You can log-in using your last name and the ID
number on your badge. You will then be asked to complete
a short evaluation of the Congress and indicate which days
you attended the Congress. After you have completed
these steps, a CME Certificate will print.
If you do not have time to visit the CME Kiosks during the
Congress, the same evaluation and form will be available
on the WAO website after the Congress.
CME (CONTINUED)
National Board of Clinical Immunology
and Allergy (CONICA)
The 2011 World Allergy Congress is approved
by the National Board of Clinical Immunology
and Allergy (CONICA) to offer 15 credit hours
towards the re-certification of Mexican
allergists.
Continuing Education (CE)
WAC 2011 offers 7.80 Contact Hours.
The American Academy of Allergy, Asthma,
& Immunology (AAAAI), approved by the
California Board of Registered Nursing
(Provider #10704), will provide WAC 2011
with up to 7.80 Contact Hours.
Detailed information on how to receive credits will be
distributed to Allied Health registrants during the 1st WAO
Allied Health Program on 3 and 4 December.
The 2011 World Allergy Congress is
designated for a maximum of 27 hours
of European external CME credits. Each
medical specialist should claim only those hours of credit
that he/she actually spent in the educational activity.
12
Final Program
EAACI-WAO
World Allergy & Asthma
Congress 2013
22 – 26 June 2013
Milan, Italy
EAACI-WAO Congress 2013
Allergy, a global health challenge
t
Abstrac n
sio
Submis e:
Deadlin ry
ua
21 Jan 3
201
www.eaaci-wao2013.com
COFFEE BREAKS
HANDOUT KIOSKS
Coffee Breaks on 4, 5, 6, 7, and 8 December are included in
the registration fee and will be available during designated
times.
Handout Kiosks are located on the 1st and 2nd Floor of
the Cancún Center and on the Ground Floor of the Fiesta
Americana Grand Coral Beach Hotel. Congress participants
are encouraged to use these kiosks to view, download or
print handouts. Handouts are provided by the Congress
speakers and should be used to enhance your learning
experience. Handouts include reading lists, outlines of
presentations or PowerPoint slides.
Coffee Breaks on 4 and 8 December will be located outside
the Gran Cancún (3rd Floor), Cozumel (2nd Floor) and Costa
Maya (1st Floor) rooms in the Cancún Center.
Coffee Breaks on 5, 6 and 7 December will be located inside
the Exhibit Hall on the Ground Floor of the Cancún Center.
DRESS
Dress for the Congress is business casual.
EVALUATIONS
Congress evaluations can be filled out using the self-serve
CME Kiosks in the Registration Area on the Ground Floor of
the Cancún Center beginning on Tuesday, 6 December.
If you do not have time to visit the CME Kiosks during the
Congress, the same evaluation will be available on the WAO
website after the Congress.
EXHIBIT HALL
A commercial exhibition will take place on the following
dates and times and is located on the Ground Floor of the
Cancún Center.
Monday, 5 December ................................................... 09:00 – 17:00
Tuesday, 6 December.................................................... 09:00 – 17:00
Wednesday, 7 December............................................ 09:00 – 17:00
Please view the Exhibit Hall Map and Directory on page 155
for more information.
GENERAL INFORMATION / TOURS /
HOUSING DESK
A General Information/Tours/Housing Desk is located near
the Punta Cana Entrance of the Cancún Center.
GUESTS AND CHILDREN
Delegates are asked to refrain from bringing unregistered
guests and children to the 2011 World Allergy Congress.
To register a guest or child, please visit the Registration
Assistance Desk in the Registration Area.
To find a specific handout, you can search by the handout
number (displayed on the left side of the talk title in this Final
Program), by author name, session, talk title or topic.
Congress participants may also use the Handout Kiosks
to view, download or print abstracts that are of interest.
Abstract numbers are listed to the left of the abstract title in
this Final Program.
INSURANCE/LIABILITIES AND
DISCLAIMER
WAO will not be held liable for personal injuries or for
loss of or damage to property incurred by participants or
guests at the 2011 World Allergy Congress, including those
participating in tours and social events. Participants and
guests are encouraged to purchase insurance to cover loss
incurred in the event of cancellation, medical expenses
or damage to or loss of personal effects when traveling
outside of their own countries.
WAO cannot be held liable for any hindrance or disruption
of the 2011 World Allergy Congress proceedings arising
from natural, political, social or economic events or other
unforeseen incidents beyond its control. Registration of a
participant implies acceptance of this condition.
The materials presented at this continuing medical
education activity are made available for educational
purposes only. The materials are not intended to represent
the only, nor necessarily best, methods or procedures
appropriate for the medical situations discussed, but rather
are intended to present an approach, view, statement, or
opinion of the faculty that may be helpful to others who
face similar situations.
14
Final Program
Congress Information A-Z
INTERNET CAFÉ
LOST AND FOUND
An Internet Café, sponsored by Nycomed – A Takeda
Company, is located in the Exhibit Hall, on the Ground
Floor of the Cancún Center. Registrants are encouraged to
use the Internet Café, but to limit use to 15 minutes or less
when others are waiting.
Please visit the Registration Assistance Desk in the
Registration Area for any lost and found items.
The Internet Café is only available when the Exhibit Hall is
open.
LOST BADGES
If you lose your badge, a new one can be purchased at the
Registration Assistance Desk on the Ground Floor of the
Cancún Center for $50 USD with photo identification.
LUNCH
Boxed lunches, sponsored by Alcon, will be available to
delegates attending the Poster Sessions in the Poster Hall
on 5, 6 and 7 December.
LANGUAGE
The official language of the Congress is English. Spanish is
the official language of Cancún, although English, German,
French, Italian and other languages are also spoken. All
sessions at the Congress will be in English.
LEAD RETRIEVAL
Each attendee at WAC is assigned a unique registration
number, which will be shown on the badge in two different
formats: A human-readable number and a machinereadable 2-dimensional QR-code.
If you have Internet Access at WAC 2011 (ordered through
the Cancún Center), you can use a badge number to
retrieve an attendee’s name and contact information from
a special web page, and on that web page you can also
record details of the lead - what you talked about, or any
other notes about the person. If you have a Smartphone
with a QR-code scanning application, simply scanning
the badge will take you to that web page automatically. If
you do not wish to use the QR-code, you can also look up
attendees by badge number.
To register your device, simply visit http://wao.confex.com/
wao/2011wac/ContactList.cgi and either log-in or create an
account. Once logged-in, you can also use the above link
to manually look up attendees by badge ID.
If you don’t have Internet Access at WAC 2011, use pen
and paper to record attendee badge numbers. When you
return to your office, you can use the badge numbers to
retrieve the desired profiles at the same address:
http://wao.confex.com/wao/2011wac/ContactList.cgi.
You can also download and print a list of all contacts you
encountered, along with their contact information and the
notes you jotted down.
MEMBER SOCIETY VILLAGE
Continuing the WAO tradition of promoting Member
Societies at World Allergy Congresses, a Member Society
Village will be open during the following dates and times
on the 1st Floor of the Cancún Center.
Monday, 5 December ................................................... 09:00 – 17:00
Tuesday, 6 December.................................................... 09:00 – 17:00
Wednesday, 7 December............................................ 09:00 – 17:00
MESSAGE BOARD
A message board is located in the Registration Area on the
Ground Floor of the Cancún Center.
MOBILE PHONE POLICY
Use of mobile phones is strictly prohibited within the
scientific session rooms, Exhibit Hall and Poster Hall. Please
ensure that your mobile phone is silenced while you are in
the Congress venues.
NO SMOKING POLICY
Smoking is not permitted during any meeting activity or
event.
PARKING
Free parking is available to registered delegates in the
parking lot at the front entrance of the Cancún Center.
PAYMENTS
On-site payments can be made by credit card (Visa,
MasterCard, or American Express) or cash (USD only).
15
Final Program
PHOTOGRAPHY
REFUNDS
By registering to attend the 2011 World Allergy Congress,
you acknowledge and agree that official photographs
taken during the Congress may be used for future WAO
meeting promotional purposes and may be shared in the
Congress Photo Gallery and post event news updates.
Please contact the WAO Secretariat if you have any
concerns with this policy. Personal photography is allowed,
but please refrain from flash photography during the
sessions.
There are no refunds for on-site payments.
POSTER SESSIONS
Poster Sessions will take place in the Cancún Center, 1st
Floor, Poster Hall on 5, 6 and 7 December from 12:15 –
14:15. Presenting Authors will stand next to their posters
and be available for discussion and questions.
Posters will only be set for the day of the presentation,
and poster set-up is each morning from 07:00 – 09:30. The
abstract number, which is listed to the left of the abstract
title in this Final Program, will also refer to the poster
board number in the Poster Hall. Each poster will remain
on display throughout the assigned day, and must be
dismantled by 17:30. Posters not dismantled by 17:30 on
the day of the presentation will be discarded.
Please note: Any posters set-up prior to 07:00 on the day
of presentation may be accidentally discarded. Posters are
only allowed to be set between 07:00 – 09:30.
Lunch boxes are available to delegates attending the Poster
Sessions.
PRESS ROOM
The Press Room is located on the 1st Floor of the Cancún
Center in the Kohulich Room. Members of the press are
invited to attend the 2011 World Allergy Congress. To
obtain a press pass on-site, journalists must provide media
identification or a business card issued by their news
organization. Freelance writers must provide a letter of
assignment on a news organization letterhead or bylined
articles from a recognized news organization. Press badges
will only be issued to journalists representing the editorial
staff of print, broadcast, or internet media.
The Press Room will be open during the following hours:
Saturday, 3 December.....................................................16:00 – 20:00
Sunday, 4 December........................................................07:00 – 17:00
Monday, 5 December......................................................07:00 – 17:00
Tuesday, 6 December......................................................07:00 – 17:00
Wednesday, 7 December..............................................07:00 – 17:00
Thursday, 8 December....................................................07:00 – 10:00
REGISTRATION
Registration is located on the Ground Floor of the Cancún
Center.
Sunday, 4 December........................................................06:30 – 20:00
Monday, 5 December......................................................06:30 – 17:00
Full Congress Registration Fee Includes:
Types: Delegates, Fellows-in-Training, Allied Health
Professional, Students
•
•
•
•
•
Admission to all scientific sessions
Congress registration bag and meeting materials
Admission to Exhibit Hall
Certificate of Attendance
CME
RIBBONS
Ribbons are available at the Congress Bag and Ribbon Desk
on the Ground Floor of the Cancún Center. Ribbons that
you are entitled to will be noted on your registration badge
print-off.
SPEAKER READY ROOM
The Speaker Ready Room is located in the Cancún Center
on the 2nd Floor in the Coba Room. There is not a Speaker
Ready Room in the Fiesta Americana Grand Coral Beach.
Speakers that have sessions at the hotel are required to
check-in at the Cancún Center, Coba Room.
Speakers are requested to check-in, drop off and finalize
their slide presentations. It is requested that speakers visit
the Speaker Ready Room at least one hour before the
beginning of their session. Speakers making early morning
presentations should check in the previous day.
The hours of the Speaker Ready Room are:
Sunday, 4 December........................................................07:00 – 17:00
Monday, 5 December......................................................07:00 – 17:00
16
Final Program
TICKETS
To reserve or exchange a ticket for a Breakfast Symposium
or Workshop, please visit the Tickets Desk in the Registration
Area on the Ground Floor of the Cancún Center.
Breakfast Symposia and Workshops have limited capacity.
Fees:
Breakfast Symposia....................................................................... $20 USD
(includes continental breakfast)
Workshops..............................................................................................No fee
TRANSPORTATION
It is very easy and inexpensive to get around Cancún using
local transportation. You can take a bus or taxi to most
places within Cancún.
There is a bus every hour from Cancún Airport to downtown
Cancún and the Hotel Zone Loop. From the Cancún bus
terminal in downtown Cancún, you will find regular services
to all parts of México. In addition, the public buses in Cancún
go around the Hotel Zone Loop every few minutes for a fee
of 8 Mexican Pesos, or $0.60 USD.
For assistance on public and private transportation, contact
staff at the General Information/ Tours/ Housing Desk on
the Ground Level of the Cancún Center.
VENUES
The venues of the 2011 World Allergy Congress are the
Cancún Center Conventions and Exhibitions and the Fiesta
Americana Grand Coral Beach Hotel, which is located
directly across from the Cancún Center.
Cancún Center Convention and Exhibitions (CC)
Blvd. Kukulkan Km. 9 1 er Piso
Zona Hotelera 77500 Cancún
Quintana Roo, México
Fiesta Americana Grand Coral Beach Hotel (FAGCB)
Blvd. Kukulcán Km. 9.5
Zona Hotelera, 77500 Cancún
Quintana Roo, México
Use the FAGCB Convention Center door by the hotel gift shop
for easy access to the Cancún Center.
WAO 60TH ANNIVERSARY DISPLAY
Celebrate the World Allergy Organization’s 60th
Anniversary!
WAO is proud and honored to celebrate its 60th
Anniversary in 2011. Please stop by the WAO History display
(located next to the WAO Booth on the 1st Floor of the
Cancún Center). Relive WAO’s proudest achievements,
scientific break throughs, and honor the pioneering leaders
of our specialty. Copies of WAO History articles, written by
Prof. Alain de Weck and Prof. Michael A. Kaliner for the WAO
Journal, will be available to visitors of the display.
WAO FRIEND RIBBON
To make a donation to the WAO program and receive a
“WAO Friend” ribbon, visit the Registration Assistance Desk.
Minimum donation is $5 USD.
17
Final Program
WAO EDUCATION RESEARCH TRUST
It is about ownership! Support World Allergy Organization Programs and Initiatives.
BECOME A “WAO FRIEND!”
WAO offers you the opportunity to ensure personally
that WAO programs and initiatives flourish. The WAO
Board of Directors asks you to contribute to the WAO
Education Research Trust by adding an amount, in
increments starting at $5, to your registration fee.
The WAO Education Research Trust raises funds for
the following programs: Emerging Societies, WAO
Research Fellowships and International Travel Grants.
If you choose to participate, your contribution will be
added to your registration fee and will appear on your
receipt as a separate line item.
For your support, you will be recognized as a “WAO
Friend” on the WAO web site and with a ribbon
attached to your name badge at the World Allergy
Congress.
18
Final Program
Business Meetings (All Business Meetings are by Invitation Only)
BUSINESS MEETINGS
COMPEDIA Business Meeting
Monday, 5 December
12:00 – 17:00
FAGCB, 4th, Grand Coral 1
WAO Regional Leadership Meeting
Wednesday, 7 December
11:45 – 12:45
CC, Ground, Auditorium
WAO Presidential Symposium and Reception
Monday, 5 December
16:30 - 18:30
CC, 1st, Bacalar
WAO House of Delegates
13:00 – 17:00
CC, Ground, Auditorium
CMICA Business Meeting
Tuesday, 6 December
12:00 – 17:00
FAGCB, 4th, Grand Coral 1
PROPERTY KEY
PROPERTIES
CC
Cancún Center
FAGCB
Fiesta Americana
Grand Coral Beach
Hotel
WAO White Book on Allergy
ATION
GANIZ
RGY OR
D ALLE
WORL
Allergic disease: A major global public health concern
WAO llergy
ook on A
B
e
Whit
gy
on Aller
te Book
hi
WAO W
Editors:
Ruby Pawankar
Stephen T. Holgate
G. Walter Canonica
Richard F. Lockey
An important planning
resource for physicians,
NGOs, and health agencies.
Executive Summary available
in several languages including
Czech, English, Japanese,
Polish and Spanish.
The WAO WHITE BOOK ON ALLERGY
provides evidence about the increasing
prevalence of allergic diseases worldwide
and offers “high level” recommendations
for action on allergy education for health
care professions and enhanced patient
service provision.
The 79 authors of the WAO WHITE BOOK
ON ALLERGY cover all aspects of
allergic disease:
Concise clinical overview
Prevalence and treatment, unmet needs, and
future therapies
Healthcare perspective
The burden of the diseases on quality
of life of patients, their socio-economic
Coun
try-specific
consequences, and the
information from
WAO
need for cost-benefit
Member Societie
s
around the world
analysis of appropriate
care services.
The WAO WHITE BOOK ON ALLERGY
includes reports on the impact of allergic
diseases in countries around the world
provided by Member Societies of the
World Allergy Organization. Although
this information is a mixture of published
literature and anecdotal comment, it
provides a consistent message that allergic
diseases are reaching epidemic proportions
in the world and are not being appropriately
diagnosed and treated.
To download the Executive Summary or full book,
visit www.worldallergy.org/definingthespecialty/white-book.php
WAO-1011-332
19
Final Program
Committee and Council Meetings
(All Committee and Council
Meetings are by Invitation Only)
Joint EAACI-WAO World Allergy and Asthma Congress
Sunday, 4 December
08:00 – 13:00
FAGCB, Lobby, Board of Directors Room
WAO Communications Council Meeting
Tuesday, 6 December
09:45 – 10:45
FAGCB, Lobby, Coral Sea 2
WAO Industry Leadership Group
Sunday, 4 December
13:00 – 14:30
FAGCB, Lobby, Coral Kingdom
WAO Anaphylaxis Committee Meeting
Tuesday, 6 December
10:45 – 11:30
WAO Allergic Rhinitis Working Group
Monday, 5 December
07:30 – 08:30
CC, 2nd, Tulum 4
WAO Journal Editorial Board
Tuesday, 6 December
11:00 – 12:00
Joint EAACI-WAO World Allergy and Asthma Congress
Monday, 5 December
07:30 – 10:30
WAO Junior Members Group Meeting
Tuesday, 6 December
14:15 – 15:00
CC, Lobby, Coral Island 1
WAO Food Allergy Special Committee and DRACMA
Implementation Meeting
Monday, 5 December
08:45 – 09:45
WAO Special Committee on Immunotherapy
Tuesday, 6 December
15:00 – 15:45
WAO Web Editorial Board Meeting
Monday, 5 December
09:45 – 10:45
WAO Probiotics Author Group Meeting
Monday, 5 December
09:45 – 10:45
WAO Climate Change Special Committee
Monday, 5 December
14:15 – 15:00
FAGCB, Lobby, Coral Island
WAO ESP Meeting
07:45 – 08:45
WAO Testing for IgE Sensitization Author Group
08:45 – 09:45
WAO International Scientific Conference
WISC 2012 Scientific Program (WISC) Meeting
Thursday, 8 December
08:00 – 11:00
WAO Evidence Based Medicine Special Committee
Meeting
Tuesday, 6 December
09:45 – 10:30
WORLD ALLERGY TRAINING SCHOOL
World Allergy Training School (WATS)
Sunday, 4 December
08:00 – 16:00
FAGCB, 1st, Coral Garden 1
WATS Luncheon
Sunday, 4 December
11:45 – 13:00
FAGCB, 1st, Coral Garden 2 & 3
WATS is sponsored by:
20
Final Program
Congratulations to the 2011
WAO Travel Grant Recipients
Manel Amri
Argentina
María Victoria
Sánchez Vallecillo
Austria
Barbara Gepp
Alina Neunkirchner
Klaus Schmetterer
Cornelia Schultz
Ursula Smole
Brazil
Marcela Asanuma Odaira
Laura Araujo
Luciana Kase Tanno
Canada
Karine Issa-El-Khoury
Thatchai Kampitak
Teresa Pun
Chile
Additional funding
provided by
Cuba
Rocio Tordecilla
Consuelo Fernanda
Rodríguez Martínez
Mirta Alvarez
Alexis Labrada
Arelis Más Quintero
Wendy Ramírez González
México
Jonathan Maya
Nancy Mendez Berreondo
Elizabeth Mendieta
Jeannette Mendiola Marin
Laura Mendoza
Lizette Montejano-Elías
David Alexander
Morales Marin
Armando Partida-Gaytan
Gabriela Ramírez
Eunice Sandoval-Ramírez
Paraguay
Cinthia Perez Ortiz
Peru
Juan Aldave Becerra
Philippines
Aileen Elorde
Poland
Damian Tworek
Romania
Ioana Adriana Bujor
Russia
Pavel Samoylikov
Igor Shilovskiy
South Africa
Jaisubash Jayakumar
South Korea
Hyun-Jung Jin
Jae-Woo Jung
Jeong-Eun Kim
Min-Suk Yang
Spain
Fco. de Borja Callejas
Barbara Cases
El Salvador
Mauricio Flores
France
Oussama Abou Chakra
Juan Manuel Leyva Castillo
Germany
Liliana Cifuentes
Mareike McIntyre
Hungary
Dorottya Csuka
United
Kingdom
India
Animesh Jain
Gaurab Sircar
Ulugbek Nurmatov
Mohamed Shamji
Vadim Sumbayev
Uruguay
Valeria Pomies
Indonesia
Azwin Lubis
Italy
Maria Concetta Siani
Enrico Heffler
Japan
Mariko Yamaura
Latvia
Ivans S. Kuznecovs
México
Nadia Aguilar
Freya Helena Campos
Romero
Ma del Rosario
Gonzalez Galarza
Nelva Lizbeth Guillen Rocha
Luis Octavio HernandezMondragon
Mayra Alondra Liévano Pérez
Saul Oswaldo Lugo Reyes
United States Marcella Aquino
Victoria Dimitriades
Araceli Elizalde
John Kim
John Kuryan
Xingnan Li
Jun Lu
Terri Moncrief
Doanh Nguyen
Juan Esteban Perez
Rebecca Slager
Kristen Townsend
Neetu Vasu
Venezuela
22
Ingrid Quintana Quintero
Final Program
WAO-1011-157
Travel Grants Supported by the
Algeria
WAO Junior Members Group
www.worldallergy.org/juniormembers
Please join us for the first WAO Junior Members Group Symposium
WAO Junior Members Group Symposium
Tuesday,6December2011,15:00–16:30
Bacalar(CancúnCenter)
Who qualifies to be a WAO Junior Member?
Membership is free, and
the only requirements
for membership are that
applicants must be:
• Workinginthefieldofallergy/clinicalimmunologyorarelatedspecialty
• Under35yearsofageorwithin5yearsofatrainingprograminallergy,asthma,
clinicalimmunology,orarelatedfield
• AcurrentmemberofaWAOMemberSociety(visitwww.worldallergy.org/waosocieties/membersforacompletelistofMemberSocieties)
What benefits will you enjoy as a WAO Junior Member?
Help shape the future
of WAO through global
advocacy and leadership as
a Junior Member.
• TravelgrantopportunitiesforWAOeducationalactivities
• Aworldwideprofessionalnetworkofjuniorallergists
• Occasionstointeractwiththeleadinginternationalallergyexperts
• Theopportunitytodevelopaleadershiproleinthespecialty
• JuniorMemberratesforWAOCongressesandeducationalactivities
• TheopportunitytopublishyourresearchintheWorld Allergy Organization Journal
• AdedicatedsectionforJuniorMembersontheWAOwebsite
• Specialsessions,socialeventsatWAOCongresses,andaffordable
accommodationinadedicatedJuniorMembershotel
• AJuniorMembersectionofthemonthly“WAONewsandNotes”
For more information or to apply for membership, please visit
www.worldallergy.org/juniormembers or contact us at [email protected].
WAO-1011-299
23
Final Program
Scientific Session Descriptions
The 2011 World Allergy Congress offers delegates
educational opportunities in many different formats.
ALLIED HEALTH SESSIONS
The Allied Health Sessions are designed for health care
professionals who provide care to people with allergy,
asthma and immunologic diseases. It is aimed towards
nurses, nurse practitioners, physician assistants, respiratory
therapists, medical technologists and medical assistants.
Allied Health Sessions will take place for a half-day on 3 and
4 December.
BREAKFAST SYMPOSIA
Ticket required to attend
Breakfast Symposia consist of small, interactive sessions
led by two or three expert presenters. Breakfast Symposia
are scheduled for 75 minutes on 5, 6 and 7 December and
include continental breakfast for attendees. Pre-registration
is required and requires an additional fee of $20 USD.
Please visit the Ticket Desk in the Registration Area to
purchase or exchange tickets.
COMPANY SPONSORED SYMPOSIA
Company Sponsored Symposia are organized by industry.
Company Sponsored Symposia are scheduled for 90
minutes on 5, 6 and 7 December.
COLLABORATING PARTNER SESSIONS
Collaborating Partner Sessions are proposed by invited
WAO affiliated organizations. The selection process was
competitive and the sessions have been programmed as
Symposia or Workshops. Collaborating Partner Sessions are
scheduled for 90 minutes on the 5, 6 and 7 of December.
DEBATES
Debates feature two presenters who provide opposing
views on controversial topics. Debates are scheduled for 60
NEW HORIZON SESSIONS
New Horizon Sessions are the bookend sessions of the
Congress. These 8 sessions are designed to showcase
the latest science related to allergy, asthma and clinical
immunology. Delegates hear in-depth, varied perspectives
on each topic from the premier presenters in the field. New
Horizon Sessions are scheduled as either half-day or fullday sessions on 4 and 8 December.
ORAL ABSTRACT SESSIONS
Oral Abstract Sessions are thematic sessions that have been
created using submitted abstracts. Abstract authors give
didactic presentations summarizing their research. Oral
Abstract Sessions are schedule for 90 minutes on 5, 6 and 7
December.
PLENARY SESSIONS
Plenary Sessions are the premier educational sessions
of the Congress, presenting cutting-edge information
on current and relevant topics in a didactic format.
The speakers of the Plenary Sessions are top experts in
their field. Plenary Sessions are scheduled on 5, 6 and 7
December, for 90 minutes.
POSTER SESSIONS
Poster Sessions feature accepted abstracts and the posters
are displayed from 5, 6 and 7 December. Poster Sessions are
scheduled for two hours on 5, 6 and 7 December. Boxed
lunches are provided for all delegates in attendance.
POSTER SYMPOSIA
Poster Symposia are thematic sessions that have been
created using submitted abstracts. Abstract authors give
short, didactic presentations summarizing their poster.
Posters are displayed in the session room. Poster Symposia
are schedule for 90 minutes on 5, 6 and 7 December.
SISTER SOCIETY SESSIONS
Sister Society Sessions are proposed by WAO Member
Societies. Selection process was competitive and the
sessions are programmed as Symposia, Workshops or
Breakfast Symposia. Sister Society Sessions are scheduled
on the 5, 6 and 7 of December.
SYMPOSIA
Symposia are didactic sessions and present topics of
specific interest. Symposia are scheduled for 90 minutes
on 5, 6 and 7 December. Symposia include: Company
Sponsored Symposia, Sister Society Sessions, Collaborating
Partner Sessions and University Training Program Sessions.
UNIVERSITY TRAINING PROGRAM
SESSIONS
University Training Program Sessions are proposed and
developed by universities and institutions from around
the world. These sessions are programmed as Symposia,
Workshops or Breakfast Symposia. University Training
Programs are scheduled on the 5, 6 and 7 of December.
24
Final Program
Scientific Session Descriptions
WORKSHOPS
YEAR-IN-REVIEW SESSIONS
Workshops are either interactive or didactic. These sessions
are smaller and aimed towards audience participation.
Workshops are scheduled for 90 minutes on 5, 6 and 7
December.
Year-in-Review Sessions are didactic presentations
reviewing the latest information published on specific
topics. Year-in-Review Sessions are scheduled for 90
Please visit the Ticket Desk in the Registration Area to
reserve or exchange your ticket.
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
Collaborating Partner Session
SSS
Sister Society Symposium
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
University Training Program
NH
New Horizon Session
WS
Workshop
OAS
Oral Abstract Session
YiR
Year in Review
25
Final Program
Program-at-a-Glance
SATURDAY, 3 DECEMBER 2011
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
AH 1: Asthma: Diagnosis, Management and Education—FAGCB, Ground, Coral Gallery 1&2
SUNDAY, 4 DECEMBER 2011
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
(Opens at 6:30) Registration
NH 1: Specific Immunotherapy (SIT): History,
Mechanisms and Future—CC, 3rd, Gran Cancún
Coffee
Break
NH 1: Specific Immunotherapy (SIT): Which
Patients for SIT or Anti-IgE?—CC, 3rd, Gran Cancún
Break
NH 1: Specific Immunotherapy (SIT): Effectiveness
of SIT—CC, 3rd, Gran Cancún
Coffee
Break
NH 1
Consid
NH 2: Skin Diseases: Session 1—CC, 2nd, Cozumel
NH 2: Skin Diseases: Session 2—CC, 2nd, Cozumel
NH 4: Drug Allergy: New Insights in Drug
Hypersensitivity—CC, 2nd, Cozumel
NH 4
Hypers
NH 3: Novel Scientific Approaches in Allergic and
Respiratory Diseases: Session 1—CC, 1st, Costa Maya
NH 3: Novel Scientific Approaches in Allergic and
Respiratory Diseases: Session 2—CC, 1st, Costa Maya
NH 5: Asthma and Co-Morbid Conditions:
Session 1—CC, 1st, Costa Maya
NH 5
2—CC
AH 2: Allergic Disorders: Snapshots of a Worldly View—FAGCB, Ground, Coral Gallery 1&2
PSym 1: Allied Health—FAGCB, Ground, Coral
Gallery 3
SESSION AND
PROPERTY KEY
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
PROPERTIES
CC
Cancún Center
FAGCB
Fiesta Americana
Grand Coral Beach
Hotel
26
Final Program
Program-at-a-Glance
SATURDAY, 3 DECEMBER 2011
15:15
15:30
15:45 14:30
16:00 14:45
16:15 15:00
16:30 15:15
16:45 15:30
17:00 15:45
17:15 16:00
17:30 16:15
17:45 16:30
18:00 16:45
18:15 17:00
18:30 17:15
18:45 17:30
19:00 17:45
19:15 18:00
19:30 18:15
19:45 18:30
20:00 18:45
20:15 19:00
20:30 19:15
20:45 19:30
Registration
19:45
20:00
20:15
20:30
20:45
19:45
20:00
20:15
20:30
20:45
Registration
SUNDAY, 4 DECEMBER 2011
15:15
15:30
15:45 14:30
16:00 14:45
16:15 15:00
16:30 15:15
16:45 15:30
17:00 15:45
17:15 16:00
17:30 16:15
17:45 16:30
18:00 16:45
18:15 17:00
18:30 17:15
18:45 17:30
19:00 17:45
19:15 18:00
19:30 18:15
19:45 18:30
20:00 18:45
20:15 19:00
20:30 19:15
20:45 19:30
Registration
1: Specific Immunotherapy (SIT):
Practical
Coffee
derations for SIT—CC, 3rd, GranBreak
Cancún
WAC 2011 Opening Ceremony—CC, 3rd, WAC
Gran Cancún
WAC 2011
Welcome
NH 1: Specific Immunotherapy (SIT): Practical
2011 Opening
Ceremony
—CC, Reception
3rd, Gran Cancún
(19:30–21:30)—CC, 2nd Floor
Considerations for SIT—CC, 3rd, Gran Cancún
4: Drug Allergy: Management of Drug
sensitivity—CC, 2nd, Cozumel
NH 4: Drug Allergy: Management of Drug
Hypersensitivity—CC, 2nd, Cozumel
WAC 2011 Welcome Reception
(19:30–21:30)—CC, 2nd Floor
5: Asthma and Co-Morbid Conditions: Session NH 5: Asthma and Co-Morbid Conditions: Session
C, 1st, Costa Maya
2—CC, 1st, Costa Maya
XXII WORLD
ALLERGY CONGRESS
Cancún, Mexico
4-8 December 2011
Proud sponsors of the XXII World Allergy Congress
& the World Allergy Training School
Use only as directed.
ZYRTEC® is a brand distributed by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. in the United States and of Johnson & Johnson Pacific Pty Limited in Australia. BENADRYL® is a brand distributed by McNeil Consumer Healthcare Division of
McNEIL-PPC, Inc. in the United States and of McNeil Products Ltd. in the United Kingdom. REACTINE® is a brand distributed by McNeil Consumer Healthcare, Division of Johnson & Johnson Inc. in Canada. LIVOCAB® is a brand distributed by McNeil
GmbH & Co. oHG in Germany. LIVOSTIN® is a brand distributed by McNeil Sweden AB in Sweden.
27
Final Program
Program-at-a-Glance
MONDAY, 5 DECEMBER 2011
6:30
6:45
7:00
7:15
7:30
7:45
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13
Registration
Exhibition
BS1: Food Allergy and Anaphylaxis—
FAGCB, Ground, Coral Gallery 1
PS1: Asthma: From Genetics to Treatment—CC, 3rd,
Gran Cancún
Coffee Break
SSS 1: Japanese Society of Allergology: Update on
Atopic Dermatitis—CC, 3rd, Gran Cancún 1
BS2: Clinical Process to Properly Prescribe
Immunotherapy—FAGCB, Ground, Coral
Gallery 2
SY 1: Risk Factors for Recurrent Early Wheezing in
Childhood—CC, 3rd,Gran Cancún 2
BS3: Neonatal Infant Interventions to
Prevent Asthma and Allergic Disease—
SY2: 2012 WISC: Superantigens and Severe Airway
Disease—CC, 3rd,Gran Cancún 3
BS4: Biology of Aeroallergens in Latin
America—FAGCB, Lobby, Coral Island
DB 1: Urticaria: Is There a Role
for Sedating Antihistamines and
Steroids?—CC, 3rd,Gran Cancún 4
BS5: Management of COPD—FAGCB,
Lobby, Coral Sea
CPS 1: ATS: Emerging Issues in COPD—CC, 3rd, Gran
Cancún 5
BS6: Kuwait Society of Allergy and
Clinical Immunology Sister Society Session:
Omalizumab (Anti-IgE) for Asthma—FAGCB,
1st, Coral Kingdom 1
PS2: Mastocytosis and Mast Cell Activation Syndromes
—CC, 2nd, Cozumel
Poster Group1—CC, 1st, Poster Hal
SSS 2: AAAAI: Eosinophilic Gastrointestinal (GI)
Diseases—CC, 2nd, Cozumel 1
PSym2: Asthma Tre
BS7: Flushing Syndromes—FAGCB, 1st,
Coral Kingdom 2
CSS 1: Sanofi-Aventis: Controlling Allergic Rhinitis
—CC, 2nd, Cozumel 2
OAS1: Allergen Imm
Cancún 1
BS8: What to Do with a Patient that Cannot
Smell?—FAGCB, 1st, Coral Kingdom 3
SY3: Genetic Susceptibility to Airway Diseases—CC,
2nd, Isla Mujeres
OAS2: Allergen Stru
BS9: Case Discussion on Patients with
Possible Immune Deficiencies—FAGCB, 1st,
Coral Garden 1
SSS3: SLAAI: Hot Topics in Latin America—CC,
2nd, Tulum
OAS3: Allergic Mod
Gran Cancún 3
BS10: Differential Diagnosis of Headaches,
Including Temporomandibular Joint Disorder
(TMJ)—FAGCB, 1st, Coral Garden 2
SY4: Environmental Aspects of Asthma—CC, 2nd,
Xcaret
OAS4: Allergic Rhin
CPS 2: NIAID: Immunological Features of
Immunotherapy—CC, 1st, Costa Maya 1
OAS5: Atopic Derm
SY5: Rhinosinusitis—CC, 1st, Costa Maya 2
OAS6: Conjunctivit
SY6: Obstructive Sleep Apnea (OSA) Syndrome and
Allergic Respiratory Diseases—CC, 1st, Bacalar
OAS7: Immunodefi
SSS 4: Brazilian Society: Debate:
Allergy and Breast Feeding—CC,
Ground, Auditorium
OAS8: Indoor Risk F
Tulum
BS11: Inflammasomes and Allergic
Diseases—FAGCB: 1st, Coral Garden 3
PS3: Novel Cytokines in Allergic Diseases—CC, 1st,
Costa Maya
OAS9: Mechanisms
OAS10: Sublingua
Costa Maya 1
OAS 11: Urticaria a
Costa Maya 2
SESSION AND
PROPERTY KEY
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
PROPERTIES
CC
Cancún Center
FAGCB
Fiesta Americana
Grand Coral Beach
Hotel
28
Final Program
13:15
Program-at-a-Glance
MONDAY, 5 DECEMBER 2011
13:30
13:45
14:00
12:15
14:15
12:30
14:30
12:45
14:45
13:00
15:00
13:15
15:15
13:30
15:30
13:45
15:45
14:00
16:00
14:15
16:15
14:30
16:30
14:45
16:45
15:00
17:00
15:15
17:15
15:30
17:30
15:45
17:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
Registration
Exhibition
UTP 1: Harvard: Adverse Drug Reactions
and Break
Poster Coffee
Group1Break
—CC, 1st, Poster Hall
Coffee
Managements—CC, 3rd, Gran Cancún 1
ll
UTP 1: Harvard: Adverse Drug Reactions and
Managements—CC, 3rd, Gran Cancún 1
SY7: Allergen Avoidance Strategies—CC, 3rd, Gran
Cancún 2
SY7: Allergen Avoidance Strategies—CC, 3rd, Gran
Cancún 2
DB2: Small Airways: Are They
Important in the Pathogenesis of
Asthma?—CC, 3rd, Gran Cancún 3
DB2: Small Airways: Are They
Important in the Pathogenesis of
Asthma?—CC, 3rd, Gran Cancún 3
SY8: Mast Cell: The Central Inflammatory Cell—CC,
3rd, Gran Cancún 4
SY8: Mast Cell: The Central Inflammatory Cell—CC,
3rd, Gran Cancún 4
YiR 1: Atopic Dermatitis—CC, 3rd, Gran Cancún 5
YiR 1: Atopic Dermatitis—CC, 3rd, Gran Cancún 5
reatment—CC, 1st, Bacalar
SY9: Asthma
Are They a Spectrum of the
PSym2: Asthma Treatment
—CC,and
1st,COPD:
Bacalar
Same Disease?—CC, 2nd, Cozumel 1
SY9: Asthma and COPD: Are They a Spectrum of the
Same Disease?—CC, 2nd, Cozumel 1
munotherapy 1—CC, 3rd, Gran
CSS2: MSD: Uncontrolled
Asthma: Burden, Patient
OAS1: Allergen Immunotherapy
1—CC, 3rd, Gran
Perceptions and Clinical Implications—CC, 2nd,
Cancún 1
Cozumel 2
CSS2: MSD: Uncontrolled Asthma: Burden, Patient
Perceptions and Clinical Implications—CC, 2nd,
Cozumel 2
ucture 1—CC, 3rd, Gran Cancún 2
DB3: Is1the
Hygiene
Hypothesis
OAS2: Allergen Structure
—CC,
3rd, Gran
Cancún 2
Important?—CC, 2nd, Isla Mujeres
DB3: Is the Hygiene Hypothesis
Important?—CC, 2nd, Isla Mujeres
dels of Inflammation—CC, 3rd,
SSS5:
INTERASMA: Control
and Prevention of Asthma
OAS3: Allergic Models
of Inflammation
—CC, 3rd,
Exacerbation—CC, 2nd, Tulum
Gran Cancún 3
SSS5: INTERASMA: Control and Prevention of Asthma
Exacerbation—CC, 2nd, Tulum
nitis—CC, 3rd, Gran Cancún 4
SY10:
Genetic
Respiratory
and Their
OAS4: Allergic Rhinitis
—CC,
3rd, Gran
CancúnDiseases
4
Association with Asthma—CC, 2nd, Xcaret
SY10: Genetic Respiratory Diseases and Their
Association with Asthma—CC, 2nd, Xcaret
matitis 1—CC, 3rd, Gran Cancún 5
SY11:1Pregnancy:
Allergic
Diseases
OAS5: Atopic Dermatitis
—CC, 3rd, Gran
Cancún
5 and Asthma—CC,
1st, Costa Maya 1
SY11: Pregnancy: Allergic Diseases and Asthma—CC,
1st, Costa Maya 1
tis—CC, 2nd, Cozumel 2
SSS6:
When Food
OAS6: Conjunctivitis
—CC,ACAAI:
2nd, Cozumel
2 Allergies are Unusual,
Unexpected, and Potentially Fatal—CC, 1st, Costa
Maya 2
SSS6: ACAAI: When Food Allergies are Unusual,
Unexpected, and Potentially Fatal—CC, 1st, Costa
Maya 2
ficiency—CC, 2nd, Isla Mujeres
WS1: Evidence
Based
for Clinical
OAS7: Immunodeficiency
—CC, 2nd,
Isla Recommendations
Mujeres
Practice—FAGCB, Ground, Coral Gallery 1
WS1: Evidence Based Recommendations for Clinical
Practice—FAGCB, Ground, Coral Gallery 1
Factors for Asthma—CC, 2nd,
Reactions
Non-Steroid AntiOAS8: Indoor RiskWS2:
FactorsAdverse
for Asthma
—CC, to
2nd,
Inflammatory Drugs—FAGCB, Ground, Coral Gallery 2
Tulum
WS2: Adverse Reactions to Non-Steroid AntiInflammatory Drugs—FAGCB, Ground, Coral Gallery 2
s of Asthma—CC, 2nd, Xcaret
WS3:
Update
OAS9: Mechanisms
of Asthma
—onCC,Vaccinations
2nd, Xcaret for the Allergist and
Immunologist—FAGCB, Ground, Coral Gallery 3
WS3: Update on Vaccinations for the Allergist and
Immunologist—FAGCB, Ground, Coral Gallery 3
al Immunotherapy 1—CC, 1st,
WS4:
Management1—
of Asthma
OAS10: Sublingual
Immunotherapy
CC, 1st, Exacerbations—
FAGCB, Lobby, Coral Sea
Costa Maya 1
WS4: Management of Asthma Exacerbations—
and Angioedema—CC, 1st,
Skin Prick Testing:
What Can We Still Improve?
OAS 11: UrticariaWS5:
and Angioedema
—CC, 1st,
—FAGCB, 1st, Coral Kingdom 1
Costa Maya 2
WS5: Skin Prick Testing: What Can We Still Improve?
WS6: UTP- University of Sao Paulo: Allergy and
Asthma: Risk Factors, Diagnosis and Treatment—
FAGCB, 1st, Coral Kingdom 2
WS6: UTP- University of Sao Paulo: Allergy and
Asthma: Risk Factors, Diagnosis and Treatment—
WS7: Undergraduate and Postgraduate Training
in Allergy: New Developments—FAGCB, 1st, Coral
Kingdom 3
WS7: Undergraduate and Postgraduate Training
in Allergy: New Developments—FAGCB, 1st, Coral
Kingdom 3
WS8: Hands-On Session: Pulmonary Function—
WS8: Hands-On Session: Pulmonary Function—
WS9: Hands-On Session: Rhinolaryngoscopy
(Session 1)—FAGCB, 1st, Coral Garden 2
WS9: Hands-On Session: Rhinolaryngoscopy
(Session 1)—FAGCB, 1st, Coral Garden 2
WS10: The Internet and Allergy—FAGCB, 1st, Coral
Garden 3
WS10: The Internet and Allergy—FAGCB, 1st, Coral
Garden 3
29
Final Program
Program-at-a-Glance
TUESDAY, 6 DECEMBER 2011
7:00
7:15
7:30
7:45
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13
Registration
Exhibition
BS12: Diagnostic and Therapeutic Approach
to Multiple Food Allergic Children—FAGCB,
Ground, Coral Gallery 1
PS5: Specific Immunotherapy (SIT)—CC, 3rd, Gran
Cancún
Coffee Break
SY12: Eosinophilic Respiratory Problems—CC, 3rd,
Gran Cancún 1
BS13: Practical Considerations for
Prescribing Sublingual Immunotherapy (SLIT)
—FAGCB, Ground, Coral Gallery 2
DB 4: Skin Test or In-Vitro Test
for Food Allergy?—CC, 3rd, Gran
Cancún 2
BS14: Pruritus: Scratching the Surface—
CPS 3: NIAID and NHLBI: Standardizing Outcomes in
Asthma Clinical Research—CC, 3rd, Gran Cancún 3
BS15: UTP - Universidad Autonoma de
Nuevo Leon: Insect Allergy—FAGCB, Lobby,
Coral Island
SY13: Immunomodulators in Allergic/Immunologic
Diseases—CC, 3rd, Gran Cancún 4
BS16: Treatment of the Asthmatic Patient
Under Age 5—FAGCB, Lobby, Coral Sea
SY14: Clinical Use of Probiotic Products for Allergy –
A WAO Paper—CC, 3rd, Gran Cancún 5
BS17: Evaluation of Patients for Antibody
Deficiency—FAGCB, 1st, Coral Kingdom 1
DB5: Sublingual Immunotherapy
(SLIT) vs Subcutaneous
Immunotherapy (SCIT)—CC, 2nd,
Cozumel 1
PSym3: Allergic Rhinitis—CC, 1st, Baca
BS18: Exercise-Induced Asthma and
Allergic Conditions—FAGCB, 1st, Coral
Kingdom 2
CSS3: Nestle Nutrition Institute: Dietary Prevention
and Management of Allergies in Childhood – An
Outlook into the Future—CC, 2nd, Cozumel 2
OAS12: Food & Drug Allergy: Late-Brea
3rd, Gran Cancún 1
BS19: Pharmacotherapy for the Geriatric
Asthma Patient—FAGCB, 1st, Coral Kingdom 3
SY15: Patient Education and Treatment Compliance in
Allergic Rhinitis—CC, 2nd, Isla Mujeres
OAS13: Allergen Structure 2—CC, 3rd,
BS20: Anti-IgE: Beyond Asthma—FAGCB,
1st, Coral Garden 1
SY16: Smooth Muscle and Asthma—CC, 2nd, Tulum
OAS14: Anaphylaxis—CC, 3rd, Gran Ca
BS21: Diagnosis and Management of
Anaphylaxis—FAGCB, 1st, Coral Garden 2
SY17: Neural Mechanisms in Airway Diseases—CC,
2nd, Xcaret
OAS15: Global Asthma Epidemiology—
Gran Cancún 4
SSS7: EAACI: Phenotypes and Endotypes of Allergic
Disease—CC, 1st, Costa Maya 1
OAS16: Hereditary Angioedema—CC,
Cancún 5
SY18: Hereditary Angioedema (HAE) and the WAO
Consensus Document—CC, 1st, Costa Maya 2
OAS17: Immunomodulators—CC, 2nd
UTP 2: Wake Forest: Translational Medicine and
Personalized Asthma Management—CC, 1st, Bacalar
OAS18: Inhaled Corticosteroids for Asth
2nd, Isla Mujeres
SY19: Air Pollution and Climate Change and Their
Effects on Allergic Respiratory Diseases—CC, Ground,
Auditorium
OAS19: Mechanisms of Allergic Inflamm
2nd, Tulum
BS22: Differential Diagnosis of Cough—
PS6: Asthma Phenotypes: Implications for Treatment
—CC, 2nd, Cozumel
Poster Group 2—CC, 1st, Poster Hall
PS7: Microbiome: A New Window to Health and
Allergic Diseases?—CC, 1st, Costa Maya
OAS20: Patho-Biology of Nasal Polyps—
Xcaret
OAS21: Respiratory Infections—CC, 1s
Maya 1
OAS 22: Rhinitis Treatment 1—CC, 1st
OAS23: Sublingual Immunotherapy 2—
Auditorium
SESSION AND
PROPERTY KEY
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
PROPERTIES
CC
Cancún Center
FAGCB
Fiesta Americana
Grand Coral Beach
Hotel
30
Final Program
13:45
Program-at-a-Glance
TUESDAY, 6 DECEMBER 2011
14:00
14:15
14:30
12:15
14:45
12:30
15:00
12:45
15:15
13:00
15:30
13:15
15:45
13:30
16:00
13:45
16:15
14:00
16:30
14:15
16:45
14:30
17:00
14:45
17:15
15:00
17:30
15:15
17:45
15:30
18:00
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
Registration
Exhibition
Coffee Break
Poster Group DB
2—6:
CC,Environmental
1st, Poster HallControl for
Allergic Diseases: Does it Work?—
CC, 3rd, Gran Cancún 1
Coffee Break
DB 6: Environmental Control for
Allergic Diseases: Does it Work?—
SSS8: German Society: Microbes - Friends or Foes of
Allergic Disease?—CC, 3rd, Gran Cancún 2
SSS8: German Society: Microbes - Friends or Foes of
Allergic Disease?—CC, 3rd, Gran Cancún 2
DB7: Atopic Eczema: Barrier
Dysfunction or Immune Deviation?
—CC, 3rd, Gran Cancún 3
DB7: Atopic Eczema: Barrier
Dysfunction or Immune Deviation?
CPS4: ALA - Asthma Clinical Research Network:
Asthma in the Elderly (AIE): Challenges and
Opportunities—CC, 3rd, Gran Cancún 4
CPS4: ALA - Asthma Clinical Research Network:
Asthma in the Elderly (AIE): Challenges and
Opportunities—CC, 3rd, Gran Cancún 4
SY20: Chronic Rhinosinusitis (CRS) in Children—CC,
3rd, Gran Cancún 5
SY20: Chronic Rhinosinusitis (CRS) in Children—CC,
3rd, Gran Cancún 5
alar
SSS9:
PSym3:
COMPEDIA:
Allergic Rhinitis
Food Allergy
—CC,—
1st,CC,Bacalar
2nd, Cozumel 1
SSS9: COMPEDIA: Food Allergy—CC, 2nd, Cozumel 1
akers—CC,
CSS4:
OAS12:
Robert
FoodMichael
& Drug Education
Allergy: Late-Breakers
Institute: A —CC,
Worldwide
3rd, Gran Cancún
Perspective
1 on Hereditary Angioedema
(HAE): Current Practices, Evolving Therapies, and Special
Populations—CC, 2nd, Cozumel 2
CSS4: Robert Michael Education Institute: A
Worldwide Perspective on Hereditary Angioedema
(HAE): Current Practices, Evolving Therapies, and Special
Populations—CC, 2nd, Cozumel 2
, Gran Cancún 2
SSS10:
OAS13:Allergy
Allergen
Society
Structure
of South
2—Africa:
CC, 3rd,Aetiology
Gran Cancún
of 2
Allergy - Can Africa Help Provide the Answer?—CC,
2nd, Isla Mujeres
SSS10: Allergy Society of South Africa: Aetiology of
Allergy - Can Africa Help Provide the Answer?—CC,
2nd, Isla Mujeres
ancún 3
SY21:
OAS14:
TheAnaphylaxis
Innate and —
Adaptive
CC, 3rd,Immune
Gran Cancún
Systems
3
—CC, 2nd, Tulum
SY21: The Innate and Adaptive Immune Systems
—CC, 2nd, Tulum
—CC, 3rd,
SY22:
OAS15:
NewGlobal
Concepts
Asthma
about
Epidemiology
Occupational
—Asthma
CC, 3rd,
—CC,
Gran Cancún
2nd, Xcaret
4
SY22: New Concepts about Occupational Asthma
—CC, 2nd, Xcaret
, 3rd, Gran
SSS11:
OAS16:KAAACI:
Hereditary
Severe
Angioedema
Asthma——
CC,CC,1st,3rd,Costa
Gran
Maya
Cancún
15
SSS11: KAAACI: Severe Asthma—CC, 1st, Costa
Maya 1
d, Cozumel 2
YiR
OAS17:
2: Rhinosinusitis
Immunomodulators
—CC, 1st,—
Costa
CC, 2nd,
MayaCozumel
2
2
YiR 2: Rhinosinusitis—CC, 1st, Costa Maya 2
hma—CC,
SY23:
OAS18:
WAOInhaled
JuniorCorticosteroids
Members Group
for—Asthma
CC, 1st,—
Bacalar
CC,
2nd, Isla Mujeres
SY23: WAO Junior Members Group—CC, 1st, Bacalar
mation—CC,
WS11:
OAS19:Betalactams
MechanismsReactions
of Allergic
—Inflammation
FAGCB, Ground,—CC,
Coral
2nd, Gallery
Tulum 1
WS11: Betalactams Reactions—FAGCB, Ground,
Coral Gallery 1
—CC, 2nd,
WS12:
OAS20:Chronic
Patho-Biology
Cough—ofFAGCB,
NasalGround,
Polyps—
Coral
CC, 2nd,
Gallery
Xcaret 2
WS12: Chronic Cough—FAGCB, Ground, Coral
Gallery 2
st, Costa
WS13:
OAS21:Severe
Respiratory
Cutaneous
Infections
Drug Reactions
—CC, 1st,—
Costa
FAGCB,
Ground,
Maya 1 Coral Gallery 3
WS13: Severe Cutaneous Drug Reactions—FAGCB,
t, Costa Maya 2
WS14:
OAS 22:
Advances
RhinitisinTreatment
the Diagnosis
1—CC,
and1st,
Management
Costa Maya 2
of Ocular Allergy—FAGCB, Lobby, Coral Island
WS14: Advances in the Diagnosis and Management
of Ocular Allergy—FAGCB, Lobby, Coral Island
—CC, Ground,
WS15:
OAS23:Contact
Sublingual
Dermatitis
Immunotherapy
in Children—
2—FAGCB,
CC, Ground,
Lobby,
Auditorium
Coral Sea
WS15: Contact Dermatitis in Children—FAGCB,
Lobby, Coral Sea
WS16: Obstructive Sleep Disorders in Breathing in
Childhood—FAGCB, 1st, Coral Kingdom 1
WS16: Obstructive Sleep Disorders in Breathing in
Childhood—FAGCB, 1st, Coral Kingdom 1
WS17: The Use of Forms and Templates in Office
Practice—FAGCB, 1st, Coral Kingdom 2
WS17: The Use of Forms and Templates in Office
Practice—FAGCB, 1st, Coral Kingdom 2
WS18: UTP - University of South Florida: Hands-On
Session: Rhinolaryngoscopy (Session #2)—FAGCB, 1st,
Coral Kingdom 3
WS18: UTP - University of South Florida: Hands-On
Session: Rhinolaryngoscopy (Session #2)—FAGCB, 1st,
Coral Kingdom 3
WS19: Controversies Surrounding Long-Acting
Beta Agonists (LABAs) in Asthma—FAGCB, 1st, Coral
Garden 1
WS19: Controversies Surrounding Long-Acting
Beta Agonists (LABAs) in Asthma—FAGCB, 1st, Coral
Garden 1
WS20: Decreasing the Prevalence of Allergic Diseases
and Asthma—FAGCB, 1st, Coral Garden 2
WS20: Decreasing the Prevalence of Allergic Diseases
and Asthma—FAGCB, 1st, Coral Garden 2
WS21: Diagnostic Procedures for Rhinitis—FAGCB,
1st, Coral Garden 3
WS21: Diagnostic Procedures for Rhinitis—FAGCB,
1st, Coral Garden 3
31
Final Program
Program-at-a-Glance
WEDNESDAY, 7 DECEMBER 2011
7:00
7:15
7:30
7:45
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13
Registration
Exhibition
BS23: Topical Treatments of Atopic
Dermatitis—FAGCB, Ground, Coral Gallery 1
PS8: Environment and Allergy—CC, 3rd, Gran Cancún
Coffee Break
YiR 3: Asthma—CC, 3rd, Gran Cancún 1
Poster Group 3—CC, 1st, Poster Hall
BS24: Clinical and Laboratory Diagnosis
of Autoimmune Diseases—FAGCB, Ground,
Coral Gallery 2
SY24: Why are Small Airways Important in Asthma?
BS25: Milk Induced Disorders—FAGCB,
SY25: WAO Anaphylaxis Guidelines—CC, 3rd, Gran
Cancún 3
BS26: Gastrointestinal (GI) Complaints in
Food Allergy—FAGCB, Lobby, Coral Island
SY26: Vitamin D: How Important in Allergic Diseases?
BS27: SSS - Danish Society: Basophil
Activation as a Measure of Allergic Response
—FAGCB, Lobby, Coral Sea
SSS12: Southern European Allergy Societies (SEAS):
Immunotherapy—CC, 3rd, Gran Cancún 5
BS28: Genes, Allergens and Asthma—
PS9: Obesity and Asthma—CC, 2nd, Cozumel
SY27: 2013 EAACI-WAO WAAC - Milan, Italy: Novel
and Emerging Therapeutic Strategies for Allergy and
Asthma—CC, 2nd, Cozumel 1
PSym4: Immunotherapy—CC, 1st, Bac
BS29: How to Publish a Scientific Paper
CPS 5: NHLBI Clinical Research Network’s New
Findings on the Stepwise Approach to Managing
Asthma—CC, 2nd, Cozumel 2
OAS24: Atopic Dermatitis 2—CC, 3rd, G
BS30: Otitis Media—FAGCB, 1st, Coral
Kingdom 3
SSS13: Venezuelan Society : Genetic and Epigenetic
Implications in Allergic and Asthmatic Latin Americans
—CC, 2nd, Isla Mujeres
OAS25: Childhood Asthma and Allergie
Gran Cancún 2
BS31: Choosing a Career Path in Allergy and
Immunology—FAGCB, 1st, Coral Garden 1
CPS6: Insights from the Global Allergy and Asthma
Network (GA²LEN)—CC, 2nd, Xcaret
OAS26: Cytokines and Chemokines—C
Cancún 3
BS32: Cold Induced Skin Disorders—
DB8: Genetically Modified Foods:
Are They a Problem?—CC, 1st,
Costa Maya 1
OAS27: Drug Allergy—CC, 3rd, Gran Ca
SY28: Immunobiologic Approaches in Allergy—CC,
1st, Costa Maya 2
OAS28: Food Allergy—CC, 3rd, Gran Ca
DB9: Long-Acting Beta Agonists
(LABAs) vs. Tiotropium for Asthma
—CC, Ground, Auditorium
OAS29: Hymenoptera Allergy—CC, 2n
BS33: Complementary and Alternative
Medicine: Does it Work?—FAGCB, 1st, Coral
Garden 3
PS10: New Concepts in Mast Cell Mediators—CC,
1st, Costa Maya
OAS30: Immunobiology of Allergens—
Isla Mujeres
OAS31: Mechanisms of Asthma and Al
Inflammation—CC, 2nd, Tulum
OAS32: Primary Immunodeficiency—
OAS33: Rhinitis Treatment 2—CC, 1st,
OAS34: Allergen Immunotherapy 2—
Costa Maya 2
THURSDAY, 8 DECEMBER 2011
7:00
7:15
7:30
7:45
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
Registration
NH6: Advances in Food Allergy: Session 1—CC, 3rd,
Gran Cancún
Coffee
Break
NH6: Advances in Food Allergy: Session 2—CC, 3rd,
Gran Cancún
NH7: Asthma in Children: Risk Factors—CC, 2nd,
Cozumel
NH7: Asthma in Children: Treatment—CC, 2nd,
Cozumel
NH8: Is Your Patient Immunodeficient (ID)?: Session 1
—CC, 1st, Costa Maya
NH8: Is Your Patient Immunodeficient (ID)?: Session 2
—CC, 1st, Costa Maya
32
Final Program
13:45
Program-at-a-Glance
WEDNESDAY, 7 DECEMBER 2011
14:00
14:15
14:30
12:15
14:45
12:30
15:00
12:45
15:15
13:00
15:30
13:15
15:45
13:30
16:00
13:45
16:15
14:00
16:30
14:15
16:45
14:30
17:00
14:45
17:15
15:00
17:30
15:15
17:45
15:30
18:00
15:45
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
Registration
Exhibition
Coffee Break
Allergy
Do Cats and Dogs Feed
Poster Group 3UTP
—CC,3:1st,
PosterPrevention:
Hall
Infants Microbes?—CC, 3rd, Gran Cancún 1
Coffee Break
UTP 3: Allergy Prevention: Do Cats and Dogs Feed
Infants Microbes?—CC, 3rd, Gran Cancún 1
All-Congress Event (19:00-23:00)
—Tickets are required for entrance.
Iberostar Cancún, Blvd Kukulcan Km 17, Cancún
DB10: Are Basophils Important in
Allergy?—CC, 3rd, Gran Cancún 2
DB10: Are Basophils Important in
Allergy?—CC, 3rd, Gran Cancún 2
SSS14: CMICA: Genetics and Immune Responses—
SSS14: CMICA: Genetics and Immune Responses—
SY29: Primary Immune Deficiencies: Rapid Diagnosis
and Referral—CC, 3rd, Gran Cancún 4
SY29: Primary Immune Deficiencies: Rapid Diagnosis
and Referral—CC, 3rd, Gran Cancún 4
SY30: Allergy, Asthma and the Athlete—CC, 3rd,
Gran Cancún 5
SY30: Allergy, Asthma and the Athlete—CC, 3rd,
Gran Cancún 5
calar
SY31: Hymenoptera
Allergy:
Ants1st,and
Flying Insects
PSym4:
Immunotherapy
—CC,
Bacalar
SY31: Hymenoptera Allergy: Ants and Flying Insects
Gran Cancún 1
DB11: Are
We Ready
for Oral
OAS24:
Atopic
Dermatitis
2—CC, 3rd, Gran Cancún 1
Immunotherapy for Food Allergy?
DB11: Are We Ready for Oral
Immunotherapy for Food Allergy?
es—CC, 3rd,
SSS15: IPCRG:
Rhinitis
and Asthma
in Primary
OAS25:
Childhood
Asthma
and Allergies
—CC,Care
3rd,
—CC,Cancún
2nd, Xcaret
Gran
2
SSS15: IPCRG: Rhinitis and Asthma in Primary Care
—CC, 2nd, Xcaret
CC, 3rd, Gran
YiR 4: COPD
—CC, 1st,
Maya 1—CC, 3rd, Gran
OAS26:
Cytokines
andCosta
Chemokines
Cancún 3
YiR 4: COPD—CC, 1st, Costa Maya 1
ancún 4
SSS16: Argentine
Association:
OAS27:
Drug Allergy
—CC, 3rd,Eosinophilic
Gran CancúnRelated
4
Conditions—CC, 1st, Costa Maya 2
SSS16: Argentine Association: Eosinophilic Related
Conditions—CC, 1st, Costa Maya 2
ancún 5
WS22: Immunotherapy
OAS28:
Food Allergy—for
CC, the
3rd,Polysensitized
Gran Cancún 5Patient:
Balancing the Evidence with Experience—FAGCB,
WS22: Immunotherapy for the Polysensitized Patient:
Balancing the Evidence with Experience—FAGCB,
nd, Cozumel 2
WS23: Austrian
Society:Allergy
Novel—
Laboratory
Tests for2
OAS29:
Hymenoptera
CC, 2nd, Cozumel
Allergic Diseases—FAGCB, Ground, Coral Gallery 2
WS23: Austrian Society: Novel Laboratory Tests for
Allergic Diseases—FAGCB, Ground, Coral Gallery 2
—CC, 2nd,
WS24: UTP
- Cleveland Clinic:
An Evidence
OAS30:
Immunobiology
of Allergens
—CC,Based
2nd,
Approach
Isla
Mujeresto Diagnosis and Management of Urticaria
and Angioedema—FAGCB, Ground, Coral Gallery 3
WS24: UTP - Cleveland Clinic: An Evidence Based
Approach to Diagnosis and Management of Urticaria
and Angioedema—FAGCB, Ground, Coral Gallery 3
WS25: Drug
Allergy Testing
and Desensitization
OAS31:
Mechanisms
of Asthma
and Allergic —
FAGCB, Lobby,—
Coral
Inflammation
CC,Sea
2nd, Tulum
WS25: Drug Allergy Testing and Desensitization—
—CC, 2nd, Xcaret
WS26: Obesity
Asthma: Implications
Asthma
OAS32:
Primaryand
Immunodeficiency
—CC,for2nd,
Xcaret
Control and Treatment—FAGCB, 1st, Coral Kingdom 1
WS26: Obesity and Asthma: Implications for Asthma
Control and Treatment—FAGCB, 1st, Coral Kingdom 1
, Costa Maya 1
WS27: Update
Smoking 2Cessation
—Costa
FAGCB,
1st,1
OAS33:
RhinitisonTreatment
—CC, 1st,
Maya
Coral Kingdom 2
WS27: Update on Smoking Cessation—FAGCB, 1st,
Coral Kingdom 2
WS28: Allergic
and Its Impact
OAS34:
AllergenRhinitis
Immunotherapy
2—onCC,Asthma
1st,
(ARIA)Maya
—FAGCB,
Costa
2 1st, Coral Kingdom 3
WS28: Allergic Rhinitis and Its Impact on Asthma
(ARIA)—FAGCB, 1st, Coral Kingdom 3
WS29: Adherence to Treatment: How Can It Be
Improved?—FAGCB, 1st, Coral Garden 1
WS29: Adherence to Treatment: How Can It Be
Improved?—FAGCB, 1st, Coral Garden 1
WS30: Hands-On Demonstration: Bronchial
Provocation Challenges—FAGCB, 1st, Coral Garden 2
WS30: Hands-On Demonstration: Bronchial
Provocation Challenges—FAGCB, 1st, Coral Garden 2
WS31: Non-Allergic Rhinitis— FAGCB, 1st, Coral
Garden 3
WS31: Non-Allergic Rhinitis— FAGCB, 1st, Coral
Garden 3
llergic
—CC, 1st,
SESSION AND
PROPERTY KEY
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
PROPERTIES
CC
Cancún Center
FAGCB
Fiesta Americana
Grand Coral Beach
Hotel
33
Final Program
World Allergy Organization Journal
TM
Official publication of the World Allergy Organization
A Global Exchange of Scientific and Clinical
Knowledge in Allergy, Asthma and Clinical Immunology
Allergic disease is a growing public health issue in
the world today, compounded by environmental
and socio-economic problems and medical
management. The World Allergy Organization
Journal (WAO Journal)—the official publication of the
World Allergy Organization, the only global umbrella
organization for national and regional allergology
and clinical immunology societies—provides a
dynamic platform for the exchange of ideas and
knowledge among researchers and practitioners
from different regions of the world.
Visit WAOJournal.org and…
4 Examine new information that extends your
understanding of pathogenesis and disease
function
4 Learn new approaches for evaluation of disease
and outcomes concerning treatments and
interventions
4 Publish clinical reviews and editorials on basic
and clinical translational science in allergy and
clinical immunology
4 Sign up for eAlerts and receive the linked table of
contents as soon as a new issue is posted
Encompassing both translational research and
clinical issues, the WAO Journal is dedicated to
providing quality, up-to-date science to its readers,
and a quick production schedule and worldwide
recognition for its contributors.
Free access for members of current WAO Member
Societies: Go to WorldAllergy.org. Click “Members
Only” then “WAO Journal”
Not a WAO member? Visit us at WAOJournal.org
EDITOR-IN-CHIEF
Lanny J. Rosenwasser, MD
Dee Lyons/Missouri Endowed Chair in Pediatric Immunology Research
Professor of Pediatrics, Allergy-Immunology Division
Children’s Mercy Hospital
Professor of Pediatrics, Medicine and Basic Science
University of Missouri-Kansas City School of Medicine
Monthly ISSN: 1939-4551
Chief Editor Podcasts
Listen in as Lanny J.
Rosenwasser, Editor-in-Chief,
interviews authors of key
articles on the science and
practice of allergy and clinical
immunology.
NEW!
Visit WAOJournal.org.
WAOJournal.org
08:00 - 12:00 ALLIED HEALTH 1
FAGCB, GROUND, CORAL GALLERY 1&2
1st World Allergy Organization Allied Health Session
Asthma: Diagnosis, Management and Education
Chairperson: 08:00 - 08:10
08:10 - 08:30 08:30 - 08:50 08:50 - 09:10 09:10 - 09:30 09:30 - 09:50 09:50 - 10:20 10:20 - 10:40 10:40 - 11:00 11:00 - 11:20 11:20 - 11:40 Jeanette Arnold (United States)
Welcoming Remarks | Thomas B. Casale (United States) and Richard F. Lockey (United States)
1-3AH Eosiniphilic Esophagitis | Jonathan Spergel (United States)
1-4AH Guideline-Driven Care | Louis-Philippe Boulet (Canada)
1-5AH Prevention | Erkka Valovirta (Finland)
1-6AH New Paradigms | Jeanette Arnold (United States)
Discussion
Coffee Break
1-7AH Unrecognized Co-morbidity | Phillip E. Korenblat (United States)
1-8AH Exacerbations | Ronald Dahl (Denmark)
1-9AH Asthma Care: Education and Adherence | Maureen George (United States)
Discussion
SESSION AND
PROPERTY KEY
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
PROPERTIES
CC
Cancún Center
FAGCB
Fiesta Americana
Grand Coral Beach
Hotel
Fighting
the cause
of allergy
ALK is the world leader in specific
immunotherapy (SIT). Our mission is
to improve quality of life by preventing
and curing allergy.
During the New Horizon Session on
Specific Immunotherapy (SIT) on
4 December, the WAO Henning
Løwenstein Research Award will be
presented to a scientist, for excellence
shown within the field of allergy.
35
Final Program
Saturday, 3 December 2011
Scientific Program — Saturday, 3 December 2011
L
O
G SC H O
RA
INI
N
W
OR
LD A L L
Y
G
ER
The Emerging Societies Program
is co-hosted by
the World Allergy Organization
and the American College of Allergy, Asthma
T
and Immunology:
The Emerging Societies Program (ESP) is an outreach initiative to WAO’s Member Societies and to emerging societies in various regions to
promote education in allergy and to assist societies in the promotion and development of the specialty of allergy and asthma. The initiative
enables the ESP’s leadership to learn more about the challenges faced in countries where the specialty of allergy and asthma is either nonexistent, or is developing, and how best to assist these efforts.
The main objective of the World Allergy Training School (WATS) is to develop learning communities, which will help build a sustainable
capacity in the field of allergy by strengthening already existing knowledge and skills. WATS also strives to encourage local experts to apply
this knowledge to further develop the specialty of allergy and to widen the provision of patient care. The World Allergy Training School is for
physicians /general practitioner /researchers with a general background in allergy and immunology.
The WAC 2011 – World Allergy Training School is sponsored by:
WAO-1011-584
08:00 - 12:30 ALLIED HEALTH 2
FAGCB, GROUND, CORAL GALLERY 1&2
1st World Allergy Organization Allied Health Session
Allergic Disorders: Snapshots of a Worldly View
Chairperson: 08:00 - 08:10 08:10 - 08:30 08:30 - 08:50 08:50 - 09:10 09:10 - 09:30 09:30 - 09:50 09:50 - 10:20 10:20 - 10:40 10:40 - 11:00 11:00 - 11:20 11:20 - 11:40 11:40 - 12:00 12:00 - 12:30 Maureen George (United States)
Welcoming Remarks
2-1AH Drug Reactions | Barbara Daubner (Switzerland)
2-2AH Rhinosinusitis | Jeanette Arnold (United States)
2-3AH Urticaria and Angioedema | Mario Sánchez-Borges (Venezuela)
2-4AH Atopic Dermatitis | Mark Glaum (United States)
Discussion
Coffee Break
2-5AH Anaphylaxis | Johannes Ring (Germany)
2-6AH Sublingual Immunotherapy | Moises Calderon (United Kingdom)
2-7AH Food Allergy | Hugh Sampson (United States)
2-8AH Asthma Treatment | Peter Creticos (United States)
2-9AH Conclusions | Maureen George (United States)
Discussion
12:30 - 14:00 POSTER SYMPOSIUM 1
FAGCB, GROUND, CORAL GALLERY 3
Allied Health
Chairpersons: 12:30 - 13:15 1000
Birthe Dahl (Denmark)
Connie Katelaris (Australia)
Dennis Ledford (United States)
Poster Viewing
Reduction In Allergic Rhinitis Index by Decreasing Aero-Allergens and Malodor Causing
Volatile Organic Compounds by Luna Air Purifiers Using Photo-Catalytic Oxidation (PCO)
Technology
Ghosh, N. 1, Aguaiza, C. 2, Guzman, A. 2, Chudasama, J. 3, Bennert, J. 4 and Das, A. B. 5
1
Life, Earth and Environmental Sciences, West Texas A&M University, Canyon, TX. 2Life, Earth &
Environmental Sciences, West Texas A&M University, Canyon, TX. 3Research and Development, LUNA US
LLC , Las Vegas, NV. 4Research & Development, Air Oasis, Amarillo, TX. 5Dept. of Agricultural Biotechnology,
College of Agriculture, Orissa University of Agriculture & Technology, Bhubaneswar, India.
1001
The Missing Link!! Specialist Nurse-Led Education for Parents of Children with Atopic
Eczema
Thompson, D.
Allergy and Dermatology Outpatients, Children’s Youth and Women’s Health Service, North Adelaide,
Australia.
1002
Sublingual Immunotherapy for Grass Pollen Allergy In Children: A Systematic Review
and Meta-Analysis
Bryson, R.
Women and Childrens Services, Wirral University Teaching Hospital Arrowe Park, Merseyside, United
Kingdom; Faculty of Medicine University of Southampton, MSc Allergy, Southampton, United Kingdom.
1003
Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1)
and Triglycerides in Obese Adolescents with Hypertriglyceridemia
Mendez Berreondo, N.
3204, Distrito Federal, México.
1004
A Pilot Study of Caregiver’s Recall of Their Child’s Skin Test Results and Environmental
Remediation Education
Townsend, K. 1, Corry, J. 2, Quigley, B. 3 and George, M. 4
1
University of Pennslyvania School of Nursing, Philadelphia, PA. 2Allergy and Immunology, Children’s
Hospital of Philadelphia, Philadelphia, PA. 3Family and Community Health, University of Pennslyvania
School of Nursing, Philadelphia, PA. 4Family and Community Health, University of Pennsylvania School of
Nursing, Philadelphia, PA.
37
Final Program
Sunday, 4 December 2011
Scientific Program — Sunday, 4 December 2011
1005
Evaluation and Comparison of Lung Function by Plethysmography In Adolescents with
Morbid Obesity, Not Morbid Obesity and Healthy Eutrophic Children
Hernandez-Mondragon, L. O. 1, del Rio, B. 2, Pietropaolo-Cienfuegos, D. 2, del Rio, J. 2 and Rosas-Vargas, M. A. 2
1
Pediatric Allergy and Clinical Immunology , Hospital Infantil Federico Gomez, México City, México. 2Pediatric
Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México.
1006
Delivering An Educational Model for Allergy Immunotherapy
1007
Selecting Primal Therapy Appropriate for the Type of Pollinosis – TOPIC-J Study
1008
Olfactory Disfunctions in Patients with Chronic Rhinosinusitis
1009
Perceptions of Caregivers of Patients with Cow’s Milk Allergy Regarding the Treatment
1010
Incidence of Systemic Reactions (SRs) to Prick (P) and Intradermal (ID) Tests, Response
to Immediate (“Stat”) Epinephrine IM (epi IM) Dose Vs. BMI, Number of Delayed SRs, and
WAO Systemic Reaction Grade
Murphy, C. , Yoon, S. , Meg, A. , Hoff, S. , Sloane, D. , Rebecca, B. , Cieri, S. and Goldstein, R.
Pulmonary/Allergy, New England VA Healthcare System, West Roxbury, MA.
Okubo, K. and Gotoh, M.
Department of Otolaryngology, Nippon Medical School, Tokyo, Japan.
Sánchez Vallecillo, M. V. 1,2, Fraire, M. E. 3, Baena-Cagnani, C. E. 4,5 and Zernotti, M. 6
1
Otorrinolaringología, Sanatorio Allende, Córdoba, Argentina. 2Research Centre of Respiratory Medicine Faculty of Medicine, Catholic University of Cordoba, Córdoba, Argentina. 3Otorrinolaringología, Sanatorio
Allende, Córdoba. Argentina, Córdoba, Argentina. 4LIBRA Foundation, Cordoba, Argentina. 5CIMER (Centro
de Investigación en Medicina Respiratoria). Faculty of Medicine. Catholic University of Cordoba. Fundación
LIBRA Argentina , Cordoba, Argentina. 6Otorrinolaringologia, Sanatorio Allende, Córdoba. Argentina,
Córdoba, Argentina.
Yonamine, G. H. 1, Contim, D. 2, Castro, A. P. B. M. 3, Jacob, C. M. A. 4 and Pastorino, A. C. 3
1
Division of Nutrition, Instituto da Criança - Faculdade de Medicina do Hospital das Clínicas da
Universidade de São Paulo, São Paulo, Brazil. 2Universidade Federal do Triângulo Mineiro, Uberaba, Brazil.
3
Department of Pediatrics, Instituto da Criança - Faculdade de Medicina do Hospital das Clínicas da
Universidade de São Paulo, São Paulo, Brazil. 4Instituto da Criança - Faculdade de Medicina do Hospital das
Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Shearer, D. 1, Lockey, R. F. 2, Fox, R. 2, Ledford, D. 2 and Glaum, M. 2
1
Division of Allergy & Immunology, University of South Florida, Tampa, FL. 2Division of Allergy &
Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL.
1011
The “Allergy Blog” and Laypersons Questions: An Interactive Educational Experience
1012
Anaphylaxis After Anesthetic Reversal
1013
Establishment of Reference Values for Differential Cell Counts in Nasal Lavage of Healthy
Young Adults
Rios, J. L. 1, Emerson, F. 1, Pereira, N. 2,3 and Duque, M. 1
1
Allergy, Policlinica Geral do Rio de Janeiro , Rio de Janeiro, Brazil. 2Policlinica Geral do Rio de Janeiro, Rio
de Janeiro, Brazil. 3Faculdade de Medicina de Petrópolis, Petrópolis, Brazil.
Chugo, S.
Allergy , MIR, Navarra , Spain.
Xie, Y. 1, Xie, J. 1, Huang, R. 2, Lai, K. 1, Zhong, N. 3 and Li, J. 4
1
State Key Laboratory of Respiratory Diseases Guangzhou, Guangzhou Institute of Respiratory Disease, The
First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China. 2Guangzhou Medical College,
Guangzhou, China. 3State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou
Medical College, Guangzhou, China. 4State Key Laboratory of Respiratory Disease, The First Affiliated
Hospital, Guangzhou Medical College., Guangzhou, China.
Enhance your Learning Experience!
Use the number to the left-side of the talk title or abstract to view,
download or print materials at Handout Kiosks, located in the CC or FAGCB. Example: 1-5NH or 2001
38
Final Program
08:00 – 16:30 NEW HORIZON SESSION 1
CC, 3RD, GRAN CANCÚN
Specific Immunotherapy (SIT)
08:00 - 09:30 History, Mechanisms and Future
Chairpersons: Richard F. Lockey (United States)
Dermot Ryan (United Kingdom, Scotland)
08:00 - 08:10 Welcoming Remarks
08:10 - 08:30 1-1NH History of SIT | Richard Weber (United States)
08:30 - 08:50 1-2NH Mechanisms of Sub-Cutaneous Immunotherapy (SCIT) | Stephen Durham (United Kingdom)
08:50 - 09:10 1-3NH Mechanisms of Sub-Lingual Immunotherapy (SLIT) | Jean-Pierre Allam (Germany)
09:10 - 09:30 1-4NH Newer Forms of SIT | Rudolf Valenta (Austria)
09:30 – 10:00
Coffee Break
10:00 - 11:45 Chairpersons: 10:00 - 10:05 10:05 - 10:30 1-5NH 10:30 - 10:55 1-6NH 10:55 - 11:20 1-7NH 11:20 - 11:35 1-8NH Which Patients for SIT and Anti-IgE?
Richard F. Lockey (United States)
Barbara Rogala (Poland)
Welcoming Remarks
For SCIT? | Harold Nelson (United States)
For SLIT? | G. Walter Canonica (Italy)
For Anti-IgE? | Daniel Jackson (United States)
Presentation of the WAO Henning Løwenstein Research Award to Zoulfia Allakhverdi
(Canada) and Natalija Novak (Germany) | Richard F. Lockey (United States)
and Henning Løwenstein (Denmark)
11:35 - 11:45 Discussion
11:45 – 13:00 BREAK
13:00 - 14:30 Effectiveness of SIT
Chairpersons: Anthony Frew (United Kingdom)
Eliana Risquez (Venezuela)
Carlo Tomino (Italy)
13:05 - 13:30 1-9NH SLIT | Giovanni Passalacqua (Italy)
13:30 - 13:55 1-10NH SIT and Children | Erkka Valovirta (Finland)
13:55 - 14:20 1-11NH SIT and Asthma | Moises Calderon (United Kingdom)
14:30 – 15:00
Coffee Break
15:00 - 16:30 Practical Considerations for SIT
Chairpersons: John Kelso (United States)
Désirée Larenas Linnemann (México)
15:05 - 15:30 1-12NH When Should SIT be Started and Why? | Lars Jacobsen (Denmark)
15:30 - 15:55 1-13NH Adverse Effects | Linda Cox (United States)
15:55 - 16:20 1-14NH Cost Effectiveness and Compliance | Cheryl Hankin (United States)
The New Horizon on Specific Immunotherapy is co-sponsored by:
39
Final Program
CC, 2ND, COZUMEL
Skin Diseases
08:00 - 09:30 Chairpersons: 08:00 - 08:05 08:05 - 08:25 2-1NH 08:25 - 08:45 08:45 - 09:05 09:05 - 09:25 09:25 - 09:30 Session 1
Marcus Maurer (Germany)
María Isabel Rojo Gutiérrez (México)
Welcoming Remarks
Allergic Skin Disease: Immunologic Consequences of Playing Host to Pathogenic
Microbes | Mark Boguniewicz (United States)
2-2NH Itch: The Primary “Lesion” in Eczema | Johannes Ring (Germany)
2-3NH Urticaria and Angioedema | Torsten Zuberbier (Germany)
2-4NH Cutaneous Vasculitis | Roger Fox (United States)
Discussion
09:30 – 10:00
Coffee Break
10:00 - 11:30 Session 2
Chairpersons: David Fitzhugh (United States)
Allen P. Kaplan (United States)
10:05 - 10:25 2-5NH Hereditary Angioedema (HAE) | Bruce Zuraw (United States)
10:25 - 10:45 2-6NH Atopic Dermatitis | Peter Schmid-Grendelmeier (Switzerland)
10:45 - 11:05 2-7NH Contact Dermatitis | Luz Fonacier (United States)
11:05 - 11:25 2-8NH Anti-IgE Therapy in Allergic Skin Diseases | Marcus Maurer (Germany)
The New Horizon Session on Skin Diseases is co-sponsored by:
CC, 1ST, COSTA MAYA
Novel Scientific Approaches in Allergic and Respiratory Diseases
08:00 - 09:30 Chairpersons: 08:00 - 08:05 08:05 - 08:30 3-1NH 08:30 - 08:55 3-2NH 08:55 - 09:20 3-3NH Session 1
Peter Creticos (United States)
Hae-Sim Park (South Korea)
Welcoming Remarks
Unique Immunotherapy Approaches | Enrique Fernández-Caldas (Spain, United States)
Nanomedicine: Introduction and Overview | James Baker (United States)
Genetics and Genomics Overview: Beyond Genome-Wide Association Studies (GWAS) |
Deborah Meyers (United States)
09:30 – 10:00
Coffee Break
10:00 - 11:30 Session 2
Chairpersons: Kari Nadeau (United States)
Susan L. Prescott (Australia)
10:05 - 10:30 3-4NH Systems Biology Applications for Allergy and Asthma | Lanny Rosenwasser (United States)
10:30 - 10:55 3-5NH Nanomedicine Applications for Allergy and Vaccines | Shyam Mohapatra (United States)
10:55 - 11:20 3-6NH Genetics and Genomics for Severe Asthma and COPD | Stephen P. Peters (United States)
40
Final Program
11:30 – 13:00 BREAK
CC, 2ND, COZUMEL
Drug Allergy
13:00 – 14:30
Chairpersons: 13:00 - 13:05 13:05 - 13:30 4-1NH 13:30 - 13:55 4-2NH 13:55 - 14:20 4-3NH New Insights in Drug Hypersensitivity
Luis Felipe Chiaverini Ensina (Brazil)
Nelson Rosário (Brazil)
Welcoming Remarks
Immunogenetics of Severe Drug Hypersensitivity | Daniel Yerly (Switzerland)
Virus Infections and Drug Hypersensitivity | Barbara Daubner (Switzerland)
In-Vitro Diagnosis of Drug Allergy: Current Status and Perspectives |
Thomas Fleisher (United States)
14:30 – 15:00
Coffee Break
15:00 - 16:30 Management of Drug Hypersensitivity
Chairperson: Roger Fox (United States)
15:05 - 15:30 4-4NH Beta-Lactam Allergy Diagnosis and Management | Louis Mendelson (United States)
15:30 - 15:55 4-5NH Intra-Operative Reactions | Pascal Demoly (France)
15:55 - 16:20 4-6NH Adverse Reactions to Biologics | Thomas Platts-Mills (United States)
13:00 16:30 NEW HORIZON SESSION 5
CC, 1ST, COSTA MAYA
Asthma and Co-Morbid Conditions
13:00 – 14:30
Session 1
Chairpersons: Alejandra Macías-Weinmann (México)
Mario Zernotti (Argentina)
13:05 - 13:30 5-1NH Overview of Co-Morbid Conditions | Richard F. Lockey (United States)
13:30 - 13:55 5-2NH Polyposis | Marek L Kowalski (Poland)
13:55 - 14:20 5-3NH Rhinosinusitis | Ruby Pawankar (Japan)
14:30 – 15:00
Coffee Break
15:00 - 16:30 Chairpersons: 15:00 - 15:05 15:05 - 15:30 5-4NH 15:30 - 15:55 5-5NH Session 2
Marek L Kowalski (Poland)
Richard Martin (United States)
Welcoming Remarks
Vitamin D, Obesity and Asthma | Juan Carlos Celedon (United States)
Gastroesophageal Reflux Disease (GERD) or Laryngopharyngeal Reflux |
15:55 - 16:20 5-6NH Vocal Cord Dysfunction | Mario Zernotti (Argentina)
41
Final Program
What if you could
reduce the risk of infant
allergies by 50%?1
?
Ask about our scientifically proven solutions for
allergy prevention and management at our stand!
Information for the medical profession only.
1. Szajewska H, Horvath A. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin. 2010;26(2):423-37.
Ticket required to attend Breakfast Symposia
Fee: $20 USD (includes continental breakfast)
07:00 - 08:15 BREAKFAST SYMPOSIUM 1
Food Allergy and Anaphylaxis
Speakers: 1-1BS 1-2BS Ticket required to attend
A. Wesley Burks (United States)
Alessandro Fiocchi (Italy)
Clinical Process to Properly Prescribe Immunotherapy
Désirée Larenas Linnemann (México)
Noel Rodríguez-Perez (México)
Neonatal Infant Interventions to Prevent Asthma and Allergic Disease
Speakers: 3-1BS
3-2BS Ticket required to attend
Susan L. Prescott (Australia)
Hugo P. Van Bever Sr. (Singapore)
FAGCB, LOBBY, CORAL ISLAND
Biology of Aeroallergens in Latin America
Luis Caraballo (Colombia)
Alfonso Cepeda (Colombia)
FAGCB, LOBBY, CORAL SEA
Management of COPD
Nicola Hanania (United States)
Marc Peters-Golden (United States)
FAGCB, 1ST, CORAL KINGDOM 1
Sister Society Session – Kuwait Society of Allergy and Clinical Immunology
Omalizumab (Anti-IgE) for Asthma Speakers: 6-1BS 6-2BS Ticket required to attend
Mona Al-Ahmad (Kuwait)
Michael S. Blaiss (United States)
43
Final Program
Monday, 5 December 2011
Scientific Program — Monday, 5 December 2011
Flushing Syndromes
Speakers:
7-1BS 7-2BS Ticket required to attend
Cem Akin (United States)
What to Do with a Patient that Cannot Smell?
Speakers:
Mark Dykewicz (United States)
Joaquim Mullol (Spain)
FAGCB, 1ST, CORAL GARDEN 1
Case Discussion on Patients with Possible Immune Deficiencies
Speakers:
Mark Ballow (United States)
John Sleasman (United States)
Differential Diagnosis of Headaches, Including Temporomandibular Joint
Disorder (TMJ)
Speakers:
Roger Fox (United States)
Lyndon Mansfield (United States)
Inflammasomes and Allergic Diseases
Speakers:
Hal Hoffman (United States)
Shyam Mohapatra (United States)
08:30 - 10:00 PLENARY SESSION 1 CC, 3RD, GRAN CANCÚN
Asthma: From Genetics to Treatment
Chairpersons: Alberto Escalante Domínguez (México)
James Kiley (United States)
08:35 - 09:00 1-1PS Identification of Novel Genes | Donata Vercelli (United States)
09:00 - 09:25 1-2PS Subphenotyping Asthma to Uncover Novel Genes | Eugene R. Bleecker (United States)
09:25 - 09:50 1-3PS Personalized Medicine – Is There a Future? | Stephen Liggett (United States)
44
Final Program
08:30 - 10:00 PLENARY SESSION 2 CC, 2ND, COZUMEL
Mastocytosis and Mast Cell Activation Syndromes
Chairpersons: Stephen J. Galli (United States)
Francesca Levi-Schaffer (Israel)
08:35 - 09:00 2-1PS Systemic Mastocytosis | Cem Akin (United States)
09:00 - 09:25 2-2PS Mast Cell Activation Syndromes | Luis Escribano (Spain)
09:25 - 09:50 2-3PS Anaphylaxis in Mastocytosis and Hymenoptera Allergy | Mariana Castells (United States)
08:30 - 10:00 PLENARY SESSION 3
CC, 1ST, COSTA MAYA
Novel Cytokines in Allergic Diseases
Chairpersons: 08:30 - 08:35 08:35 - 09:00 3-1PS Shyam Mohapatra (United States)
Andrew Wardlaw (United Kingdom)
Welcoming Remarks
Asthma Phenotypes Shaped by Innate and Adaptive Immunity |
Dale Umetsu (United States)
09:00 - 09:25 3-2PS IL-33 | Susumu Nakae (Japan)
09:25 - 09:50 3-3PS IL-1 and Inflammasomes | Hal Hoffman (United States)
10:00 – 10:45 COFFEE BREAK
10:45 - 12:15 SISTER SOCIETY SYMPOSIUM 1
Japanese Society of Allergology
Update on Atopic Dermatitis CC, 3RD, GRAN CANCÚN 1
Chairpersons: Mark Boguniewicz (United States)
Michihiro Hide (Japan)
10:50 - 11:10 1-1SSS Altered Skin Barrier Functions | Ichiro Katayama (Japan)
11:10 - 11:30 1-2SSS Role of Dendritic Cells | Natalija Novak (Germany)
11:30 - 11:50 1-3SSS The Role of Food and Egg Allergy | Atsuo Urisu (Japan)
10:45 - 12:15 SYMPOSIUM 1
CC, 3RD, GRAN CANCÚN 2
Risk Factors for Recurrent Early Wheezing in Childhood
Chairpersons: Carlos Nunes (Portugal)
Silvia Sánchez-Garcia (Spain)
10:50 - 11:10 1-1SY Overview | Fernando D. Martinez (United States)
11:10 - 11:30 1-2SY Viral Infections | Robert Lemanske (United States)
11:30 - 11:50 1-3SY Allergens | Dennis Ownby (United States)
45
Final Program
10:45 - 12:15 SYMPOSIUM 2
2012 WAO International Scientific Conference
Superantigens and Severe Airway Disease Chairpersons: Lanny Rosenwasser (United States)
Ashok Shah (India)
10:50 - 11:10 2-1SY New Insights Into Immunologic Mechanisms | Claus Bachert (Belgium)
11:10 - 11:30 2-2SY Upper Airway | Hae-Sim Park (South Korea)
11:30 - 11:50 2-3SY Lower Airway | Phillipe Gevaert (Belgium)
10:45 - 11:45 DEBATE 1
Urticaria: Is There a Role for Sedating Antihistamines and Steroids?
Chairpersons:
Richard Weber (United States)
10:50 - 11:05 1-1DB Yes | Allen P. Kaplan (United States)
11:05 - 11:20 1-2DB No | Torsten Zuberbier (Germany)
11:20 - 11:25 Yes Rebuttal
11:25 - 11:30 No Rebuttal
10:45 - 12:15 COLLABORATING PARTNER SYMPOSIUM 1
American Thoracic Society
Emerging Issues in COPD Chairperson: 10:45 - 10:50 10:50 - 11:10 11:10 - 11:30 11:30 - 11:50 CC , 3RD, GRAN CANCÚN 5
Monica Kraft (United States)
Welcoming Remarks
Biomarkers and COPD Phenotypes | Klaus Rabe (Germany)
The Microbiome in Asthma and COPD | Richard Martin (United States)
COPD as a Systemic Disease and its Impact Upon Co-morbidities |
Monica Kraft (United States)
1-1CPS 1-2CPS 1-3CPS 10:45 - 12:15 SISTER SOCIETY SYMPOSIUM 2
CC, 2ND, COZUMEL 1
American Academy of Allergy, Asthma and Immunology
Eosinophilic Gastrointestinal (GI) Diseases Chairpersons: Mark Ballow (United States)
10:50 - 11:10 2-1SSS Biology of Eosinophils | Bruce Bochner (United States)
11:10 - 11:30 2-2SSS Pathogenesis | Seema Aceves (United States)
11:30 - 11:50 2-3SSS Diagnosis and Management | Jonathan Spergel (United States)
46
Final Program
10:45 - 12:15 COMPANY SPONSORED SYMPOSIUM 1
CC, 2ND, COZUMEL 2
Sanofi-Aventis
Controlling Allergic Rhinitis Chairpersons: 10:45 - 10:50 10:50 - 11:10 1-1CSS 11:10 - 11:30 1-2CSS 11:30 - 11:50 1-3CSS 11:50 - 12:15 José Antonio Sacre Hazouri (México)
Welcoming Remarks
Managing Rhinitis in Day-to-Day Practice: The International Survey on the Management
of Allergic Rhinitis (ISMAR) Registry | Carlos E. Baena-Cagnani (Argentina)
Co-morbidities in Children with Allergic Rhinitis | Eli Meltzer (United States)
Allergic Rhinitis: Evidence Based Medicine | G. Walter Canonica (Italy)
Panel Discussion
10:45 - 12:15 SYMPOSIUM 3
CC, 2ND, ISLA MUJERES
Genetic Susceptibility to Airway Diseases
Chairpersons: 10:45 - 10:50 10:50 - 11:10 3-1SY Stephen P. Peters (United States)
Michael Teng (United States)
Welcoming Remarks
Limitation of Genetic Variants in Asthma Genetics and Advance of Epigenetics |
Choon-Sik Park (South Korea)
11:10 - 11:30 3-2SY Asthma | Donata Vercelli (United States)
11:30 - 11:50 3-3SY COPD | Eugene R. Bleecker (United States)
CC, 2ND, TULUM
Latin American Society of Allergy, Asthma and Immunology
Hot Topics in Latin America Chairpersons: Carlos Báez Loyola (México)
Sandra González-Díaz (México)
10:50 - 11:10 3-1SSS Air Pollution and Respiratory Disease | Juan Carlos Sisul Alvariza (Paraguay)
11:10 - 11:30 3-2SSS Frequent Co-morbid Conditions with Asthma | Nelson Rosario (Brazil)
11:30 - 11:50 3-3SSS Asthma Genotypes to Phenotypes | Carlos E. Baena-Cagnani (Argentina)
10:45 - 12:15 SYMPOSIUM 4
CC, 2ND, XCARET
Environmental Aspects of Asthma
Chairpersons: Roberto O. Aguila de la Coba (Cuba)
Ulrich Wahn (Germany)
10:50 - 11:10 4-1SY Asthma in Underserved Populations | Alvaro Cruz (Brazil)
11:10 - 11:30 4-2SY Inner-City Asthma | Cheryl Hankin (United States)
11:30 - 11:50 4-3SY Rural Asthma | Roy Gerth van Wijk (Netherlands)
47
Final Program
CC, 1ST, COSTA MAYA 1
National Institute of Allergy and Infectious Disease (NIAID)
Immunological Features of Immunotherapy
Chairpersons: 10:45 - 10:50 10:50 - 11:10 2-1CPS 11:10 - 11:30 2-2CPS 11:30 - 11:50 2-3CPS Alkis Togias (United States)
Rudolf Valenta (Austria)
Welcoming Remarks
Immunological Models for Successful Immunotherapy | Cezmi Akdis (Switzerland)
How the Immune System Generates Tolerance | Kari Nadeau (United States)
How Immunology Informs the Design of Immunotherapeutics |
Stephen Durham (United Kingdom)
10:45 - 12:15 SYMPOSIUM 5
Rhinosinusitis
Chairpersons: Lawrence DuBuske (United States)
Ralph Mösges (Germany)
10:50 - 11:10 5-1SY Asthma Exacerbations | Marek L Kowalski (Poland)
11:10 - 11:30 5-2SY Otitis Media | Robert Naclerio (United States)
11:30 - 11:50 5-3SY Management | Michael A. Kaliner (United States)
10:45 - 12:15 SYMPOSIUM 6
CC, 1ST, BACALAR
Obstructive Sleep Apnea (OSA) Syndrome and Allergic Respiratory Diseases
Chairpersons: Ivan Chérrez (Ecuador)
Stanley Fineman (United States)
10:50 - 11:10 6-1SY Upper Airway Diseases | Athanasios Kaditis (Greece)
11:10 - 11:30 6-2SY Asthma | Fulvio Braido (Italy)
11:30 - 11:50 6-3SY Management | Timothy J. Craig (United States)
10:45 - 11:45 SISTER SOCIETY SYMPOSIUM 4: DEBATE
CC, GROUND, AUDITORIUM
Brazilian Society of Allergy and Immunopathology
Allergy and Breast Feeding Chairpersons: A. Wesley Burks (United States)
Joao Negreiros Tebyrica (Brazil)
10:50 - 11:05 4-1SSS Pro | Renata R. Cocco (Brazil)
11:05 - 11:20 4-2SSS Con | Hugo P. Van Bever Sr. (Singapore)
11:20 - 11:25 Pro Rebuttal
11:25 - 11:30 Con Rebuttal
48
Final Program
12:15 - 14:15 POSTER GROUP 1
CC, 1ST, POSTER HALL
For full details on the below Poster Sessions, please view the “Poster” section of this Final Program.
PS 1: Asthma and Co-Morbid Conditions
PS 2: Pediatric Asthma
PS 3: Pediatric Asthma Epidemiology
PS 4: Aerobiology
PS 5: Mechanisms of Asthma and Allergic Inflammation
PS 6: Allergy to Antimicrobials
PS 7: Drug Allergy 1
PS 8: Food Allergy
PS 9: Food Allergy: Epidemiology
PS 10: Incidence and Prevalence of Food Allergy
PS 11: Food Allergy: Gastrointestinal Manifestations
PS 12: IgE Poster
PS 13: Anti-IgE
PS 14: Immunotherapy
PS 15: Hymenoptera Allergy
Lunch boxes are available in the Poster Hall for delegates attending the Poster Session.
CC, 1ST, BACALAR
Asthma Treatment
Chairpersons:
12:45 - 13:30 2143
Paul O’Byrne (Canada)
Michael Schatz (United States)
Poster Viewing
Reduction in Asthma Deteriorations in Subjects with Persistent Asthma Not Well
Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis
From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol
Weinstein, S. 1, Nathan, R. 2, Meltzer, E. 3, Gates, D. 4 and Nolte, H. 5
1
Allergy & Asthma Specialists Medical Group, Huntington Beach, CA. 2Asthma & Allergy Associates, P.C.
and Research Center , Colorado Springs, CO. 3Allergy and Asthma Medical Group & Research Center, San
Diego, CA. 4Schering-Plough Research Institute (now Merck Research Laboratories), Kenilworth, NJ. 5Merck
Research Laboratories, Kenilworth, NJ.
2144
Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/
Salmeterol Combination Therapies in Subjects with Persistent Asthma: Noninferiority
and Onset-of-Action Findings
Bernstein, D. 1, Murphy, K. 2 and Nolte, H. 3,4
1
Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine,
Cincinatti, OH. 2Boys Town National Research Hospital, Boys Town, NE. 3Merck Research Laboratories,
Kenilworth, NJ. 4Respiratory Research Unit, Bispebjerg Copenhagen University Hospital, Copenhagen,
Denmark.
2145
Efficacy and Safety of Two Doses of Mometasone Furoate/Formoterol Combination
Treatment in Subjects with Severe Asthma
Weinstein, S. 1, Murphy, K. 2, Corren, J. 3, Nolte, H. 4 and White, M. 5
1
Allergy & Asthma Specialists Medical Group, Huntington Beach, CA. 2Boys Town National Research
Hospital, Boys Town, NE. 3Allergy Medical Clinic, Los Angeles, CA. 4Merck Research Laboratories,
Kenilworth, NJ. 5Institute for Asthma and Allergy, Wheaton, MD.
2146
Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal
Awakenings in Subjects with Persistent Asthma
Pearlman, D. 1, Nathan, R. 2, Meltzer, E. 3, Nolte, H. 4 and Weinstein, S. 5
1
Colorado Allergy and Asthma Centers, P.C., Denver, CO. 2Asthma & Allergy Associates, P.C. and Research
Center , Colorado Springs, CO. 3Allergy and Asthma Medical Group & Research Center, San Diego, CA.
4
Merck Research Laboratories, Kenilworth, NJ. 5Allergy & Asthma Specialists Medical Group, Huntington
Beach, CA.
49
Final Program
2147
Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined
Mometasone Furoate and Formoterol
Murphy, K. 1, Meltzer, E. 2, Nathan, R. 3 and Nolte, H. 4
1
Boys Town National Research Hospital, Boys Town, NE. 2Allergy and Asthma Medical Group & Research
Center, San Diego, CA. 3Asthma & Allergy Associates, P.C. and Research Center , Colorado Springs, CO.
4
Merck Research Laboratories, Kenilworth, NJ.
2148
Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìg Twice Daily
in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids
Meltzer, E. 1, Nolte, H. 2 and LaForce, C. 3
1
Allergy and Asthma Medical Group & Research Center, San Diego, CA. 2Merck Research Laboratories,
Kenilworth, NJ. 3North Carolina Clinical Research, Raleigh, NC.
2149
Prevalence of Swallowing Dysfunction in Severe Asthma: Preliminary Results
2150
Small Airway Function Is Consistently Improved in Asthma Patients Treated with
Mometasone Furoate Delivered by a Dry Powder Inhaler
Salles, C. 1, Ramos, R. T. 2, Souza-Machado, A. 3, Daltro, C. 4, Almeida, P. 3 and Cruz, A. 5
1
Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia , ProAr- Núcleo de
Excelência em Asma da Universidade Federal da Bahia, (UFBA), Salvador, Brazil. 2 Faculdade de Medicina,
Universidade Federal da Bahia (UFBA), Salvador, Brazil. 3Faculdade de Medicina da Bahia – ProAr- Núcleo
de Excelência em Asma da Universidade Federal da Bahia, (UFBA), Salvador, Brazil. 4Faculdade de
Medicina- Universidade Federal da Bahia, Salvador, Brazil. 5Medicine, Faculdade de Medicina, ProAR Núcleo de Excelência em Asma da Universidade Federal da Bahia, Salvador, Brazil.
Karpel, J. 1, Noonan, M. 2, Staudinger, H. 3 and Teper, A. 4
1
North Shore University Hospital, Manhasset, NY USA, Manhasset, NY. 2Allergy Associates Research Center,
LLC, Portland, OR. 3Merck Research Laboratories, Merck Sharp & Dohme Corp, Kenilworth, NJ. 4Allergy/
Respiratory, Merck Research Laboratories, Summit, NJ.
2151
Influence of Montelukast on the State of Eosinophil Activation in Asthmatic Children
2152
The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to
Infants with Bronchial Asthma
Botan, V. , Miranda, M. , Couto, S. , Rocha, E. and Muniz-Junqueira, M. I.
Laboratory of Cellular Immunology, Brasilia University, Brasilia, Brazil.
Ogawa, N. 1, Mikami, K. 1, Sato, M. 2, Mezawa, K. 3, Iwata, S. 4, Takazawa, R. 5, Oshiba, A. 6, Hoshioka, A. 7 and
Noma, T. 8
1
Department of Pediatrics, Chiba Aiyukai Memorial Hospital, Nagareyama, Japan. 2Department of
Pediatrics, Sato Pediatric Clinic, Yokohama, Japan. 3Pediatrics, Mezawa Kid Clinic, saitama, Japan.
4
Department of Pediatrics, Iwata Pediatric Clinic, Higashi-Murayama, Japan. 5Department of Pediatrics,
Tokyo-kita Insurance Hospital, Tokyo, Japan. 6Department of Pediatrics, Tokyo Kousei-Nenkin Hospital,
Tokyo, Japan. 7Department of Pediatrics, Chiba Children’s Hospital, Chiba, Japan. 8Department of Pediatrics,
kitasato University School of Medicine, Sagamihara, Japan.
2153
Effectiveness of Montelukast In 60 Cuban Patients with Moderate and Severe Asthma
and Rhinitis
Alvarez, M. 1, Castro, R. 2, Orta, S. 3, Ronquillo, M. 1, Enriquez, I. 1 and Rodríguez, J. 1
1
Allergology Department, University Hospital Calixto García, Havana City, Cuba. 2Allergens, National Center
of Bioproducts, Havana City, Cuba. 3Center for the Quality Control of Drugs, Havana City, Cuba.
2154
Effect of the Treatment with Montelukast In Asthmatic Patient
2155
The Effectiveness of Two Different Methods of Salbutamol Nebulization in Children with
Asthma
Aguila de la Coba, R. O. 1 and Ada del Carmen, C. M. 2
1
ALLERGOLOGY, Cerro Pediatric Hospital, LA HABANA, Cuba. 2ALLERGY, Allende Hospital, LA HABANA, Cuba.
Emeryk, A. 1, Kowalska, M. 1, Czerwinska-Pawluk, I. 1 and Bartkowiak-Emeryk, M. 2
1
Department of Paediatric Pulmonology and Rheumatology, University of Medicine in Lublin, Lublin,
Poland. 2Department of Clinical Immunology, University of Medicine in Lublin, Lublin, Poland.
50
Final Program
12:45 - 14:15 ORAL ABSTRACT SESSION 1
Allergen Immunotherapy 1
Chairpersons: 12:45 - 13:00 2156
Enrico Compalati (Italy)
Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen
Extracts Is Effective and Safe in Patients with Severe SAR Highly Sensitized Against
Pollen Allergens
Gruber, M. 1 and Amon, U. 2
1
PsoriSol Clinic for Dermatology & Allergy, Hersbrcuk, Germany. 2PsoriSol Clinic for Dermatology & Allergy,
Hersbruck, Germany.
13:00 - 13:15 2157
Dose Optimizing Study of A Depigmented Polymerized Allergen Extract of Birch Pollen
by Means of Conjunctival Provocation Test
Sager, A. 1 and Worm, M. 2
1
Medical Department, LETI Pharma GmbH, Witten, Germany. 2Dermatology, Charite University Clinic,
Berlin, Germany.
13:15 - 13:30 2158
Double-Blind Study on The Use of Transfer Factor (TF) Combined With Sublingual
Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population
Rojo-Gutiérrez, M. I. 1, Gonzalez-Ibarra, M. 2, Sandoval, T. 3 and Mellado-Abrego, J. 1
1
Allergy, Juarez Hospital, México City, México. 2Allergy and immunology, Juarez Hospital, México City,
México. 3Investigation, Juarez Hospital, México City, México.
13:30 - 13:45 2159
The Risk of Severe Treatment Related Adverse Events is Significantly Lower in
Children Compared to Adults when Treated With Standardised Timothy Grass Allergy
Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials
Andersen, J. S. 1, Fejerskov, P. A. 1 and Nolte, H. 2
1
ALK-Abello, Hørsholm, Denmark. 2Merck Research Laboratories, Kenilworth, NJ.
13:45 - 14:00 2160
Post-Treatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass
Pollen Allergen Extract In Adults With Grass Pollen-Induced Allergic Rhinoconjunctivitis
Didier, A. 1, Horak, F. 2, Worm, M. 3, Malling, H. 4, Montagut, A. 5, Rodriguez, P. 6, Zeldin, R. K. 6 and LheritierBarrand, M. 7
1
Rangueil-Larrey Hospital, Respiratory Diseases Department, Toulouse, France. 2Allergy Centre
Vienna West, Dptm. - Institute for Allergy Research, Vienna, Austria. 3Allergy-Centre-Charité, Charité
- Universitätsmedizin Berlin, Berlin, Germany. 4National University Hospital, Copenhagen, Denmark.
5
Stallergenes SA, Antony, France. 6Stallergenes SA, Antony, France. 7Stallergenes, Antony Cedex , France.
14:00 - 14:15 2161
Escherichia coli Heat-labile Enterotoxin (LTS61K) Modulates Dendritic Cell Function and
Attenuates Airway Inflammation in Mouse Model of Allergic Asthma
Wang, J. 1, Hsu, Y. H. 2 and Lin, I. 3
1
College of Medicne, National Cheng Kung University HospiTak, Tainan, Taiwan. 2Development Center for
Biotechnology, Taipei, Taiwan. 3College of medicne, National cheng Kung university, Tainan, Taiwan.
Allergen Structure 1
Chairpersons: 12:45 - 13:00 13:00 - 13:15 2162
2163
Oussama Abou Chakra (France)
Enrique Fernández-Caldas (Spain, United States)
Comprehensive Detection of Allergens in Grass Pollen Extracts by Mass Spectrometry
Augustin, S. 1, Mitulski, L. 2, Cromwell, O. 3, Reese, G. 4 and Nandy, A. 5
1
Allergopharma Joachim Ganzer KG, Team Leader Laboratory Molecular Biology, 21465 Reinbek, Germany.
2
Allergopharma Joachim Ganzer KG, Scientist, 21465 Reinbek, Germany. 3Allergopharma Joachim Ganzer
KG, Head of Research and Development, 21465 Reinbek, Germany. 4Allergopharma Joachim Ganzer
KG, Head of Allergen Research, 21465 Reinbek, Germany. 5Allergopharma Joachim Ganzer KG, Head of
Molecular Biology Research, 21465 Reinbek, Germany.
Gene Expression Pattern of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass
Group 1 Pollen Allergens
Bhalla, P. , Tiwari, R. and Singh, M.
Agriculture and Food Systems, The University of Melbourne, Parkville, Australia.
51
Final Program
13:15 - 13:30 2164
Comprehensive Expression of Recombinant House Dust Mite Allergens for ComponentResolved Diagnosis
Watakabe, Y. 1, Kawamoto, S. 1, Nakahara, H. 1, Hiragun, T. 2, Aki, T. 1, Asaoku, Y. 3, Hayashi, T. 4, Mihara, S. 2,
Hide, M. 2 and Ono, K. 1
1
Department of Molecular Biotechnology, Graduate School of Advanced Science of Matter, Hiroshima
University, Higashi-Hiroshima, Japan. 2Division of Molecular Medical Science, Department of Dermatology,
Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan. 3Nagasaki Hospital,
Hiroshima, Japan. 4Takanobashi Central Hospital, Hiroshima, Japan.
13:30 - 13:45 2165
A Bioinformatic Approach to Allergen Nomenclature Applied to Allergens From the
Non-Biting Midge Chironomus Thummi Thummi
Breiteneder, H. 1, Rozynek, P. 2, Raulf-Heimsoth, M. 2, Goodman, R. 3 and Radauer, C. 1
1
Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
2
Institute of Prevention and Occupational Medicine of the German Social Accident Insurance, RuhrUniversity Bochum, Bochum, Germany. 3Food Allergy Research & Resource Program, University of
Nebraska - Lincoln, Lincoln, NE.
13:45 - 14:00 2166
Pollen Allergens Differ From Non-Allergenic Pollen Proteins by Their Lower Extent of
Evolutionary Conservation
Radauer, C. , Guhsl, E. , Bublin, M. and Breiteneder, H.
14:00 - 14:15 2167
Sensitization to Betula Verrucosa and Rbet v1 in Spain
Cases, B. 1, Orjales, R. 2, Gafvelin, G. 3, Carballada, F. 2, Boquete, M. 2, Tudela, J. I. 1 and Fernandez-Caldas, E. 1,4
1
Research & Development, Inmunotek SL, Madrid, Spain. 2Servicio de Alergia, Hospital Xeral-Calde, Lugo,
Spain. 3Karolinska Institut, Stockholm, Sweden. 4Division of Allergy and Immunology, University of South
Florida College of Medicine, Tampa.
Allergic Models of Inflammation
Chairpersons: 12:45 - 13:00 2168
Giovanni Melioli (Italy)
Harald Renz (Germany)
Common and Rare Variation In the T Helper 2 Gene Pathway Predicts Allergic Asthma
Phenotypes
Slager, R. 1, Moore, W. 2, Li, H. 2, Busse, W. 3, Castro, M. 4, Erzurum, S. 5, Fitzpatrick, A. 6, Wenzel, S. 7, Meyers, D. 1
and Bleecker, E. R. 1
1
Center for Genomics and Personalized Medicine Research, Wake Forest University Health Sciences, WinstonSalem, NC. 2Center for Genomics and Personalized Medicine Research, Wake Forest University School of
Medicine, Winston Salem, NC. 3Medicine, University of Wisconsin School of Medicine and Public Health,
Madison, WI. 4Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine,
St. Louis, MO. 5Department of Pathobiology, Lerner Research Institute, Cleveland, OH. 6Department of
Pediatrics, Emory University, Atlanta, GA. 7Medicine, University of Pittsburgh, Pittsburgh, PA.
13:00 - 13:15 13:15 - 13:30 2169
Role of Myeloid Derived Suppressor Cells in Asthma
2170
Mir-150 Suppresses Lung Inflammation In A Mouse Model of Experimental Asthma
Nelson, A. 1, Parkerson, J. 2, Lockey, R. F. 2, Mohapatra, S. 3, Mohapatra, S. 4 and Nagaraj, S. 1
1
Nanomedicine Research Center and Divisions of Translational Medicine and Allergy and Immunology,
Dept of Internal Medicine, University of South Florida, Tampa, FL. 2Division of Allergy & Immunology,
University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 3Nanomedicine Research
Center and Divison of Translational Medicine, Depts of Molecular Medicine and Internal Medicine ,
University of South Florida and James V Haley Veterans’ Hospital , Tampa, FL. 4Nanomedicine Research
Center and Divisions of Translational Medicine, Allergy and Immunology, Depts of Internal Medicine and
Molecular Medicine, University of South Florida and James V Haley Veterans ‘Hospital , Tampa, FL.
Wang, J. 1, Li, K. 1, Hellermann, G. 1, Lockey, R. F. 2, Mohapatra, S. 3 and Mohapatra, S. 4
1
Internal Medicine, University of South Florida, Tampa, FL. 2Division of Allergy & Immunology, University
of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 3Nanomedicine Research Center and
Divison of Translational Medicine, Depts of Molecular Medicine and Internal Medicine , University of South
Florida and James V Haley Veterans’ Hospital , Tampa, FL. 4USF Nanomedicine Research Center, University
of South Florida College of Medicine & VA Hospital, Tampa, FL.
52
Final Program
13:30 - 13:45 2171
Serine Protease Inhibitor Attenuates OVA Induced Inflammation In Mouse Model of
Allergic Airway Disease
Saw, S. , Kale, S. , Singh, B. P. and Arora, N.
Allergy and Immunology, Institute of Genomics and Integrative Biology, Delhi, India.
13:45 - 14:00 2172
Potential Role of Scavenger Receptors in Human Mast Cell Cytokine Response to
Oxidized LDL
Faiger, R. 1, Lappalainen, J. 2, Schneider, W. J. 3, Kovanen, P. 2 and Levi-Schaffer, F. 4
1
Department of Pharmacology, The Hebrew University of Jerusalem, Jerusalem, Israel. 2Wihuri Research
Institute, Helsinki, Finland. 3Dept. of Molecular Genetics, University of Vienna, Vienna, Austria. 4Department
of Pharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew
University of Jerusalem, Jerusalem, Israel.
Allergic Rhinitis
Chairpersons: 12:45 - 13:00 13:00 - 13:15 13:15 - 13:30 13:30 - 13:45 2173
Yeong Ho Rha (South Korea)
Allergic Rhinitis to Ragweed Pollen
2174
Ragweed Allergy – What Role Does It Play in Bavaria?
Bocsan, I. C. 1, Bujor, I. A. 2, Barbinta, C. 3 and Deleanu, D. 4
1
Clinical Pharmacology, University of Medicine and Pharmacy, Cluj Napoca, Romania. 2ImmunologyAllergology, University of Medicine and Pharmacy , Cluj- Napoca, Romania. 3Allergology, Almedo Clinic,
Cluj Napoca, Romania. 4Immunology- Allergology, University of Medicine and Pharmacy , Cluj-Napoca,
Romania.
McIntyre, M. 1,2, Jaeger, T. 1,2, Huss-Marp, J. 1,2, Hauser, M. 3, Ferreira, F. 3, Ollert, M. 1, Ring, J. 1, Schmidt-Weber,
C. 2, Behrendt, H. 2 and Darsow, U. 1,2
1
Department of Dermatology and Allergy Biederstein, Technische Universitaet Muenchen, Munich,
Germany. 2Center of Allergy and Environment (ZAUM), Helmholtz Center Munich/Technische Universitaet
Muenchen, Munich, Germany. 3Department of Molecular Biology, University of Salzburg, Salzburg, Austria.
2175
Nasal Nitric Oxide and Nasal Polyposis As Determinants of Asthma Control
2176
Peak Nasal Inspiratory Flow Levels In Children with Allergic Rhinitis and Their Health
Related Quality of Life (HRQL)
Heffler, E. , Pizzimenti, S. , Quaccia, C. , Badiu, I. and Rolla, G.
Biomedical Sciences and Human Oncology, Allergy and Clinical Immunology - University of Torino - AO
Mauriziano “Umberto I”, Torino, Italy.
Nagaraju, M. K.
Pediatric Allergy and Immunology, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
13:45 - 14:00 2177
Exhaled Nitric Oxide and Airway Function in Seasonal Allergic Rhinitis
Shinogami, M. 1, Kagoya, R. 1, Nakanishi, W. 2 and Yoshinami, H. 3
1
Otolaryngology, Tokyo Metropolitan Police Hospital, Tokyo, Japan. 2University of Tokyo, Tokyo, Japan.
3
Otorhhinolaryngology, Saitama Medical University, Saitama, Japan.
Atopic Dermatitis 1
Chairpersons: 12:45 - 13:00 13:00 - 13:15 2178
2179
Peter Schmid-Grendelmeier (Switzerland)
Atsuo Urisu (Japan)
Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis
Imai, Y. 1, Yasuda, K. 2, Yoshimoto, T. 3, Nakanishi, K. 2 and Yamanishi, K. 1
1
Department of Dermatology, Hyogo College of Medicine, Nishinomiya, Japan. 2Department of Immunology
and Medical Zoology, Hyogo College of Medicine, Nishinomiya, Japan. 3Laboratory of Allergic Diseases,
Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Japan.
S100A8/A9, A DAMP Molecule Activated by IL-17 and House Dust Mite Is Upregulated In
Atopic Dermatitis
Jin, S. , Park, C. O. , Noh, J. Y. , Lee, Y. S. , Bae, B. G. , Noh, S. and Lee, K. H.
Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of
Medicine, Seoul, South Korea.
53
Final Program
13:15 - 13:30 13:30 - 13:45 13:45 - 14:00 14:00 - 14:15 2180
Arginase I Levels Are Decreased In Pediatric Patients with Atopic Dermatitis
2181
Polyprenol Could Prevent Loss of Filaggrin In Epithelial Cells In Atopic Dermatitis
2182
Role of Sweating On Impaired Skin Barrier Functions In Atopic Dermatitis
2183
Reduced Occurrence of Early Atopic Dermatitis Due to Immunoactive Prebiotics Among
Low Atopy Risk Infants
Dimitriades, V. 1 and Ochoa, A. 2
1
Pediatrics- Division of Allergy/Immunology, Louisiana State University School of Medicine, New Orleans,
LA. 2Louisiana State University Health Sciences Center, New Orleans, LA.
Kuznecovs, I. S. 1, Joksta, I. 1, Kuznecovs, S. 2 and Kuznecova, G. 3
1
Allergy and Immunology, Preventive Medicine Institute, Riga, Latvia. 2Preventive Medicine Institute, Riga,
Latvia. 3Epidemiology, Preventive Medicine Institute, Riga, Latvia.
Takahashi, A. , Kimura, A. , Matsui, S. , Kijima, A. , Kitaba, S. , Murota, H. and Katayama, I.
Osaka University School of Med., Suita-shi, Japan.
Grüber, C. 1, van Stuivenberg, M. 2, Mosca, F. 3, Moro, G. 4, Chirico, G. 5, Braegger, C. 6, Riedler, J. 7, Boehm, G. 8
and Wahn, U. 1
1
Pediatric Pneumology / Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. 2Division
of Neonatology, Beatrix Children’s Hospital, UMC Groningen, Groningen, Netherlands. 3University
Department of Mother and Infant Sciences, University of Milan, IRCCS “Ca’Granda” Ospedale Maggiore
Policlinico, Milan, Italy. 4Macedonio Melloni Hospital, Milan, Italy. 5Department of Neonatology, Spedali
Civili, Brescia, Italy. 6Division of Paediatric Gastroenterology and Nutrition, University Children’s Hospital,
Zurich, Switzerland. 7Children’s Hospital, Schwarzach Hospital, Schwarzach, Austria. 8Danone Research
Centre for Specialized Nutrition, Friedrichsdorf, Germany.
12:45 - 14:15 ORAL ABSTRACT SESSION 6 CC, 2ND, COZUMEL 2
Conjunctivitis
Chairpersons: 12:45 - 13:00 2184
Leonard Bielory (United States)
Sergio Bonini (Italy)
Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in An
Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model
Blaiss, M. S.
University of Tennessee Health Science Center`, Memphis, TN.
13:00 - 13:15 13:15 - 13:30 13:30 - 13:45 2185
Increased Frequency of CD4+ CD25+ FOXP3- in Allergic Conjunctivitis Patients
2186
Increased Frequency of CD4+ CCR4+ CCR9+ Cells in Patients with Allergic Conjunctivitis
2187
Long-Term IFN-g Treatment Alters Allergic Inflammation-Associated Gene Expression in
Conjunctival Fibroblasts
Galicia-Carreón, J. 1, Alonso-Sánchez, M. E. 1, Robles-Contreras, A. 1, Hong, E. 2, Chávez, R. 3 and JiménezMartínez, M. C. 1,3
1
Research Unit and Department of Immunology, Institute of Ophthalmology, México D.F., México.
2
Farmacobiología, Cinvestav, México D.F., México. 3Department of Biochemistry, Faculty of Medicine,
UNAM, México D.F., México.
Alonso-Sánchez, M. E. 1, Galicia-Carreón, J. 1, Ayala-Balboa, J. 1, Robles-Contreras, A. 1, Hong, E. 2, Chávez, R. 3
and Jiménez-Martínez, M. C. 1,3
1
Research Unit and Department of Immunology, Institute of Ophthalmology, México D.F., México.
2
Farmacobiologia, Cinvestav, México D.F., México. 3Department of Biochemistry, Faculty of Medicine,
UNAM, México D.F., México.
Okada, N. 1,2, Oboki, K. 1, Fukagawa, K. 2, Fujishima, H. 3, Kawakita, T. 2, Tsubota, K. 2, Saito, H. 1 and
Matsumoto, K. 1
1
Department of Allergy and Immunology, National Research Institute for Child Health & Development,
Tokyo, Japan. 2Department of Ophthalmology, Keio University , Tokyo, Japan. 3Department of
Ophthalmology, Tsurumi University Dental Hospital, Kanagawa, Japan.
13:45 - 14:00 2188
Hyperosmolar Conjunctival Provocation Test (HCPT) in the Evaluation of Ocular
Symptoms
Mourão, E. M. M. and Rosario, N.
Allergy and Immunology, Federal University of Paraná, Curitiba, Brazil.
54
Final Program
14:00 - 14:15 2189
Tear IFN-g Is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis
Patients and Correlates with Clinical Improvement
Aguilar-Velazquez, G. 1, Santacruz, C. 2, Hernandez, P. M. 1, Chavez, R. 3, Ayala-Balboa, J. 4, Estrada-Parra, S. 5,
Perez-Tapia, M. 6 and Jimenez-Martinez, M. C. 3
1
Research Unit, Department of immunology, Institute of Ophthalmology “Conde de Valenciana”,
México, México. 2Department of Cornea, Institute of Ophthalmology “Conde de Valenciana”, México,
México. 3Department of Biochemistry, Faculty of Medicine, UNAM, México, México. 4Research Unit and
Department of Immunology, Institute of Ophthalmology, México D.F., México. 5Molecular Immunology
Lab-I, National School of Biological Sciences, IPN, México, México. 6Unidad de desarrollo e investigacion de
biologicos, National School of Biological Sciences, IPN, México, México.
Immunodeficiency
Chairpersons: 12:45 - 13:00 2190
Francisco Espinosa-Rosales (México)
Anxiety and Depression in Patients with Variable Common Immunodeficiency in the
Service of Allergy and Clinical Immunology - Centro Médico Nacional Siglo XXI
Guillen Rocha, N. L. 1, Segura Mendez, N. H. 2, Silva Perea, J. 3 and Vazquez Estupiñan, M. F. 3
1
Allergy and Immunology , Speciality Hospital - Centro Médico Nacional Siglo XXI , México Distrito
Federal, México. 2Specialty Hospital Centro Medico Nacional Siglo XXI, Allergy and Clinical Immunology
, México City, México. 3Psychiatry, Specialty Hospital - Centro Medico Nacional Siglo XXI, México City,
México.
13:00 - 13:15 2191
Transient Immune Reconstitution Following Gastric Bypass Surgery with Ensuing
Sjogren’s Syndrome
Kim, J. and Kaplan, B.
Division of Allergy and Immunology, North Shore-Long Island Jewish Health System, Great Neck, NY.
13:15 - 13:30 2192
Computed Tomography Findings Consistent with Rhinosinusitis, Clinical Correlation and
Quality of Life in Patients with Common Variable Immunodeficiency. Original Article
Mendieta, E. 1 and Del Rivero, L. G. 2
1
Allergy & Clinical Immunology, Specialty Hospital Medical Center XXI Century, México, México City,
Author, México City , México. 2Allergy and Immunology , MD, México City , México.
13:30 - 13:45 2193
Subcutanous Vivaglobulin® Replacement Therapy in Patients with Primary
Immunodeficiency Confers Protective Antibody Titers to Major Organisms
Nguyen, D.
University of South Florida, College of Medicine, Saint Petersburg, FL.
13:45 - 14:00 2194
Case Report: Recurrent Mucocutaneous Candidiasis and Recurrent Diarrhea by Gram
Negative Bacteria
Aldave Becerra, J.
Allergy and Immunology, Edgardo Rebagliati Martins National Hospital, Lima, Peru.
14:00 - 14:15 2195
Bronchiectasis: Localization and Characteristics, Identified by Using a High Resolution
CT Scan in Adults with Common Variable Immunodeficiency
Mendoza, L. 1, Segura, D. N. H. 2, Flores, F. 3, Campos, F. 1 and Guillén, N. 1
1
Allergy and Clinical Immunology, Specialty Hospital Centro Médico Nacional Siglo XXI, México Distrito
Federal, México. 2Allergy & Clinical Immunology, Specialty Hospital Centro Medico Nacional Siglo XXI,
México, México. 3Imagenología y Radiología, Centro Medico Nacional La Raza Servicio de Radiología e
Imagenología, México Distrito Federal, México.
55
Final Program
CC, 2ND, TULUM
Indoor Risk Factors for Asthma
Chairpersons: 12:45 - 13:00 2196
Thomas Platts-Mills (United States)
Myron Zitt (United States)
The Relationship of Pets, Vitamin D and IgE Concentrations to Upper Respiratory
Infections In the First Year of Life
Ownby, D. 1, Peterson, E. 2, Wegienka, G. 2, Lyncy, S. 3, Boushey, H. 4, Lukacs, N. 5, Zoratti, E. 6, Havstad, S. 2,
Bobbitt, K. 2, Woodcroft, K. 2 and Johnson, C. C. 7
1
Pediatrics, Section of Allergy, Immunology, Rheumatology, Georgia Health Sciences University, Augusta,
GA. 2Public Health Sciences, Henry Ford Hospital & Health System, Detroit, MI. 3University of California
San Francisco, San Francisco, CA. 4Medicine, University of California, San Francisco, San Francisco, CA.
5
Pathology, University of Michigan, Ann Arbor, MI. 6Allergy and Immunology, Henry Ford Hospital & Health
System, Detroit, MI. 7Public Health Sciences, Henry Ford Health System, Detroit, MI.
13:00 - 13:15 2197
Prevalence of Cockroach and Mouse Sensitization Among Children Hospitalized for
Wheezing and Asthma
Moncrief, T. 1, Beck, A. 2, Greenberg, E. 2, Strong, H. 2, Simmons, J. 2 and Kahn, R. 2
1
Allergy/Immunology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH. 2General and
Community Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.
13:15 - 13:30 13:30 - 13:45 2198
Is Pet Ownership Associated with Higher Vitamin D?
2199
Sick Building Syndrome (SBS) Among Workers of Two Buildings and Exposure to Indoor
Fungal Allergens in Rio De Janeiro, Brazil
Johnson, C. C. 1, Peterson, E. 1, Wegienka, G. 1, Havstad, S. 1, Woodcroft, K. 1, Bobbitt, K. 1, Lynch, S. 2, Boushey,
H. 2, Lukacs, N. 3, Zoratti, E. 4 and Ownby, D. 5
1
Public Health Sciences, Henry Ford Hospital & Health System, Detroit, MI. 2Medicine, University of
California, San Francisco, San Francisco, CA. 3Pathology, University of Michigan, Ann Arbor, MI. 4Allergy
and Immunology, Henry Ford Hospital & Health System, Detroit, MI. 5Pediatrics, Section of Allergy,
Immunology, Rheumatology, Georgia Health Sciences University, Augusta, GA.
Boechat, J. L. 1, Rios, J. L. 1, Klaus V. Ramos, M. D. C. 2, Luiz, R. 3, Radler de Aquino Neto, F. 4 and Lapa e Silva, J. R. 1
1
Thorax Disease Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 2Chemistry Institute,
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 3IESC, Federal University of Rio de Janeiro, Rio de
Janeiro, Brazil. 4Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro , Brazil.
13:45 - 14:00 2200
Asthma Among Office Workers and Exposure to Chemical and Biological Indoor Pollutants
Rios, J. L. 1, Boechat, J. L. 1, Klaus V. Ramos, M. D. C. 2, Luiz, R. 3, Radler de Aquino Neto, F. 4 and Lapa e Silva, J. R. 1
Thorax Disease Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 2Chemistry Institute,
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 3IESC, Federal University of Rio de Janeiro, Rio de
Janeiro, Brazil. 4Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro , Brazil.
1
14:00 - 14:15 2201
Taxonomic Identification of the House Dust Mites Associated to Allergic Patients In Six
Locations From México
Cuervo, N. 1, Fernandez, B. 2, Rodriguez, J. 3, Murillo, C. 3, Perez, T. M. 4 and Juarez, D. 3
1
Zoology of Invertebrates, Institute of Ecology and Systematic, Habana, Cuba. 2National Center of
Bioproducts, Bejucal, Cuba. 3Rocel Laboratories, Puebla, México. 4Institute of Biology, UNAM, D.F., México.
CC, 2ND, XCARET
Mechanisms of Asthma
Chairpersons: 12:45 - 13:00 2202
Daniel Jackson (United States)
Bradley Undem (United States)
EGCG Down-Regulates Mucin Gene Expression Through the MAPK Signaling Pathway in
Asthma
Kim, Y. , Ye, S. B. , Bae, C. H. and Song, S.
Yeungnam University College of Medicine, Daegu, South Korea.
56
Final Program
13:00 - 13:15 2203
Enhancer of Zeste Homolog 2: A Pivotal Role in Pulmonary Artery Smooth Muscle Cell
Proliferation
Aljubran, S. 1, Cox, R. 2, Tamarapu Parthasarathy, P. 3, Lockey, R. F. 4 and Kolliputi, N. 2,5
1
Allergy and immunology, University of South Florida, Tampa, FL. 2Internal Medicine, University of South
Florida, Tampa, FL. 3University of South Florida, Tampa, FL. 4Division of Allergy & Immunology, University of
South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 5Division of Allergy and Immunology.
13:15 - 13:30 13:30 - 13:45 2204
The Features of Airway Remodeling Are More Severe in Female Mice
2205
Ovalbumin-Induced Bronchial Asthma Is Compromised in Apoptosis Signal-Regulating
Kinase-Deficient Mice
Takeda, M. , Ito, W. , Ueki, S. , Hirasawa, H. , Fujita, M. , Konno, Y. , Chihara, M. , Itoga, M. , Moritoki, Y. ,
Kobayashi, Y. , Kayaba, H. and Chihara, J.
Department of Infection, Allergy, Clinical Immunology and Laboratory Medicine, Akita University Graduate
School of Medicine, Akita, Japan.
Mizuguchi, J. 1, Furuhata, M. 1, Ichijo, H. 2 and Takada, E. 1
1
Immunology, Tokyo Medical University, Tokyo, Japan. 2Laboratory of Cell Signaling, University of Tokyo,
Tokyo, Japan.
13:45 - 14:00 2206
Role of the CC−Chemokine Receptor CCR9 In the Regulation of Inflammatory Process
During Allergic Airway Inflammation
López-Pacheco, C. 1, Du Pont, G. 1, Wurbel, M. 2, Fortoul, T. 3, Soldevila, G. 1 and García-Zepeda, E. 1
1
Immunology, Biomedical Research Institute, UNAM, México City, México. 2Children’s Hospital Boston,
Harvard Medical School, Boston, MA. 3Cell and Tissue Biology, School of Medicine, UNAM, México City,
México.
14:00 - 14:15 2207
Serum IL6 and Soluble IL6R Are Correlated with Lung Function In Non-Hispanic Whites
with Asthma
Hawkins, G. 1, Robinson, M. 2, Moore, W. 1, Hastie, A. 2, Pascual, R. 2, Peters, S. P. 3, Meyers, D. 2 and Bleecker, E. R. 2
1
Center for Genomics and Personalized Medicine Research, Wake Forest University School of Medicine,
Winston Salem, NC. 2Center for Genomics and Personalized Medicine Research, Wake Forest School of
Medicine, Winston Salem, NC. 3Center for Genomics and Personalized Medicine Research, Wake Forest
University Health Sciences, Winston-Salem, NC.
Sublingual Immunotherapy 1
Chairpersons: 12:45 - 13:00 2208
Moises Calderon (United Kingdom)
Peter Creticos (United States)
Safety and Dose-dependent Efficacy of a Novel Ragweed Allergen Immunotherapy
Tablet in North American and European Patients: Preliminary Findings
Nolte, H. 1, Maloney, J. 1, Bernstein, D. 2, Berkowitz, R. 3, Murphy, K. 4, Kaur, A. 1 and Nekam, K. 5
1
Merck Research Laboratories, Kenilworth, NJ. 2Division of Immunology, Allergy and Rheumatology,
University of Cincinnati College of Medicine, Cincinatti, OH. 3Rx Research, Woodstock, GA. 4Boys Town
National Research Hospital, Boys Town, NE. 5Hospital of the Hospitaller Brothers of St John of God
Budapest , Budapest, Hungary.
13:00 - 13:15 2209
Economic Evaluation of Grass Tablets for Immunotherapy (Oralair) Compared to Placebo
in Adults and Children in Italy
Cicchetti, A. 1, Ruggeri, M. 1, Fiocchi, A. 2, Bonini, S. 3, Puccinelli, P. 4, Passalacqua, G. 5 and Frati, F. 6
1
Faculty of Economy, Catholic University, Rome, Rome, Italy. 2Melloni Paediatria, Milano, Italy. 3Second
University of Naples, Rome, Italy. 4Stallergenes Milan, Milano, Italy. 5Allergy & Respiratory Diseases,
Universita Degli Studi Di Genova, Genoa, Italy. 6Department of Medical and Surgical Specialties and Public
Health, Perugia, Perugia, Italy.
13:15 - 13:30 2210
The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy
Tablets in Adults with Allergic Rhinitis
Bergmann, K. 1, Demoly, P. 2, Worm, M. 1,3, Fokkens, W. 4, Anna, T. 5, Helene, N. 6, de Beaumont, O. 7, Melac, M.
, Frereux, M. 6 and Zeldin, R. K. 6
1
Allergy-Centre-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. 2Allergy, University Hospital
of Montpellier, Montpellier, France. 3Dermatology, Charite University Clinic, Berlin, Germany. 4Department
of Otorhinolaryngology, AMC, Amsterdam, Netherlands. 5Department of Allergy, Complejo Hospitalario de
Navarra, , pamplona, Spain. 6Stallergenes SA, Antony, France. 7Stallergenes SA, Antony, France.
6
57
Final Program
13:30 - 13:45 2211
Efficacy of Immunotherapy with An Oral Bacterial Lysate and Vitamin C In the Primary
Prevention of Acute Respiratory Tract Infections In Children
Socci, M. 1, Slullitel, P. 2 and Cortigiani, L. 3
Sociedad Argentina de Alergia e Inmunologia, SanJusto, Argentina. 2Sociedad Argentina de Alergia e
inmunologia, San Justo, Argentina. 3Sociedad Argentina de Inmunologia, San Justo, Argentina.
1
13:45 - 14:00 2212
Impact of Pollen Exposure on the Treatment Effect of Ragweed and Grass
Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: Preliminary Findings
Gawchik, S. 1, Nolte, H. 2, Fisher, R. 3, Kaur, A. 2 and Maloney, J. 2
1
Asthma and Allergy Associates , Glen Mills, PA. 2Merck Research Laboratories, Kenilworth, NJ. 3Allergy
Research & Care, Milwaukee, WI.
14:00 - 14:15 2213
Efficacy of Timothy Grass Allergy Immunotherapy Tablet (AIT) Treatment in Canadian
Children and Adults with Grass Pollen-Induced Allergic Rhinoconjunctivitis (ARC)
Hebert, J. 1, Nolte, H. 2, Maloney, J. 2, Blaiss, M. S. 3 and Nelson, H. 4
1
[email protected], Quebec, QC, Canada. 2Merck Research Laboratories, Kenilworth, NJ. 3University of
Tennessee Health Science Center, Memphis, TN. 4National Jewish Health, Greenwood Villaage, CO.
Urticaria and Angioedema
Chairpersons: 12:45 - 13:00 2214
Jonathan Bernstein (United States)
David Lang (United States)
The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic
Treatment In Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
Csuka, D. , Zotter, Z. , Szabó, E. , Kelemen, Z. and Farkas, H.
3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
13:00 - 13:15 2215
Pre-Procedural Administration of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INHnf) for the Prevention of Hereditary Angioedema (HAE) Attacks After Medical, Dental, or
Surgical Procedures
Lumry, W. 1, Busse, P. 2, Baker, J. 3, Davis-Lorton, M. 4, Hurewitz, D. 5, Grant, J. A. 6, White, M. 7, Kalfus, I. 8, Broom,
C. 9 and Mariano, D. 9
1
Allergy and Asthma Specialists, Dallas, TX. 2Mount Sinai School of Medicine, New York, NY. 3Allergy Asthma
& Dermatology Assoc., Lake Oswego, OR. 4Winthrop - University Hospital, Mineola, NY. 5Allergy Clinic of
Tulsa, Inc., Tulsa, OK. 6University Texas Medical Branch, Galveston, TX. 7Institute for Asthma and Allergy,
Wheaton, MD. 8M2G Consulting , New York, NY. 9ViroPharma Incorporated, Exton, PA.
13:15 - 13:30 2216
Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the
Treatment of Hereditary Angioedema (HAE) Attacks
Zuraw, B. 1, Lumry, W. 2, Baker, J. 3, Levy, R. 4, Hurewitz, D. 5, White, M. 6, Craig, T. J. 7, Riedl, M. 8, Busse, P. 9,
Bielory, L. 10, Grant, J. A. 11, Kalfus, I. 12, Broom, C. 13 and Mariano, D. 13
1
Medicine, University of California, San Diego, La Jolla, CA. 2Allergy and Asthma Specialists, Dallas, TX.
3
Allergy Asthma & Dermatology Assoc., Lake Oswego, OR. 4Family Allergy and Asthma Center, PC, Atlanta,
GA. 5Allergy Clinic of Tulsa, Inc., Tulsa, OK. 6Institute for Asthma and Allergy, Wheaton, MD. 7Penn State
University, Hershey, PA. 8Clinical Immunology and Allergy, UCLA - David Geffen School of Medicine, Los
Angeles, CA. 9Mount Sinai School of Medicine, New York, NY. 10University of Medicine and Dentistry
NJ, Newark, NJ. 11University Texas Medical Branch, Galveston, TX. 12M2G Consulting , New York, NY.
13
ViroPharma Incorporated, Exton, PA.
13:30 - 13:45 13:45 - 14:00 2217
Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
2218
Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2
Receptor Antagonist, in Patients with Hereditary Angioedema Due to C1-INH Deficiency
Siani, M. C. 1, Petraroli, A. 2, Bova, M. 3, Loffredo, S. 2 and Triggiani, M. 4
1
Clinical Immunology and Allergy , University of Naples Federico II, Naples, Italy. 2Clinical Immunology and
Allergy, University of Naples Federico II, Naples, Italy. 3Department of Clinical Immunology and Allergy,
University of Naples Federico II, Naples, Italy. 4Division of Allergy and Clinical Immunology and Center for
Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
Bork, K. 1 and Hardt, J. 2
1
Department of Dermatology, University Hospital Mainz, Mainz, Germany. 2Department of Medical
Psychology and Medical Sociology, University Mainz, Mainz, Germany.
58
Final Program
14:00 - 14:15 2219
Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNFα and MMP-9 Release
Falkencrone, S. 1, Poulsen, L. 2, Maurer, M. 3, Bindslev-Jensen, C. 4 and Stahl Skov, P. 5
1
Dpt. of Dermatology - Allergycenter, Odense University Hospital, Odense C, Denmark. 2Region Hovestaden,
Kopenhagen, Denmark. 3Dpt. of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin,
Germany. 4Odense University Hospital, Odense, Denmark. 5Reflab ApS, Copenhagen N, Denmark.
15:00 - 16:30 UNIVERSITY TRAINING PROGRAM 1
CC, 3RD GRAN CANCÚN 1
Harvard University
Adverse Drug Reactions and Managements Chairpersons: Miguel Blanca (Spain)
David Khan (United States)
15:05 - 15:20 1-1UTP Chemo-Therapeutic Agents | Mariana Castells (United States)
15:20 - 15:35 1-2UTP Monoclonal Antibodies | Aleena Banerji (United States)
15:35 - 15:50 1-3UTP Antibiotics | David Khan (United States)
15:50 - 16:05 1-4UTP Non-Steroid Anti-Inflammatory Drugs (NSAIDs) |
Katharine Woessner (United States)
15:00 - 16:30 SYMPOSIUM 7
Allergen Avoidance Strategies
Chairpersons: Antonio Castillo (Dominican Republic)
Harold Nelson (United States)
15:05 - 15:25 7-1SY Dust Mites | Roy Gerth van Wijk (Netherlands)
15:25 - 15:45 7-2SY Storage Mites | Enrique Fernández-Caldas (Spain, United States)
15:45 - 16:05 7-3SY Molds | Jonathan Bernstein (United States)
15:00 - 16:00 DEBATE 2
Small Airways: Are They Important in the Pathogenesis of Asthma?
Chairpersons: Qutayba Hamid (Canada)
Charles Irvin (United States) 15:00 - 15:05 Welcoming Remarks
15:05 - 15:20 2-1DB Pro | Monica Kraft (United States)
15:20 - 15:35 2-2DB Con | Ignacio J. Ansotegui (Spain)
The Small Airways Working Group is sponsored through an unrestricted educational grant from:
59
Final Program
15:00 - 16:30 SYMPOSIUM 8 CC, 3RD, GRAN CANCÚN 4
Mast Cell: The Central Inflammatory Cell
Chairpersons: Elham Hossny (Egypt)
Larry Schwartz (United States)
15:05 - 15:25 8-1SY Mast Cells as Regulators and Effectors | Stephen J. Galli (United States)
15:25 - 15:45 8-2SY Mast Cells, Eosinophils and Nerves | Allison Fryer (United States)
15:45 - 16:05 8-3SY Mast Cells: Novel Ways for Suppression | Francesca Levi-Schaffer (Israel)
15:00 - 16:30 YEAR IN REVIEW 1
Atopic Dermatitis
15:00 - 15:35 1-1YiR Pathophysiology | Mark Boguniewicz (United States)
15:35 - 16:10 1-2YiR Treatment | Peter Schmid-Grendelmeier (Switzerland)
15:00 - 16:30 SYMPOSIUM 9
CC, 2ND, COZUMEL 1
Asthma and COPD: Are They a Spectrum of the Same Disease?
Chairpersons: James Baraniuk (United States)
Yehia El-Gamal (Egypt)
15:05 - 15:25 9-1SY Pathophysiology | Nicola Hanania (United States)
15:25 - 15:45 9-2SY Severe Asthma vs. COPD | Sally Wenzel (United States)
15:45 - 16:05 9-3SY Treatment Responses | Ronald Dahl (Denmark)
CC, 2ND, COZUMEL 2
MSD: Uncontrolled Asthma—Burden, Patient Perceptions and Clinical Implications Chairperson: 15:00 - 15:10 15:10 - 15:25 2-1CSS 15:25 - 15:45 2-2CSS 15:45 - 16:15 2-3CSS 16:15 - 16:30 Jorge Máspero (Argentina)
Chairman’s Welcome and Introduction
Uncontrolled Asthma and Its Burden | Paolo Tassinari (Venezuela)
Bridging the Gap Between Patient Perceptions and Realities in Asthma: Findings from
the Asthma Insight and Management Surveys | Jorge Maspero (Argentina)
Role of New Fixed Dose Combinations in the Management of Uncontrolled Asthma |
Steven Weinstein (United States)
Panel Discussion & Summary
15:00 - 16:00 DEBATE 3
Is the Hygiene Hypothesis Important?
Chairpersons: Robert Lemanske (United States)
Dale Umetsu (United States)
15:05 - 15:20 3-1DB Pro | Tari Haahtela (Finland)
15:20 - 15:35 3-2DB Con | Susan L. Prescott (Australia)
60
Final Program
INTERASMA
Control and Prevention of Asthma Exacerbation CC, 2ND, TULUM
Chairpersons: Carlos E. Baena-Cagnani (Argentina)
You-Young Kim (South Korea)
Carlos Nunes (Portugal)
15:05 - 15:25 5-1SSS Asthma Exacerbation | Louis-Philippe Boulet (Canada)
15:25 - 15:45 5-2SSS Biologic Therapeutics as Preventive Medications | Lawrence DuBuske (United States)
15:45 - 16:05 5-3SSS Asthma Evolution from Childhood to Adulthood | Carlos Nunes (Portugal)
15:00 - 16:30 SYMPOSIUM 10
CC, 2ND, XCARET
Genetic Respiratory Diseases and Their Association with Asthma
Chairpersons: Veronica Giubergia (Argentina)
Marc Peters-Golden (United States)
15:05 - 15:25 10-1SY Alpha1 Antitrypsin | Stephen P. Peters (United States)
15:25 - 15:45 10-2SY Ciliary Dyskinesia | Jose L. Lezana (México)
15:25 - 15:45 10-3SY Cystic Fibrosis | Nelson Rosário (Brazil)
15:00 - 16:30 SYMPOSIUM 11
Pregnancy: Allergic Diseases and Asthma
Chairpersons: Kamal Hanna (Egypt)
15:05 - 15:25 11-1SY Rhinitis and Pregnancy | Glenis Scadding (United Kingdom)
15:25 - 15:45 11-2SY Asthma and Pregnancy | Michael Schatz (United States)
15:45 - 16:05 11-3SY Anaphylaxis and Pregnancy | F. Estelle R. Simons (Canada)
American College of Allergy, Asthma and Immunology
When Food Allergies are Unusual, Unexpected, and Potentially Fatal
Chairperson: 15:00 - 15:05 15:05 - 15:25 15:25 - 15:45 15:45 - 16:05 16:05 - 16:30 Gailen Marshall (United States)
Welcoming Remarks
6-1SSS Atypical Manifestations | Amal Assa’ad (United States)
6-2SSS Non-Ingestant Routes | Sami Bahna (United States)
6-3SSS Food-Induced Anaphylaxis: Diagnosis and Treatment | Dana Wallace (United States)
Discussion
61
Final Program
15:00 - 16:30 WORKSHOP 1
Evidence Based Recommendations for Clinical Practice
WAO Special Committee on Evidence Based Medicine
Chairperson: 15:00 - 15:05 15:05 - 15:20 1-1WS Luigi Terracciano (Italy)
Welcoming Remarks
WAO Position Paper: Diagnosis and Rational for Action against Cows Milk Allergy
(DRACMA) | Holger Schunemann (Canada)
15:20 - 15:35 1-2WS Evidence Based Use of Diagnostic Tests | Jan Brozek (Canada)
15:35 - 15:50 1-3WS DRACMA in Clinical Practice | Alessandro Fiocchi (Italy)
15:00 - 16:30 WORKSHOP 2
Adverse Reactions to Non-Steroid Anti-Inflammatory Drugs (NSAIDS)
15:05 - 15:20 2-1WS Respiratory | Marek L Kowalski (Poland)
15:20 - 15:35 2-2WS Cutaneous | Mario Sánchez-Borges (Venezuela)
15:35 - 15:50 2-3WS Desensitization | Pascal Demoly (France)
15:00 - 16:30 WORKSHOP 3
Update on Vaccinations for the Allergist and Immunologist
15:05 - 15:20 3-1WS Pediatric Considerations | James Oleske (United States)
15:20 - 15:35 3-2WS Geriatric Considerations | Monroe James King (United States)
15:35 - 15:50 3-3WS Adverse Reactions | John Kelso (United States)
15:00 - 16:30 WORKSHOP 4
Management of Asthma Exacerbations
15:05 - 15:20 4-1WS Outpatient Management | Paul O’Byrne (Canada)
15:20 - 15:35 4-2WS Emergency Department Management | Gustavo Rodrigo (Uruguay)
15:35 - 15:50 4-3WS Intensive Care Unit Management | Arturo Gomez-González (México)
15:00 - 16:30 WORKSHOP 5
Skin Prick Testing: What Can We Still Improve?
15:00 - 15:15 5-1WS Which Allergens to Use? | Richard Weber (United States)
15:15 - 15:30 5-2WS Techniques | Désirée Larenas Linnemann (México)
15:30 - 15:45 5-3WS Reporting Results | Paul Greenberger (United States)
15:45 - 16:00 Hands-On Demonstration
16:00 - 16:10 Result Writing
16:10 - 16:30 Case Reports
62
Final Program
15:00 - 16:30 WORKSHOP 6
University Training Program - University of São Paulo
Allergy and Asthma: Risk Factors, Diagnosis and Treatment 15:00 - 15:05 15:05 - 15:20 6-1WS Welcoming Remarks
Risk Factors for Allergy and Asthma in Latin America |
Virginia Paes Leme Ferriani (Brazil)
15:20 - 15:35 6-2WS Cross-Reactive IgE Responses to Invertebrates | L. Karla Arruda (Brazil)
15:35 - 15:50 6-3WS Immunotherapy with Mite Vaccines: Risk Factor for Shrimp Allergy? | Ariana Yang (Brazil)
15:00 - 16:30 WORKSHOP 7
Undergraduate and Postgraduate Training in Allergy: New Developments
WAO Specialty and Training Council
15:00 - 15:05 15:05 - 15:20 7-1WS 15:20 - 15:35 7-2WS Welcoming Remarks
Allergy Education and Training: The WAO White Book on Allergy | Ruby Pawankar (Japan)
WAO Guidelines on Undergraduate Allergy Education and Training |
Paul Potter (South Africa)
15:35 - 15:50 7-3WS WAO Guidelines on Postgraduate Allergy Education and Training |
Connie Katelaris (Australia)
15:00 - 16:30 WORKSHOP 8
Hands-On Session: Pulmonary Function
Speakers:
8-1WS 8-2WS 8-3WS Ticket required to attend
Dennis Ownby (United States)
Robert C. Strunk (United States)
Choon-Sik Park (South Korea)
15:00 - 16:30 WORKSHOP 9
Hands-On Session: Rhinolaryngoscopy (Session 1)
Speakers:
9-1WS 9-2WS Ticket required to attend
Mark Glaum (United States)
Jose A. Sacre - Hazouri (México)
15:00 - 16:30 WORKSHOP 10
The Internet and Allergy
Welcoming Remarks
WAO Resources on the Internet | Juan Carlos Ivancevich (Argentina)
The Internet as a Source of Learning for the Allergist | Ves Dimov (United States)
Can Internet Surveys Help Us Understand Allergic Disorders? |
Martin Penagos (United Kingdom, México)
15:00 - 15:05 15:05 - 15:20 15:20 - 15:35 15:35 - 15:50 10-1WS 10-2WS 10-3WS www.worldallergy.org
63
Final Program
The state of the art in pathophysiology, epidemiology,
diagnosis and treatment
Contents
Anaphylaxis to General Anesthetics: Moneret-Vautrin, D.A.;
History and Epidemiology
History and Classification of Anaphylaxis: Ring, J.; Behrendt, H.;
Anaphylactic Reactions to Local Anesthetics: Ring, J.; Franz, R.;
de Weck, A.
Mertes, P.M.
Brockow, K.
Epidemiology of Anaphylaxis: Worm, M.
Treatment and Prevention
Anaphylaxis: Acute Treatment and Management: Ring, J.;
Mechanisms
T-Cell Response to Allergens: Ozdemir, C.; Akdis, M.; Akdis, C.A.
Anaphylaxis: Mechanisms of Mast Cell Activation: Kalesnikoff, J.;
Epinephrine (Adrenaline) in Anaphylaxis: Simons, F.E.R.; Simons, K.J.
Galli, S.J.
Kinins, Airway Obstruction, and Anaphylaxis: Kaplan, A.P.
Role for Basophils in Systemic Anaphylaxis: Karasuyama, H.;
Tsujimura, Y.; Obata, K.; Mukai, K.
Human Cardiac Mast Cells in Anaphylaxis: Genovese, A.; Rossi, F.W.;
Spadaro, G.; Galdiero, M.R.; Marone, G.
Diagnosis and Clinical Symptomatology
Mastocytosis: Brockow, K.; Metcalfe, D.D.
In vitro Diagnosis of Anaphylaxis: Sanz, M.L.; Gamboa, P.M.;
García-Figueroa, B.E.; Ferrer, M.
Allergens and Elicitors
Insect Venoms: Müller, U.R.
Classification and Pathophysiology of Radiocontrast Media
Hypersensitivity: Brockow, K.; Ring, J.
Analgesics: Szczeklik, A.
www.karger.com/chial
Grosber, M.; Möhrenschlager, M.; Brockow, K.
‘The book provides a thorough overview of anaphylaxis. It is
a concise, to the point review, which helps keep the reader‘s
attention ... I recommend this text to physicians and other
medical professionals primarily because it explains the
rationale for current guidelines used to treat and manage
anaphylaxis through evidence based medicine.’
Ahmed Butt, MD, Univ. of South Florida, Tampa, Fla.
(Website of the World Allergy Organization)
Chemical Immunology and Allergy, Vol. 95
Anaphylaxis
Editor: Ring, J. (Munich)
XXVI + 228 p., 32 fig., 1 in color, 37 tab., hard cover, 2010
CHF 198.– / EUR 165.– / USD 233.00
ISBN 978–3–8055–9441–7
e-ISBN 978–3–8055–9442–4
Prices subject to change
EUR price for Germany, USD price for USA only
KI12212
Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
Speakers:
Motohiro Ebisawa (Japan)
Hugh Sampson (United States)
Practical Considerations for Prescribing Sublingual Immunotherapy (SLIT)
Speakers:
Moises Calderon (United Kingdom)
Giovanni Passalacqua (Italy)
Pruritus: Scratching the Surface
Speakers:
Iris Ale (Uruguay)
James Baraniuk (United States)
León
University Training Program: Universidad Autónoma de Nuevo
Insect Allergy Speakers:
Alfredo Arias-Cruz (México)
Treatment of the Asthmatic Patient Under Age 5
Speakers:
16-1BS 16-2BS 16-3BS Ticket required to attend
Carlos E. Baena-Cagnani (Argentina)
Alfonso Cepeda (Colombia)
Stanley Szefler (United States)
Evaluation of Patients for Antibody Deficiency
Speakers:
Zuhair Ballas (United States)
Sara Espinosa (México)
65
Final Program
Tuesday, 6 December 2011
Scientific Program — Tuesday, 6 December 2011
Exercise-Induced Asthma and Allergic Conditions
Speakers:
Matteo Bonini (Italy)
Kai-Hakon Carlsen (Norway)
Pharmacotherapy for the Geriatric Asthma Patient
Speakers:
Monroe James King (United States)
Anti-IgE: Beyond Asthma
Speakers:
Yehia El-Gamal (Egypt)
07:00 - 08:15 BREAKFAST SYMPOSIUM 21 FAGCB, 1ST, CORAL GARDEN 2
Diagnosis and Management of Anaphylaxis
Speakers:
Cem Akin (United States)
F. Estelle R. Simons (Canada)
Differential Diagnosis of Cough
Speakers:
Pramod Kelkar (United States)
Paul Potter (South Africa)
Specific Immunotherapy (SIT)
Chairpersons: Richard F. Lockey (United States)
08:35 - 09:00 5-1PS Mechanisms | Cezmi Akdis (Switzerland)
09:00 - 09:25 5-2PS Preventions of New Sensitizations and Asthma | Anthony Frew (United Kingdom)
09:25 - 09:50 5-3PS Novel Immunotherapies | Thomas B. Casale (United States)
66
Final Program
CC, 2ND, COZUMEL
Asthma Phenotypes: Implications for Treatment
Chairpersons: You-Young Kim (South Korea)
J. Christian Virchow (Germany)
08:35 - 09:00 6-1PS Eosinophilic/Th2 | Jan Lötvall (Sweden)
09:00 - 09:25 6-2PS Neutrophilic | Monica Kraft (United States)
09:25 - 09:50 6-3PS Pharmacogenetics in Therapy | Elliot Israel (United States)
CC, 1ST, COSTA MAYA
Microbiome: A New Window to Health and Allergic Diseases?
Chairpersons: Tari Haahtela (Finland)
Christopher Karp (United States)
08:35 - 09:00 7-1PS Asthma | Homer Boushey (United States)
09:00 - 09:25 7-2PS Atopic Dermatitis | Richard Gallo (United States)
09:25 - 09:50 7-3PS Sinusitis | Claus Bachert (Belgium)
10:45 - 12:15 SYMPOSIUM 12
Eosinophilic Respiratory Problems
Chairpersons: John Kelso (United States)
Riccardo Polosa (Italy)
10:50 - 11:10 12-1SY
Aspirin-Exacerbated Respiratory Disease (AERD) | Hae-Sim Park (South Korea)
11:10 - 11:30 12-2SY Churg-Strauss Syndrome | John Sleasman (United States)
11:30 - 11:50 12-3SY Allergic Bronchopulmonary Aspergillosis (ABPA) | Paul Greenberger (United States)
10:45 - 11:45 DEBATE 4
Skin Test or In-Vitro Test for Food Allergy?
Chairpersons: Alvaro Cruz (Brazil)
Rudolf Valenta (Austria)
10:50 - 11:05 4-1DB In-Vitro | Motohiro Ebisawa (Japan)
11:05 - 11:20 4-2DB Skin Test | Linda Cox (United States)
11:20 - 11:25 In-Vitro Rebuttal
11:25 - 11:30 Skin Test Rebuttal
67
Final Program
National Institute of Allergy and Infectious Disease (NIAID)
National Heart, Lung and Blood Institute (NHLBI)
Standardizing Outcomes in Asthma Clinical Research
Chairperson: 10:45 - 10:50 10:50 - 11:05 3-1CPS 11:05 - 11:20 11:20 - 11:35 11:35 - 11:50 11:50 - 12:05 12:05 - 12:15 Alkis Togias (United States)
Welcoming Remarks
Standardizing Asthma Outcomes Measures: Overview of the NIH Asthma Outcomes
Project | Alkis Togias (United States)
3-2CPS Defining and Measuring Asthma Exacerbations | David Peden (United States)
3-3CPS Defining and Measuring Asthma Symptoms | Robert Lemanske (United States)
3-4CPS Defining and Measuring Asthma Control | Michael Schatz (United States)
3-5CPS Biomarkers as Outcome Measures in Asthma Clinical Research |
Discussion
10:45 - 12:15 SYMPOSIUM 13
Immunomodulators in Allergic/Immunologic Diseases
Chairpersons: Zuhair Ballas (United States)
Erika Jensen-Jarolim (Austria)
10:50 - 11:10 13-1SY Immune-modulatory Strategies in Severe Atopic Eczema | Johannes Ring (Germany)
11:10 - 11:30 13-2SY Long-Term Use of Omalizumab: Is the IgE Response Modified? | Ulrich Wahn (Germany)
11:30 - 11:50 13-3SY Anticytokine Therapies for Autoinflammatory Diseases | Hal Hoffman (United States)
10:45 - 12:15 SYMPOSIUM 14
Clinical Use of Probiotic Products for Allergy – A WAO Paper
WAO Special Committee on Food Allergy
Chairpersons: A. Wesley Burks (United States)
Rosa Elena Huerta Hernández (México)
10:50 - 11:10 14-1SY Presentation of the WAO Paper | Alessandro Fiocchi (Italy)
11:10 - 11:30 14-2SY The Microbiological Underpinnings | Claudia Traidl-Hoffmann (Germany)
11:30 - 11:50 14-3SY Probiotics and Allergic Diseases | Leonard Bielory (United States)
10:45 - 11:45 DEBATE 5
CC, 2ND, COZUMEL 1
Sublingual Immunotherapy (SLIT) vs Subcutaneous Immunotherapy (SCIT)
Chairpersons: Enrico Compalati (Italy)
Richard Weber (United States)
10:50 - 11:05 5-1DB SCIT | Anthony Frew (United Kingdom)
11:05 - 11:20 5-2DB SLIT | Giovanni Passalacqua (Italy)
11:20 - 11:25 SCIT Rebuttal
11:25 - 11:30 SLIT Rebuttal
68
Final Program
CC, 2ND, COZUMEL 2
Nestle Nutrition Institute: Dietary Prevention and Management
of Allergies in Childhood – An Outlook into the Future
Print CMYK | Blue = C 100% / M 72% / B 18% | Green = C 80% / Y 90%
Chairperson: 10:45 - 10:50 10:50 - 11:10 3-1CSS 11:10 - 11:30 3-2CSS 11:30 - 11:50 3-3CSS 11:50 - 12:15 Ferdinand Haschke (Switzerland)
Welcoming Remarks
Oral Tolerance Induction: Are we any Closer to a Cure for Food Allergy? |
Mimi Tang (Australia)
Treatment and Management of Severe Cases of Food Allergy | Ralf G. Heine (Australia)
Nutrition in Allergic Children: Recommendations and Guidelines |
Christophe Dupont (France)
Panel Discussion
10:45 - 12:15 SYMPOSIUM 15
Patient Education and Treatment Compliance in Allergic Rhinitis
Chairpersons: Eli Meltzer (United States)
Ruby Pawankar (Japan)
10:45 - 10:55 15-1SY Introduction to Allergic Rhinitis Surveys | Ruby Pawankar (Japan)
10:55 - 11:15 15-2SY In Asia Pacific | Connie Katelaris (Australia)
11:15 - 11:35 15-3SY In the United States | Michael S. Blaiss (United States)
11:35 - 11:55 15-4SY In Latin America | R Maximiliano Gómez (Argentina)
Supported through an unrestricted educational grant from Nycomed: A Takeda Company
10:45 - 12:15 SYMPOSIUM 16
CC, 2ND, TULUM
Smooth Muscle and Asthma
Chairpersons: Narasaiah Kolliputi (United States)
10:50 - 11:10 16-1SY Inflammatory Cell | Klaus Rabe (Germany)
11:10 - 11:30 16-2SY Response Element | Reynold A. Panettieri, Jr. (United States)
11:30 - 11:50 16-3SY Thermoplasty | Mario Castro (United States)
10:45 - 12:15 SYMPOSIUM 17
CC, 2ND, XCARET
Neural Mechanisms in Airway Diseases
Chairpersons: Michael A. Kaliner (United States)
Stephen Liggett (United States)
10:50 - 11:10 17-1SY Cough Reflex | Bradley Undem (United States)
11:10 - 11:30 17-2SY Nasal Reflexes | James Baraniuk (United States)
11:30 - 11:50 17-3SY Novel Treatments for Neuromechanisms | Allison Fryer (United States)
69
Final Program
European Academy of Allergy and Clinical Immunology
Phenotypes and Endotypes of Allergic Disease Chairpersons: Cezmi Akdis (Switzerland)
Jan Lötvall (Sweden)
10:50 - 11:10 7-1SSS Molecular Markers of Phenotypes and Endotypes | Ioana Agache (Romania)
11:10 - 11:30 7-2SSS Infection and Asthma Endotypes | Adnan Custovic (United Kingdom)
11:30 - 11:50 7-3SSS Phenotypes of Food Allergy | Maria Antonella Muraro (Italy)
10:45 - 12:15 SYMPOSIUM 18
Hereditary Angioedema (HAE) and the WAO Consensus Document
WAO HAE International Alliance
Chairpersons: Timothy J. Craig (United States)
Michihiro Hide (Japan)
10:50 - 10:55 18-1SY Summary of the WAO Document | Timothy J. Craig (United States)
10:55 - 11:15 18-2SY Pathogenesis | Michael Frank (United States)
11:15 - 11:35 18-3SY Clinical Presentation | Marco Cicardi (Italy)
11:35 - 11:55 18-4SY New Approaches to Treatment | Aleena Banerji (United States)
CC, 1ST, BACALAR
Wake Forest University
Translational Medicine and Personalized Asthma Management
Chairpersons: 10:45 - 10:50 10:50 - 11:05 2-1UTP 11:05 - 11:20 11:20 - 11:35 11:35 - 11:50 11:50 - 12:15 Donata Vercelli (United States)
Sally Wenzel (United States)
Welcoming Remarks
Defining Asthma Susceptibility and Severity with Genomic Medicine |
Deborah Meyers (United States)
2-2UTP Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management |
Eugene R. Bleecker (United States)
2-3UTP Understanding Therapeutic Heterogeneity and Responsiveness in Asthma: Future
Trends | Stephen P. Peters (United States)
2-4UTP Biologic Asthma Therapies and Individualized Medicine |
Discussion
70
Final Program
10:45 - 12:15 SYMPOSIUM 19
Air Pollution and Climate Change and Their Effects on Allergic Respiratory Diseases
WAO Special Committee on Climate Change
Chairpersons: 10:45 - 10:50 10:50 - 11:10 19-1SY Menachem Rottem (Israel)
Juan José Luis Sienra-Monge (México)
Welcoming Remarks
Air Pollution, Climate Change and Extreme Events Leading to Asthma Exacerbations |
Gennaro D’Amato (Italy)
11:10 - 11:30 19-2SY Air Pollution, Climate Change and Hygiene Hypothesis | Ignacio J. Ansotegui (Spain)
11:30 - 11:50 19-3SY Interaction Between Outdoor and Indoor Air Pollution | Thomas Platts-Mills (United States)
12:15 - 14:15 POSTER GROUP 2
PS 16: Asthma
PS 17: Asthma Diagnostic Tools
PS 18: Pathophysiology of Childhood Asthma
PS 19: Pediatric Asthma Treatment
PS 20: Aeroallergen Sensitization
PS 21: Dust Mite Allergy
PS 22: Testing for Sensitization
PS 23: Occupational Allergies
PS 24: Contact Dermatitis
PS 25: Atopic Dermatitis
PS 27: Aspirin-Exacerbated Respiratory Disease
PS 28: Immunotherapy Training
PS 29: Food Allergy Case Reports
PS 30: Food Allergy: Diagnosis and Treatment
PS 31: Eosinophilic Diseases
PS 32: Immunodeficiency
PS 33: Primary Immunodeficiency
PS 34: X-linked and Common Variable Immunodeficiency
PS 35: HIV-Related Problems
CC, 1ST, BACALAR
Allergic Rhinitis
Chairpersons: 12:45 - 13:30 3148
3149
Michael A. Kaliner (United States)
Glenis Scadding (United Kingdom)
Poster Viewing
Allergen Sensitization In Children with Allergic Rhinitis and Asthma In Guatemala
Rigalt, A. M. 1, Maselli, J. P. 1,2, Alvarado, N. 1, Carpio, P. 1, Chur, V. 1, Mayén, P. 1, Morán, E. 1, Pinto, M. 1 and
Rodríguez, J. M. 1
1
Asociación Guatemalteca de Alergia, Asma e Inmunología Clínica, Guatemala, Guatemala. 2Career of
Medicine, Universidad Rafael Landivar, Profesor of Immunology, Guatemala, Guatemala.
The Impact of Breast-Feeding Duration and Mode of Delivery on Allergic Rhinitis in
Korean Children: Cohort of Allergic Rhinitis in Korea (COAR-Korea) Study
Han, D. H. 1, Shin, J. M. 2, Lee, J. 1, Won, T. 1, Kim, D. 1, Lee, C. H. 1, Min, Y. 1 and Rhee, C. 1
1
Otorhinolaryngology, Seoul National University College of Medicine, Seoul, South Korea.
2
Otorhinolaryngology, Soonchunhyang University College of Medicine, Cheonan, South Korea.
71
Final Program
3150
The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis
Media In Atopic Children
Nsouli, S.
Asthma and Allergy, Danville Asthma and Allergy Clinic, California, USA, Danville, CA.
3151
A Study Evaluating the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal
Aerosol In the Relief of Nasal Symptoms of Seasonal Allergic Rhinitis
Howland, W. 1, Ratner, P. 2, Martin, B. 3, Andrews, C. 4, Huang, H. 5, Desai, S. 5 and Bode, F. 5
1
Sirius Clinical Research, Austin, TX. 2Sylvana Research Associates, San Antonio, TX. 3Southwest Allergy
and Asthma Center, San Antonio, TX. 4Diagnostics Research Group, San Antonio, TX. 5Sunovion
Pharmaceuticals, Inc., Marlborough, MA.
3152
Combination of a Nasal Antihistamine Olopatadine and a Leukotriene Receptor
Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients Not
Currently Controlled On Monotherapy Intranasal Antihistamine or a Leukotriene Receptor
Antagonist
Nsouli, S.
3153
Desloratadine Is Safe and Well Tolerated in Adults ³55 Years Old
3154
Augmentation of CXCL10 Expression in Nasal Fibroblasts Derived From Patients with
Recalcitrant Chronic Rhinosinusitis Associated with Bronchial Asthma
Del Carpio, J. 1, Gopalan, G. 2 and Morrison, M. 2
1
McGill University, Montreal, QC, Canada. 2Merck & Co., Kenilworth, NJ.
Yoshikawa, M. 1, Yoshimura, T. 1, Asaka, D. 1, Okada, N. 2, Saito, H. 2 and Moriyama, H. 1
1
Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan. 2National Research
Institute for Child Health & Development, Tokyo, Japan.
3155
Correlation Between Cu/Zn-SOD and Macrophages or MUC5AC in Eosinophilic Chronic
Rhinosinusitis with Nasal Polyps
Ono, N. 1, Kusunoki, T. 1 and Ikeda, K. 2
1
Otorhinolaryngology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
2
Otorhinolaryngology, Juntendo University Faculty of Medicine, Tokyo, Japan.
3156
Relationship Between Allergic Rhinitis and Dental-Facial Abnormalities
Medina, M. A.
Alergia Pediatrica Hospital General Issste Veracruz, Colegio Mexicano De Alergia E Inmunologia Clinica,
Veracruz, México.
Food & Drug Allergy: Late-Breakers
Chairpersons: 12:45 - 13:00 13:00 - 13:15 3157
3158
Emilia María Hidalgo Castro (México)
Daniel Yerly (Switzerland)
Delayed- Type Hypersensitivity to Aminopenicillins: “Hands Desquamation Syndrome”
Miguel Polo, L. D. C.
Allergy, Hospital Virgen del Valle. Toledo., Spain , Spain.
Influence of Transglutaminase and the Reducing Agent Glutathione in the Gastric
Digestion and Immunogenicity of Beta-Lactoglobulin
Vuolo, M. M. 1, Villas-Boas, M. B. 1, Netto, F. M. 1 and Zollner, R. D. L. 2
1
Food and Nutrition, University of Campinas (UNICAMP), Campinas, Brazil. 2Dept.of Clinical Imunology and
Allergy, Faculty of Medical Sciences, UNICAMP, Campinas, Brazil.
13:15 - 13:30 3159
Immediate and no immediate reactions induced by iodinated contrast medium nonionic
among hospitalized patients: incidence and severity
Bedolla-Barajas, M.
Servicio de Alergia e Inmunología Clínica, Hospital Civil de Guadalajara , Guadalajara, México.
13:30 - 13:45 3160
Severe Cutaneus Drug Reactions: Description of a Serie Cases
Fernandes, F. , Camporez, A. , Tanno, L. K. , Curi, S. V. , Perini, P. , Andrade, M. E. , Aun, W. T. and Mello, J. F.
Allergy and Immunology, Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil.
72
Final Program
13:45 - 14:00 3162
Frequency of Sensitization for Food and Aero-Allergens in Patients Recieved in a
Venezuelan Laboratory During 2010-2011 Period
Figueroa, D. 1, Barroso, R. 2, Camacho, N. 1, Najm, C. 1, Guzmán, J. 1, Perdomo, A. 1, García, N. 1 and Silva, N. A. 1
1
Corpodiagnostica´s Laboratory, Caracas, Venezuela. 2Clínica Lepoldo Aguerrevere, Caracas , Venezuela.
Allergen Structure 2
Chairpersons: 12:45 - 13:00 13:00 - 13:15 3163
3164
Heimo Breiteneder (Austria)
Barbara Cases (Spain)
Proteomic and Immunological Characterization of Ragweed Allergens
Augustin, S. 1, Stock, M. 2, Cromwell, O. 3, Nandy, A. 4 and Reese, G. 5
1
Allergopharma Joachim Ganzer KG, Team Leader Laboratory Molecular Biology, 21465 Reinbek, Germany.
2
Allergopharma Joachim Ganzer KG, Lab Technician, 21465 Reinbek, Germany. 3Allergopharma Joachim
Ganzer KG, Head of Research and Development, 21465 Reinbek, Germany. 4Allergopharma Joachim
Ganzer KG, Head of Molecular Biology Research, 21465 Reinbek, Germany. 5Allergopharma Joachim
Ganzer KG, Head of Allergen Research, 21465 Reinbek, Germany.
Proteomic Analysis of Major and Minor Allergens From Isolated Pollen Cytoplasmic
Granules
Abou Chakra, O. 1,2, Sutra, J. 1, Demey Thomas, E. 3, Vinh, J. 3, Poncet, P. 1,4, Lacroix, G. 5 and Sénéchal, H. 1,6
1
LSABM - Allergy and Environment, ESPCI ParisTech, Paris, France. 2R&D, FAREVACARE, Savigny le Temple,
France. 3SMBP - CNRS USR 3149, ESPCI ParisTech, Paris, France. 4Infection and Epidemiology, Institut
Pasteur, Paris, France. 5DRC - TOXI, INERIS, Verneuil-en-Halatte, France. 6CSS 5, INSERM, Paris, France.
13:15 - 13:30 13:30 - 13:45 3165
Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain
3166
Molecular Properties and Immunological Reactivity of Arabidopsis EXPB1, a NonAllergenic Homologue of Grass Group 1 Allergens
Fernandez-Caldas, E. 1, Ibañez, M. D. 2, Cases, B. 1, Fernandez, E. A. 1, Tudela, J. I. 1, Sanchez-Garcia, S. 2,
Rodriguez del Rio, P. 2 and Casanovas, M. 1
1
Research & Development, Inmunotek SL, Madrid, Spain. 2Allergy Section, Hospital Infantil Universitario
Niño Jesús, Madrid, Spain.
Singh, M. , Tiwari, R. and Bhalla, P.
Agriculture and Food Systems, The University of Melbourne, Parkville, Australia.
13:45 - 14:00 3167
Protein-protein interactions determine IgE reactivity to polygalacturonase from
Cupressus sempervirens pollen
Shahali, Y. 1, Sutra, J. 1, Chollet-Martin, S. 2, Haddad, I. 3, Vinh, J. 3, Mari, A. 4, Charpin, D. 5, Sénéchal, H. 1,6 and
Poncet, P. 1,7
1
UMR 7195 LSABM, ESPCI-ParisTech, Paris, France. 2Unity of Immunology Autoimmunity and
Hypersensibility, Bichat Hospital, Paris, France. 3USR 3149 SMBP, ESPCI-ParisTech, Paris, France. 4CMA,
Rome, Italy. 5Hopital Nord de Marseille, Marseille , France. 6CSS 5, INSERM, Paris, France. 7Infection and
Epidemiology, Institut Pasteur, Paris, France.
14:00 - 14:15 3168
Grafting of Bet v 1 Epitopes Onto Its Homologue Api g 1 Reveals Patient-Specific IgE
Recognition Profiles
Gepp, B. 1, Balazs, N. 1, Hemmer, W. 2, Radauer, C. 1 and Breiteneder, H. 1
1
2
Floridsdorfer Allergiezentrum, Vienna, Austria.
73
Final Program
Anaphylaxis
Chairpersons: 12:45 - 13:00 13:00 - 13:15 3169
3170
Felicidad Cua-Lim (Philippines)
F. Estelle R. Simons (Canada)
Immunologic Evaluation of the Patients with Ranitidine Anaphylaxis
Jin, H. 1, Kim, J. 2, Nam, Y. 1, Eui- Kyung, H. 3, Chang, Y. 4, Lee, S. I. 5, Kim, S. 6 and Park, H. 7
1
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon-si, South
Korea. 2Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School
of Medicine, Changwon, South Korea. 3Department of Allergy and clinical immunology, Ajou University
School of Medicine, Suwon, South Korea. 4Department of Internal Medicine, Seoul National University
Bundang Hospital, Seongnam, South Korea. 5Department of Allergy and Clinical Immunology, Ajou
University School of Medicine, Suwon, South Korea. 6Department of Allergy & Clinical Immunology, Ajou
University School of Medicine, Suwon, South Korea. 7Department of Allergy & Clincal Immunology, Ajou
University School of Medicine, Suwon-si, South Korea.
Body Mass Index (BMI) and Immediate (“Stat”) Dose of Epinephrine IM (epi IM) Needed
to Treat Subcutaneous Allergen Immunotherapy (SCIT) Systemic Reactions (SRs)
Alkhalil, M. 1, Shearer, D. 2, Hattaway, S. 2, Fox, R. 1, Glaum, M. 1, Ledford, D. 1 and Lockey, R. F. 1
1
Division of Allergy & Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa,
FL. 2University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL.
13:15 - 13:30 13:30 - 13:45 13:45 - 14:00 14:00 - 14:15 3171
Muscle Relaxant Induced Allergic Reactions
3172
Features of 51 Patients with Perioperative Anaphylaxis History
3173
Drug Induced Anaphylaxis In A University Hospital In Sao Paulo, Brazil
3174
Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian
Pharmacovigilance Database
Hur, G. 1, Hwang, E. 2, Moon, J. 3, Ye, Y. 2, Shim, J. 3, Park, H. 2,4 and Kang, K. 3
1
Internal Medicine, Korea University College of Medicine, Seoul, South Korea. 2Department of Allergy and
Clinical Immunology, Ajou University School of Medicine, Suwon-si, South Korea. 3Internal Medicicne,
Korea Univesity College of Medicine, Seoul, South Korea. 4Department of Allergy & Clincal Immunology,
Ajou University School of Medicine, Suwon-si, South Korea.
Garro, L. S. , Rodrigues, A. T. , Ribeiro, M. R. , Aun, M. V. , Motta, A. A. , Kalil, J. and Giavina-Bianchi, P.
Clinical Immunology and Allergy, University of Sao Paulo, Sao Paulo, Brazil.
Aun, M. V. 1, Rodrigues, A. T. 1, Ribeiro, M. R. 1, Garro, L. S. 1, Castro-Coelho, A. P. 1, Tanno, L. K. 1, Ensina, L. F. C.
2,3
, Kalil, J. 1, Motta, A. A. 1 and Giavina-Bianchi, P. 1
1
Clinical Immunology and Allergy, University of Sao Paulo, Sao Paulo, Brazil. 2Rheumatology, Federal
University of Sao Paulo, Sao Paulo, Brazil. 3Rheumatology, Allergy and Immunology, University of Santo
Amaro, Sao Paulo, Brazil.
Moretti, U. 1, Sottosanti, L. 2, Potenza, S. 2, Boccola, E. 3 and Zanoni, G. 3
1
Clinical Pharmacology Unit, University of Verona, Verona, Italy. 2Italian Medicine Agency,
Pharmacovigilance Office, Rome, Italy. 3Immunology Unit, University Hospital, Verona, Italy.
Global Asthma Epidemiology
Chairpersons:
12:45 - 13:00 13:00 - 13:15 3175
3176
Jing Li (China)
Gailen Marshall (United States)
Recurrent Wheezing In Infancy: Epidemiological Changes Between EISL Phase I and III
Chong Neto, H. J. , Rosario, N. , Silva, F. C. , Bojarski, L. F. M. , Grasselli, E. A. , Rosario, C. S. , Rosario, B. A. and
Chong, F. H.
Asthma Admission Rates in Germany: An Analysis of the Nationwide DRG-Statistic of the
Year 2009
Weyermann, M. , Knorr, S. and Drösler, S. E.
Faculty of Health Care, Niederrhein University of Applied Sciences, Krefeld, Germany.
74
Final Program
13:15 - 13:30 3177
Prevalence and Classification of Asthma In Freshmen Students of A Guatemalan
University and Its Relationship with Aeroallegens Sensitization
Maselli, J. P. 1, Mazariegos, J. 2, Allara, R. 2, Coti, J. 2, Cortave, K. 2, Garcia, M. 2 and Sun, L. 2
1
Career of Medicine, Universidad Rafael Landivar, profesor of Immunology, Guatemala, Guatemala. 2Career of
Medicine, Universidad Rafael Landivar, Student of Medicine, Guatemala, Guatemala.
13:30 - 13:45 13:45 - 14:00 3178
Asthma Mortality in Brazil (1998-2006)
3179
Dose Response Relationship Between Ascaris Sensitisation and Atopy and Bronchial
Hyper-Responsiveness but Not Allergic Diseases in Black South Africans
Souza-Machado, C. 1,2, Souza-Machado, A. 2,3, Coelho, A. C. C. 1,2, Amaral, M. T. R. 4 and Cruz, A. 5
1
School of Nursing, Federal University of Bahia, Salvador, Brazil. 2ProAR - Centro de Excelência em Asma,
Federal University of Bahia, Salvador, Brazil. 3Institute of Science Biomorphology Health Department ,
Federal University of Bahia, Salvador, Brazil. 4State University of Feira de Santana, Salvador, Brazil. 5Medicine,
Faculdade de Medicina, ProAR - Núcleo de Excelência em Asma da Universidade Federal da Bahia,
Salvador, Brazil.
Levin, M. 1, Muloiwa, R. 2, Le Souëf, P. 3 and Motala, C. 4
1
Red Cross Hospital, University of Cape Town, Rondebosch, South Africa. 2University of Cape Town, Cape
Town, South Africa. 3School of Paediatrics and Child Health, University of Western Australia, Perth, Australia.
4
Division of Allergy, University of Cape Town, Cape Town, South Africa.
14:00 - 14:15 3180
Association of Matrix Metalloproteinase-7 and -12 Genes Polymorphisms with Asthma: A
Case-Control Study of MMP-7 and -12 In a Japanese Population
Yamaide, F. 1,2, Mashimo, Y. 1, Shimojo, N. 2, Arima, T. 2, Morita, Y. 2, Hirota, T. 3, Doi, S. 4, Sato, K. 5, Suzuki, S. 5,
Nishimuta, T. 5, Watanabe, H. 5, Hoshioka, A. 6, Tomiita, M. 6, Yamaide, A. 6, Watanabe, M. 7, Okamoto, Y. 8, Kohno,
Y. 2, Tamari, M. 3, Hata, A. 1 and Suzuki, Y. 1
1
Department of Public Health, Graduate School of Medicine, Chiba University, Chiba, Japan. 2Department
of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan. 3Laboratory for Respiratory
Diseases, Center for Genomic Medicine, RIKEN, Yokohama, Japan. 4Osaka Prefectural Medical Center for
Respiratory and Allergic Diseases, Habikino, Japan. 5Department of Pediatrics, National Shimoshizu Hospital,
Yotsukaido, Japan. 6Department of Allergy and Rheumatology, Chiba Children’s Hospital, Chiba, Japan.
7
The First Department of Pediatrics, Toho University Omori Medical Center, Tokyo, Japan. 8Department of
Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hereditary Angioedema
Chairpersons: 12:45 - 13:00 3181
Michael Frank (United States)
Bruce Zuraw (United States)
Hereditary Angioedema and Normal C1-Inhibitor (HAE Type III): A Novel Mutation In the
Coagulation Factor 12 Gene
Bork, K. 1, Wulff, K. 2, Meinke, P. 2, Wagner, N. 3, Hardt, J. 4 and Witzke, G. 5
1
Department of Dermatology, University Hospital Mainz, Mainz, Germany. 2Institute of Human Genetics,
University Greifswald, Greifswald, Germany. 3Department of Dermatology, District Hospital Darmstadt,
Darmstadt, Germany. 4Department of Medical Psychology and Medical Sociology, University Mainz, Mainz,
Germany. 5Department of Dermatology, University Mainz, Mainz, Germany.
13:00 - 13:15 3182
Immuno-Safety of Recombinant Human C1 Inhibitor in Patients with Hereditary
Angioedema: An Integrated Analysis
Hack, E. 1, Relan, A. 2, Kaufman, L. 3 and Pijpstra, R. 2
1
Department of Immunology, Dermatology/Allergology & Reumatology, University Medical Center,
Utrecht, Utrecht, Netherlands. 2Pharming Technologies BV, Leiden, Netherlands. 3Veeda Clinical Research,
Brussels, Belgium.
75
Final Program
13:15 - 13:30 3183
Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary
Angioedema Attacks
Reshef, A. 1, Riedl, M. 2, Moldovan, D. 3, Lockey, R. F. 4, Montinaro, V. 5, Suez, D. 6, Relan, A. 7, Cicardi, M. 8 and
Zuraw, B. 9
1
Head of Allergy and Immunology, Sheba Medical Center, Angioedema Center, Tel Aviv, Israel. 2Clinical
Immunology and Allergy, UCLA - David Geffen School of Medicine, Los Angeles, CA. 3University
of Medicine and Pharmacy, Mures County Hospital, Tirgu Mures, Romania. 4Division of Allergy &
Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 5Azienda
Ospedaliera Policlinico Consorziale di Bari, Bari, Italy. 6Allergy, Asthma & Immunology Clinic, P.A., Irving,
TX. 7Pharming Technologies BV, Leiden, Netherlands. 8Scienze Cliniche “Luigi Sacco”, Università di Milano,
Ospedale L.Sacco, Milano, Italy. 9Medicine, University of California, San Diego, La Jolla, CA.
13:30 - 13:45 3184
Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the
Prophylaxis of Hereditary Angioedema (HAE) Attacks
Zuraw, B. 1, Baker, J. 2, Hurewitz, D. 3, White, M. 4, Vegh, A. 5, Bielory, L. 6, Lumry, W. 7, Riedl, M. 8, Davis-Lorton,
M. 9, Levy, R. 10, Grant, J. A. 11, Busse, P. 12, Banerji, A. 13, Li, H. H. 14, Kalfus, I. 15, Broom, C. 16 and Mariano, D. 16
1
Medicine, University of California, San Diego, La Jolla, CA. 2Allergy Asthma & Dermatology Assoc., Lake
Oswego, OR. 3Allergy Clinic of Tulsa, Inc., Tulsa, OK. 4Institute for Asthma and Allergy, Wheaton, MD. 5Puget
Sound Allergy Asthma and Imm., Tacoma, WA. 6University of Medicine and Dentistry NJ, Newark, NJ.
7
Allergy and Asthma Specialists, Dallas, TX. 8Clinical Immunology and Allergy, UCLA - David Geffen School
of Medicine, Los Angeles, CA. 9Winthrop - University Hospital, Mineola, NY. 10Family Allergy and Asthma
Center, PC, Atlanta, GA. 11University Texas Medical Branch, Galveston, TX. 12Mount Sinai School of Medicine,
New York, NY. 13Massachusetts General Hospital, Boston, MA. 14Institute for Asthma & Allergy, Chevy Chase,
MD. 15M2G Consulting , New York, NY. 16ViroPharma Incorporated, Exton, PA.
13:45 - 14:00 3185
The Efficacy and Safety of Human Plasma-Derived C1-Inhibitor Concentrate
Administered for the Treatment of Attacks in Pediatric Patients with Hereditary
Angioedema Due to C1-Inhibitor Deficiency
Farkas, H. 1, Csuka, D. 1, Zotter, Z. 1, Szabó, E. 1, Kelemen, Z. 1, Varga, L. 1, Fejes, J. 2 and Harmat, G. 2
1
3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary. 2“Heim Pál” Children’s
Hospital, Budapest, Hungary.
14:00 - 14:15 3186
Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant
Lleonart, R. 1, Andres, B. 2, Jacob, J. 3, Pasto, L. 4 and Corominas, M. 5
1
Allergy Unit, Hospital Universitari de Bellvitge , L’Hospitalet Llobregat, Spain. 2Allergy Unit, Hospital
Universitari de Bellvitge, L’Hospitalet Llobregat, Spain. 3Emergency Department, Hospital Universitari
de Bellvitge, L’Hospitalet, Spain. 4Pharmacy Service, Hospital Universitari de Bellvitge, L’Hospitalet de
Llobregat, Spain. 5Allergy Unit, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain.
CC, 2ND, COZUMEL 2
Immunomodulators
Chairpersons: 12:45 - 13:00 13:00 - 13:15 3187
3188
Anthony Frew (United Kingdom)
Jorge Kalil (Brazil)
Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein
Dooper, M. 1, Myrset, H. 1, Egaas, E. 1, Thompson, K. 2 and Bogen, B. 2
1
Norwegian Veterinary Institute, Oslo, Norway. 2University of Oslo and Oslo University Hospital, Oslo, Norway.
Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPs)
As Carriers for B-Cell Vaccines
Jensen-Jarolim, E. 1,2, Szalai, K. 1,3, Thell, K. 1,3, Singer, J. 1,3, Ritter, M. 4, Pfanzagl, B. 1, Willensdorfer, A. 1,3,
Stremnitzer, C. 1 and Michaelis, U. 4
1
Medical University Vienna, Inst. of Pathophysiology and Allergy Research, Vienna, Austria. 2Messerli
Institute Vienna, Veterinary University Vienna, Vienna, Austria. 3Biomedical Int. R+D, Vienna, Austria.
4
MediGene AG, Martinsried, Germany.
13:15 - 13:30 3189
M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application
in Oral Immunotherapy
Diesner, S. C. 1, Schultz, C. 2, Wang, X. 3, Ratzinger, G. 3, Starkl, P. 2, Assmann, V. 2, Kreiner, K. 2, Roth-Walter, F. 2,
Pali, I. 2, Jensen-Jarolim, E. 2, Gabor, F. 3 and Untersmayr, E. 2
1
Medical University of Vienna, Department of Pathophysiology and Allergy Research and Department
of Pedriatics and Adolescent Medicine, Vienna, Austria. 2Medical University of Vienna, Department
of Pathophysiology and Allergy Research, Vienna, Austria. 3University of Vienna, Department of
Pharmaceutical Technology and Biopharmaceutics, Vienna, Austria.
76
Final Program
13:30 - 13:45 13:45 - 14:00 3190
Neisseria Meningitidis Derived Proteoliposome As An Adjuvant for Allergen Vaccines
3191
Immunomodulatory Effects of Manumycin-Type Antibiotics On Human Macrophages
Ramírez González, W. 1, Labrada, A. 2, Bourg, V. 3, González, B. 4, Torralba, D. 5, Más Quintero, A. 1, Pérez, O. 6
and Lastre, M. 6
1
Allergens Laboratory , National Center of Bioproducts, Havana, Cuba. 2Allergens, National Center of
Bioproducts, Havana City, Cuba. 3Department of Biological Tests, National Center of Bioproducts, Havana,
Cuba. 4CENPALAB, Havana, Cuba. 5Allergens Laboratory , National Center of Bioproducts, Havana City,
Cuba. 6Finlay Institute, Havana City, Cuba.
Striz, I. 1, Brabcova, E. 1, Petrickova, K. 2, Kolesar, L. 1, Thorburn, E. 1, Jaresova, M. 1, Sekerkova, A. 1 and Petricek, M. 2
1
Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 2Institute of Microbiology, Academy
of Sciences of Czech Republic, Prague, Czech Republic.
Inhaled Corticosteroids for Asthma
Chairpersons: 12:45 - 13:00 3192
Diana Deleanu (Romania)
A Post-Hoc Analysis of Asthma Control and Lung Function Following Treatment with
Ciclesonide 80 µg HFA-MDI Twice Daily In Subjects with Mild-to-Moderate Persistent
Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol
Meltzer, E. 1, Prenner, B. 2, Desai, S. 3, Karafilidis, J. 3 and Walsh, J. 3
1
Allergy and Asthma Medical Group & Research Center, San Diego, CA. 2Allergy Associates Medical Group,
Inc., San Diego, CA. 3Sunovion Pharmaceuticals, Inc., Marlborough, MA.
13:00 - 13:15 3193
The Particle Size of Mometasone Furoate 100 Mcg and 200 Mcg Dry Powder
Formulations
Berger, R. 1, Li, S. 2 and Staudinger, H. 3
1
Device Development, Merck Research Laboratories, Summit, NJ. 2Merck Research Laboratories,
Kenilworth, NJ. 3Merck Research Laboratories, Merck Sharp & Dohme Corp, Kenilworth, NJ.
13:15 - 13:30 3194
Clinical Efficacy of Once-Daily Mometasone Furoate in Children with Persistent Asthma
Switched From Treatment with Fluticasone Propionate
Weinstein, S. 1, Noonan, M. 2, Berger, W. 3, Staudinger, H. 4 and Teper, A. 5
1
Allergy & Asthma Specialists Medical Group, Huntington Beach, CA. 2Allergy Associates Research Center,
LLC, Portland, OR. 3Allergy & Asthma Associates, Mission Viejo, CA. 4Merck Research Laboratories, Merck
Sharp & Dohme Corp, Kenilworth, NJ. 5Allergy/Respiratory, Merck Research Laboratories, Summit, NJ.
13:30 - 13:45 3195
Inhaled Mometasone Furoate Improved Efficacy in Pediatric Asthma Patients Regardless
of Previous Inhaled Corticosteroid Therapy: Pooled Data From the
Milgrom, H. 1, Berger, W. 2, Meltzer, E. 3 and Teper, A. 4
1
Department of Pediatrics, Ambulatory Pediatric Allergy Program National Jewish Health, Denver, CO. 2Allergy
& Asthma Associates, Mission Viejo, CA. 3Allergy and Asthma Medical Group & Research Center, San Diego,
CA. 4Allergy/Respiratory, Merck Research Laboratories, Summit, NJ.
13:45 - 14:00 3196
Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in
Children
Arablin Oropeza, S. 1, Huerta Lopez, J. 2 and Del Olmo Tellez, H. 3
1
Allergy and Clinical Immunology, Fellow in Training, Instituto Nacional de Pediatría, México City, México.
2
Instituto Nacional De Pediatria, México City, México. 3Allergy, Private Practice, México City, México.
14:00 - 14:15 3197
Mometasone Furoate vs Fluticasone Propionate in Mild Persistent Asthma: Retrospective
Analysis of Asthma Control and Adherence
Navaratnam, P. 1, Friedman, H. 2 and Allen-Ramey, F. 3
1
Eympres Research Llcý, Hilliard, OH. 2Analytic Solutions, LLC, New York, NY. 3Merck & Co., Inc., West Point, PA.
77
Final Program
CC, 2ND, TULUM
Mechanisms of Allergic Inflammation
Chairpersons: 12:45 - 13:00 3199
Mubeccel Akdis (Switzerland)
Hirohisa Saito (Japan)
Type I and III Interferon Are Attenuated in a Human Invitro Model of Alternatively
Activated Macrophages
EL Fiky, A.
Laboratory of Immunobiochemistry, Us Food and Drug Administration, Rockville, MD.
13:00 - 13:15 13:15 - 13:30 13:30 - 13:45 3200
A Highly Sensitive and Specific Universal Mirna Profiling Method
3201
Caspase-4 Plays a Role in the Activation of the Cryopyrin/NLRP3 Inflammasome
3202
Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis
Direction From Autoimmune Diseases
Wang, J. 1, Li, K. 1, Lockey, R. F. 2, Mohapatra, S. 3 and Mohapatra, S. 4
1
Internal Medicine, University of South Florida, Tampa, FL. 2Division of Allergy & Immunology, University
of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 3Nanomedicine Research Center and
Divison of Translational Medicine, Depts of Molecular Medicine and Internal Medicine , University of South
Florida and James V Haley Veterans’ Hospital , Tampa, FL. 4USF Nanomedicine Research Center, University
of South Florida College of Medicine & VA Hospital, Tampa, FL.
Cox Jr., R. 1, Aljubran, S. 2, Lockey, R. F. 3 and Kolliputi, N. 1,4
1
Internal Medicine, University of South Florida, Tampa, FL. 2Allergy and Immunology, University of South
Florida, Tampa, FL. 3Division of Allergy & Immunology, University of South Florida and James A. Haley
Veterans’ Hospital, Tampa, FL. 4Division of Allergy and Immunology.
Li, X. 1, Ampleford, E. 1, Howard, T. 1, Torgerson, D. 2, Li, H. 1, Moore, W. 1, Busse, W. 3, Castro, M. 4, Erzurum, S.
5
, Fitzpatrick, A. 6, Gaston, B. 7, Israel, E. 8, Jarjour, N. 9, Teague, W. G. 7, Wenzel, S. 10, Hawkins, G. 1, Ober, C. 2,
Nicolae, D. 2, Bleecker, E. R. 11 and Meyers, D. 11
1
Center for Genomics and Personalized Medicine Research, Wake Forest University School of Medicine,
Winston Salem, NC. 2Department of Human Genetics, University of Chicago, Chicago, IL. 3Department
of Medicine, University of Wisconsin, Madison, WI. 4Division of Pulmonary and Critical Care Medicine,
Washington University School of Medicine, St. Louis, MO. 5The Lerner Research Institute, Cleveland, OH.
6
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA. 7Department of Pediatrics,
University of Virginia Health Systems, Charlottesville, VA. 8Brigham & Women’s Hospital, Harvard University,
Boston, MA. 9Departments of Medicine and Public Health Sciences, University of Wisconsin Hospitals
and Clinics, Madison, WI. 10Medicine, University of Pittsburgh, Pittsburgh, PA. 11Center for Genomics and
Personalized Medicine Research, Wake Forest School of Medicine, Winston Salem, NC.
13:45 - 14:00
3203
Allergy Is An Epithelial Barrier Disease
Renkonen, R.
Transplantation Laboratory & Infection Biology Research Program, University of Helsinki & Helsinki
University Central Hospital, Helsinki, Finland.
CC, 2ND, XCARET
Patho-Biology of Nasal Polyps
Chairpersons: 12:45 - 13:00 3204
Mark Glaum (United States)
Robert Naclerio (United States)
Mutiplex Analyses of Cytokine and Chemokine Release From the Cultured Fibroblast of
Nasal Polyp: The Effect of IL-17A
Ikeda, K.
Otorhinolaryngology, Juntendo University Faculty of Medicine, Tokyo, Japan.
13:00 - 13:15 3205
Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in
Human Nasal Polyps (NP); Cmparison with NP From Allergic Patients with Aspirin
Intolerance
Fundova, P. 1, Funda, D. 2, Kovar, D. 1 and Tlaskalova-Hogenova, H. 2
1
ENT Department, Central Military Hospital, Prague, Prague 6, Czech Republic. 2Immunology &
Gnotobiology, Institute of Microbiology , Prague 4, Czech Republic.
78
Final Program
13:15 - 13:30 3206
Characterization of Two Epithelial Cell Air-Liquid Interface (ALI) Culture Models for
Human Healthy Nasal Mucosa and Nasal Polyps
Callejas, F. D. B. 1,2, Martínez-Antón, A. 1,2, Roca-Ferrer, J. 1,2, Cortijo, J. 2, Picado, C. 1,2,3 and Mullol, J. 2,4,5,6
Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Hospital Clínic, Barcelona, Spain. 2CIBER
of Respiratory Diseases (CIBERES), Palma de Mallorca, Spain. 3Allergy Unit, Pneumology and Allergy
Department, Hospital Clínic, Barcelona, Spain. 4Clinical and Experimental Respiratory Immunoallergy,
IDIBAPS, Barcelona, Spain. 5Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona,
Spain. 6Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic i Universitari, Barcelona, Spain.
1
13:30 - 13:45 3207
Corticosteroid Treatment Reduces Tissue Eosinophilia and the Expression of Matrix
Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1)
in Nasal Polyps
Callejas, F. D. B. 1,2, Martínez-Antón, A. 1,2, Roca-Ferrer, J. 1,2, Alobid, I. 3, Picado, C. 1,2,4 and Mullol, J. 2,3,5,6
1
Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Hospital Clínic, Barcelona, Spain. 2CIBER of
Respiratory Diseases (CIBERES), Palma de Mallorca, Spain. 3Rhinology Unit & Smell Clinic, ENT Department,
Hospital Clínic, Barcelona, Spain. 4Allergy Unit, Pneumology and Allergy Department, Hospital Clínic,
Barcelona, Spain. 5Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain.
6
Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic i Universitari, Barcelona, Spain.
13:45 - 14:00 14:00 - 14:15 3208
3209
Expression and Localization of CysLT2 Receptor In Human Nasal Mucosa
Hideaki, S. 1, Kanaizumi, E. 1, Fujita, M. 2 and Himi, T. 1
1
Otolaryngology, Sapporo Medical University, Sapporo, Japan. 2Minase Research Institute, Ono
Pharmaceutical, Osaka, Japan.
Increased Expression and Role of Thymic Stromal Lymphopoietin In Nasal Polyposis
Kimura, S. 1, Pawankar, R. 2, Mori, S. 1 and Chika, O. 1
1
Rhinology and Allergy, Nippon Medical School, Tokyo, Japan. 2Allergy and Rhinology, Nippon Medical
School, Tokyo, Japan.
Respiratory Infections
Chairpersons: 12:45 - 13:00 3210
Hyun Hee Kim (South Korea)
Robert C. Strunk (United States)
Inhibition of AKT Kinase Activity Decreases Replication of Human Respiratory Syncytial
Virus
Tran, K. 1,2, Fuentes, S. 3,4, He, B. 3,4 and Teng, M. 1,2
1
Internal Medicine, University of South Florida, Tampa, FL. 2Biochemistry and Molecular Biology, Pennsylvania
State University, University Park, PA. 3Infectious Diseases, University of Georgia, Athens, GA. 4Veterinary and
Biomedical Sciences, Pennsylvania State University, University Park, PA.
13:00 - 13:15 3211
Abnormal Immune Response Against Respiratory Pathogens In Olympic Athletes
Kurowski, M. 1, Jurczyk, J. 2, Jarzebska, M. 1, Moskwa, S. 1, Makowska, J. S. 1, Krysztofiak, H. 2 and Kowalski, M. L. 1
Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Lodz, Poland.
2
National Centre for Sports Medicine (COMS), Warsaw, Poland.
1
13:15 - 13:30 3212
The Immune Response Against Respiratory Pathogens in Patients with Chronic
Rhinosinusitis/Nasal Polyps and Asthma with or without Sensitivity to Aspirin
Olszewska-Ziąber, A. , Jarzębska, M. and Kowalski, M. L.
Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Łódź 91-360, Poland.
13:30 - 13:45 3213
Immunologic and Clinical Characteristics of Pediatric Population with Human Influenza
Virus H1N1 infection in Federal Hospital of México
Mellado-Abrego, J. 1, Gastaldi, D. 2, Mariscal-Martinez, B. 3, Rojo-Gutierrez, M. I. 1, Bermejo, M. 1 and
Sandoval-Hernandez, T. 1
1
Allergy And Immunology, Juarez Hospital, México, México. 2Pediatric , Juarez Hospital, México, México.
3
Internal Medicine, Juarez Hospital México City, México, México.
13:45 - 14:00 3214
Evaluation of Various Forms of Sinusitis Using Bone SPECT
Ulus, S. 1, Tosun, F. 2, Durmaz, A. 2, Gerek, M. 2 and Ulus, S. 3
1
Otorhinolaryngology, Gulhane Military Medical Academy, Ankara, Turkey. 2Otorhinolaryngology , Gulhane
Military Medical Academy, Ankara, Turkey. 3Public Health, Gulhane Military Medical Academy, Ankara, Turkey.
79
Final Program
14:00 - 14:15 3215
Rhinitis: Where Is the Biofilm?
Gelardi, M. 1, Quaranta, N. 1, Fiorella, M. L. 1 and Passalacqua, G. 2
1
Unit of Rhinology and Nasal Cytology, Clinical Otorhynolaringology, University of Bari, Bari, Italy. 2Allergy &
Respiratory Diseases, Universita Degli Studi Di Genova, Genoa, Italy.
Rhinitis Treatment 1
Chairpersons: 12:45 - 13:00 3216
Teet Pullerits (Sweden)
A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal
Aerosol In the Relief of Nasal Symptoms of Perennial Allergic Rhinitis
Mohar, D. 1, Berger, W. 2, Raphael, G. 3, LaForce, C. 4, Huang, H. 5, Desai, S. 5, Bode, F. 5 and Karafilidis, J. 5
1
Kerrville Research Associates, Kerrville, TX. 2Allergy & Asthma Associates, Mission Viejo, CA. 3Asthma,
Allergy & Clinical Research, Bethesda, MD. 4North Carolina Clinical Research, Raleigh, NC. 5Sunovion
13:00 - 13:15 13:15 - 13:30 3217
3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
3218
Levels of VCAM and ICAM In Patients with Allergic Rhino-Conjunctivitis and H1
Antihistamines
Achilles, N. 1, Moesges, R. 1, El Hassan, E. 1, Wein, B. 2 and Schröder, W. 3
1
Institute of Medical Statistics, Informatics and Epidemiology, University Hospital of Cologne, Cologne,
Germany. 2Praxisgemeinschaft im Kapuzinerkarree, Aachen, Germany. 3Institute of Aerodynamics, RWTH
Aachen, Aachen, Germany.
Bujor, I. A. 1, Ioana Corina, B. 2 and Deleanu, D. 3
1
Immunology- Allergology, University of Medicine and Pharmacy , Cluj- Napoca, Romania. 2Pharmacology,
University of Medicine and Pharmacy , Cluj- Napoca, Romania. 3Immunology- Allergology, University of
Medicine and Pharmacy , Cluj- Napoca, Romania.
13:30 - 13:45 3219
Once Daily Intranasal Fluticasone Furoate Decreases Daytime Sleepiness and Improves
Cognitive Performance in Symptomatic Seasonal Allergic Rhinitis
Diaz, A.
Research, Western Sky Medical Research, El Paso, TX.
13:45 - 14:00 3220
International Survey on the Management of Allergic Rhinitis by Physicians and Patients
(ISMAR). Physicians’ View
Badellino, H. A. 1, Teijeiro, A. 2, Gomez, R. M. 1, Zernotti, M. 1, Croce, J. S. 1, Murrieta-Aguttes, M. 3 and BaenaCagnani, C. E. 1
1
CIMER (Centro de Investigación en Medicina Respiratoria). Faculty of Medicine. Catholic University of
Cordoba. Fundación LIBRA Argentina , Cordoba, Argentina. 2CIMER (Centro de Investigación en Medicina
Respiratoria ). Faculty of Medicine. Catholic University of Cordoba. Fundación LIBRA Argentina, Cordoba,
Argentina. 3Sanofi, Paris, France.
14:00 - 14:15 3221
International Survey on the Management of Allergic Rhinitis by Physicians and Patients
(ISMAR): The Patients’ View
Teijeiro, A. 1, Badellino, H. A. 2, Gomez, R. M. 2, Zernotti, M. 2, Croce, J. S. 2, Murrieta-Aguttes, M. 3 and BaenaCagnani, C. E. 2
1
CIMER (Centro de Investigación en Medicina Respiratoria ). Faculty of Medicine. Catholic University of
Cordoba. Fundación LIBRA Argentina, Cordoba, Argentina. 2CIMER (Centro de Investigación en Medicina
Respiratoria). Faculty of Medicine. Catholic University of Cordoba. Fundación LIBRA Argentina , Cordoba,
Argentina. 3Sanofi, Paris, France.
80
Final Program
Sublingual Immunotherapy 2
Chairpersons: 12:45 - 13:00 3222
G. Walter Canonica (Italy)
Linda Cox (United States)
Therapeutic Effect and Safety of the Sublingual Immunotherapy with Tropical House
Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patiens
Castro Almarales,, R. L. 1, Ronquillo Díaz, M. 2, Labrada Rosado, A. 3, Alvarez Castello, M. 4, González León,
M. 5, Rodríguez Canosa, J. S. 6, Enríquez Domínguez, I. 7, Navarro Viltres, B. I. 8, Oliva Díaz, Y. 9 and Mateo
Morejón, M. 10
1
National Center of Bioproducts, Member of WAO, Cuban Society or Allergy, Cuban Society of
Immunology and Cuban Society of Family Medicine , Mayabeque, Cuba. 2Allergy Service, University
Hospital General Calixto García, WAO Member, Cuban Society of Allergy Member, Cuban Society of
Immunology Member, Havana, Cuba. 3Allergen Department, Naitonal Center of Bioproducts, WAO
Member, Cuban Society of Allergy Member, Cuban Society of Immunology, Mayabeque, Cuba.
4
Allergology Department, University Hospital General Calixto García, WAO Member, Cuban Society of
Allergy , Asthma and Clinical Immunology, Member, Cuban Society of Immunology Member, Havana,
Cuba. 5Docent Policlinic Pedro Fonseca, Member of Cuban Society of Family Medicine, Cuban Society
of Allergy, Havana, Cuba. 6Allergy Service, Univesity Hospital General Calixto García, Member of WAO,
Cuban Society of Family Medicine, Cuban Society of Allergy, Havana, Cuba. 7Allergy Service, Univesity
Hospital General Calixto García, Member of Cuban Society of Family Medicine, Cuban Society of Allergy,
Havana, Cuba. 8Cuban Society of Allergy Member, Havana, Cuba. 9Allergen Department, Naitonal Center
of Bioproducts, Member of Cuban Society of Immunology, Mayabeque, Cuba. 10Allergen Department,
Naitonal Center of Bioproducts, Member of Cuban Society of Immunology, Mayabeque, Cuba.
13:00 - 13:15 3223
Candidate for Response Monitoring or Prognostic Biomarkers In Two-Year Sublingual
Immunotherapy for Japanese Cedar Pollinosis
Fujimura, T. 1, Yonekura, S. 2, Horiguchi, S. 2, Sakaguchi, M. 3, Taniguchi, M. 1 and Okamoto, Y. 2
1
Research Center for Allergy and Immunology, Yokohama Institute, RIKEN (The Institute of Physical and
Chemical Research), Kanagawa, Japan. 2Department of Otolaryngology, Head and Neck Surgery, Graduate
School of Medicine, Chiba University, Chiba, Japan. 3Department of Veterinary Microbiology, School of
Veterinary Medicine, Azabu University, Kanagawa, Japan.
13:15 - 13:30 3224
Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets
in US Adults with Grass-Pollen Allergic Rhinoconjunctivitis
Cox, L. 1, Casale, T. B. 2, Nayak, A. 3, Bernstein, D. 4, Creticos, P. 5, Mekhaldi, S. 6, de Beaumont, O. 7, Melac, M. 6,
Montagut, A. 7, Ambroisine, L. 8 and Zeldin, R. K. 6
1
Medicine, Nova Southeastern University , Ft. Lauderdale, FL. 2Creighton University, Omaha, NE. 3Sneeze,
Wheeze, and Itch Associates, LLC, Normal, Normal, IL. 4Division of Immunology, Allergy and Rheumatology,
University of Cincinnati College of Medicine, Cincinatti, OH. 5Johns Hopkins University, Baltimore, MD.
6
Stallergenes SA, Antony, France. 7Stallergenes SA, antony, France. 8stallergenes SA, antony, France.
13:30 - 13:45 3225
Establishing the Effectiveness, Cost-Effectiveness and Safety of Oral and Sublingual
Immunotherapy for Food Allergy: A Systematic Review and Meta-Analysis of
Intervention Studies
Nurmatov, U. 1, Devereux, G. 2 and Sheikh, A. 1
1
Centre for Population Health Sciences, Allergy & Respiratory Research Group, The University of Edinburgh,
Edinburgh, United Kingdom. 2Department of Child Health, Royal Aberdeen Children’s Hospital, The
University of Aberdeen, Aberdeen, United Kingdom.
13:45 - 14:00 3226
Safety of Timothy Grass Allergy Immunotherapy Tablet In North American Adults and
Children
Creticos, P. 1, Blaiss, M. S. 2, Nolte, H. 3, Maloney, J. 3 and Nelson, H. 4
1
Johns Hopkins University, Baltimore, MD. 2University of Tennessee Health Science Center, Memphis, TN.
3
Merck Research Laboratories, Kenilworth, NJ. 4National Jewish Health, Greenwood Village, CO.
14:00 - 14:15 3227
Safety and Tolerability of Timothy Grass Allergy Immunotherapy Tablet In Adults and
Children with Allergic Rhinoconjunctivitis: Post Hoc Analysis of 7 Clinical Trials
Nolte, H. 1, Nelson, H. 2, Durham, S. 3, Blaiss, M. S. 4, Bufe, A. 5, Shneyer, L. 1 and Dahl, R. 6
1
Merck Research Laboratories, Kenilworth, NJ. 2National Jewish Health, Greenwood Village, CO. 3Allergy
and Clinical Immunology, Imperial College London, London, United Kingdom. 4University of Tennessee
Health Science Center, Memphis, TN. 5Ruhr University, Bochum, Germany. 6Aarhus University Hospital,
Aarhus, Denmark.
81
Final Program
15:00 - 16:00 DEBATE 6
Environmental Control for Allergic Diseases: Does it Work?
Chairpersons: David Lang (United States)
Juan Carlos Sisul Alvariza (Paraguay)
15:05 - 15:20 6-1DB Pro | Thomas Platts-Mills (United States)
15:20 - 15:35 6-2DB Con | Adnan Custovic (United Kingdom)
German Society for Allergology and Clinical Immunology
Microbes - Friends or Foes of Allergic Disease? Chairpersons: 15:00 - 15:05 15:05 - 15:25 8-1SSS 15:25 - 15:45 8-2SSS Mubeccel Akdis (Switzerland)
Massimo Triggiani (Italy)
Welcoming Remarks
Role of Skin-Colonizing Microbes in Atopic Dermatitis | Thomas Werfel (Germany)
From Staphylococcus Aureus Enterotoxins to Nasal Polyps and Asthma |
Claus Bachert (Belgium)
15:45 - 16:05 8-3SSS The Role of Microbes in Allergy Protection | Harald Renz (Germany)
15:00 - 16:00 DEBATE 7
Atopic Eczema: Barrier Dysfunction or Immune Deviation?
Chairperson: 15:00 - 15:05 15:05 - 15:20 15:20 - 15:35 15:35 - 15:40 15:40 - 15:45 15:45 - 16:00 Myron Zitt (United States)
Welcoming Remarks
7-1DB Immune Deviation in Atopic Eczema is Crucial | Johannes Ring (Germany)
7-2DB Barrier Dysfunction in Atopic Eczema is Crucial | Richard Gallo (United States)
Barrier Dysfunction Rebuttal
Immune Deviation Rebuttal
Discussion
American Lung Association - Asthma Clinical Research Network
Asthma in the Elderly (AIE): Challenges and Opportunities
Chairpersons: Alvaro Cruz (Brazil)
Shyam Mohapatra (United States)
15:05 - 15:25 4-1CPS Diagnostic and Management Challenges | Nicola Hanania (United States)
15:25 - 15:45 4-2CPS Atopy and Aging: An Ongoing Challenge | Monroe James King (United States)
15:45 - 16:05 4-3CPS Immunologic Changes in Aging | Linda Rogers (United States)
82
Final Program
15:00 - 16:30 SYMPOSIUM 20
Chronic Rhinosinusitis (CRS) in Children
Chairpersons: Juan Carlos Ivancevich (Argentina)
Joel Oyoqui Flores (México)
15:05 - 15:25 20-1SY Is it Allergy or Something Else? | Kai-Hakon Carlsen (Norway)
15:25 - 15:45 20-2SY Clinical Characteristics | Hector Stone-Aguilar (México)
15:45 - 16:05 20-3SY Management | Jose A. Sacre - Hazouri (México)
CC, 2ND, COZUMEL 1
Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology
Food Allergy Chairpersons: 15:00 - 15:05 15:05 - 15:25 9-1SSS Fernando Iduñate-Palacios (México)
José Antonio Ortega Martell (México)
Welcoming Remarks
WAO Position Paper: Diagnosis and Rational for Action Against Cows Milk Allergy
(DRACMA) | Rosa Elena Huerta Hernández (México)
15:25 - 15:45 9-2SSS Risk Factors for Food Allergy for the Latin American Population |
Emilia María Hidalgo Castro (México)
15:45 - 16:05 9-3SSS Food Hypersensitivity and Atopic Dermatitis in Toddlers | Elizabeth Estrada Reyes (México)
CC, 2ND, COZUMEL 2
Robert Michael Education Institute
A Worldwide Perspective on Hereditary Angioedema (HAE): Current Practices,
Evolving Therapies, and Special Populations
Chairpersons: 15:00 - 15:05 15:05 - 15:25 4-1CSS 15:25 - 15:45 4-2CSS 15:45 - 16:05 4-3CSS 16:05 - 16:30 Konrad Bork (Germany)
Michael Frank (United States) Welcoming Remarks
HAE Epidemiology and Worldwide Practices | Marcus Maurer (Germany)
HAE Treatments: Improving Outcomes with Evolving Therapies |
HAE in Special Populations: A Focus on Women and Type III HAE | Marc Riedl (United States)
Panel Discussion
Aetiology of Allergy - Can Africa Help Provide the Answer?
Chairpersons: Sami Bahna (United States)
15:05 - 15:30 10-1SSS Linking Allergy and Asthma - Lessons from Africa | Michael Levin (South Africa)
15:30 - 15:55 10-2SSS Food Allergy in South Africa: Increasing Prevalence | Claudia Gray (South Africa)
15:55 - 16:20 10-3SSS Eosinophilic Esophagitis in South Africa | Michael Levin (South Africa)
83
Final Program
15:00 - 16:30 SYMPOSIUM 21
CC, 2ND, TULUM
The Innate and Adaptive Immune Systems
Chairpersons: Alejandro Escobar-Gutiérrez (México)
James Oleske (United States)
15:05 - 15:25 21-1SY Innate | Elena Perez (United States)
15:25 - 15:45 21-2SY Adaptive Immune System | Cezmi Akdis (Switzerland)
15:45 - 16:05 21-3SY Laboratory Testing | Thomas Fleisher (United States)
15:00 - 16:30 SYMPOSIUM 22
CC, 2ND, XCARET
New Concepts about Occupational Asthma
Chairpersons: Louis-Philippe Boulet (Canada)
15:05 - 15:25 22-1SY Genetic Predisposition | Hae-Sim Park (South Korea)
15:25 - 15:45 22-2SY Pathogenesis | David Peden (United States)
15:45 - 16:05 22-3SY Prevention and Therapy | Jonathan Bernstein (United States)
Korean Academy of Allergy, Asthma and Clinical Immunology
Severe Asthma Chairpersons: Hee-Bom Moon (South Korea)
Ho Joo Yoon (South Korea)
15:05 - 15:25 11-1SSS Clinical Features of Severe Asthma: Korean Cohort Study | You Sook Cho (South Korea)
15:25 - 15:45 11-2SSS Findings from the US Cohort Study | Sally Wenzel (United States)
15:45 - 16:05 11-3SSS Management of Severe Asthma | Heung-Woo Park (South Korea)
Rhinosinusitis
15:00 - 15:35 2-1YiR Pathophysiology | Robert Naclerio (United States)
15:35 - 16:10 2-2YiR Treatment | Glenis Scadding (United Kingdom)
84
Final Program
15:00 - 16:30 SYMPOSIUM 23
CC, 1ST, BACALAR
WAO Junior Members Group
Chairpersons: 15:00 - 15:05 15:05 - 15:20 23-1SY 15:20 - 15:35 15:35 - 15:50 15:50 - 16:05 16:05 - 16:20 16:20 - 16:30 Matteo Bonini (Italy)
Silvia Sánchez-Garcia (Spain)
Welcoming Remarks
How a Protein Becomes an Allergen and an Allergen a Candidate for Correct Diagnosis
and/or Immunotherapy. Ole e 11 as a Model to Study | Guillermo Salamanca (Spain)
23-2SY Allergic Rhinitis and Oral Malocclusion in Children | Claudia Gallego (México)
23-3SY Sensitization to Fungi and its Relation to Asthma and Allergic Rhinitis |
Alexander Díaz Rodríguez (Cuba)
23-4SY Skin Irritation and Allergic Contact Sensitization in Atopic Dermatitis |
Razvigor Darlenski (Bulgaria)
23-5SY Efficacy of Slow Oral Immunotherapy for Cow’s Milk Allergy |
Kiyotake Ogura (Japan)
Discussion
15:00 - 16:30 WORKSHOP 11
Betalactams Reactions
15:00 - 15:05 Introductory Remarks
15:05 - 15:20 11-1WS Diagnosis of Betalactam Sensitivity | Louis Mendelson (United States)
15:20 - 15:35 11-2WSDesensitization | David Khan (United States)
15:35 - 15:50 11-3WS Cross Reactions | Daniel Yerly (Switzerland)
15:00 - 16:30 WORKSHOP 12
Chronic Cough
15:05 - 15:20 12-1WS Mechanisms | James Baraniuk (United States)
15:20 - 15:35 12-2WS Children | Pramod Kelkar (United States)
15:35 - 15:50 12-3WS Adults | Riccardo Polosa (Italy)
15:00 - 16:30 WORKSHOP 13
Severe Cutaneous Drug Reactions
15:00 - 15:05 15:05 - 15:20 13-1WS 15:20 - 15:35 13-2WS Welcoming Remarks
Acute Severe Drug Reactions: Genes to Biomarkers | Miguel Blanca (Spain)
Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Syndrome |
Mariana Castells (United States)
15:35 - 15:50 13-3WS Toxic Epidermal Necrolysis (TEN) and Stevens Johnson Syndrome | Ichiro Katayama (Japan)
85
Final Program
15:00 - 16:30 WORKSHOP 14
Advances in the Diagnosis and Management of Ocular Allergy
15:05 - 15:20 14-1WS Pathophysiology of Conjunctival Inflammation | Sergio Bonini (Italy)
15:20 - 15:35 14-2WS The Clinical Spectrum of Ocular Allergy | Connie Katelaris (Australia)
15:35 - 15:50 14-3WS Ocular Allergy Treatment | Leonard Bielory (United States)
15:00 - 16:30 WORKSHOP 15
Contact Dermatitis in Children
15:05 - 15:20 15-1WS Mechanisms of Allergic Contact Dermatitis | Claudia Traidl-Hoffmann (Germany)
15:20 - 15:35 15-2WS New Contact Allergens | Luz Fonacier (United States)
15:35 - 15:50 15-3WS Contact Dermatitis in Children: Do We Need Regular Patch Testing? | Iris Ale (Uruguay)
15:00 - 16:30 WORKSHOP 16
Obstructive Sleep Disorders in Breathing in Childhood
15:05 - 15:20 16-1WS School and Behavior Problems | Michael S. Blaiss (United States)
15:20 - 15:35 16-2WS Allergic Rhinitis | Timothy J. Craig (United States)
15:35 - 15:50 16-3WS Adenotonsillar Hypertrophy | Athanasios Kaditis (Greece)
15:00 - 16:30 WORKSHOP 17
The Use of Forms and Templates in Office Practice
15:05 - 15:20 17-1WS History, Physical Examination and Skin Testing | Michael A. Kaliner (United States)
15:20 - 15:35 17-2WS Immunotherapy | Dana Wallace (United States)
15:35 - 15:50 17-3WS Patient Information | Désirée Larenas Linnemann (México)
15:00 - 16:30 WORKSHOP 18
University Training Program - University of South Florida
Hands-On Session: Rhinolaryngoscopy (Session #2) Speakers: 18-1WS 18-2WS Ticket required to attend
Roger Fox (United States)
86
Final Program
15:00 - 16:30 WORKSHOP 19
Controversies Surrounding Long-Acting Beta Agonists (LABAs) in Asthma
15:05 - 15:20 19-1WS Safety of LABAs | Jan Brozek (Canada)
15:20 - 15:35 19-2WS Step-Down Therapy | Robert C. Strunk (United States)
15:35 - 15:50 19-3WS Step-Up Therapy | Homer Boushey (United States)
15:00 - 16:30 WORKSHOP 20
Decreasing the Prevalence of Allergic Diseases and Asthma
The WAO World Allergy Action Plan
15:05 - 15:20 20-1WS Changing the Allergy Paradigm - Time to Act | Tari Haahtela (Finland)
15:20 - 15:35 20-2WS Allergy Health in Children | Mika Mäkelä (Finland)
15:35 - 15:50 20-3WS Allergy as an Immune Adaptation Syndrome | Joshua Boyce (United States)
15:00 - 16:30 WORKSHOP 21
Diagnostic Procedures for Rhinitis
Welcoming Remarks
Nasal Challenges | Alkis Togias (United States)
Assessing the Sense of Smell | Joaquim Mullol (Spain)
Clinical Considerations and Quality of Life: Implications for Treatment | Mark Dykewicz
(United States)
15:00 - 15:05 15:05 - 15:20 15:20 - 15:35 15:35 - 15:50 21-1WS 21-2WS 21-3WS www.worldallergy.org
87
Final Program
Wednesday, 7 December 2011
Scientific Program — Wednesday, 7 December 2011
07:00 - 08:15 BREAKFAST SYMPOSIUM 23 FAGCB, GROUND, CORAL GALLERY 1
Topical Treatments of Atopic Dermatitis
Speakers:
Adnan Custovic (United Kingdom)
Tatiana A. Slavyanskaya (Russia)
Claudia Traidl-Hoffmann (Germany)
Clinical and Laboratory Diagnosis of Autoimmune Diseases
Speakers:
James Baker (United States)
Milk Induced Disorders
Speakers:
Amal Assa’ad (United States)
Hirohisa Saito (Japan)
07:00 - 08:15 BREAKFAST SYMPOSIUM 26 FAGCB, LOBBY, CORAL ISLAND
Gastrointestinal (GI) Complaints in Food Allergy
Speakers:
Dan Atkins (United States)
Ichiro Nomura (Japan)
07:00 - 08:15 BREAKFAST SYMPOSIUM 27 FAGCB, LOBBY, CORAL SEA
Sister Society Session - Danish Society of Allergology
Basophil Activation as a Measure of Allergic Response Speakers:
S.G.O. Johansson (Sweden)
Kaare Lund (Denmark)
07:00 - 08:15 BREAKFAST SYMPOSIUM 28 FAGCB, 1ST, CORAL KINGDOM 1
Genes, Allergens and Asthma
Speakers:
Juan Carlos Celedón (United States)
Luis Caraballo (Colombia)
88
Final Program
How to Publish a Scientific Paper
Speakers:
Lanny Rosenwasser (United States)
Larry Schwartz (United States)
Otitis Media
Speakers:
Robert Naclerio (United States)
Choosing a Career Path in Allergy and Immunology
Speakers:
Stanley Fineman (United States)
Cold Induced Skin Disorder
Speakers:
Hal Hoffman (United States)
Marcus Maurer (Germany)
Complementary and Alternative Medicine: Does it Work?
Speakers:
Leonard Bielory (United States)
David Peden (United States)
William Silvers (United States)
Environment and Allergy
Chairpersons: Alfonso Cepeda (Colombia)
Enrique Fernandez-Caldas (Spain, United States)
08:35 - 09:00 8-1PS Allergic Diseases and Climate Change | Jeffrey Demain (United States)
09:00 - 09:25 8-2PS Biodiversity Hypothesis | Tari Haahtela (Finland)
09:25 - 09:50 8-3PS Innate Immunity to Microbes and Allergy | Christopher Karp (United States)
89
Final Program
CC, 2ND, COZUMEL
Obesity and Asthma
Chairpersons: Athanasios Kaditis (Greece)
Revaz I. Sepiashvili (Russia)
08:35 - 09:00 9-1PS Obesity, Airway Hyperresponsiveness and Inflammation | Fernando Holguin (United States)
09:00 - 09:25 9-2PS Does Obesity Influence Medication Response? | Marc Peters-Golden (United States)
09:25 - 09:50 9-3PS Obesity and Asthma Control/Severity | Louis-Philippe Boulet (Canada)
CC, 1ST, COSTA MAYA
New Concepts in Mast Cell Mediators
Chairpersons: Cem Akin (United States)
Mariana Castells (United States)
08:35 - 09:00 10-1PS Novel Leukotriene Receptors | Joshua Boyce (United States)
09:00 - 09:25 10-2PS Tryptase: From Anaphylaxis to Mastocytosis | Larry Schwartz (United States)
09:25 - 09:50 10-3PS Prostaglandin D2 (PGD2): Therapeutic Implications | Andrew Wardlaw (United Kingdom)
Asthma
10:45 - 11:20 3-1YiR Pathophysiology | Sally Wenzel (United States)
11:20 - 11:55 3-2YiR Treatment | Paul O’Byrne (Canada)
10:45 - 12:15 SYMPOSIUM 24
Why are Small Airways Important in Asthma?
Chairpersons: 10:45 - 10:50 10:50 - 11:10 24-1SY 11:10 - 11:30 24-2SY 11:30 - 11:50 24-3SY Ken Ohta (Japan)
J. Christian Virchow (Germany)
Welcoming Remarks
Pathophysiology of Small Airways Disease | Qutayba Hamid (Canada)
Physiology of Small Airways Disease | Charles Irvin (United States)
Particle Deposition and Pharmacotherapy of Small Airways Disease |
Lanny Rosenwasser (United States)
This WAO Symposium is supported through unrestricted educational grants from Nycomed: A Takeda Company and Teva.
90
Final Program
10:45 - 12:15 SYMPOSIUM 25
WAO Anaphylaxis Guidelines
WAO Anaphylaxis Special Committee
Chairpersons: Yehia El-Gamal (Egypt)
Stephen Galli (United States)
10:50 - 11:10 25-1SY Epidemiology | Paul Greenberger (United States)
11:10 - 11:30 25-2SY Clinical Aspects and Diagnosis | Mario Sánchez-Borges (Venezuela)
11:30 - 11:50 25-3SY Treatment | F. Estelle R. Simons (Canada)
Supported through an unrestricted educational grant by:
10:45 - 12:15 SYMPOSIUM 26
Vitamin D: How Important in Allergic Diseases?
Chairpersons: Jeffrey Demain (United States)
Robert Lemanske (United States)
10:50 - 11:10 26-1SY Anaphylaxis | Carlos Camargo (United States)
11:10 - 11:30 26-2SY Asthma | Attilio Boner (Italy)
11:30 - 11:50 26-3SY Viral-Respiratory Infections | Robert C. Strunk (United States)
Southern European Allergy Societies (SEAS)
Immunotherapy Chairpersons: Luigi Fontana (Italy)
Carlos Nunes (Portugal)
10:50 - 11:10 12-1SSS Safety and Efficacy with Polimerized Extracts | Ignacio J. Ansotegui (Spain)
11:10 - 11:30 12-2SSS Omalizumab Plus Immunotherapy | Mario Morais de Almeida (Portugal)
11:30 - 11:50 12-3SSS Economical Impact | Massimo Triggiani (Italy)
10:45 - 12:15 SYMPOSIUM 27
CC, 2ND, COZUMEL 1
2013 EAACI-WAO World Allergy & Asthma Congress - Milan, Italy
Novel and Emerging Therapeutic Strategies for Allergy and Asthma
Chairpersons: 10:45 - 10:50 10:50 - 11:10 27-1SY Cezmi Akdis (Switzerland)
Ruby Pawankar (Japan)
Welcoming Remarks
Immunomodulators - A Brave New World |
Zuhair Ballas (United States)
11:10 - 11:30 27-2SY Inducing Immune Tolerance to Allergens - Implications for Treatment |
11:30 - 11:50 27-3SY Preventive Strategies | Susan L. Prescott (Australia)
91
Final Program
CC, 2ND, COZUMEL 2
National Heart, Lung and Blood Institute (NHLBI) Clinical Research Network
New Findings on the Stepwise Approach to Managing Asthma
Chairpersons: 10:45 - 10:50 10:50 - 11:10 5-1CPS 11:10 - 11:30 5-2CPS 11:30 - 11:50 5-3CPS Thomas B. Casale (United States)
James Kiley (United States)
Welcoming Remarks
Step Up Therapy in Children | Daniel Jackson (United States)
Adjusting Therapy in Adults | Elliot Israel (United States)
Intermittent Versus Daily Inhaled Corticosteroid Therapy in Children |
Fernando D. Martinez (United States)
Venezuelan Society of Allergy and Immunology: Genetic and Epigenetic
Implications in Allergic and Asthmatic Latin Americans Chairperson: 10:45 - 10:50 10:50 - 11:10 11:10 - 11:30 11:30 - 11:50 11:50 - 12:15 Luis Sarmiento (Venezuela)
Welcoming Remarks
13-1SSS Genetics | Paolo Tassinari (Venezuela)
13-2SSS Prescription Patterns | Fernán Caballero-Fonseca (Venezuela)
13-3SSS Specific Immunotherapy | Eliana Risquez (Venezuela)
Discussion
10:45 - 12:15 COLLABORATING PARTNER SYMPOSIUM 6 CC, 2ND, XCARET
Insights from the Global Allergy and Asthma Network (GA²LEN)
Chairpersons: Marek L Kowalski (Poland)
Joaquim Mullol (Spain) 10:45 - 10:50 Welcoming Remarks
10:50 - 11:10 6-1CPS Can the Severity of Allergy be Uniformly Defined? | Sergio Bonini (Italy)
11:10 - 11:30 6-2CPS GA²LEN in Europe and Beyond | Torsten Zuberbier (Germany)
11:30 - 11:50 6-3CPS GA²LEN, WAO and Guidelines | G. Walter Canonica (Italy)
10:45 - 11:45 DEBATE 8
Genetically Modified Foods: Are They a Problem?
Chairpersons: Thomas Holzhauser (Germany)
Hugh Sampson (United States)
10:50 - 11:05 8-1DB Pro | Dan Atkins (United States)
11:05 - 11:20 8-2DB Con | Amal Assa’ad (United States)
92
Final Program
10:45 - 12:15 SYMPOSIUM 28
Immunobiologic Approaches in Allergy
Chairpersons: Hal Hoffman (United States)
Riccardo Polosa (Italy)
10:50 - 11:10 28-1SY Translational Research and Immunomodulators in Allergy | Jorge Kalil (Brazil)
11:10 - 11:30 28-2SY Anti-IgE Use in Allergy | Pedro Giavina-Bianchi (Brazil)
11:30 - 11:50 28-3SY Anti-Eosinophil Strategies | Seema Aceves (United States)
10:45 - 11:45 DEBATE 9
Long-Acting Beta Agonists (LABAs) vs. Tiotropium for Asthma
Chairpersons: Allison Fryer (United States)
Reynold A. Panettieri, Jr. (United States)
10:50 - 11:05 9-1DB LABAs | Klaus Rabe (Germany)
11:05 - 11:20 9-2DB Tiotropium | Mario Castro (United States)
11:20 - 11:25 LABAs Rebuttal
11:25 - 11:30 Tiotropium Rebuttal
12:15 - 14:15 POSTER GROUP 3 CC, 1ST, POSTER HALL
PS 36: Epidemiology of Allergic Rhinitis
PS 37: Diagnostic Test for Allergic Rhinitis
PS 38: Allergic Rhinitis
PS 39: Conjunctivitis
PS 40: Mastocytosis
PS 41: Anaphylaxis
PS 42: Radiocontrast Media Allergy
PS 43: Hereditary Angioedema
PS 44: Urticaria
PS 45: Urticaria Treatment
PS 46: Urticaria Case Reports
PS 47: Autoimmunity Case Reports
PS 48: Autoimmunity
PS 49: Allergies in Other Diseases
PS 50: Asthma Epidemiology
PS 51: Quality of Life Measures in Asthma and Allergic Diseases
PS 52: Health Outcomes for Asthma
PS 53: Severe and Fatal Asthma
93
Final Program
CC, 1ST, BACALAR
Immunotherapy
Chairpersons:
12:45 - 13:30 4146
Harold Nelson (United States)
Poster Viewing
AAAAI Survey On Immunotherapy Practice Patterns Concerning Dosing, DoseAdjustment After Missed Doses and Duration of Immunotherapy
Larenas Linnemann, D. 1, Gupta, P. 2, Mithani, S. 3 and Ponda, P. 3
1
Allergy, Hospital Médica Sur, México DF, México. 2Allergy and Immunology department, SUNY
Downstate/ Long Island College Hospital, New York, NY. 3Division of Allergy and Immunology, NSLIJ Health
System, Great Neck, NY.
4147
4148
4149
Development of A National Guideline On Skin Testing and Immunotherapy
Larenas Linnemann, D. 1, Ortega Martell, J. A. 2, del Rio, B. 3, Rodriguez-Perez, N. 4, Arias-Cruz, A. 5 and
Estrada, A. 6
1
Allergy, Hospital Médica Sur, México DF, México. 2Medicina, Universidad autónoma del Estado de Hidalgo,
Pachuca, México. 3Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez,
México City, México. 4State Autonomous University of Tamaulipas, H. Matamoros, TAM., México. 5Allergy
and Clinical Immunology, University Hospital UANL, Monterrey, México. 6Private practice, Playa del
Carmen, México.
Efficacy of Mite Sublingual Immunotherapy In 130 Children with Atopic Dermatitis
Tang, J.
Dermatology, Hunan Children’s Hospital, Changsha,Hunan, China.
Down Regulation of Allergic Inflammation with Allergy Vaccine Timpol In A Murine
Model of Asthma
Shilovskiy, I. , Babakhin, A. , Khaitov, M. and Martinov, A.
National Research Center - Institute of Immunology, Moscow, Russia.
4150
Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual
Immunotherapy in Mite-Allergic Children: A Randomized Double-Blind, PlaceboControlled Study in Brazil
Queirós, M. 1, Silva, D. 1, Siman, I. 1, Ynoue, L. 1, Araújo, N. 1, Pereira, F. 2, Almeida, K. 2, Miranda, J. 2, Pena, J. 3
and Taketomi, E. 1,2
1
Laboratory of Allergy and Clinical Immunology, Federal University of Uberlândia, Uberlândia, Brazil.
2
Alergia e Imunologia Clínica, Laboratório de Investigação em Alergia Ltda, Uberlândia, Brazil. 3Division of
Medical Research, Bayer Health Care, São Paulo, Brazil.
4151
Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting
4152
Long Term Follow-up After Completion of Inhalant Allergen-Specific Subcutaneous
Immunotherapy
Hadler, M. 1, Schnitzer, S. 2, Schnitker, J. 3 and Sieber, J. 1
1
Medical Department, Stallergenes GmbH, Kamp-Lintfort, Germany. 2Private Office, Grevesmuehlen,
Germany. 3Institut für angewandte Statistik, Bielefeld, Germany.
Nocon, C. 1, Yoo, E. 1, Namiranian, M. 2 and Corey, J. 1
1
Section of Otolaryngology Head and Neck Surgery, University of Chicago Medical Center, Chicago, IL.
2
Otolaryngology, Massachusetts General Hospital, Quincy, MA.
4153
Long-Term Clinical Efficacy of Immunotherapy in Rhino-Conjunctivitis with Pollen
Extract
Nunes, C. and Ladeira, S.
Center of Allergy of Algarve, Portimao, Portugal.
4154
IgE/IgG4 Ratio As a Possible Surrogate Marker of Clinical Efficacy During AllergenSpecific Immunotherapy with House Dust Mite Vaccines
Labrada, A. 1, Mateo, M. 1 and Naranjo, R. 2
1
Allergens, National Center of Bioproducts, Mayabeque, Cuba. 2Alllergy, “Joaquin Albarran” Hospital,
Havana, Cuba.
94
Final Program
4155
Allergy Training and Immunotherapy in Latin America: How Survey-results lead to a
Regional Overview
Gomez, R. M. 1, Larenas-Linnemann, D. 2, Passalacqua, G. 3, Gonzalez Diaz, S. N. 4, Croce, V. H. 5, Canonica, G.
W. 6 and Baena-Cagnani, C. E. 7
1
Centro Investigacion Medicina Respiratoria (CIMER-UCC), Salta, Argentina. 2Latin American Society of
Allergy, Asthma & Immunology, México DF, México. 3Universita Degli Studi Di Genova, Liguria, Italy. 4Latin
American Society of Allergy, Asthma & Immunology, Monterrey, México. 5Centro Investigacion Medicina
Respiratoria (CIMER-UCC), Cordoba, Argentina. 6Allergy & Respiratory Diseases, Universita Degli Studi Di
Genova, Genova, Italy. 7CIMER (Centro de Investigación en Medicina Respiratoria). Faculty of Medicine.
Catholic University of Cordoba. Fundación LIBRA Argentina , Cordoba, Argentina.
4156
Clinical Effects of Immunotherapy in Patients with Allergic Disease in the National
Institute of Respiratory Diseases
Gonzalez Galarza, M. D. R. , Garcia Cruz, M. D. L. L. , Ramirez Jimenez, F. , Ruiz Cervantes, K. P. , Najera
Villatoro, C. G. and Teran Juarez, L. M.
Clinical Immunology and Allergy , National Institute of Respiratory Disease, Distrito Federal, México.
4157
Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent
Allergic Rhinitis
Fiocchi, A. 1, Passalacqua, G. 2, Bonini, S. 3, Frati, F. 4, Terracciano, L. 1, Seneci, S. 5 and Mazzina, O. 1
1
Melloni Paediatria, Milano, Italy. 2Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genoa,
Italy. 3Second University of Naples, Rome, Italy. 4Department of Medical and Surgical Specialties and Public
Health, Perugia, Perugia, Italy. 5Allegria, Milan, Italy.
4158
Compliance and Persistence to Grass Immunotherapy Treatment Is Comparable for Allergy
Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study
Andreasen, J. N. 1, Lawton, S. 2, Bæch, S. B. 3 and Svärd, M. 4
1
Market Access, ALK-Abelló, Hørsholm, Denmark. 2Medical Advice, ALK-Abelló, Hørsholm, Denmark. 3Global
Clinical Development, ALK-Abelló, Hørsholm, Denmark. 4Market Access, ALK Nordic, Kungsbacka, Sweden.
Atopic Dermatitis 2
Chairpersons: 12:45 - 13:00 13:00 - 13:15 4159
4160
Mona Al-Ahmad (Kuwait)
Elizabeth Estrada Reyes (México)
The Risk of Atopic Dermatitis in Children Exposed to Pets During Pregnancy
Vasu, N. 1, Wegienka, G. 2, Havstad, S. 2, Johnson, C. C. 3 and Zoratti, E. 4
1
Allergy Immunology, Henry Ford Health System, Birmingham, MI. 2Public Health Sciences, Henry Ford
Hospital & Health System, Detroit, MI. 3Public Health Sciences, Henry Ford Health System, Detroit, MI.
4
Allergy and Immunology, Henry Ford Hospital & Health System, Detroit, MI.
Economic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic
Dermatitis: Results From 5 European Countries
Detzel, P. 1, Spieldenner, J. 1, Navarro, V. 2, Berbari, J. 3 and Iskedjian, M. 3
1
Health Economics, Nestlé Nutrition Institute, Vevey, Switzerland. 2PharmIdeas Europe SAS, Lyon, France.
3
PharmIdeas Research and Consulting Inc., Ottawa, ON, Canada.
13:15 - 13:30 13:30 - 13:45 4161
4162
Prevalence and Associated Risk Factors for Atopic Dermatitis Symptoms in Mexican Children
Sandoval-Ramírez, E. 1, del Rio, B. 2, del Rio, J. 2, Pietropaolo-Cienfuegos, D. 2, Rosas-Vargas, M. A. 2, Avila, L. 2,
González-Díaz, S. 3, García-Almaraz, R. 4, Merida Palacios, J. V. 5, Romero Tapia, S. D. J. 6, Linares Zapien, F. J. 7 and
Escalante Dominguez, A. 8
1
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México “Federico Gomez”, México, México.
2
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez, México City,
México. 3Hospital Universitario, Medical School, Universidad Autónoma de Nuevo León, Monterrey, México.
4
COMPEDIA, Tamaulipas, México. 5Mexicali Health Care, Mexicali, México. 6Hospital Angeles Villahermosa,
Villahermosa, México. 7COMPEDIA, Toluca, México. 8Hospital General de Rosarito, Tijuana, México.
Involvement of Human Histamine N-Methyltransferase Gene Polymorphisms in
Susceptibility to Atopic Dermatitis in Korean Children
Lee, H. S. 1, Kim, K. 2 and Lee, Y. J. 3
1
Department of Pediatrics and Institute of Allergy, Yonsei University College of Medicine, Seoul, South
Korea. 2Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea. 3Pediatrics,
Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea.
95
Final Program
13:45 - 14:00 4163
Circadian Regulation of Scratching Behavior in NC/Tnd Mice, a Mouse Model for Human
Atopic Dermatitis
Ohmori, K. , Tanaka, A. , Matsuda, A. and Matsuda, H.
Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan.
14:00 - 14:15 4164
Metallic Soap Aggravates Skin Conditions in Patients with Atopic Dermatitis and a
Mouse Model for Human Atopic Dermatitis, NC/Tnd Mice
Tanaka, A. 1, Matsuda, A. 1, Makita, Y. 2, Takai, M. 2, Ohmori, K. 1 and Matsuda, H. 1
1
Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan. 2Miura CO., LTD., Matsuyama, Ehime,
Japan.
Childhood Asthma and Allergies
Chairpersons: 12:45 - 13:00 13:00 - 13:15 4165
4166
S.G.O. Johansson (Sweden)
Mika Mäkelä (Finland)
The Allergic March Resolved At Allergen Component Level
Melioli, G. 1, Marcomini, L. 1, Agazzi, A. 1, Bazurro, G. 1, Rossi, L. 1, Tosca, M. 2, Minale, P. 3, Rossi, R. 4,
Passalacqua, G. 5 and Canonica, G. W. 6
1
Laborario Centrale di Analisi, Istituto Giannina Gaslini, Genoa, Italy. 2UO Pediatria ad indirizzo
penumologico ed allergologico, Istituto Giannina Gaslini, Genoa, Italy. 3Allergologia, AOU San Martino,
Genoa, Italy. 4Rete di Allergologia Regione Piemonte, Azienda Sanitaria Cuneo 1, Cuneo, Italy. 5Allergy
& Respiratory Diseases, Universita Degli Studi Di Genova, Genoa, Italy. 6Allergy & Respiratory Diseases,
Universita Degli Studi Di Genova, Genova, Italy.
Prevalence of Wheezing and Risk Factors Associated to Wheezing in Infants in the First
Year of Life, Cuiabá, MT, Brazil
Moraes, L. S. L. 1, Takano, O. A. 2 and Solé, D. 1
1
Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil. 2Department of Pediatrics,
Federal University of Mato Grosso, Cuiabá, Brazil.
13:15 - 13:30 4167
Specific IgE Sensitisation In A Six-Year Old Infant Cohort In New Zealand
Siebers, R. 1, Lampshire, P. 1, Wickens, K. 1, Ingham, T. 1, Epton, M. 2, Town, I. 3 and Crane, J. 1
University of Otago, Wellington, New Zealand. 2University of Otago, Christchurch, New Zealand.
3
University of Canterbury, Christchurch, New Zealand.
1
13:30 - 13:45 4168
Risk Factors Associated to Wheezing In Mexican Children. A Multicentric ISAAC-Based
Survey Study
Partida-Gaytan, A. 1, del Rio, B. 1, Pietropaolo-Cienfuegos, D. 1, del Rio, J. 1, Avila, L. 1, Merida Palacios, J. V. 2,
Romero Tapia, S. D. J. 3, Linares Zapien, F. J. 4, Escalante Dominguez, A. 5, González-Díaz, S. 6, García-Almaraz,
R. 7 and Carvajal Abdala, S. 8
1
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez, México City,
México. 2Mexicali Health Care, Mexicali, México. 3Hospital Angeles Villahermosa, Villahermosa, México.
4
COMPEDIA, Toluca, México. 5Hospital General de Rosarito, Tijuana, México. 6Hospital Universitario, Medical
School, Universidad Autónoma de Nuevo León, Monterrey, México. 7COMPEDIA, Tamaulipas, México.
8
COMPEDIA, Veracruz, México.
13:45 - 14:00 4169
Association Between Eosinophil Apoptosis in Induced Sputum and Asthma Severity in
Children
Nakonechna, A. 1, Antipkin, Y. 2, Umanets, T. 2, Lapshyn, V. 2 and Zadorozhnaja, T. 2
1
Allergy, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Neston, United Kingdom.
2
Institute of Paediatrics, Obstetrics and Gynaecology, Kiev, Ukraine.
14:00 - 14:15 4170
Antibiotics but Not Paracetamol Reduce the Risk for Recurrent Wheezing in Infants
Chong Neto, H. J. , Rosario, N. , Silva, F. C. , Bojarski, L. F. M. , Grasselli, E. A. , Rosario, C. S. , Rosario, B. A. and
Chong, F. H.
96
Final Program
Cytokines and Chemokines
Chairpersons: 12:45 - 13:00 4171
Hypoxia-Inducible Factor 1 (HIF-1) Transcription Is a “Signalling Driver” for Allergic
Inflammation, Host Innate Immune Defence and Leukaemia Progression
Sumbayev, V. , Yasinska, I. and Gibbs, B.
Medway School of Pharmacy, University of Kent, Chatham Maritime, United Kingdom.
13:00 - 13:15 4172
Keratinocytic Thymic Stromal Lymphopoietin Plays An Important Role in Epicutaneous
Sensitization and the Atopic March
Leyva Castillo, J. M. , Hener, P. , Jiang, H. , Metzger, D. , Chambon, P. and Li, M.
Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS
UMR-7104/INSERM U964/UdS, Illkirch CEDEX, France.
13:15 - 13:30 13:30 - 13:45 4173
Pivotal Role of Intestinal Interleukin-17-Producing Gammadeltat Cells In the Food Allergy
4174
Effect of Formoterol on Eosinophil Trans-Basement Migration Induced by Interleukin-8Stimulated Neutrophils
Nakagawa, R.
Immunology, University of Yamanashi, Faculty of Medicine, Chuoh, Japan.
Kawashima, A. , Nishihara, F. , Kobayashi, T. , Nakagome, K. and Nagata, M.
Allergy Center , Department of Respiratory Medicine, Saitama Medical University, Moroyama-Machi, Japan.
Drug Allergy
Chairpersons: 12:45 - 13:00 13:00 - 13:15 4175
4176
Luis Felipe Chiaverini Ensina (Brazil)
David Khan (United States)
Characteristics of Liver Injury in Drug-Induced Systemic Hypersensitivity Reactions
Park, C. S. 1, Lee, T. 2, Lee, Y. S. 2, Kwon, H. 2, Kim, S. 2, Yoon, S. 2, Bae, Y. 2, Kim, T. 2, Cho, Y. S. 2 and Moon, H. 2
1
Department of Internal Medicine, Inje university Heaundae Paik Hospital, Busan, South Korea.
2
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of
Medicine, Seoul, South Korea.
Outcomes of Reintroducing Antituberculous Drugs Following Cutaneous Adverse Drug
Reactions
Lehloenya, R.
Medicine, University of Cape Town, Cape Town, South Africa.
13:15 - 13:30 13:30 - 13:45 13:45 - 14:00 4177
Penicillin - Diagnosis of Allergy
4178
Clinical Features and Risk Factors of Oxaliplatin Hypersensitivity in Koreans
4179
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): What We Still Have to
Learn?
Hjortlund, J.
Dermatology and Allergy Centre, Odense University hospital, junior membership, 5000 Odense C, Denmark.
Kim, M. 1, Kim, M. 2, Kim, W. K. 3, Kim, S. 4, Kim, S. 2, Song, W. 2, Park, H. 2, Kwon, J. 5, Yang, M. 2, Jung, J. 2, Lee, K. 6,
Cho, S. 2, Min, K. 2, Kim, Y. 7, Kim, J. H. 8 and Chang, Y. 4
1
Internal Medicine, Seoul National Univesity College of Medicine, Seoul, South Korea. 2Department of Internal
Medicine, Seoul National University College of Medicine, Seoul, South Korea. 3Asthma & Allergy, Dongguk
University Ilsan Hospital, Goyang, South Korea. 4Department of Internal Medicine, Seoul National University
Bundang Hospital, Seongnam, South Korea. 5Internal Medicine, Kangwon National University, Choonchun,
South Korea. 6Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
7
Department of Internal medicine, division of allergy and clinical immunology, National Medical Center,
Seoul, South Korea. 8Seoul National Univesity College of Medicine, Seongnam, South Korea.
Tanno, L. K. 1,2, Dracoulakis, M. 3, Ensina, L. F. C. 4,5, Giavina-Bianchi, P. 1, Kalil, J. 1, Aun, W. T. 2, Mello, J. F. 2 and
Motta, A. A. 1
1
Clinical Immunology and Allergy, University of Sao Paulo, Sao Paulo, Brazil. 2Allergy and Immunology,
Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil. 3Allergy, Hospital Servidor Público
Estadual de São Paulo, São Paulo, Brazil. 4Rheumatology, Federal University of Sao Paulo, Sao Paulo, Brazil.
5
Rheumatology, Allergy and Immunology, University of Santo Amaro, Sao Paulo, Brazil.
97
Final Program
Food Allergy
Chairpersons: 12:45 - 13:00 4180
Sami Bahna (United States)
Kyu-Earn Kim (South Korea)
Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent
Egg-Allergic Patients
Roth-Walter, F. 1, Starkl, P. 2, Zuberbier, T. 3, Brunner, R. 2, Pali-Schöll, I. 2, Kinkel, J. 2, Felix, F. 2, Jensen-Jarolim, E.
2
and Kinaciyan, T. 4
1
Department of Pathophysiology and Allergy Research , Medical University of Vienna, Vienna, Austria.
2
3
Clinic for Dermatology, Venereology and Allergology, Charité – Universitätsmedizin Berlin, Berlin,
Germany. 4DIAID, Department of Dematology , Medical University of Vienna, Vienna, Austria.
13:00 - 13:15 4181
The Choice of Hypoallergens for Fish and Peach to Develop Food Allergy Specific
Immunotherapy (The FAST Project)
Zuidmeer-Jongejan, L. 1, Versteeg, S. 1, Poulsen, L. 2, Fernandez-Rivas, M. 3, Kowalski, M. L. 4, Papadopoulos,
N. 5, Mari, A. 6, Swoboda, I. 7, Clausen, M. 8, Bindslev-Jensen, C. 9, Neubauer, A. 10, Koppelman, S. 11, Mills, C. 12,
Asturias, J. A. 13 and van Ree, R. 14
1
Experimental Immunology, Academic medical center, Amsterdam, Netherlands. 2Region Hovestaden,
Kopenhagen, Denmark. 3Hospital Clinico San Carlos, Madrid, Spain. 4Immunology,Rheumatology & Allergy,
Faculty of Medicine, Medical University of Lodz, Poland, Lodz, Poland. 5National Kapodistrian University of
Athens, Athens, Greece. 6Instituto Dermopatico dell’Immacolata, Rome, Italy. 7Medical University of Vienna,
Vienna, Austria. 8Landspitali University Hospital Reykjavik, Reykjavik, Iceland. 9Odense University Hospital,
Odense, Denmark. 10Biomay AG, Vienna, Austria. 11HAL Allergy BV, Leiden, Netherlands. 12Institute of Food
Research, Norwich, United Kingdom. 13BIAL Aristegui , Bilbao, Spain. 14Academisch Medisch Centrum,
Amsterdam, Netherlands.
13:15 - 13:30 4182
IFN-ã Induces Milk Allergen-Specific IL-10-Producing Regulatory B Cells in Non -IgE
Mediated Milk Allergy
Lee, Sr., J. H.
Department of Pediatrics, School of Medicine, Chungnam National University, Taejeon, South Korea.
13:30 - 13:45 4183
Analysis of IgE, IgE RAST Value and Prick Test in Wheat or Hen’s Egg-Allergy Infants
Treated with Slow Specific Oral Tolerance Induction Therapy
Noma, T. 1, Ogawa, N. 3, Ogawa, N. 3, Oshiba, A. 4 and Mikami, K. 3
1
Department of Pediatrics, kitasato University School of Medicine, Sagamihara, Japan. 2Department of
Pediatrics, Kitasato University School of medicine, Sagamihara, Japan. 3Department of Pediatrics, Chiba
Aiyukai Memorial Hospital, Nagareyama, Japan. 4Department of Pediatrics, Tokyo Kousei-nenkin Hospital,
Tokyo, Japan.
13:45 - 14:00 14:00 - 14:15 4184
Efficacy of Slow Oral Immunotherapy for Cow’s Milk Allergy
4185
Factors Associated with Development of Food Allergy in Liver-Transplanted Children
Ogura, K. 1, Komata, T. 1, Hasegawa, M. 2, Hayashi, N. 2, Satou, M. 1, Goto, M. 1, Utsunomiya, T. 1, Iikura, K. 1,
Satou, S. 2, Sugizaki, C. 2, Tomikawa, M. 1, Shukuya, A. 1, Imai, T. 1 and Ebisawa, M. 3
1
Department of Pediatrics, Sagamihara National Hospital, Sagamihara, Japan. 2Clinical Research Center for
Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan. 3Clinical Research Center for
Allergy and Rheumatology , Sagamihara National Hospital, Sagamihara, Japan.
Shoda, T. 1, Nomura, I. 1, Ohya, Y. 1, Sakamoto, S. 2 and Kasahara, M. 2
1
Division of Allergy, National Center for Child Health and Development, Tokyo, Japan. 2Department of
Transplant Surgery , National Center for Child Health and Development , Tokyo, Japan.
98
Final Program
CC, 2ND, COZUMEL 2
Hymenoptera Allergy
Chairpersons: 12:45 - 13:00 4186
James Tracy (United States)
Clinical Features and Diagnostic Value of Specific IgE to Component Allergen in Bee
Venom Allergy in Korea
Shin, Y. S. 1, Liu, J. N. 1, Hur, G. 2, Hwang, E. 1, Nam, Y. 1, Jin, H. 1, Ye, Y. 1, Nahm, D. 1 and Park, H. 3
1
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon-si, South
Korea. 2Internal Medicine, Korea University College of Medicine, Seoul, South Korea. 3Department of
Allergy & Clincal Immunology, Ajou University School of Medicine, Suwon-si, South Korea.
13:00 - 13:15 13:15 - 13:30 13:30 - 13:45 4187
Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells?
4188
Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis
4189
Efficacy of Venom Immunotherapy Given Every 3 or 4 Months. A Direct Prospective
Comparison with the Conventional Regimen
Kucera, P. 1, Hulikova, K. 2, Cvackova, M. 3, Planska, D. 4 and Riegerova, K. 5
1
Dept. Allergy Immunology, 3rd Medical Faculty Charles Univ, Univ Hospital KV, Prague, Czech Republic.
2
Dept. Allergy Immunology, 3rd Medical Facultym, CHU, Prague, Czech Republic. 3Dept. Allergy
Immunology, 3rd Medical Faculty Charles University, University Hospital KV, Prague, Czech Republic.
4
Dept Allergy Immunology, 3rd Medical Faculty, Charles Univ, Prague, Czech Republic. 5Dept. Allergy
Immunology, 3rd Medical Faculty, Charles University, Prague, Czech Republic.
Cifuentes, L. 1, Balzer, L. 2, Simon, B. 3, Seismann, H. 4, Darsow, U. 5, Spillner, E. 4, Ring, J. 6 and Ollert, M. 5
1
Dermatology and Allergy, Clinical Research Division of Molecular and Clinical Allergotoxicology,
Department of Dermatology and Allergy, Technical University Munich, Germany, Munich, Germany.
2
Clinical Research Division of Molecular and Clinical Allergotoxicology, Department of Dermatology and
Allergy, Technical University Munich, Germany, Munich, Germany. 3Institute of Biochemistry and Molecular
Biology, Department of Chemistry, University of Hamburg, Germany., Hamburg, Germany. 4Institute
of Biochemistry and Molecular Biology, Department of Chemistry, University of Hamburg, Hamburg,
Germany. 5Department of Dermatology and Allergy Biederstein, Technische Universitaet Muenchen,
Munich, Germany. 6Department of Dermatology and Allergy Biederstein, Technische Universität München,
Munich, Germany.
Simioni, L. 1, Vianello, A. 1, Bonadonna, P. 2, Marcer, G. 3, Severino, M. 4, Pagani, M. 5, Morlin, L. 3, Crivellaro, M. 3
and Passalacqua, G. 6
1
Allergy and clin. immunology, int. med. dpt., S. Maria del Prato - Feltre Hospital, Feltre, Italy. 2Allergy
Unit, Verona General Hospital, Verona, Italy. 3Occupational and Environmental Medicine, University of
Padua, Padova, Italy. 4Allergy Clinic, Nuovo Ospedale San Giovanni di Dio - Firenze, Firenze, Italy. 5Allergy
and Oncology Unit, Asola Hospital, Asola, Italy. 6Allergy & Respiratory Diseases, Universita Degli Studi Di
Genova, Genoa, Italy.
13:45 - 14:00 4190
SERUM CTLA-4 and IL-10 In Hymenoptera Venom Immunotherapy: Equivalence of
Different Induction Regimens
Riccio, A. M. 1, Saverino, D. 2, Rogkakou, A. 1, Bagnasco, M. 2, Bonadonna, P. 3, Canonica, G. W. 4, Ridolo, E. 5,
Severino, M. 6, Pesce, G. 2 and Passalacqua, G. 7
1
Allergy and Respiratory Diseases, Universita Degli Studi Di Genova, Genoa, Italy. 2Medical and
Radiomethabolic Therapy, Università di Genova, Genoa, Italy. 3Allergy Service, Verona General Hospital,
Verona, Italy. 4Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genova, Italy. 5Department
of Clinical Sciences, University of Parma, Parma, Italy. 6Allergy Clinic, Nuovo Ospedale San Giovanni di Dio Firenze, Firenze, Italy. 7Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genoa, Italy.
14:00 - 14:15 4191
Purification of the Allergenic Protein Hyaluronidase From the Venom of Social Wasp
Polybia Paulista (Hymenoptera: Vespidae)
Jacomini, D. L. J. 1, Pereira, F. D. C. 1, Pinto, J. R. A. D. S. 2, Santos, L. D. D. 2, Menegasso, A. R. D. S. 2, Palma, M. S.
2
, Zollner, R. D. L. 3 and Brochetto-Braga, M. R. 1
1
Dept.of Biology, Univ Estadual Paulista, Rio Claro, Brazil. 2Center of the Study of Social Insects/Dept.
Biology, Univ Estadual Paulista, Rio Claro, Brazil. 3Dept.of Clinical Imunology and Allergy, Faculty of Medical
Sciences, UNICAMP, Campinas, Brazil.
99
Final Program
Immunobiology of Allergens
Chairpersons: 12:45 - 13:00 4192
Barbara Gepp (Austria)
Christian Radauer (Austria)
High Immunogenicity of the Allergen Phl p 5 Expressed in Transgenic Mice As a
Membrane-Anchored Protein
Farkas, A. 1, Baranyi, U. 1, Valenta, R. 2 and Wekerle, T. 1
1
Department of Surgery; Div. of Transplantation, Medical University of Vienna, Vienna, Austria. 2Department
of Pathophysiology; Div. of Immunopathology; Center of Pathophysiology, Infectiology and Immunology,
Medical University of Vienna, Vienna, Austria.
13:00 - 13:15 4193
Specific Recognition of the Major Birch Pollen Allergen Bet v 1 Programs Dendritic Cells
to Induce Either Th2 or Tolerogenic Responses
Smole, U. , Balazs, N. , Radauer, C. , Sobanov, Y. , Bublin, M. , Gaier, S. , Hoffmann-Sommergruber, K. , JensenJarolim, E. , Mechtcheriakova, D. and Breiteneder, H.
13:15 - 13:30 13:30 - 13:45 4194
Recombinant Scfv Antibodies for IgE Epitope Mapping and Detection of Parvalbumins
4195
Bet v 1-Specific T-Cell Receptor/Forkhead Box Protein 3 Transgenic T-Cells Suppress Bet
v 1-Specific T-Cell Effector Function in An Activation-Dependent Manner
Bublin, M. 1, Kostadinova, M. 1, Ackerbauer, D. 1, Ebner, C. 2, Radauer, C. 1 and Breiteneder, H. 1
1
2
Allergy Clinic Reumannplatz, Vienna, Austria.
Schmetterer, K. 1, Haiderer, D. 1, Reichl, V. 1,2, Neunkirchner, A. 1,2, Jahn-Schmid, B. 3, Steinberger, P. 1, Bohle, B.
2,3
and Pickl, W. F. 1,2
1
Institute of Immunology, Medical University of Vienna, Vienna, Austria. 2Christian Doppler Laboratory
for Immunomodulation, Vienna, Austria. 3Department of Pathophysiology and Allergy Research, Medical
University of Vienna, Vienna, Austria.
13:45 - 14:00 4196
Grass Pollen Allergen-Induced Surface Expression of CD203c, CD63 and CD107a on
CRTH2+ Basophils: Novel Biomarkers for Monitoring Efficacy of Allergen-Specific
Immunotherapy
Shamji, M. 1, Layhadi, J. A. 1, Cheung, D. K. 1, Khan, S. Q. 1, Phippard, D. 2 and Durham, S. 1
1
Allergy and Clinical Immunology, Imperial College London, London, United Kingdom. 2Immune Tolerance
Network, Washington, WA.
14:00 - 14:15 4197
Specific IgE and IgG Binding to Allergoids of Phleum Pratense
Cases, B. 1, Fernandez-Caldas, E. 1,2, Tudela, J. I. 1, Fernandez, E. A. 1, Sanchez-Garcia, S. 3, Ibañez, M. D. 3,
Escudero, C. 3 and Casanovas, M. 1
1
Research & Development, Inmunotek SL, Madrid, Spain. 2Division of Allergy and Immunology, University
of South Florida College of Medicine, Tampa. 3Allergy Section, Hospital Infantil Universitario Niño Jesús,
Madrid, Spain.
CC, 2ND, TULUM
Mechanisms of Asthma and Allergic Inflammation
Chairpersons: 12:45 - 13:00 4198
Homer Boushey (United States)
Elliot Israel (United States)
Heterogeneity of Allergen Epitope-Specific CD4+ T Cells Responses: Steps Toward
Optimal Composition for Peptide-Based Immunotherapy
Wambre, E. 1, Delong, J. 1, James, E. 1, Torres-Chinn, N. 1, Robinson, D. 2 and Kwok, W. 1
1
Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA. 2Asthma, Allergy and Clinical
Immunology, Virginia Mason Medical Center, Seattle, WA.
13:00 - 13:15 4199
The Association Between Mast Cells and Remodelling of the Small Airways in Chronic
Asthma
Snibson, K. and Van der Velden, J.
Veterinary Science, University of Melbourne, Parkville, Australia.
100
Final Program
13:15 - 13:30 4200
Creation of a Humanized Model for Respiratory Allergy Using a Human MugwortSpecific T-Cell Receptor and HLA-DR1
Neunkirchner, A. 1,2, Mager, L. 2, Reichl, V. 1,2, Schmetterer, K. 2, Haiderer, D. 2, Rosloniec, E. 3, Naumann, R. 4,
Jahn-Schmid, B. 5, Bohle, B. 1,5 and Pickl, W. F. 1,2
1
Christian Doppler Laboratory for Immunomodulation, Vienna, Austria. 2Institute of Immunology, Medical
University of Vienna, Vienna, Austria. 3Veterans Affairs Medical Center, Memphis, TN. 4Max Planck Institute
for Molecular Cell Biology and Genetics, Dresden, Germany. 5Department of Pathophysiology and Allergy
Research, Medical University of Vienna, Vienna, Austria.
13:30 - 13:45 4201
Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of
Cysteinyl Leukotrines
Halwani, R. 1, Al-Muhsen, S. 2, Bahammam, A. 3, Al-Jahdali, H. 4 and Hamid, Q. 5
1
Asthma Research Chair and Prince Naif Center for Immunological Research, College of Medicine, King
Saud University., Riyadh, Saudi Arabia. 2 Asthma Research Chair and Prince Naif Center for Immunology
Research, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
3
Asthma Research Chair and Prince Naif Center for Immunology Research, College of Medicine, King Saud
University, Riyadh, Saudi Arabia. 4King Saud University for health sciences, Riyadh, Saudi Arabia. 5McGill
University, Meakins-Christie Laboratories, Montreal, QC, Canada.
13:45 - 14:00 4202
Colour Change In the Human Histamine Wheal; A Sign of Desensitized Histamine
Vasoconstrictory Receptors
Malm, L.
Clinical Science, Lund University, 224 67 Lund, Sweden.
14:00 - 14:15 4203
Involvement of the Hypoxia-Inducible Factor-1 Transcription Complex in the
Inflammatory Responses of Human Mast Cells and Basophils
Yasinska, I. , Sumbayev, V. and Gibbs, B.
Medway School of Pharmacy, University of Kent, Chatham Maritime, United Kingdom.
CC, 2ND, XCARET
Primary Immunodeficiency
Chairpersons: 12:45 - 13:00 13:00 - 13:15 4204
4205
Hani Ababneh (Jordan)
Charlotte Cunningham-Rundles (United States)
Mycobacterial Infections In Children with Chronic Granulomatous Disease
Lugo Reyes, S. O. 1, Blancas Galicia, L. 2 and Bustamante, J. 3
1
National Institute of Pediatrics, Immunodeficiencies Research Unit, México City, México.
2
Immunodeficiencies Research Unit, National Institute of Pediatrics, México City, México. 3Laboratory of
Human Genetics of Infectious Diseases, Faculté de Médecine Necker-Enfants Malades, Paris, France.
Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation
in Patients with X-Linked Agammaglobulinemia
Gonzalez Serrano, M. E. 1, López Herrera, G. 1, Berrón Ruiz, L. 1, Estrada García, I. C. 2, Mogica Martínez,
D. 3, Espinosa, S. 1, Yamazaki Nakashimada, M. A. 4, González Garay, A. 4, Vargas Hernández, A. 5, Santos
Argumedo, L. 6, Estrada Parra, S. A. 2 and Espinosa Rosales, F. J. 4
1
Immunodeficiency Research Unit, National Institute of Pediatrics , México City, México. 2National School
of Biological Sciences, México City, México. 3Medical Center “La Raza”, Mexican Social Security Institute,
México City, México. 4National Institute of Pediatrics , México City, México. 5Center for Research and
Advanced Studies , México City, México. 6Department of Molecular Biomedicine, Center for Research and
Advanced Studies , México City, México.
13:15 - 13:30 4206
Hypogammaglobulinemia in a Boy: Consider Also X- Linked Lymphoproliferative
Disease
Gamez, L. 1, Yamazaki, M. A. 2, Espinosa, S. 3, Lugo, D. S. 4 and Hernandez, V. 5
1
Allergy and Immunolgy clinic, National Institute of Pediatrics, México Distrito Federal, México. 2National
Institute of Pediatrics, México D.F., México. 3Immunodeficiency Research Unit, National Institute of
Pediatrics , México City, México. 4Allergy & Clinical Immunology, National Institute of Pediatrics, México
City, México. 5National Institute of Pediatrics, México, México.
101
Final Program
13:30 - 13:45 4207
Transmission Pattern and Carriers Identification in Male Patients with Chronic
Granulomatous Disease
Lizbeth, B. 1, Berrón-Ruiz, L. 2, Andrea, M. 3, Marco Antonio, Y. 4 and Espinosa-Rosales, F. 5
1
Unidad de Investigación en Inmunodeficiencias, Instituto nacional de Peditría, México City, México.
2
Unidad de Investigación para Inmunodeficiencias, Instituto Nacional de Pedriatría, Distrito Federal,
México. 3Unidad De Investigacion En Inmunodeficiencias, Instituto nacional de Peditría, México City,
México. 4Inmunologia, Instituto nacional de Peditría, México City, México. 5Unidad de Investigación para
Inmunodeficiencias, Instituto Nacional de Pediatría, Distrito Federal, México.
13:45 - 14:00
4207A Genetic Association Study of the IgE Immunodeficiency in Mexican Population
Malpica Cruz, J. A. 1, Gomez Vera, J. 2, María Elena, R. D. P. 3, Lopez Tiro, J. 4, Jimenez Morales, S. 5 and Orozco, L. 6
Alergia e Inmunologia , Hospital Regional , Ciudad de México, México. 2Alergia e Inmunologia, Hospital
Regional “Lic. Adolfo López Mateos” ISSSTE, Ciudad de México, México. 3Alergia e Inmunologia, Hospital
Regional “Lic, Adolfo López Mateos” ISSSTE, Ciudad de México, México. 4Alergia e Inmunología, Hospital
Regional “Lic. Adolfo López Mateos”, Ciudad de México, México. 5Genetica, Instituto Nacional de Medicina
Genómica de México, Ciudad de México, México. 6Immunogenomics and Metabolic Diseases Laboratory,
Instituto Nacional de Medicina Genomica, México, México.
1
13:45 - 14:00 4208
CD21-/Low B Cells Are Increased in Both Common Variable Immune Deficiency (CVID)
and Specific Antibody Deficiency (SAD)
Elizalde, A. 1, Stephanie, H. 2, Morna, D. 1, Perez, E. 3, Sleasman, J. 4 and Sriaroon, P. 1
1
University of South Florida, College of Medicine, Saint Petersburg, FL. 2University of South Florida, College
of Medicine, Tampa, FL. 3University of South Florida College of Medicine, Saint Petersburg, FL. 4University
of South Florida College of Medicine, St Petersburg, FL.
Rhinitis Treatment 2
Chairpersons: 12:45 - 13:00 4209
James Baraniuk (United States)
Joaquim Mullol (Spain)
Patterns of Initiation and Adherence to De Novo Allergen-Specific Immunotherapy
Among Adults and Children with Newly-Diagnosed Allergic Rhinitis: Findings From
Research Jointly Funded by the AAAAI and ACAAI
Hankin, C. 1, Cox, L. 2, Wang, Z. 1 and Bronstone, A. 1
1
Health Economics and Outcomes Research, BioMedEcon, LLC, Moss Beach, CA. 2Medicine, Nova
Southeastern University , Ft. Lauderdale, FL.
13:00 - 13:15 4210
Effect of Simvastatin on Transforming Growth Factor Beta-1-Induced Myofibroblast
Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts
Park, I. 1 and Lee, H. 2
1
Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine,
Seoul, South Korea. 2Department of Otorhinolaryngology, Korea University College of Medicine, Seoul,
South Korea.
13:15 - 13:30 13:30 - 13:45 13:45 - 14:00 4211
Onset of Action of MP29-02 in the Treatment of Seasonal Allergic Rhinitis
4212
MP29-02 in the Treatment of Nasal Symptoms of Seasonal Allergic Rhinitis
4213
A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane
Nasal Aerosol in Subjects with Perennial Allergic Rhinitis
Bernstein, J. 1, Munzel, U. 2 and Wheeler, W. 3
1
Bernstein Allergy Group, Cincinnati, OH. 2Meda Pharmaceuticals, Bad Hamburg, Germany. 3Meda
Pharmaceuticals, Somerset, NJ.
Wheeler, W. 1 and Carr, W. 2
1
Meda Pharmaceuticals, Somerset, NJ. 2Allergy & Asthma Associates, Mission Viejo, CA.
Berger, W. 1, Mohar, D. 2, Raphael, G. 3, LaForce, C. 4, Huang, H. 5, Desai, S. 5, Bode, F. 5 and Karafilidis, J. 5
1
Allergy & Asthma Associates, Mission Viejo, CA. 2Kerrville Research Associates, Kerrville, TX. 3Asthma,
Allergy & Clinical Research, Bethesda, MD. 4North Carolina Clinical Research, Raleigh, NC. 5Sunovion
14:00 - 14:15 4214
Omalizumab Improves Asthma but Not Nasal Symptoms in Japanese Patients with
Severe Allergic Asthma and Rhinitis
Nishihara, F. , Takaku, Y. , Nakagome, K. , Kobayashi, T. and Nagata, M.
Allergy Center , Department of Respiratory Medicine, Saitama Medical University, Moroyama-Machi, Japan.
102
Final Program
Allergen Immunotherapy 2
Chairpersons: 12:45 - 13:00 4215
Lars Jacobsen (Denmark)
Guillermo Salamanca (Spain)
Efficacy and Safety of Ragweed Allergy Immunotherapy Tablet in Multisensitized North
American Adults: Preliminary Findings
Creticos, P. 1, Maloney, J. 2, Nolte, H. 2, Berman, G. 3, Cheema, A. 4, Kaur, A. 2 and Hebert, J. 5
1
Johns Hopkins University, Baltimore, MD. 2Merck Research Laboratories, Kenilworth, NJ. 3Minneapolis
Allergy & Asthma Specialists, Minneapolis, MN. 4Alpha Medical Research, Mississauga, ON, Canada.
5
[email protected], Quebec, QC, Canada.
13:00 - 13:15 4216
Comparison of Efficacy and Safety of A Depigmented Polymerized Allergen Extract of
Grass and Birch with Placebo In Patients with Type-I Allergic Rhinoconjunctivitis
Sager, A. 1, Tilo, B. 2 and Pfaar, O. 3
1
Medical Department, LETI Pharma GmbH, Witten, Germany. 2Department of Dermatology, University of
Tuebingen, Tuebingen, Germany. 3Center for Rhinology and Allergology, Dept. of Otorhinolaryngology,
University Hospital Mannheim, Wiesbaden, Germany.
13:15 - 13:30 4217
Allergenic Composition of Polymerized Allergen Extracts of Betula Verrucosa,
Dermatophagoides Pteronyssinus and Phleum Pratense
Fernandez-Caldas, E. 1,2, Cases, B. 1, Tudela, J. I. 1, Fernandez, E. A. 1, Casanovas, M. 1 and Subiza, J. L. 1
1
Research & Development, Inmunotek SL, Madrid, Spain. 2Division of Allergy and Immunology, University
of South Florida College of Medicine, Tampa.
13:30 - 13:45 4218
A Proteomic Style Approach to Characterise a Grass Mix Product Reveals Potential
Immunotherapeutic Benefit
Skinner, M. , Bullimore, A. , Swan, N. and Alawode, W.
R&D, Allergy Therapeutics, Worthing, United Kingdom.
13:45 - 14:00 14:00 - 14:15 4219
Seasonal vs. Symptom-Based Evaluation of A Depigmented Grass-Birch Allergoid
4220
Efficacy and Tolerability of HDM Injective Immunotherapy with Monomeric Allergoid
Pfaar, O. 1, Biedermann, T. 2 and Sager, A. 3
1
Center for Rhinology and Allergology, Dept. of Otorhinolaryngology, University Hospital Mannheim,
Wiesbaden, Germany. 2Dept. of Dermatology, University Hospital , Tübingen, Germany. 3Medical
Department, LETI Pharma GmbH, Witten, Germany.
Compalati, E. 1, Atzeni, I. 2, Cabras, S. 3, Fancello, P. 2, Gaspardini, G. 4, Longo, R. 5, Patella, V. 6,7 and Tore, G. 8
1
Allergy & Respiratory Diseases Clinic, University of Genoa, Genova, Italy. 2Servizio di Allergologia, Ospedale
“San Gavino Monreale”, ASL 6, Sanluri (CR), Italy. 3Casa di Cura “Madonna del Rimedio”, Oristano, Italy.
4
Divisione ORL, Ospedale , Cagliari, Italy. 5Servizio Territoriale di Allergologia, Azienda Sanitaria Provinciale ,
Vibo Valenzia, Italy. 6Division of Clinical Immunology and Allergy, General Hospital, ASL SALERNO, Agropoli
(SA), Italy. 7U.O. di Allergologia e Immunologia Clinica, Ospedale Generale, Agropoli (SA), Italy. 8Divisione
ORL, Ospedale “Santissima Trinità”, Cagliari, Italy.
Henry Ford Hospital, Georgia Health Sciences University, University of California
San Francisco, The University of Michigan
Allergy Prevention: Do Cats and Dogs Feed Infants Microbes?
Chairpersons: 15:00 - 15:05 15:05 - 15:25 3-1UTP 15:25 - 15:45 3-2UTP Christine Cole Johnson (United States)
Edward Zoratti (United States)
Welcoming Remarks
The Link Between Pets and Reduced Risk of Allergic Disease | Dennis Ownby (United States)
Molecular Analysis of the Link Between Pets and an Infant’s Microbiome |
Homer Boushey (United States)
15:45 - 16:05 3-3UTP The Microbiome-Allergy Hypothesis | Nicholas Lukacs (United States)
103
Final Program
15:00 - 16:00 DEBATE 10
Are Basophils Important in Allergy?
Chairpersons: Joshua Boyce (United States)
15:05 - 15:20 10-1DB Pro | Hirohisa Saito (Japan)
15:20 - 15:35 10-2DB Con | Massimo Triggiani (Italy)
15:00 - 16:30 SISTER SOCIETY SYMPOSIUM 14 CC, 3RD, GRAN CANCÚN 3
Mexican College of Clinical Immunology and Allergy
Genetics and Immune Responses Chairpersons: Jaime Mellado Abrego (México)
Maria Antonia Rivera Gomez (México)
15:05 - 15:25 14-1SSS Genetic Risk Factor for Asthma in Latin America | Nora Martínez Aguilar (México)
15:25 - 15:45 14-2SSS Gene Environment Interactions with Air Pollution | Lorena Orozco (México)
15:45 - 16:05 14-3SSS Immunogenetics and Pharmacogenomics of Allergic Diseases | Clara Gorodezky (México)
15:00 - 16:30 SYMPOSIUM 29 CC, 3RD, GRAN CANCÚN 4
Primary Immune Deficiencies: Rapid Diagnosis and Referral
Chairpersons: Thomas Fleisher (United States)
15:05 - 15:25 29-1SY Clinical Presentation | James Oleske (United States)
15:25 - 15:45 29-2SY Screening | Charlotte Cunningham-Rundles (United States)
15:45 - 16:05 29-3SY Treatment Options | Elena Perez (United States)
15:00 - 16:30 SYMPOSIUM 30
Allergy, Asthma and the Athlete
Chairpersons: Estrella Asayag (Argentina)
Zineb Sayah (Morocco)
15:05 - 15:25 30-1SY Mechanisms of Exercise-Induced Asthma | Timothy J. Craig (United States)
15:25 - 15:45 30-2SY Exercise-Induced Allergic Diseases | Sergio Bonini (Italy)
15:45 - 16:05 30-3SY Asthma and Elite Athletes | Kai-Hakon Carlsen (Norway)
104
Final Program
15:00 - 16:30 SYMPOSIUM 31
CC, 2ND, COZUMEL 1
Hymenoptera Allergy: Ants and Flying Insects
Chairpersons: Ioana Agache (Romania)
John Kelso (United States)
15:05 - 15:25 31-1SY Overview | Jeffrey Demain (United States)
15:25 - 15:45 31-2SY Immunotherapy | James Tracy (United States)
15:45 - 16:05 31-3SY Immunologic Response with Venom Immunotherapy | Mubeccel Akdis (Switzerland)
15:00 - 16:00 DEBATE 11
CC, 2ND, COZUMEL 2
Are We Ready for Oral Immunotherapy for Food Allergy?
Chairpersons: Héctor Badellino (Argentina)
Sami Bahna (United States)
15:05 - 15:20 11-1DB Pro | Lyndon Mansfield (United States)
15:20 - 15:35 11-2DB Con | A. Wesley Burks (United States)
CC, 2ND, XCARET
The International Primary Care Respiratory Group
Rhinitis and Asthma in Primary Care Chairpersons: 15:00 - 15:05 15:05 - 15:25 15-1SSS 15:25 - 15:45 15-2SSS 15:45 - 16:05 15-3SSS Roy Gerth van Wijk (Netherlands)
Welcoming Remarks
Adaption of Asthma Guidelines to Primary Care | Miguel Roman Rodriguez (Spain)
Sublingual Immunotherapy (SLIT) in Primary Care | Dermot Ryan (Scotland, United Kingdom)
Management of Rhinitis or Sinusitis in Primary Care Patients with Asthma |
Michael Schatz (United States)
COPD
15:00 - 15:35 4-1YiR Pathophysiology | Qutayba Hamid (Canada)
15:35 - 16:10 4-2YiR Treatment | Klaus Rabe (Germany)
Argentine Association of Allergy and Clinical Immunology
Eosinophilic Related Conditions Chairpersons: Jorge Alvarez (Argentina)
Jorge Maspero (Argentina)
15:05 - 15:25 16-1SSS Evaluation of Patients with Eosinophilia | Martin Bozzola (Argentina)
15:25 - 15:45 16-2SSS Hypereosinophilic Syndromes | Mónica S. De Gennaro (Argentina)
15:45 - 16:05 16-3SSS Novel Therapies for Eosinophilic Disorders | Bruce Bochner (United States)
105
Final Program
15:00 - 16:30 WORKSHOP 22
Immunotherapy for the Polysensitized Patient
Balancing the Evidence with Experience
15:05 - 15:20 22-1WS Monotherapy for the Polysensitized Patient | Noel Rodríguez-Perez (México)
15:20 - 15:35 22-2WS Multiallergen Immunotherapy: The Evidence | Harold Nelson (United States)
15:35 - 15:50 22-3WS Multiallergen Immunotherapy: The Experience | Linda Cox (United States)
15:00 - 16:30 WORKSHOP 23
Sister Society Session: Austrian Society of Allergology and Immunology
Novel Laboratory Tests for Allergic Diseases 15:00 - 15:05 15:05 - 15:20 23-1WS 15:20 - 15:35 23-2WS Welcoming Remarks
Recombinant Allergens for Diagnosis | Susanne Vrtala (Austria)
Improving Diagnosis of Venom Allergy with Recombinant Allergens |
Irene Mittermann (Austria)
15:35 - 15:50 23-3WS Diagnosing and Monitoring Allergy | Rudolf Valenta (Austria)
15:00 - 16:30 WORKSHOP 24
University Training Program: Cleveland Clinic—An Evidence Based Approach
to Diagnosis and Management of Urticaria and Angioedema
Welcoming Remarks
24-1WS Evaluation | Jonathan Bernstein (United States)
24-2WS Management | David Lang (United States)
24-3WS C1 Inhibitor Deficiency Syndromes |
15:00 - 15:05 15:05 - 15:20 15:20 - 15:35 15:35 - 15:50 15:00 - 16:30 WORKSHOP 25
Drug Allergy Testing and Desensitization
15:05 - 15:20 25-1WS Beta-lactams | Louis Mendelson (United States)
15:20 - 15:35 25-2WS Non Betalactic Antibiotics | David Khan (United States)
15:35 - 15:50 25-3WS Biologics | Miguel Blanca (Spain)
106
Final Program
15:00 - 16:30 WORKSHOP 26
Obesity and Asthma: Implications for Asthma Control and Treatment
15:05 - 15:20 26-1WS Observational Studies | Fernando Holguin (United States)
15:20 - 15:35 26-2WS Interventional Studies | Carlos Camargo (United States)
15:35 - 15:50 26-3WS Genetics of Obesity and Asthma | Juan Carlos Celedón (United States)
15:00 - 16:30 WORKSHOP 27
Update on Smoking Cessation
Welcoming Remarks
Natural History of Tobacco Dependence | R Maximiliano Gomez (Argentina)
New Pharmaceutical Options and Electronic Cigarette | Riccardo Polosa (Italy)
Clinical Trials and Patient Education for Smoking Cessation |
Maureen George (United States)
15:00 - 15:05 15:05 - 15:20 15:20 - 15:35 15:35 - 15:50 27-1WS 27-2WS 27-3WS Workshop supported through an unrestected educational grant from:
15:00 - 16:30 WORKSHOP 28
Allergic Rhinitis and Its Impact on Asthma (ARIA)
15:00 - 15:05 15:05 - 15:20 28-1WS Welcoming Remarks
How Can the GRADE System Improve Guideline Driven Care? |
Holger Schunemann (Canada)
15:20 - 15:35 28-2WS Are Rhinitis and Asthma Two Manifestations of One Disease? |
15:35 - 15:50 28-3WS Rhinitis: A Risk Factor for Asthma? | Ronald Dahl (Denmark)
15:00 - 16:30 WORKSHOP 29
Adherence to Treatment: How Can It Be Improved?
15:05 - 15:20 29-1WS Non-Adherent Patient | Fulvio Braido (Italy)
15:20 - 15:35 29-2WS Socio-economic Status and Adherence | Alvaro Cruz (Brazil)
15:35 - 15:50 29-3WS Improving Adherence | Fernán Caballero-Fonseca (Venezuela)
107
Final Program
15:00 - 16:30 WORKSHOP 30
Hands-On Demonstration: Bronchial Provocation Challenges
15:05 - 15:20 30-1WS Methacholine | Paul O’Byrne (Canada)
15:20 - 15:35 30-2WS Mannitol | Charles Irvin (United States)
15:35 - 15:50 30-3WS Exercise | Matteo Bonini (Italy)
15:50 - 16:30 Hands-On Demonstration
15:00 - 16:30 WORKSHOP 31
Non-Allergic Rhinitis
15:05 - 15:20 31-1WS Classification | Glenis Scadding (United Kingdom)
15:20 - 15:35 31-2WS Mechanisms | Ruby Pawankar (Japan)
15:35 - 15:50 31-3WS Treatment | Alkis Togias (United States)
The only INS designed in a
HYPOTONIC FORMULATION5
Reference: 1. Patel P, Patel D, Kunjibettu S, Hall N, et al. Onset of Action of Ciclesonide Once Daily in the Treatment of Seasonal Allergic Rhinitis. ENT J. 2008;87:340-353.
2.Chervinsky P, Kunjibettu S, Miller DL, Prenner BM, et al. Long-term safety and efficacy of ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy
Asthma Immunol. 2007;99:69-76.3.Ratner PH, Wingertzahn MA, van Bavel JH, Hampel F, et al. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic
rhinitis. J Allergy Clin Immunol. 2006;118:1142-1148. 4.Meltzer EO, Kunjibettu S, Hall N, Wingertzahn MA, et al. Efficacy and safety of ciclesonide 200 μg once daily for
treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007;98:175-181. 5.Meltzer, EO. Formulation considerations of intranasal corticosteroids for the
treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2007;98:12–21.
108
Final Program
Advances in Food Allergy
08:00 - 09:30 Session 1
Chairpersons: Alessandro Fiocchi (Italy)
Ichiro Nomura (Japan)
08:05 - 08:30 6-1NH Allergen Component and Cross Reactivity | Motohiro Ebisawa (Japan)
08:30 - 08:55 6-2NH Advances in Diagnosis | Hugh Sampson (United States)
08:55 - 09:20 6-3NH Oral Immunotherapy | A. Wesley Burks (United States)
09:30 – 10:00 Coffee Break
10:00 - 11:30 Session 2
Chairpersons: Alessandro Fiocchi (Italy)
Miguel Vinuesa (Argentina)
10:05 - 10:30 6-4NH Hidden Food Allergens | Thomas Holzhauser (Germany)
10:30 - 10:55 6-5NH Food Allergy and Eosinophilic Esophagitis | Jonathan Spergel (United States)
10:55 - 11:20 6-6NH Non-IgE-Mediated Gastrointestinal Food Reactions | Ichiro Nomura (Japan)
CC, 2ND, COZUMEL
Asthma in Children
08:00 - 09:30 Risk Factors
Chairpersons: Kazuo Akiyama (Japan)
Cissy Rachiana Sudjana Prawira (Indonesia)
08:05 - 08:30 7-1NH Genetics | Fernando D. Martinez (United States)
08:30 - 08:55 7-2NH Environmental | Dennis Ownby (United States)
08:55 - 09:20 7-3NH Viral | Robert Lemanske (United States)
10:00 - 11:30 Treatment
Chairpersons: José Antonio Ortega Martell (México)
Alvaro Teijeiro (Argentina)
10:05 - 10:30 7-4NH Prevention | Ulrich Wahn (Germany)
10:30 - 10:55 7-5NH Step Care | Stanley Szefler (United States)
10:55 - 11:20 7-6NH Management of Asthma Exacerbations | José A. Castro-Rodríguez (Chile)
109
Final Program
Thursday, 8 December 2011
Scientific Program — Thursday, 8 December 2011
Thursday, 8 December 2011
Scientific Program — Thursday, 8 December 2011
CC, 1ST, COSTA MAYA
Is Your Patient Immunodeficient (ID)?
08:00 - 09:30 Session 1
Chairpersons: Angelo Passaleva (Italy)
Elena Perez (United States)
08:05 - 08:30 8-1NH Primary IDs | Charlotte Cunningham-Rundles (United States)
08:30 - 08:55 8-2NH Common Variable | Mark Ballow (United States)
08:55 - 09:20 8-3NH Approach to the Patient with Recurrent Infections | Zuhair Ballas (United States)
10:00 - 11:30 Chairpersons: 10:00 - 10:05 10:05 - 10:30 8-4NH Session 2
Charlotte Cunningham-Rundles (United States)
Elopy Sibanda (Zimbabwe)
Welcoming Remarks
Immunodeficiency Secondary to Anticytokine Autoantibodies |
Steven Holland (United States)
10:30 - 10:55 8-5NH HIV | John Sleasman (United States)
10:55 - 11:20 8-6NH Susceptibility to Infections | Elena Perez (United States)
110
Final Program
European Academy of
Allergy and Clinical Immunology
16 – 20 June 2012
Congress 2012
Geneva, Switzerland
EAACI Congress 2012
www.eaaci2012.com
©Genève Tourisme
t
Abstrac n
sio
Submis e:
Deadlin ry
ua
18 Jan 2
201
Posters
Posters at the 2011 World Allergy Congress are divided
into 3 groups. Group 1 will be displayed on Monday, 5
December, Group 2 on Tuesday, 6 December and Group 3
on Wednesday, 7 December.
Poster Sessions are scheduled during the lunch hour on 5,
6 and 7 December from 12:15 – 14:15 in the Cancún Center,
1st floor, Poster Hall.
Presenting Authors will stand next to their poster and be
available for discussion and questions.
Lunch boxes are available to delegates attending the Poster
Sessions.
POSTER SET-UP
Posters will only be set for the day of the presentation
and poster set-up is each morning from 07:00 – 09:30. The
abstract number, which is listed to the left of the abstract
title in this Final Program, will also refer to the poster
board number in the Poster Hall. Each poster will remain
on display throughout the assigned day, and must be
dismantled by 17:30. Posters not dismantled by 17:30 on
the day of the presentation will be discarded.
Please note: Any posters set-up previous to 07:00 on the
day of presentation may be accidentally discarded. Posters
are only allowed to be set between 07:00 – 09:30.
POSTER GROUP 1
Monday, 5 December
12:15 – 14:15
Poster Session
Abstract
Numbers
Poster Session
Abstract
Numbers
PS 1: Asthma and Co-Morbid Conditions
2000-2020
PS 9: Food Allergy: Epidemiology
2089-2097
PS 2: Pediatric Asthma
2021-2024
2098-2103
PS 3: Pediatric Asthma Epidemiology
2025-2035
PS 10: Incidence and Prevalence of Food
Allergy
PS 4: Aerobiology
2036-2047
2104-2108
PS 5: Mechanisms of Asthma and Allergic
Inflammation
2048-2064B
PS 11: Food Allergy: Gastrointestinal
Manifestations
PS 12: IgE Poster
2109-2115
PS 6: Allergy to Antimicrobials
2065-2069
PS 13: Anti-IgE
2116-2128
2070-2081
PS 14: Immunotherapy
2129-2135
2082-2088
PS 15: Hymenoptera Allergy
2136-2142
Poster Session
Abstract
Numbers
Poster Session
Abstract
Numbers
PS 16: Asthma
3000-3011
3087-3094
PS 17: Asthma Diagnostic Tools
3012-3020
PS 27: Aspirin-Exacerbated Respiratory
Disease
PS 18: Pathophysiology of Childhood
Asthma
3021-3024
PS 28: Immunotherapy Training
3095-3096
PS 29: Food Allergy Case Reports
3097-3101
PS 19: Pediatric Asthma Treatment
3025-3032
3102-3109
PS 20: Aeroallergen Sensitization
3033-3041
PS 30: Food Allergy: Diagnosis and
Treatment
PS 21: Dust Mite Allergy
3042-3047
PS 31: Eosinophilic Diseases
3110-3112
PS 22: Testing for Sensitization
3048-3057
PS 32: Immunodeficiency
3113-3121
PS 23: Occupational Allergies
3058-3064
PS 33: Primary Immunodeficiency
3122-3131
PS 24: Contact Dermatitis
3065-3068
3132-3143
PS 25: Atopic Dermatitis
3069-3076
PS 34: X-linked and Common Variable
Immunodeficiency
3077-3086
PS 35: HIV-Related Problems
3144-3146
PS 8: Food Allergy
POSTER GROUP 2
Tuesday, 6 December
12:15 – 14:15
112
Final Program
Posters
POSTER GROUP 3
12:15 – 14:15
Poster Session
Abstract
Numbers
Poster Session
Abstract
Numbers
PS 36: Epidemiology of Allergic Rhinitis
4000-4007
PS 45: Urticaria Treatment
4075
PS 37: Diagnostic Test for Allergic Rhinitis
4008-4013
PS 46: Urticaria Case Reports
4076-4085
PS 38: Allergic Rhinitis
4014-4036
PS 47: Autoimmunity Case Reports
4086-4089
PS 39: Conjunctivitis
4037-4045
PS 48: Autoimmunity
4090-4098
PS 40: Mastocytosis
4046-4047
PS 49: Allergies in Other Diseases
4099-4109
PS 41: Anaphylaxis
4048-4054
PS 50: Asthma Epidemiology
4110-4119
PS 42: Radiocontrast Media Allergy
4055-4058
4120-4126
PS 43: Hereditary Angioedema
4059-4064
PS 51: Quality of Life Measures in Asthma
and Allergic Diseases
PS 44: Urticaria
4065-4074
PS 52: Health Outcomes for Asthma
4127-4137
PS 53: Severe and Fatal Asthma
4138-4145
POSTER GROUP 1
MONDAY, 5 DECEMBER
POSTER SESSION 1: ASTHMA AND CO-MORBID CONDITIONS 12:15 – 14:15
2000 Screening for Allergic Bronchopulmonary Aspergillosis in Patients with Aspergillus + Asthma From 2000-2010
Greenberger, P.
Northwestern University Feinberg School of Medicine, Chicago, IL.
2001 Sleep-Disordered Breathing in Obese and Eutrophic Adolescents, Asthmatics and Not Asthmatics, in the
Hospital Infantil of México Federico Gómez
Morales MARIN, D. A.
Immunology and Allergy, 98231, Distrito Federal, México.
2002 Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies
Ravindran, M. 1, Adewuyi, O. 1, Zheng, Y. 1, Le, U. 2, Timbol, C. 1, Merck, S. 3, Esteitie, R. 1, Cooney, M. 4, Read, C. 4 and Baraniuk, J. 1
1
Medicine-Section of Rheumatology, Allergy, & Immunology, Georgetown University, Washington, DC. 2Section of Rheumatology,
Allergy & Immunology, Medicine, Washington, DC. 3Medicine, Section of Rheumatology, Allergy & Immunology, Washington, DC.
4
Division of Pulmonary, Critical Care and Sleep Medicine, Georgetown University, Washington, DC.
2003 Proteomics of Induced Sputum in COPD, Healthy Smokers and Chronic Bronchitis
Casado, B. 1, Luisetti, M. 2, Iadarolo, P. 3, Di Poto, C. 4 and Baraniuk, J. 5
1
Division of Rheumatology, Immunology & Allergy, Georgetown University, Washington, DC. 2Clinica di Malattie dell’Apparato
Respiratorio, IRCCS Policlinico San Matteo, Pavia, Italy. 3Dipartimento di Biochimica “A. Castellani”, Universita di Pavia, Pavia, Italy.
4
Medicine, Section of Rheumatology, Allergy & Immunology, Washington, DC. 5Medicine-Section of Rheumatology, Allergy, &
Immunology, Georgetown University, Washington, DC.
2004 Incidence of Allergy In Patients with Benign Lesions of the Vocal Cords: Preliminary Report
Eyigor, H. 1, Osma, U. 1, Yalcin, A. D. 2, Yilmaz, M. D. 1 and Pirtik, I. 1
1
ENT Head and Neck Surgery, Antalya Training and Research Hospital, Antalya, Turkey. 2Allergology and Clinical Immunology Unit,
Antalya Education and Training Hospital, Antalya, Turkey.
2005 Echocardiographic Findings In Obese Adolescents with and without Asthma
Montejano-Elías, L.
Hospital Infantil de México Federico Gómez, Distrito Federal, México.
113
Final Program
Posters
2006 Asthma Prevalence and Body Mass Index in Children
Herbarth, O. 1, Richter, M. 2 and Richter, T. 3
1
Environmental Medicine and Hygiene, University of Leipzig, Faculty of Medicine, Leipzig, Germany. 2Helmholtz-Center for
Environmental Research, Leipzig, Germany. 3St. Georg Hospital, Leipzig, Germany.
2007 Evaluation and Comparison of Lung Volumes and Capacities In A Group of Morbid Obese, Obese and
Eutrophic Adolescents
Mendiola Marin, J.
Allergy and Immunology , Instituto Mexicano del Seguro Social , México City, México.
2008 Difficult-to-Treat Asthma with Idiopathic Chronic Eosinophilic Pneumonia
Pauk, N.
3rd Faculty of Charles University, Dept of Pneumology, Faculty Hospital Na Bulovce, Prague, Czech Republic.
2009 Diagnosis and Management of Post-Radiation Pneumonitis In Patients with Asthma
Syrigou, E. 1, Ralli, M. 2, Psarros, F. 1, Makrilia, N. 2, Charpidou, A. 2, Dannos, I. 2 and Syrigos, K. N. 3
1
Department of Allergy, Sotiria General Hospital, Athens, Greece, Athens, Greece. 2Oncology Unit, 3rd Department of Medicine,
Sotiria General Hospital, Athens School of Medicine, Greece, Athens, Greece. 3Oncology Unit, 3rd Department of Medicine, Sotiria
General Hospital, Athens School of Medicine, Greece, Athens, Greece.
2010 Pathogenesis of Radiation-Induced Pneumonitis In Patients with Chronic Obstructive Pulmonary Disease
Politi, E. 1, Tolia, M. 1, Makrilia, N. 1, Psarros, F. 2, Dannos, I. 1, Syrigos, K. N. 3 and Syrigou, E. 2
1
Oncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece, Athens, Greece.
2
Sotiria General Hospital, Athens School of Medicine, Greece, Athens, Greece.
2011 Medication Responses in Chronic Fatigue Syndrome (CFS) and Non-CFS Subjects
Esteitie, R. 1, Adewuyi, O. 1, Ravindran, M. 1, Zheng, Y. 1, Merck, S. 2, Timbol, C. 1, Di Poto, C. 2, Rayhan, R. 3 and Baraniuk, J. 1
1
Medicine-Section of Rheumatology, Allergy, & Immunology, Georgetown University, Washington, DC. 2Medicine, Section
of Rheumatology, Allergy & Immunology, Washington, DC. 3Medicine, Section of Rheumatology, Allergy & Immunology ,
Washington, DC.
2012 Psychogenic Intractable Sneezing. Case Report
González-Díaz, S. 1, Arias-Cruz, A. 1, Mejia, K. 1, Gallego, C. 2, Garcia, D. 1, Calva, M. 1 and Dominguez, L. 1
1
Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 2Regional Center of Allergy and
Clinical Immunology, University Hospital, Monterrey, México.
2013 Clinical Investigation of Cough Associated with or without Cough-Variant Asthma or Bronchial Asthma
In the Outpatient Cases Including Pertussis, Chlamydophilia Pneumoniae Bronchitis, and Mycoplasma
Pneumoniae Bronchitis
Nakajima, H. 1, Nakajima, S. 2 and Tohda, Y. 3
1
Respiratory Medicine and Allergology, Kinki University School of Medicine, Osakasayama, Japan. 2Allergy and Respiratory
Diseases, Nara Hospital, Kinki Unidersity School of Medicine, Ikoma, Japan. 3Respiratory Medicine and Allergology, , Kinki
University School of Medicine, Osakasayama, Japan.
2014 GERD Screening by the Use of F-Scale and Allergy Screening for Diagnosis and Treatment of Chronic Cough
Nishihira, R. , Komatsu, S. , Shinohara, T. , Tagawa, A. , Ogura, T. and Takahashi, H.
Department of Respiratory Disease, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
2015 Diagnosis of Gastroesophageal Reflux Disease in Patients with Chronic Cough
Agondi, R. C. 1, Kalil, J. 2 and Giavina-Bianchi, P. 2
1
Clinical Immunolgy and Allergy, Sao Paulo University, Sao Paulo, Brazil. 2Clinical Immunology and Allergy, University of Sao Paulo,
Sao Paulo, Brazil.
2016 Botox Injections in Larynx As a Treatment for Vocal Cord Dysfunction
Perez, J. E. , Pongdee, T. and Guarderas, J.
Allergy and Pulmonary Medicine, Mayo Clinic, Jacksonville, FL.
2017 The Importance of Recognizing Vocal Cord Dysfunction in the Presence of Allergy and Asthma
Issa-El-Khoury, K. 1 and Bayuk, J. 2
1
Allergy and Immunology, McGill University, Montreal Children’s Hospital, Montreal, QC, Canada. 2Allergy and Immunology,
Hampden County Physician Associates, Northampton, MA.
114
Final Program
Posters
2018 Myasthenia Gravis and Asthma, Relationship Between Two Different Disorders of the Immune System
Velasco-Medina, A. A. , Barreto-Sosa, A. , Gonzalez-Carsolio, A. , Burbano-Ceron, A. and Velázquez-Sámano, G.
Servicio de Alergia e Inmunología Clínica, Hospital General de México, México City, México.
2019 Immunological Characteristics of Patients with Bronchial Asthma and Obesity
Konischeva, A. 1, Gervazieva, V. 2 and Lavrentyeva, E. 1
1
Mechnickov Research Institute for Vaccines and Sera, Moscow, Russia. 2Mechnikov Research Institute of Vaccines and Sera,
Moscow, Russia.
2020 Association Between Body Mass Index, Asthma Severity and Quality of Life in Allergic Asthmatic Adults
Olvera-Marquez, J. A. 1 and Segura, D. N. H. 2
1
Allergy and Clinical Immunology, IMSS, México, México. 2Allergy & Clinical Immunology, Specialty Hospital Centro Medico
Nacional Siglo XXI, México, México.
POSTER SESSION 2: PEDIATRIC ASTHMA CC, 1ST, POSTER HALL
2021 Not All Who Wheeze Have Asthma - Tracheal Diverticulum with Stenosiis of Trachea In 9 Years Old Boy
Kopriva, F.
Pediatrics, Medical Faculaty, Olomouc, Czech Republic.
2022 Recurrent Wheezing in Childhood - Is It Always Asthma?
Muti, A. D. 1,2, Iacob, D. 3, Farcau, D. 3 and Fufezan, O. 4
1
Immunology and Allergy, University of Medicine and Pharmacy “Iuliu Hatieganu” , Cluj-Napoca, Romania. 2Pulmonology, CHU,
Clermont-Ferrand, France. 3Pediatrics, University of Medicine and Pharmacy, Cluj-Napoca, Romania. 4Radiology, 3rd Pediatric
Clinic, Cluj-Napoca, Romania.
2023 Bronchial Hyperresponsiveness In Children with Suggestive Asthma Symptoms
Sanchez-Garcia, S. , Fermin, I. , Andregnette, V. , Rodriguez del Rio, P. , Escudero, C. and Ibañez, M. D.
Allergy Section, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
2024 Relationship Between Fractional Exhaled Nitric Oxide (FeNO) and Forced Expiratory Volume in One Second
(FEV1) and Forced Vital Capacity (FVC) in Children with Asthma
Kim, M. 1 and Rha, Y. H. 2
1
Department of Pediatrics, Idream Children’s Hospital, Daegu, South Korea. 2Department of Pediatrics, Kyung Hee University
Hospital, Seoul, South Korea.
POSTER SESSION 3: PEDIATRIC ASTHMA EPIDEMIOLOGY CC, 1ST, POSTER HALL
2025 Evaluation of the September Epidemic of Asthma Exacerbation in Children in Our Practice
Nemeth, A.
2nd Department of Pediatrics, Semmelweis University, Faculty of Medicine, Budapest, Hungary.
2026 Elevated Asthma Prevalence in Mexican-American Children in El Paso TX
Ruiz-Payan, A.
Health Science, University of Texas at El Paso , El Paso, TX.
2027 Prevalence of Bronchitis and Revealing of the Risk Factors in the Children’s Population
Adamia, N. 1, Chkhaidze, I. 1, Kherkheulidze, M. 1, Kherkheulidze, M. 1, Kandelaki, E. 2, Kavlashvili, N. 2, Nareklishvili, N. 3, Liluashvili, E. 4,
Chkhaidze, N. 5, Barabadze, K. 6, Gotsiridze, K. 7 and Gotsadze, K. 8
1
General Pediatrics, Tbilisi State Medical University, Tbilisi, Georgia. 2Pediatrics, State Medical University, Tbilisi, Georgia. 3Pediatrics,
Mikheil Guramishvili Pediatric Clinic, Tbilisi, Georgia. 4Residence Department, Tbilisi State Medical University, Tbilisi, Georgia.
5
Tbilisi State Medical University, Tbilisi, Georgia. 6Pediatrics, Tatishvili Medical Center, Tbilisi, Georgia. 7Mikheil Guramishvili Pediatric
Clinic, Tbilisi, Georgia. 8Tatishvili Medical Center, Tbilisi, Georgia.
2028 Atopic Phenotype In Children Under 6 Years with Persistent Wheezing In El Salvador
Flores, M. 1 and Salazar, P. 2
1
Pediatrics Service, Hospital Nacional San Rafael, Santa Tecla, El Salvador. 2Dr. José Matías Delgado University, Antiguo Cuscatlán,
El Salvador.
115
Final Program
Posters
2029 Comparison of Exhaled Nitric Oxide and Spirometry in Hispanic/Latino Children Living in Miami to Those
Living in Latin America
Lanz, M. J. 1 and Bautista, A. 2
1
Allergy and Asthma, AAADRS Clinical Research Center, Coral Gables, FL. 2AAADRS Clinical Research Center, Coral Gables, FL.
2030 Maximum Expiratory Flow in Health Children From the Metropolitan Area of Monterrey México
Valdes, D. 1, González-Díaz, S. 1, Macias, A. 1, Arias-Cruz, A. 1, Canseco, J. 1, Gallego, C. 2, Garcia, D. 1, Calva, M. 1, Mejia, K. 1 and
Dominguez, L. 1
1
2031 Sensitization to Mites. Relation with Atopic Diseases In School Children From San Antonio De Los Baños
Diaz Rodriguez, A. 1 and Fabré Ortíz, D. E. 2
1
Department of Allergy, Medical Center. Guira de Melena, Havana, Cuba, Cuban Society of Allergy, Asthma and Immunology,
Havana, Cuba. 2Cuban Society of Allergy, Asthma and Immunology, Havana, Cuba, Havana, Cuba.
2032 Clinical and Immunological Findings in Childhood Asthma
Muti, A. D. 1, Iacob, D. 2, Farcau, M. 3, Ilies, O. 3, Panaete, A. 3, Cretu, D. 4 and Gherman, P. 4
1
Immunology and Allergy, University of Medicine and Pharmacy “Iuliu Hatieganu” , Cluj-Napoca, Romania. 2Pediatrics, University
of Medicine and Pharmacy, Cluj-Napoca, Romania. 3Pediatrics, 3rd Pediatric Clinic, Cluj-Napoca, Romania. 4University of Medicine
and Pharmacy, Cluj-Napoca, Romania.
2033 Prevalence of Bronchial Asthma in Rural Indian Children: A Cross Sectional Study From South India
Jain, A. 1, Bhat, H. V. 2 and Acharya, D. 3
1
Community Medicine, Kasturba Medical College (Manipal University), Mangalore, India, Mangalore, India. 2Kasturba Medical
College (Manipal University), Manipal, India, Manipal, India. 3Fr Muller Medical College, Mangalore, India, Mangalore, India.
2034 Viral Respiratory Infections and the Development of Atopy and Asthma
Kartasasmita CB, C. B. 1 and Setiabudiawan, B. 2
1
Child Health, Respirology Division, Bandung, Indonesia. 2Department of Child Health, Hasan Sadikin Hospital/School of Medicine
Universitas Padjadjaran, Bandung, Indonesia.
2035 Clinical Characteristics of Eosinophilic Asthma Compared to Noneosinophilic Asthma in Children
Lee, Y. J. 1, Kim, K. W. 2,3, Choi, B. S. 4, Sohn, M. H. 2,3 and Kim, K. 2
1
Pediatrics, Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea. 2Department of Pediatrics, Yonsei University
College of Medicine, Seoul, South Korea. 3Institute of Allergy, Yonsei University College of Medicine, Seoul, South Korea.
4
Pediatrics, Good Gangan Hospital, Busan, South Korea.
POSTER SESSION 4: AEROBIOLOGY CC, 1ST, POSTER HALL
2036 Connections in Health-Web 2.0, Tele-Aerobiology, Through a Global Allergy Database
Dalan, D. 1 and Anderson, J. 2
1
Allergy Asthma Care Center, Fargo, ND. 2London Health Sciences Center, London, ON, Canada.
2037 Thunderstorm-Related Asthma in Patients Sensitised to Olea Europaea Pollen: Twenty Emergency
Department Visits for Asthmatic Symptoms in One Single Day
Losappio, L. 1, Heffler, E. 2, Contento, F. 1, Falco, A. 1, Cannito, C. D. 1 and Rolla, G. 2
1
Emergency Department, PO Dimiccoli Barletta, Barletta, Italy. 2Biomedical Sciences and Human Oncology, Allergy and Clinical
Immunology - University of Torino - AO Mauriziano “Umberto I”, Torino, Italy.
2038 The Revised Edition of Korean Calendar for Allergenic Pollens
Oh, J. 1, Kim, J. 1, Kim, S. 2, Kang, I. 3, Kim, B. 4, Kook, M. 5, Park, K. 6, Lee, H. 7, Kim, K. R. 8 and Choi, Y. 8
1
Pediatrics, Hanyang university Guri Hospital, Guri, South Korea. 2Pediatrics, Busan St. Maria Hospital, Busan, South Korea.
3
Pediatrics, Daegu Fatima Hospital, Daegu, South Korea. 4Pediatrics, Kangneung Asan Hospital, Kangneung, South Korea.
5
Pediatrics, Kwangju Veteran’s Hospital, Kwangju, South Korea. 6Pediatrics, Jeonju Jesus Hospital, Jeoju, South Korea. 7Pediatrics,
Hanyang university Seoul Hospital, Seoul, South Korea. 8Applied Meteorology Research Laboratory, National Institute of
Meteorological Research, Seoul, South Korea.
2039 Aerobiological Study of Anemophilous Pollens in the City of Toluca, México
Cid del Prado - Izquierdo, M. 1, Piedras-Gutierrez, B. 1, Del Olmo - Tellez, H. 2 and Zarco - Cid del Prado, O. 1
1
Fundacion Regional Para El Estudio De Asma Y Alergia, Clinica De Asma, Alergia E Inmunologia, Toluca, México. 2Pediatric Allergy
& Clinical Immunology, Phd In Science, Private Practice, México City, México.
116
Final Program
Posters
2040 Allergenic Significance of Airborne Rhizopus Stolonifer (Ehrenb.) Vuill., a Common Bread Mold
Sircar, G. and Gupta Bhattacharya, S.
Division of Plant Biology, Bose Institute, Kolkata, India.
2041 Aerobiological and Immunological Studies On Coconut Pollen Allergy
Saha, B. and Gupta Bhattacharya, S.
Division of Plant Biology, Bose Institute, Kolkata, India.
2042 Sensitization to Casuarina Equisetifolia and Pinus Spp Pollen In A Group of Mexican Patients
Velasco-Medina, A. A. 1, Cortés-Morales, G. 2, Barreto-Sosa, A. 1 and Velázquez-Sámano, G. 1
1
Servicio de Alergia e Inmunología Clínica, Hospital General de México, México City, México. 2Hospital General de México, México
City, México.
2043 Patterns of Skin Prick Test Positivity In 519 Patients with Allergic Rhinitis and Asthma In México CITY
Ruiz Cervantes, K. P. 1, Garcia Cruz, M. D. L. L. 2, Gonzalez Galarza, M. D. R. 2, Ramirez Jimenez, F. 2, Najera Villatoro, C. G. 2, Teran
Juarez, L. M. 2 and Pavon Romero, F. G. 3
1
Clinical Immunology and Allergy, National Institute of Respiratory Disease Calzada de Tlalpan 4502 Col. Sección XVI, Del. Tlalpan,
México, D.F. C.P. 14080, México, México. 2Clinical Immunology and Allergy , National Institute of Respiratory Disease, Distrito
Federal, México. 3Clinical Immunology and Allergy , National Institute of Respiratory Disease Calzada de Tlalpan 4502 Col. Sección
XVI, Del. Tlalpan, México, D.F. C.P. 14080, México, México.
2044 Risk Factors and Their Impact On Development and Severity of Allergic Diseases In the CIS-Region
Slavyanskaya, T.
Department of Allergology and Clinical Immunology, Institute of Immunophysiology, Moscow, Russia.
2045 Monitoring of AIR-Pollutants Concentration In Children with Allergic Diseases
Chikhladze, M. V. 1 and Sepiashvili, R. I. 2
1
National Institute of Allergology, Asthma & Clinical Immunology, Georgian Academy of Sciences, Tskhaltubo, Georgia.
2
Department of Allergology and Clinical Immunology, Institute of Immunophysiology, Moscow, Russia.
2046 Analysis of An After-Care Questionnaire In Allergic People to Dust Mites Using Anti-Dust Mites Bed Covers
Boukhettala, N. and Bourgeon, S.
Laboratoire Protec’Som, Valognes, France.
2047 Changing Scenario of Airborne Allergens in Bangalore India
Pendakur, A. 1 and Ramdas, B. 2
1
Allergy Asthma ENT Clinic, Fellow: Indian College of Allergy Asthma and Applied Immunology, Bangalore 560025, India.
2
Community Medicine, Member: Indian Academy of Allergy, Bangalore, India.
POSTER SESSION 5: MECHANISMS OF ASTHMA
AND ALLERGIC INFLAMMATION CC, 1ST, POSTER HALL
2048 Human Mononuclear Phagocytes Are Regulated by A Cross-Talk with Epithelial Cells
Striz, I. 1, Brabcova, E. 1, Kolesar, L. 1, Sekerkova, A. 1, Jaresova, M. 1 and Rennard, S. I. 2
1
Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 2Pulmonary and Critical Care, University of Nebraska
Medical Center, Omaha, NE.
2049 Activation of PAR-2 Induces Myofibroblast Transformation Via a TGF-β and GSK-3β/β-Catenin Dependent
Pathway in Tissue Remodeling in the Asthmatic Lung
Suzuki, T. 1, Downey, G. 2, Nakagome, K. 3, Nagata, M. 3 and Hagiwara, K. 1
1
Saitama Medical University, Moroyama-machi, Japan. 2National Jewish Health, Denver, CO. 3Allergy Center , Department of
Respiratory Medicine, Saitama Medical University, Moroyama-Machi, Japan.
2050 Investigating the Role of IL-4 Receptor Alpha Signalling Through CD4+ T Cells in Ovalbumin-Induced
Allergic Airway Disease
Jayakumar, J. , Nieuwenhuizen, N. , Kirstein, F. , Emedi, B. and Brombacher, F.
Division of Immunology, International Centre for Genetic Engineering and Biotechnology, Institue of Infectious Diseases and
Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
117
Final Program
Posters
2051 CD70-CD27 Interaction Regulates Asthmatic Response in a Murine Model of Asthma
Makino, F. 1,2, Harada, N. 1,2, Ito, J. 1,2, Abe, Y. 1,3, Kamachi, F. 1, Takahashi, K. 2, Okumura, K. 1 and Akiba, H. 1
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan. 2Department of Respiratory Medicine,
Juntendo University School of Medicine, Tokyo, Japan. 3Department of Internal Medicine and Rheumatology, Juntendo University
School of Medicine, Tokyo, Japan.
1
2052 Plasminogen Activator Inhibitor-1, Fibrinogen and Lung Function In Adolescents with Asthma and Obesity
Huang, F.
Departmento de Investigacion en Farmacologia y Toxicologia, Hospital Infantil del México., México, D.F, México.
2053 Increased Surfactant Protein-D In Young Infants with Bronchiolitis
Chung, H. L. , Shin, J. Y. and Yang, S. H.
Pediatrics, School of Medicine, Catholic University of Taegu, Taegu, South Korea.
2054 Peculiarities of Immune Response In Young Children with Recurrent Wheezing
Gromadina, O. , Zaytseva, O. and Shklyaeva, I.
Department of Pediatrics, Moscow State University of Medicine and Dentistry, Moscow, Russia.
2055 Participation of Invariant NKT Cells (Vα24Jα18) During Asthma Exacerbation in Children
Carpio-Pedroza, J. C. 1, del Rio-Navarro, B. E. 2, del Río-Chivardí, J. M. 3, Morales-Flores, A. 1, Jiménez-Zamudio, L. A. 4, Moreno-Lafont,
M. 5, Pedraza-Sánchez, S. 6, Vaughan-Figueroa, J. G. 7 and Escobar-Gutiérrez, A. 7
1
Investigaciones Inmunologicas, Instituto de Diagnostico y Referencia Epidemiologicos, México City, México. 2Alergia e
Inmunologia Clinica, Hospital Infantil de México Federico Gomez, México City, México. 3Alergia e Inmunologia Clinica, Hospital
Infantil de México Federico Gomez, México City , México. 4Inmunología, Escuela NAcional de Ciencias Biológicas, México City,
México. 5Inmunología , Escuela Nacional de Ciencias Biológicas, México City , México. 6Bioquímica, Instituto Nacional de Nutrición
y Ciencias Médicas Salvador Zubirán, México City , México. 7Investigaciones Inmunologicas , Instituto de Diagnostico y Referencia
Epidemiologicos , México City , México.
2056 Dexamethasone Can Reverse the Alteration of Airway Epithelial Responses to Rhinovirus Infection by Th2
Cytokines
Yang, M. 1, Lee, H. 1, Song, W. 1, Lee, S. 1, Park, H. 1, Cho, S. 1, Min, K. 1 and Chang, Y. 2
1
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. 2Department of Internal
Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
2057 Cytokine Profile Characterization in Patients Infected with AH1N1 Influenza Virus
Lopez-Espinosa, N. L. 1, Vizuet-Garcia, L. 1, Robles-Contreras, A. 2, Jiménez-Martínez, M. C. 2,3 and Bautista-de Lucio, V. M. 1
1
Research Unit, Institute of Ophthalmology, México D.F., México. 2Research Unit and Department of Immunology, Institute of
Ophthalmology, México D.F., México. 3Department of Biochemistry, Faculty of Medicine, UNAM, México D.F., México.
2058 Basal T Cell Subpopulations of Normal Humans Vary by Stress Hormone Receptor Polymorphisms
Rehm, K. , Xiang, L. and Marshall, G.
Medicine, University of Mississippi Medical Center, Jackson, MS.
2059 The Protective Effects of Exogenous IGFBP-3 on Allergic Airway Inflammation Through Blockade of VEGF
Production
Park, S. Y. 1, Choi, K. H. 2, Chung, C. R. 3, Kim, S. R. 4, Park, S. J. 4, Lee, H. B. 5, Rhee, Y. K. 4 and Lee, Y. C. 4
1
Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, South Korea. 2Deparment of Internal Medicine,
Chonbuk National University Hospital, Jeonju, South Korea. 3Department of Internal Medicine, Jeonbuk National University
Hospital, Jeonju, South Korea. 4Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South
Korea. 5Department of Internal Medicine, Jeonbuk National University Medical Schoold, Jeonju, South Korea.
2060 Antioxidants Attenuate Airway Remodeling by Regulating NF-ÊB, Nrf2, and HIF in a Murine Model of
Chronic Asthma
Park, S. J. 1, Park, S. Y. 2, Kim, S. R. 1, Rhee, Y. K. 1 and Lee, Y. C. 1
1
Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea. 2Department of Internal
Medicine, Chonbuk National University Hospital, Jeonju, South Korea.
2061 CCL3L1 protein did not affect IL-6 expression, but significantly up-regulated IL-10 expression in the allergic
response
Choi, B. W. 1, Yoon, Y. 2, Choi, J. C. 1, Lee, H. 2 and Bae, S. 3
1
Respirology and Allergy, Chung-Ang University Hospital , Seoul, South Korea. 2Microbiology, Chung-Ang University College of
Medicne, Seoul, South Korea. 3Microbiology, Chung-Ang University College of Medicne, Seoul , South Korea.
118
Final Program
Posters
2062 Caspase-9 Is Involved in CD30 Activation Induced Eosinophil Apoptosis
Kim, J. T. 1, Kim, H. H. 2 and Lee, J. S. 2
1
Pediatrics, The Catholic University of Korea, Uijeongbu, South Korea. 2Pediatrics, The Catholic University of Korea, Pucheon-si,
South Korea.
2063 Role of NLR (nucleotide oligomerization domain(NOD) – like receptor) on AllergicInflammation in a Mouse
Model of Allergic Rhinitis
KIM, S. W. 1, Shin, J. 2 and Park, H. R. 3
1
Otolaryngology HNS, The Catholic University of Korea, Seoul ST. Mary’s Hospital, Seoul, South Korea. 2The Catholic University of
Korea, Seoul, South Korea. 3The Catholic Univrsity of Korea, Seoul, South Korea.
2064 Mutant IL-3: A Common Down Regulator for Components of IgE Mediated Signal Transduction Pathway
Singh, A.
Alleergy and Immunology, Institute of Genomics and Integrative Biology, Delhi, India.
2064AIL-17 Role in the Regulatory Function of B Cells
Vazquez-Tello, A. 1, Halwani, R. 2, Hamid, Q. 3 and Al-Muhsen, S. 4
1
Asthma Research Chair and Prince Naif Center for Immunological Research, College of Medicine, King Saud University., Riyadh,
Saudi Arabia. 2Asthma Research Chair and Prince Naif Center for Immunological Research, College of Medicine, King Saud
University., Riyadh, Saudi Arabia. 3McGill University, Meakins-Christie Laboratories, Montreal, QC, Canada. 4 Asthma Research Chair
and Prince Naif Center for Immunology Research, Department of Pediatrics, College of Medicine, King Saud University, Riyadh,
Saudi Arabia.
2064B Role of Th-17 Cytokines in Steroid Insensitivity in Peripheral Blood Mononuclear Cells. Relationship to GRAlpha and GR-Beta Expression
Vazquez-Tello, A. 1, Halwani, R. 2, Hamid, Q. 3 and Al-Muhsen, S. 4
1
Asthma Research Chair and Prince Naif Center for Immunological Research, College of Medicine, King Saud University., Riyadh,
Saudi Arabia. 2Asthma Research Chair and Prince Naif Center for Immunological Research, College of Medicine, King Saud
University., Riyadh, Saudi Arabia. 3McGill University, Meakins-Christie Laboratories, Montreal, QC, Canada. 4 Asthma Research Chair
and Prince Naif Center for Immunology Research, Department of Pediatrics, College of Medicine, King Saud University, Riyadh,
Saudi Arabia.
POSTER SESSION 6: ALLERGY TO ANTIMICROBIALS CC, 1ST, POSTER HALL
2065 Penicillin Allergy Evaluation: Experience From a Drug Allergy Clinic in Kuwait
Al-Ahmad, M. 1, Arifhodzic, N. A. 2, Al-Onizi, A. 3, Fakim, N. 3 and Al-Ahmed, N. 4
1
Allergy, AL-Rashed allergy Centre, Kuwait, Kuwait, Kuwait. 2Department of Allergy Clinical Immunology, Kuwait Allergy Centre,
Kuwait city, Kuwait. 3Allergy Department, Kuwait Allergy Center, Kuwait, Kuwait. 4Department of Allergy, Al-Rashed Allergy Centre,
Ministry of Health, State of Kuwait, Kuwait, Kuwait.
2066 Association Between Genetic Polymorphisms of ABCC2 Transporter and the Susceptibility to
Maculopapular Eruption Induced by Antituberculosis Drugs
Kim, S. 1, Kim, S. 2, Lee, J. 3, Lee, B. 4 and Jee, Y. 5
1
Internal Medicine, Eulji Hospital Eulji University School of Medicine, Seoul, South Korea. 2Department of Internal Medicine,
Hanyang University College of Medicine, Seoul, South Korea. 3Internal Medicine, Eulji Hospital, Eulji University School of Medicine,
Seoul, South Korea. 4Eulji Hospital Eulji University School of Medicine, Seoul, South Korea. 5Internal Medicine, Dankook University
College of Medicine, Cheonan, South Korea.
2067 The Real Use of Beta-Lactams After “Penicillin Allergic” Label Removal
Cohen, S. 1, Khateeb-Alabbasi, A. 2, Nusem, D. 3 and Panassof, J. 3
Allergy Clinic Lin Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. 2 Allergy
Clinic Lin Medical Center, School of Public Health, University of Haifa, Haifa , Israel. 3Allergy Clinic Lin Medical Center, Haifa, Israel.
1
2068 Hypersensitivity to Beta-Lactam Antibiotics Evaluation Using the European Network Drug Allergy (ENDA)
Algorithm
Gonçalves, T. M. 1,2, Martins, E. 1,2, Alves Neto, A. 1,2, Delcourt, N. 3,4, Rios, J. 1,2, Arcanjo, L. 1,2 and Rios, J. L. 3,4
1
Policlinica Geral Do Rio De Janeiro, Rio De Janeiro, Brazil. 2Faculdade De Medicina De Petropolis, Petropolis, Brazil. 3Policlinica
Geral do Rio de Janeiro, Rio de Janeiro, Brazil. 4Faculdade de Medicina de Petropolis, Petropolis, Brazil.
2069 Clinical Features of Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by
Antituberculous Medications
Kim, S. , Lee, S. N. , Lee, S. J. , Kim, C. W. , Lee, W. Y. , Yong, S. J. and Shin, K. C.
Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea.
119
Final Program
Posters
POSTER SESSION 7: DRUG ALLERGY 1
2070 Non-Steroidal Anti-Inflammatory Drugs Hypersensitivity: Patterns of Reaction
Ensina, L. F. C. 1,2, Bittar, R. P. 3, Tanno, L. K. 3, Aun, M. V. 3, Kalil, J. 3, Giavina-Bianchi, P. 3 and Motta, A. A. 3
Rheumatology, Allergy and Immunology, University of Santo Amaro, Sao Paulo, Brazil. 2Rheumatology, Federal University of Sao
Paulo, Sao Paulo, Brazil. 3Clinical Immunology and Allergy, University of Sao Paulo, Sao Paulo, Brazil.
1
2071 Epidemiology of Immediate Type Adverse Drug Reactions and Rashes Elicited by NSAID
Kinaciyan, T. 1, Ghanim, N. 2, Roth-Walter, F. 3, Ghanim, L. 2, Woehrl, S. 2, Stingl, G. 2 and Jensen-Jarolim, E. 4
1
DIAID, Department of Dematology , Medical University of Vienna, Vienna, Austria. 2DIAID, Department of Dermatolgy, Medical
University of Vienna, Vienna, Austria. 3Department of Pathophysiology and Allergy Research , Medical University of Vienna, Vienna,
Austria. 4Medical University Vienna, Inst. of Pathophysiology and Allergy Research, Vienna, Austria.
2072 Test In Vitro to Investigate the Cytotoxicity and Cellular Nonspecific Stimulation of Basophils with
Indomethacin
Calamita, Z. 1, Antunes, R. N. S. 2, Almeida Filho, O. M. 3, Baleotti Junior, W. 4, Fukasawa, J. T. 5, Cavaretto, D. A. 5 and Calamita, A. B. P. 6
1
Allergy and Immunology, Medical School of Marilia , São Paulo, Brazil. 2Hematology, Medical School of Marilia, Marilia, Brazil.
3
Immunology, Medical School of Marilia, Marilia, Brazil. 4Clinical Pathology, Medical School of Marilia, São Paulo, Brazil. 5Flow
Citometry, Medical School of Marilia, Marilia, Brazil. 6Dermatology, Medical School of Marilia, Marilia, Brazil.
2073 Aspirin Desensitization Treatment : A Case Report
Alvarez, M. 1, Osoria, L. 2, Ronquillo, M. 1, Castro, R. 3, Perez, D. 4, Rodríguez, J. 1 and Irarragorri, C. 4
1
Allergology Department, University Hospital Calixto García, Havana City, Cuba. 2Cardiology, Calixto García University Hospital,
Havana City, Cuba. 3Allergens, National Center of Bioproducts, Havana City, Cuba. 4Calixto García University Hospital, Havana City,
Cuba.
2074 Adverse Drug Reactions to Anti-Asthmatics In Patients with Bronchial Asthma
Kim, C. 1, Cho, J. 2, Jung, E. 3 and Lee, H. 4
1
Department of Internal Medicine, Inha Regional Pharmacovigilance Center, Inha University Hospital, Incheon, South Korea.
2
Department of Internal Medicine, Inha University Hospital, Incheon, South Korea. 3Inha Regional Pharmacovigilance Center, Inha
University Hospital, Incheon, South Korea. 4Inha Regional Pharmacovigilance Center, Department of Pharmacy, Inha University
Hospital, Incheon, South Korea.
2075 Presentation of Three Cases of Allergic Reactions to Triptorelin
Diaz, M. C. 1, Lavrut, A. J. 2 and Spinelli, S. S. 2
1
Unidad de Alergia, Hospital General de Niños Pedro de Elizalde Casa Cuna, Buenos Aires, Argentina. 2Unidad Alergia, Hospital De
Niños Pedro De Elizalde, Buenos Aires, Argentina.
2076 Adverse Drug Reactions in Hospitalized Patients
Ribeiro, M. R. , Giavina-Bianchi, P. , Kalil, J. and Motta, A. A.
2077 An Unusual Reaction to Intravenous Iron Sucrose
Balduzzi, M. , Rashid, D. , Butt, A. , Lockey, R. F. and Ledford, D.
Division of Allergy & Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL.
2078 Urticaria and Arthralgias In a Nine-Year-Old with Recurrent Urinary Tract Infections
Butt, A. , Rashid, D. , Fox, R. and Lockey, R. F.
Division of Allergy & Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL.
2079 Jessner-Kanoff Lymphocytic Infiltrate As a Side Effect of Immunotherapy
Yalcin, A. D. 1, Bisgin, A. 2, Gorczynski, R. M. 3, Akman, A. 4, ErdoÐan, G. 5 and Yegin, O. 6
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Human Gene and Cell
Therapy Center of Akdeniz University Hospital and Clinics, Antalya, Turkey. 3Division of Cellular & Molecular Biology, Toronto
Hospital, University Health Network, Toronto, ON, Canada. 4Dept. Of Dermatology, Akdeniz University Faculty of Medicine,
Antalya, Turkey. 5Department of Pathology, Akdeniz University Faculty of Medicine, Antalya, Turkey. 6Dept. Of Immunology and
Allergy, Akdeniz University Faculty of Medicine, Antalya , Turkey.
2080 Improvement of Oral Lichenoid Reaction Symptoms After Removal of Amalgam Restorations: An Anusual
Case of Type IV Hypersensitivity
Tunca, Y. M. 1, Ucok, O. 2, Aydin, C. 1, Avsever, H. 3, Orhan, K. 3 and Yildiz, O. 4
1
Endodontics, Gulhane Military Medical Academy, Ankara, Turkey. 2Oral Diagnosis and Radiology, Gulhane Military Medical
Acedemy, Ankara, Turkey. 3Oral Diagnosis and Radiology, Gulhane Military Medical Academy, Ankara, Turkey. 4Medical
Pharmacology, Gulhane School of Medicine, Ankara, Turkey.
120
Final Program
Posters
2081 Hypersensitivity Reactions to Interferon Based Treatment for Hepatitis C: A Single Center 20-Year
Experience
Sidiropoulos, I. , Beltsis, A. , Gigi, E. , Sykla, A. , Bellou, A. and Raptopoulou - Gigi, M.
Allergy, Ippokration Hospital, Thessaloniki, Greece.
POSTER SESSION 8: FOOD ALLERGY CC, 1ST, POSTER HALL
2082 Effect of Hydrolysis and Polymerization on Bovine Beta-Lactoglobulin Immunoreactivity
Villas-Boas, M. B. 1, Serimarco Sabadin, I. 1, de Lima Zollner, R. 2 and Netto, F. M. 1
1
Food and Nutrition, University of Campinas (UNICAMP), Campinas, Brazil. 2Medical Science, University of Campinas (UNICAMP),
Campinas, Brazil.
2083 Immunoreactivity of Polymerized and Digested Beta-Lactoglobulin to IgE From Milk Allergic Patients
Villas-Boas, M. B. 1, Benedé, S. 2, Netto, F. M. 1, de Lima Zollner, R. 3 and Molina, E. 2
1
Food and Nutrition, University of Campinas (UNICAMP), Campinas, Brazil. 2Institute of Food Science Research, Madrid, Spain.
3
Medical Science, University of Campinas (UNICAMP), Campinas, Brazil.
2084 Identification of Novel Allergens in the Fish Parasite Anisakis Simplex
Fæste Kruse, C. 1, Dooper, M. 1, Daschner, A. 2, Egge-Jacobsen, W. 3 and Egaas, E. 1
1
Norwegian Veterinary Institute, Oslo, Norway. 2La Princesa University Hospital, Madrid, Spain. 3University of Oslo, Oslo, Norway.
2085 Milk Components As a Tool in Predicting Tolerance in Cow’s Milk Allergy
Santos, C. , Garcia, C. , Castro, A. P. B. M. , Gushken, A. , Pastorino, A. C. , Beck, C. , Brandão, A. C. and Jacob, C. M. A.
Department of Pediatrics, Instituto da Criança - Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo,
São Paulo, Brazil.
2086 Uncommon Occupational Allergy to Rice: As a Food Allergen
Pérez-Bustamante, M. S. 1, Gonzalez-de-Olano, D. 1, Antolín-Amérigo, D. 2, Gandolfo-Cano, M. 1 and González-Mancebo, E. 1
1
Allergy Unit, Fuenlabrada Hospital , Madrid, Spain. 2Allergy Unit, Alcalá de Henares Hospital, Madrid, Spain.
2087 Frequency of Food Hypersensitivity Mediated by IgG in Patients Received in a Venezuelan Laboratory
During 2011
Najm, C. 1, Benarroch, L. 2, Camacho, N. 1, Figueroa, D. 1, Guzmán, J. 1, Perdomo, A. 1, García, N. 1 and Silva, N. A. 1
1
Corpodiagnostica´s Laboratory, Caracas, Venezuela. 2Hospital de Clinicas Caracas, Caracas, Venezuela.
2088 IgE-Mediated Responses towards Fish Parasite Anisakis, Crab and House Dust Mite in Norwegian Shrimp
Allergic Individuals
Dooper, M. 1, Myrset, H. 1, Egaas, E. 1, van Do, T. 2 and Florvaag, E. 2
1
Norwegian Veterinary Institute, Oslo, Norway. 2Haukeland University Hospital, Bergen, Norway.
POSTER SESSION 9: FOOD ALLERGY: EPIDEMIOLOGY CC, 1ST, POSTER HALL
2089 Patterns of Sensitization to Common Food and Inhalant Allergens and Allergic Symptoms in Preschool
Children
Han, M. Y.
Pediatrics, CHA University College of Medicine, Seoul, South Korea.
2090 Food Allergy Prevalence and Symptomatology in Inner City African Americans: A Retrospective Study
Rodenas, M. 1, Kumar, S. 1, Durkin, H. 2, Moallem, J. 3 and Joks, R. 1
1
Department of Medicine, Allergy & Immunology Division, SUNY Downstate Medical Center, Brooklyn, NY. 2Pathology
Department, SUNY Downstate Medical Center, Brooklyn, NY. 3Department of Pediatrics, Division of Allergy & Immunology, SUNY
Downstate Medical Center, Brooklyn, NY.
2091 Prevalence of Food Allergy in Adult Patients of Service Allergy and Clinical Immunology – Centro Medico
Nacional Siglo XXI - IMSS México DF
Guillen Rocha, N. L. 1 and Segura Mendez, N. H. 2
1
Allergy and Immunology, Fellow in training, México Distrito Federal, México. 2Allergy and Clinical Immunology , Specialty
Hospital Centro Medico Nacional Siglo XXI, México City, México.
121
Final Program
Posters
2092 Sensitization to Food Allergens in Patients of the Allergy Service of the University Hospital of Monterrey,
México
Dominguez, L. 1, Arias-Cruz, A. 2, González-Díaz, S. 3, Gonzalez, A. 4, Gallego, C. 5, Garcia, D. 1, Mejia, K. 1 and Calva, M. 1
1
Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 2Allergy and Clinical Immunology,
University Hospital UANL, Monterrey, México. 3regional allergy center, University California San Diego U.C.S.D., Monterrey, CA,
México. 4Regional Center of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 5Regional Center of Allergy
and Clinical Immunology, University Hospital, Monterrey, México.
2093 Frequency of Food-Sensitization by Prick-to-Prick Test and Atopy Patch Test In Allergic Children
Maya, J. , Rosas-Vargas, M. A. and del Rio, B.
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México.
2094 Increasing Incidence of Food Allergy In Zimbabwe
Sibanda, E.
Clinical Immunology and Allergy, Asthma, Allergy and Immune Dysfunction Clinic, Harare, Zimbabwe.
2095 Ten Years Follow up of Japanese Survey on Immediate Type Food Allergy
Imai, T. 1, Sugizaki, C. 2 and Ebisawa, M. 2
1
Pediatrics, Sagamihara National Hospital, Sagamihara, Japan. 2Clinical Research Center for Allergy and Rheumatology, National
Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
2096 Association Between Cows Milk Allergy and Gastroesophageal Reflux Disease on Mexican People
Ramirez Jimenez, F. , Garcia Cruz, M. D. L. L. , Gonzalez Galarza, M. D. R. , Ruiz Cervantes, K. P. , Najera Villatoro, C. G. and Teran
Juarez, L. M.
Clinical Immunology and Allergy , National Institute of Respiratory Disease, Distrito Federal, México.
2097 An Investigation of Food Choice Behaviour of Food Allergic and Non-Food Allergic Children
Sommer, I. , Mackenzie, H. , Venter, C. and Dean, T.
University of Portsmouth, Portsmouth, United Kingdom.
POSTER SESSION 10: INCIDENCE AND PREVALENCE OF FOOD ALLERGY CC, 1ST, POSTER HALL
2098 Nationwide Survey of Immediate Type Food Allergy in Japan
Imai, T. 1, Sugizaki, C. 2 and Ebisawa, M. 3
1
Pediatrics, National Sagamihara Hospital, Kanagawa, Japan. 2National Sagamihara Hospital, Kanagawa, Japan. 3Clinical Research
Center for Allergy and Rheumatology , Sagamihara National Hospital, Sagamihara, Japan.
2099 The Prevalence of Food Allergy in Children Under 2 Years in Three Cities in China
Chen, J. 1, Li, H. 2, Liao, Y. 3, Zhao, H. 4 and Chen, J. 4
1
Department of Primary Child Care, Children`s Hospital, Chongqing Medical University, Chongqing, China, Chongqing, China.
2
Department of Primary Child Care, Children`s Hospital, Chongqing Medical University, Chongqing, China. 3Zhuhai Maternal and
Child Care Service Centre, China, Zhuhai, China. 4.Children Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
2100 Skin Sensitization to Carmine Before Onset of Systemic Allergy to Ingested Carmine
Katada, Y. 1, Harada, Y. 2, Azuma, N. 3, Hashimoto, J. 4, Saeki, Y. 5 and Tanaka, T. 6
1
Allergy and Clinical Immuology, NHO Osaka-minami Medical Center, Kawachinagano, Japan. 2Allergy and Clinical Immunology,
NHO Osaka-minami Medical Center, Kawachinagano, Japan. 3Rheumatology, Hyogo College Of Medicine, Nishinomiya, Japan.
4
Clinical Immunology, NHO Osaka-minami Medical Center, Kwachinagano, Japan. 5Clinical Investigation, NHO Osaka-minami
Medical Center, Kawachinagano, Japan. 6Department of Respiratory Medicine, Allergic and Rheumatic Diseases, Osaka University
Graduate School of Medicine, Suita City, Japan.
2101 Milk, the Most Commonly Undeclared Food Allergen Causing Unexpected Allergic Reactions in Sweden
Between 2004 and 2011
Ferm, M. and Sjogren-Bolin, Y.
Science Department, National Food Administration, Uppsala, Sweden.
2102 Cross Sectional Study of 1,822 Pediatric Food Allergy Patients
Komata, T. 1, Hasegawa, M. 2, Ogura, K. 1, Iikura, K. 1, Goto, M. 1, Utsunomiya, T. 1, Sato, S. 2, Imai, T. 1, Tomikawa, M. 1, Shukuya, A. 1 and
Ebisawa, M. 2
1
Department of Pediatrics, Sagamihara National Hospital, Sagamihara, Japan. 2Department of Allergy, Sagamihara National
Hospital Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan.
122
Final Program
Posters
2103 Surface Plasmon Resonance Imaging: New Tool for Immunodiagnostics of Food Allergy
Abou Chakra, O. 1,2, Vollmer, N. 2, Boujday, S. 3, Poncet, P. 1,4, Chardin, H. 1, Peltre, G. 1, Pradier, C. 3 and Sénéchal, H. 1,5
1
LSABM - Allergy and Environment, ESPCI ParisTech, Paris, France. 2GenOptics SA, Horiba Scientifc, Chilly-Mazarin, France. 3LRS,
UPMC, Ivry sur Seine, France. 4Infection and Epidemiology, Institut Pasteur, Paris, France. 5CSS 5, INSERM, Paris, France.
POSTER SESSION 11: FOOD ALLERGY: GASTROINTESTINAL MANIFESTATIONS CC, 1ST, POSTER HALL
2104 Probiotic Effect of the Regulation of Innate Immune Response, DC and Adaptive Cellular Immune Response
and the Balance TH1, TH2, TREG Through Sensors TLR-2 and TLR-4, On the Intestinal Mucosa In Balb/c
Health Status and Balb/c Status of Exposure to LPS
Lubis, A. 1, Endaryanto, A. 2, Sudarmo, S. M. 3, Gunadi Ranuh, . I. R. 4 and Athiyyah, A. F. 4
1
Child Health, Pediatric Allergy Immunology, Surabaya, Indonesia. 2Division of Pediatric Allergy Immunology-Child Health
Department, Faculty of Medicine,Airlangga University-Soetomo Hospital , Surabaya, Indonesia. 3Division of Pediatric
Gastroenterology-Child Health Department, Faculty of Medicine,Airlangga University-Soetomo Hospital , Surabaya, Indonesia.
4
Division of Pediatric Gastroenterology-Child Health Department, Faculty of Medicine,Airlangga University-Soetomo Hospital,
Surabaya, Indonesia.
2105 Gluten Induced Systemic Disease (GISD) with Distinct Clinical Phenotype Different From Celiac Disease
Kushnir, N. M.
Allergy & Immunology Clinic of East Bay, Berkeley, CA.
2106 Patterns of Food Allergens in Kenyan Children
Kamenwa, R. 1 and Bowry, T. 2
1
Pediatrics & Child Health, Aga Khan University Hospital, Nairobi, Kenya. 2Nairobi Diagnostic Laboratory, Upperhill Medical Centre,
Nairobi, Kenya.
2107 Coincidence of Celiac Disease and Gluten Allergy
Markiewicz, K. 1, Rowicka, G. 2 and Gołębiowska-Wawrzyniak, M. 3
1
Immunology, Institute of Mother and Child, Warsaw, Poland. 2Nutrition Department, Institute of Mother and Child, Warsaw,
Poland. 3Department of Clinical Immunology, Institute of Mother and Child, Warsaw, Poland.
2108 Immunoreactivity of ß-Lactoglobulin and Identification of the Peptides Generated After Simulated
Orogastrointestinal Digestion
Benedé, S. 1, López-Expósito, I. 1, Alonso, E. 2 and Molina, E. 1
1
Institute of Food Science Research, Madrid, Spain. 2Hospital Gregorio Marañon, Madrid, Spain.
POSTER SESSION 12: IGE CC, 1ST, POSTER HALL
2109 Levels of IL-4, INF-γ, Total IgE and IgG4 in Serum of Allergic Children within Areas of Risk of Lead Exposure in
Torreon Coahuila, México
Chavez Villarreal, K. G. 1, Avila, J. 2, Goytia Acevedo, R. C. 3, Meza Velazquez, R. 4, Rivera Guillen, M. 5, Gomez Jurado, M. 6, García-Arenas,
G. 7 and Maravilla Dominguez, A. 8
1
Investigation Department, Facultad de Medicina UJED Gómez Palacio, Gómez Palacio Durango , México. 2 Investigation Department,
Facultad de Medicina UJED Gomez Palacio, Gomez Palacio Durango, México. 3Investigation Department, Universidad Juárez Del
Estado De Durango, Gómez Palacio, Durango, México. 4Investigation Department, Universidad Juárez Del Estado de Durango , Gómez
Palacio, Durango, México. 5Dirección, Centro de Atención A Metales Pesados, Torreón Coahuila, México. 6Investigation Department,
Facultad de Medicina UJED, Gómez Palacio, Gómez Palacio, Durango, México. 7Investigation Department, Facultad de Medicina UJED
Gomez Palacio, Gómez Palacio, Dgo., México. 8Investigation Department, Facultad de Medicina, UJED, Gómez Palacio., Gómez Palacio,
Dgo., México.
2110 Relationship of Blood Lead Levels with Total IgE in Teenagers with Environmental Exposure in Torreon
Coahuila, México
Meza-Velazquez, R. 1, Goytia Acevedo, R. C. 2, Garcia Arenas, G. 3, Calderon Aranda, E. S. 4, Rosales Gonzalez, M. 5, Rubio-Andrade, M.
5
, Maravilla-Domínguez, A. 6, Cebrian, M. E. 7, Rosado, J. L. 8, Stoltzfus, R. 9 and García Vargas, G. G. 10
1
Investigacion, Universidad Juarez del Estado de Durango, Gomez Palacio, Dgo, México. 2Investigation Department, Universidad
Juárez Del Estado De Durango, Gómez Palacio, Durango, México. 3Investigacion, Universidad Juarez del Estado de Durango,
Gómez Palacio, Dgo., México. 4Toxicologia, CINVESTAV-México, D.F., México. 5Investigación, Universidad Juárez del Estado de
Durango, Gómez Palacio, Dgo., México. 6Investigación, Universidad Juárez del Estado de Durango, Gómez Palacio, Dgo., México.
7
Toxicologia, Centro de Investigación y de Estudios Avanzados del IPN, DF, México. 8Facultad de Ciencias Naturales, Universidad
Autónoma de Querétaro, Queretaro, México. 9Division of Nutritional Sciences, Cornell University, Ithaca, NY. 10Investigación,
Universidad Juárez del Estado de Durango, Gómez Palacio, México.
123
Final Program
Posters
2111 IgE From Birch Pollen Allergic Patients Cross-Reacts with Two Distinct Bet v 1 Related Proteins in Mung
Beans: Vig r 1 and Cytokinin-Specific Binding Protein
Guhsl, E. 1, Gepp, B. 1, Hofstetter, G. 1, Balazs, N. 1, Hemmer, W. 2, Breiteneder, H. 1 and Radauer, C. 1
Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria. 2Floridsdorfer Allergiezentrum,
Vienna, Austria.
1
2112 Heterogeneity of the IgE Response to Allergenic Determinants of Cefotiam in Serum Samples From Patients
with Cefotiam–Induced Occupational Allergy
Kim, J. 1, Lee, S. 2, Kim, S. 3, Jin, H. 4, Nahm, Y. 3, Ye, Y. 4 and Park, H. 5
1
Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon,
South Korea. 2Internal Medicine, College of Medicine, Dong-A University, Busan, South Korea. 3Department of Allergy & Clinical
Immunology, Ajou University School of Medicine, Suwon, South Korea. 4Department of Allergy and Clinical Immunology, Ajou
University School of Medicine, Suwon-si, South Korea. 5Department of Allergy & Clincal Immunology, Ajou University School of
Medicine, Suwon-si, South Korea.
2113 Evaluating Total Serum IgE Levels in Patients with Chronic Hepatitis B and C
Köse, S. 1, Serin Senger, S. 1, Yalcin, A. D. 2, Cavdar, G. 1, Atalay, S. 1 and Ersan, G. 1
1
Clinic of Infectious Diseases and Clinical Microbiology, Clinical Allergy and Immunology, Izmir Tepecik Education and Research
Hospital, IZMIR, Turkey. 2Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey.
2114 Relationship Between Total Serum IgE, Atopy, and Obesity in Children with or without Family History of
Atopic Disease
Setiabudiawan, B. , Ghrahani, R. , Sapartini, G. , Rayani, P. , Amelinda, C. and Sukadi, A.
Department of Child Health, Hasan Sadikin Hospital/School of Medicine Universitas Padjadjaran, Bandung, Indonesia.
2115 The Candidate Peptides in IgE for Allergy Vaccine Design
Kardar, G. A. 1, Shahandashti, T. 2 and Zare, A. 1
1
Immunology Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran. 2Department of Biology,
Science and Research Branch, Islamic Azad University, Tehran, Iran.
POSTER SESSION 13: ANTI-IGE CC, 1ST, POSTER HALL
2116 Refractory Chronic Urticaria Treated with Omalizumab
Saenz, M. 1, Del Pozo, R. 2, Tiro, L. 3 and Vera, G. 4
1
Alergia e inmunologia clínica, Hospital Regional Lic.Adolfo Lopez Mateos , Distrito Federal, México. 2Alergia e inmunologia ,
Hospital Regional Lic.Adolfo López Mateos, Distrito federal, México. 3Alergia e inmunologia , Hospital Regional Lic. Adolfo Lopez
Mateos, Distrito Federal, México. 4Alergia e Inmunologia , Hospital Regional Lic. Adolfo Lopez Mateos, ISSSTE, Distrito Federal,
México.
2117 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
Yalcin, A. D. 1, Kose, S. 2 and Gorczynski, R. M. 3
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Infectious Diseases and
Clinical Microbiology, Clinical Allergy and Immunology, Tepecik Educational and Research Hospital, Izmir, Turkey. 3Division of
Cellular & Molecular Biology, Toronto Hospital, University Health Network, Toronto, ON, Canada.
2118 Evaluation of Adverse Events Associated to Administration of Omalizumab
Gomez, R. M. 1,2, Vinuesa, M. 3, Teijeiro, A. 4, Ivancevich, J. C. 5, Jares, E. 5 and Baena-Cagnani, C. E. 6,7
1
Ayre Foundation, Salta, Argentina. 2Allergy & Asthma Unit, Hospital San Bernardo, Salta, Argentina. 3Instituto de Inmunología
y Alergia, Sanatorio Britanico, Rosario, Argentina. 4Hospital Pediatrico, Cordoba, Argentina. 5LIBRA Foundation, Buenos Aires,
Argentina. 6CIMER (Centro de Investigación en Medicina Respiratoria). Faculty of Medicine. Catholic University of Cordoba.
Fundación LIBRA Argentina , Cordoba, Argentina. 7LIBRA Foundation, Cordoba, Argentina.
2119 Gender and Different Prevalence in Asthma Treatment with Anti-IgE (omalizumab)
Patella, V. 1, Florio, G. 2 and Oricchio, C. 3
1
Division of Clinical Immunology and Allergy, General Hospital, ASL SALERNO, Agropoli (SA), Italy. 2Division of Clinical
Immunology and Allergy , General Hospital, ASL Salerno, Salerno, Italy. 3Division of Immunohaematology, General Hospital, ASL
SALERNO, Agropoli (SA), Italy.
2120 Fetal Loss in Severe Asthma and Posterior Healthy Pregnancy and Birth with the Use of Omalizumab - Case
Report
Kuschnir, F. 1, Emerson, F. 2, Cordeiro, N. 2, Rocha, M. V. 2, Filho, S. L. 2 and Rios, J. L. 2
1
Policlinica Geral do Rio de Janeiro, Rio de Janeiro, Brazil. 2Allergy, Policlinica Geral do Rio de Janeiro , Rio de Janeiro, Brazil.
124
Final Program
Posters
2121 Vasculitic Urticaria Treated with Omalizumab. Case Report
Ramírez Del Pozo, M. E. 1, Martínez Saenz, N. P. 2, Gomez Vera, J. 3 and Lopez Tiro, J. 4
1
Alergia e inmunologia , Hospital Regional “Lic. Adolfo López Mateos” ISSSTE, Distrito Federal, México. 2Alergia e Inmunologia,
Hospital Regional “Lic. Adolfo López Mateos” ISSSTE, Ciudad de México, México. 3Alergia e Inmunología , Hospital Regional “Lic.
Adolfo López Mateos”, ISSSTE, Ciudad de México, México. 4Alergia e Inmunologia, Hospital Regional “Lic. Adolfo Lopez Mateos”,
ISSSTE, Ciudad de México, México.
2122 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A
Case Report
Varricchi, G. 1, Detoraki, A. 2, Liccardo, B. 3, Spadaro, G. 4, de Paulis, A. 3, Marone, G. 3 and Triggiani, M. 3
Division of Allergy and Clinical Immunology and Center for Basic and Clinical Immunology Research (CISI) , University of Federico II,
Naples, Naples, Italy. 2 University of Naples Federico II, Division of Allergy and Clinical Immunology and Center for Basic and Clinical
Immunology Research (CISI) , Federico II, Naples, Naples, Italy. 3Division of Allergy and Clinical Immunology and Center for Basic and
Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy. 4 University of Naples Federico II, Division of Allergy
and Clinical Immunology and Center for Basic and Clinical Immunology Research (CISI) , Federico II, Naples, Italy.
1
2123 A 4-Year Follow-up in Children with Moderate/Severe Asthma After Withdrawal 1 Year Omalizumab
Treatment
Teijeiro, A. 1, Bedellino, H. 2, Gomez, R. M. 3,4, Canonica, G. W. 5 and Baena-Cagnani, C. E. 6
1
CIMER (Centro de Investigación en Medicina Respiratoria ). Faculty of Medicine. Catholic University of Cordoba. Fundación
LIBRA Argentina, Cordoba, Argentina. 2CIMER (Centro de Investigación en Medicina Respiratoria ). Faculty of Medicine. Catholic
University of Cordoba, Cordoba, Argentina. 3CIMER (Centro de Investigación en Medicina Respiratoria ). Faculty of Medicine.
Catholic University of Cordoba, Cordoba, Argentina. 4Allergy, Asthma and Immunology, ALAS Medical Institute, Salta, Argentina.
5
Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genova, Italy. 6CIMER (Centro de Investigación en Medicina
Respiratoria). Faculty of Medicine. Catholic University of Cordoba. Fundación LIBRA Argentina , Cordoba, Argentina.
2124 Serum Soluble TRAIL Levels In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab
Treatment
Yalcin, A. D. 1, Bisgin, A. 2, Kargi, A. 3 and Gorczynski, R. M. 4
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Human Gene and Cell
Therapy Center of Akdeniz University Hospital and Clinics, Antalya, Turkey. 3Oncology Unit, Denizli Education and Training
Hospital, Denizli, Turkey. 4Division of Cellular & Molecular Biology, Toronto Hospital, University Health Network, Toronto, ON,
Canada.
2125 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations In
Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
Yalcin, A. D. 1, Gorczynski, R. M. 2, Parlak, G. E. 3, Kargi, A. 4, Bisgin, A. 5, Sahin, E. 3, Kose, S. 6 and Gumuslu, S. 3
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Division of Cellular &
Molecular Biology, Toronto Hospital, University Health Network, Toronto, ON, Canada. 3Department of Biochemistry, Faculty of
Medicine, Akdeniz University, Antalya, Turkey. 4Oncology Unit, Denizli Education and Training Hospital, Denizli, Turkey. 5Human
Gene and Cell Therapy Center of Akdeniz University Hospital and Clinics, Antalya, Turkey. 6Infectious Diseases and Clinical
Microbiology, Clinical Allergy and Immunology, Tepecik Educational and Research Hospital, Izmir, Turkey.
2126 Near-Fatal Asthma Treated with Omalizumab
Contreras Contreras, E. A. 1, Ramírez Del Pozo, M. E. 2, Gomez Vera, J. 3 and Lopez Tiro, J. 4
1
Alergia e Inmunologia clinica, ISSSTE, Ciudad de México, México. 2Alergia e inmunologia , Hospital Regional “Lic. Adolfo López
Mateos” ISSSTE, Distrito Federal, México. 3Alergia e Inmunologia, Hospital Regional “Lic. Adolfo López Mateos” ISSSTE, Ciudad de
México, México. 4Alergia e Inmunologia, Hospital Regional “Lic. Adolfo Lopez Mateos”, ISSSTE, Ciudad de México, México.
2127 Use of Omalizumab In Chronic Moderate to Severe Persistent Asthma-An Indian Experience
Ansari, Q.
Chest Diseases, Apollo Hospitals, Hyderabad, India.
2128 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
Vargas Correa, J.
Internal Medicine, H. R. Merida Issste, Merida, Yucatan, México.
POSTER SESSION 14: IMMUNOTHERAPY CC, 1ST, POSTER HALL
2129 Allergen Standardisation in Allergens and Allergoids – Challenges and Considerations
Skinner, M. , Alan, B. , Hewings, S. and Swan, N.
R&D, Allergy Therapeutics, Worthing, United Kingdom.
125
Final Program
Posters
2130 Development of In-House References of House Dust Mite Allergen Vaccines
Más Quintero, A. 1, Labrada Rosado, A. 2, Ramírez González, W. 3, Oliva Díaz, Y. 4, Mateo Morejón, M. 3, Torralba Averoff, D. 3 and
Castillo Lazo de la Vega, O. 3
1
Allergen Department, Member EAACI. Cuban Society of Inmunology. Cuban Society of Allergy. , Mayabeque, Cuba. 2Allergen
Department, WAO Member. Cuban Society of Inmunology. Cuban Society of Allergy., Mayabeque, Cuba. 3Cuban Society of
Inmunology, Mayabeque, Cuba. 4Member of Cuban Society of Immunology, Mayabeque, Cuba.
2131 Therapeutic Effect and Safety of Tropical Mite Allergen Vaccines by Subcutaneous Route in Allergic
Asthmatics Patients
Castro Almarales, R. L. 1, Ronquillo Díaz, M. 2, Alvarez Castello, M. 3, Rodríguez Canosa, J. S. 4, González León, M. 5, Labrada Rosado,
A. 6, Navarro Viltres, B. I. 7, Oliva Díaz, Y. 8 and Mateo Morejón, M. 9
1
National Center of Bioproducts (BIOCEN), WAO Member, Cuban Society of Allergy Member, Cuban Society of Immunology
Member, Cuban Society of Family Medicine Member, Mayabeque, Cuba. 2Allergy Service, University Hospital General Calixto
García, WAO Member, Cuban Society of Allergy Member, Cuban Society of Immunology Member, Havana, Cuba. 3Allergology
Department, University Hospital General Calixto García, WAO Member, Cuban Society of Allergy , Asthma and Clinical
Immunology, Member, Cuban Society of Immunology Member, Havana, Cuba. 4Univesity Hospital General Calixto García, WAO
Member, Cuban Society of Allergy Member, Cuban Society of Immunology Member, Havana, Cuba. 5Docent Policlinic Pedro
Fonseca, Cuban Society of Family Medicine Member, Cuban Society of Allergy Member, Cuban Society of Immunology, Havana,
Cuba. 6Allergen Department, WAO Member. Cuban Society of Inmunology. Cuban Society of Allergy., Mayabeque, Cuba. 7Cuban
Society of Allergy Member, Cuban Society of Immunology, Havana, Cuba. 8Member of Cuban Society of Immunology, Maya,
Cuba. 9Member of Cuban Society of Immunology, Mayabeque, Cuba.
2132 Therapeutic Effect and Security in Asthmatics Adults Patients Treated with Dermatophagoides
Pteronyssinus Allergen Sublingual Immunotherapy
Rodríguez, J. 1, Castro, R. 2, Labrada, A. 3, Alvarez, M. 1, Ronquillo, M. 1, González, M. 4, Navarro, B. 3, Mateo, M. 3, Oliva, Y. 3, García, I. 1
and Enriquez, I. 1
1
Allergology Department, University Hospital Calixto García, Havana City, Cuba. 2Allergens, National Center of Bioproducts,
Havana City, Cuba. 3Allergens, National Center of Bioproducts, Mayabeque, Cuba. 4Pedro Fonseca Docent Policlinic, Havana City,
Cuba.
2133 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
Alvarez, M. 1, Castro, R. 2, Gutierrez, D. 3, Labrada, A. 2, Enriquez, I. 1, Ronquillo, M. 1, Rodríguez, J. 1 and García, I. 1
1
Allergology Department, University Hospital Calixto García, Havana City, Cuba. 2Allergens, National Center of Bioproducts,
Havana City, Cuba. 3Allergology, University Hospital Calixto García, Havana City, Cuba.
2134 The Effect of Specific Immunotherapy On the Clinical Response In Patients with Grass-Polen Induced
Rhinoconjunctivitis
Arsovski, Z. 1, Jovkovska Kaeva, B. 2, Gavrilovski, M. 2, Stefanovski, T. 2, Pejkovska, S. 2, Arbutina, S. 2, Ismaili, I. 2, Caparoska, T. 2 and
Dokic, D. 2
1
Allergy and Clinical Immunology, Clinic of Pulmonology and Allergy, Skopje, Macedonia. 2Clinic of Pulmonology and Allergy,
Skopje, Macedonia.
2135 Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism?
Sensi, L. G. 1, Panfili, E. 2, Latini, A. 3, Marcucci, F. 4 and Di Cara, G. 5
1
Medical-Surgical Specialities and Public Health, University of Perugia, Perugia, Italy. 2Medical-Surgical Specialties and Public
Health, University of Perugia-Italy, Perugia, Italy. 3Medical-Surgical Specialties and Public Health, University of perugia, perugia,
Italy. 4Medical-Surgical Specialties and Public Health, University of perugia, Perugia, Italy. 5Medical- Surgical Specialities and Public
Health, University of Perugia, Perugia, Italy.
POSTER SESSION 15: HYMENOPTERA ALLERGY CC, 1ST, POSTER HALL
2136 When Honeybees Attack: Adrenal Insufficiency as a Late Consequence of Massive Exposure
Robinson, D.
Asthma, Allergy and Clinical Immunology, Virginia Mason Medical Center, Seattle, WA.
2137 Efficacy of Immunotherapy with Allergenic Extract of Aedes Aegypti in the Treatment of Large Local
Reaction to Mosquito Bites in Children
Manrique, M. A. 1, González-Díaz, S. 1, Arias-Cruz, A. 1, Hernandez, M. 1, Gallego, C. 2, Garcia, D. 1, Mejia, K. 1, Calva, M. 1 and
Dominguez, L. 1
1
126
Final Program
Posters
2138 Specific Venom IgE Decrease During 5 Years of Venom Immunotherapy (VIT): Clinical Relevance in Stung
and Not Stung Patients
Pravettoni, V. 1, Piantanida, M. 1, Primavesi, L. 1 and Forti, S. 2
1
Clinical Allergy and Immunology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy. 2Audiology Unit,
Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
2139 Skeeter Syndrome a Case Report and Literature Review
Garcia-Calderin, D. 1, González-Díaz, S. 1, Arias-Cruz, A. 1,2, Macias, A. 1, Buenfil-Lopez, J. A. 3, Calva, M. 1, Mejia, K. 1, Dominguez, L. 1
and Gallego, C. 4
1
University Hospital UANL, Monterrey, México. 3University Hospital, Monterrey, México. 4Regional Center of Allergy and Clinical
Immunology, University Hospital, Monterrey, México.
2140 Bee Venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress
Alvarez Cardona, A. 1, Hernandez Nieto, L. 2 and Pedroza Melendez, A. 2
1
Allergy and Clinical Immunology, Star Medica Aguascalientes, Aguascalientes, México. 2Allergy and Clinical Immunology,
Instituto Nacional de Pediatria, México DF. 04530, México.
2141 Clinical Case. Bee Venom Anaphylaxis
Barreto-Sosa, A. , Velasco-Medina, A. A. , Burbano-Ceron, A. , Gonzalez-Carsolio, A. and Velázquez-Sámano, G.
2142 Urticarial Vasculitis After Bee-Sting Therapy
Lee, J. 1, Park, S. W. 2, Jang, A. 1, Kim, D. 1 and Park, C. 1
1
Respiratory and Allergy, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea. 2Division of Respiratory and
Allergy Medicine, Soonchunhyang University Hospital, College of Medicine, Bucheon, South Korea.
POSTER GROUP 2
TUESDAY, 6 DECEMBER
POSTER SESSION 16: ASTHMA
12:15 – 14:15
3000 The Correlation of Cholesterol Lowering Statin Drugs and Worsening Asthma Control In Mild Persistent
Asthmatics
Nsouli, S.
3001 Studies On The Relationship Between Airway Inflammatory Responses In Patients With Asthma Or Not-Yet
Onset Asthma And Air Pollution
Yamaura, M. 1, Kogane, T. 1, Koyama, H. 1, Obayashi, O. 1 and Takizawa, H. 2
1
The Fourth Department of Internal Medicine, Teikyo University School of Medicine, Mizonokuchi Hospital, Kawasaki, Japan.
2
Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka, Japan.
3002 The Relationship Between Maternal Atopy and Childhood Asthma
Abbott, S. and Green, R.
Department of Paediatrics, University of Pretoria, Pretoria, South Africa.
3003 Sensitization of Severe Allergic Asthma Patients
Takejima, P. 1, Kalil, J. 2, Agondi, R. C. 2 and Giavina-Bianchi, P. 3
1
Division of Clinical Immunology and Allergy of University of São Paulo Medical School, Sao Paulo, Brazil. 2Clinical Immunolgy and
Allergy, Sao Paulo University, Sao Paulo, Brazil. 3Clinical Immunology and Allergy, University of Sao Paulo, Sao Paulo, Brazil.
3004 Reference Values and Influencing Factors of Exhaled Nitric Oxide In Healthy Korean Adults
Yang, M. 1, Kim, Y. 1, Song, W. 1, Kim, M. 1, Hur, G. 2, Kim, T. 3, Kim, S. 4, Park, H. 5, Cho, Y. J. 6, Chang, S. 7, Kim, T. 1, Kim, S. 8, Kang, H. 1,
Park, H. 1, Kim, S. 1, Chang, Y. 8, Cho, S. 1, Min, K. 1 and Kim, Y. 9
1
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. 2Internal Medicine, Korea
University College of Medicine, Seoul, South Korea. 3Department of Allergy and Clinical Immunology, Asan Medical Center,
University of Ulsan College of Medicine, Seoul, South Korea. 4Department of Internal Medicine, Hanyang University College of
Medicine, Seoul, South Korea. 5Department of Allergy & Clincal Immunology, Ajou University School of Medicine, Suwon-si,
South Korea. 6Allergy and Clinical Immunology, Internal Medicine, Ewha Womans University Mockdong Hospital, Seoul, South
Korea. 7Department of Internal Medicine, Sungae General Hospital, Seoul, South Korea. 8Department of Internal Medicine, Seoul
National University Bundang Hospital, Seongnam, South Korea. 9Department of Internal Medicine, Division of Allergy and Clinical
Immunology, National Medical Center, Seoul, South Korea.
127
Final Program
Posters
3005 Association of Feno with IgE Levels in Patients with Allergic Asthma
Torres, J. 1, Chavez, E. 1, Martínez, M. 1, García, D. 2 and Pellizzeri, A. 1
1
Inmunology and Allergolgy, Resident, Caracas, Venezuela. 2Inmunology and Allergolgy, Teaching Coordinator, Caracas,
Venezuela.
3006 The Relationship of Fractional Exhaled Nitric Oxide(FeNO) and Acute Exacerbation of Childhood Asthma
Rha, Y. H. 1, Kim, M. 2 and Choi, S. H. 3
1
Department of Pediatrics, Kyung Hee University Hospital, Seoul, South Korea. 2Department of Pediatrics, Idream Children’s
Hospital, Daegu, South Korea. 3Dept of Pediatrics, Gangdong Kyung Hee University Hospital, Seoul, South Korea.
3007 Relationship Between Exhaled Nitric Oxide and Levels of Asthma Control in Asthma Patients Treated with
Inhaled Corticosteroid
Yoon, H. J. 1, Kim, S. 1, Kim, T. H. 1, Sohn, J. W. 1, Shin, D. H. 1, Park, S. S. 1 and Chang, S. 2
1
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea. 2Department of Internal
Medicine, Sungae General Hospital, Seoul, South Korea.
3008 Relationship Between Aeroallergen Sensitization and Asthma Severity in Mexican Children
Morfin-Maciel, B. M. , Hernández-Venegas, T. , Castillo-Morfin, B. M. , Perez-Chavira, M. R. and Martinez-Aguilar, N.
Allergy, Hospital Angeles Mocel, México City, México.
3009 Association of Asthma and IgE Levels
Torres, J. 1, Martínez, M. 1, Chavez, E. 1, García, D. 2 and Antelo, A. 3
1
Venezuela. 3Inmunology and Allergolgy, Attending, Caracas, Venezuela.
3010 The Method of Antigen Specific Damage of Leucocytes by Food Additives in Patients with Bronchial
Asthma
Titova, N.
Allergy, Belarussian Medical Academy of Post Graduate Education,, Minsk, Belarus.
3011 Effect of Ascorbic Acid on Aiway Hyperresponsiveness in Bronchial Asthma
Hwang, Y. S. 1, Lee, J. D. 1, Kim, H. C. 1, Cho, Y. J. 1 and Yoo, S. H. 2
1
Internal Medicine, Gyeongsang University Hospital, Jinju, South Korea. 2Internal medicine, Korea University Medical Center,
Seoul, South Korea.
POSTER SESSION 17: ASTHMA DIAGNOSTIC TOOLS CC, 1ST, POSTER HALL
3012 Bronchial Hyperresponsiveness In Obese Adolescents
Ramírez, G. 1 and del Rio, B. 2
1
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gómez, México, México. 2Pediatric Allergy and
Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México.
3013 Development of a Questionnaire for the Assessment of Bronchial Hyperresponsiveness in Korea
Lim, S. Y. 1, Yoo, K. H. 2, Shim, J. 3 and Kim, K. H. 4
1
Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea. 2Internal
Medicine, Konkuk university medical center, Seoul, South Korea. 3Internal Medicicne, Korea Univesity College of Medicine, Seoul,
South Korea. 4Internal Medicine, Catholic University Medical College, Uijeongbu, South Korea.
3014 Clinical Analysis of Salbutamol Responsiveness After Acetylcholine-Induced Bronchoconstriction in
Childhood Asthma
Kondo, T. 1, Nakashima, Y. 2 and Shikano, H. 2
1
Department of Pediatrics, Hirano General Hospital, Gifu-city, Japan. 2Department of Pediatrics, Ogaki Municipal Hospital, Ogakicity, Japan.
3015 Preoperative Cardiopulmonary Exercise Testing (CPET) In Severe Asthma Patients
Syrigou, E. 1, Kallianos, A. 2, Tsimpoukis, S. 2, Makrilia, N. 2, Dannos, I. 2, Psarros, F. 1 and Syrigos, K. N. 3
1
Sotiria General Hospital, Athens School of Medicine, Greece, Athens, Greece. 3Oncology Unit, 3rd Department of Medicine, Sotiria
General Hospital, Athens School of Medicine, Greece, Athens, Greece.
3016 Annual Change of Peak Expiratory Flow Rate in Asthma and COPD
Yoo, K. H. and Lee, K. Y.
Internal Medicine, Konkuk University Medical Center, Seoul, South Korea.
128
Final Program
Posters
3017 Evaluation of Chest Computed Tomography in Patients with Asthma
Montenegro, F. G. 1, Castro-Coelho, A. P. 2, Bisacione, C. 3, Aun, M. V. 2, Kalil, J. 1, Giavina-Bianchi, P. 2 and Agondi, R. C. 1
1
Clinical Immunolgy and Allergy, Sao Paulo University, Sao Paulo, Brazil. 2Clinical Immunology and Allergy, University of Sao Paulo,
Sao Paulo, Brazil. 3University of sao paulo, sao paulo, Brazil.
3018 Exercise-Induced Airway Obstruction and Vitamin D Deficiency
Varenni, D. 1, Heffler, E. 2, Papurello, M. 1, Culla, B. 1, Brussino, L. 3, Guida, G. 3, Bucca, C. 1 and Masoero, M. 1
1
Department of Clinical Pathophysiology, University of Turin, Turin, Italy. 2Biomedical Sciences and Human Oncology, Allergy and
Clinical Immunology - University of Torino - AO Mauriziano “Umberto I”, Torino, Italy. 3Department of Biomedical Science and
Human Oncology, University of Turin, Turin, Italy.
3019 Lung Age/Chronological Age Index As Indicator of Clinical Improvement or Severity in Asthma Patients
Castrejón, M. I.
Inmunologia Clínica y Alergia, Centro Medico Nacional ISSSTE, Distrito Federal, México.
3020 Transition From Cough Variant Asthma to Asthma with Reduced FEV1
Lee, J. 1, Park, S. W. 2, Jang, A. 1, Kim, D. 1 and Park, C. 1
1
Respiratory and Allergy, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea. 2Division of Respiratory and
Allergy Medicine, Soonchunhyang University Hospital, College of Medicine, Bucheon, South Korea.
POSTER SESSION 18: PATHOPHYSIOLOGY OF CHILDHOOD ASTHMA CC, 1ST, POSTER HALL
3021 Involvement of IL-10 Gene Promoter Polymorphisms in the Susceptibility for Childhood Asthma
Kim, K. W. , Lee, K. E. , Hong, J. Y. , Kim, M. N. , Heo, W. I. , Sohn, M. H. and Kim, K.
Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea.
3022 Serum NT-3 and NT-4 Levels Are Associated with Clinical Severity In Asthmatic Children
Szczepankiewicz, A. 1, Rachel, M. 2, Sobkowiak, P. 1, Kycler, Z. 1, Wojsyk-Banaszak, I. 1, Schoneich, N. 1 and Breborowicz, A. 1
1
Poznan University of Medical Sciences, Poznan, Poland. 2University of Rzeszow, Rzeszow, Poland.
3023 Serum Levels of Human Chitinase-Like Protein YKL-39 but Not YKL-40 Was Lower in Childhood Asthma
Inoue, Y. 1, Shimojo, N. 1, Suzuki, Y. 2, Nakano, T. 1, Morita, Y. 1, Arima, T. 1, Tomiita, M. 3 and Kohno, Y. 1
1
Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan. 2Department of Public Health, Graduate
School of Medicine, Chiba University, Chiba, Japan. 3Department of Allergy and Rheumatology, Chiba Children’s Hospital, Chiba,
Japan.
3024 Association Between Eosinophilic Airway Inflammation and Persistent Airflow Limitation in Asthmatic Children
Lee, Y. J. 1, Lee, H. H. 2, Kim, K. W. 3, Sohn, M. H. 3 and Kim, K. 3
1
Pediatrics, Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea. 2Department of Pediatrics, Kwandong University
College of Medicine, Myongji Hospital, Goyang, South Korea. 3Department of Pediatrics, Yonsei University College of Medicine, Seoul,
South Korea.
POSTER SESSION 19: PEDIATRIC ASTHMA TREATMENT CC, 1ST, POSTER HALL
3025 Correlation Between Quality of Life and Treatment Adherence in Childhood Asthma
Jessica, G.
Universidad Veracruzana, Río Blanco, México.
3026 Effect of Diet Supplementation with EPA-DHE On Pulmonary Function Tests and Metacholine Bronchial
Challenge Test In Obese Mexican Children
Pineda-Bahena, L. G. and del Rio, B.
3027 Use of Complementary and Alternative Medicines by Children Suffering From Asthma At Mangalore, India
Jain, A. 1 and K D, P. 2
1
Community Medicine, Kasturba Medical College (Manipal University), Mangalore, India, Mangalore, India. 2Kasturba Medical
College (Manipal University), Mangalore, India , Mangalore, India.
3028 Long-Term Follow up Outcomes of Early Intervention with Anti-Inflammatory Therapy in Patients with
Asthma Under 2 Year-Old
Ikeda, M. , Araki, T. , Takahashi, N. , Nojima, I. , Kitada, K. , Sekimoto, K. , Sakamoto, T. , Ogasawara, H. , Okamura, T. and Fujiwara, K.
Department of Pediatrics, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan.
129
Final Program
Posters
3029 Asthma Treatment May Be Useful to Treat Recurrent Wheezing In Infancy
Chong Neto, H. J. , Rosario, N. , Silva, F. C. , Grasselli, E. A. , Bojarski, L. F. M. , Rosario, C. S. , Rosario, B. A. and Chong, F. H.
3030 Safety and Inhaler Use with Mometasone Furoate Delivered Via Dry Powder Inhaler for Children with
Persistent Asthma
Berger, R. 1, Teper, A. 2, Moreno-Cantu, J. 3 and Skoner, D. 4
1
Device Development, Merck Research Laboratories, Summit, NJ. 2Allergy/Respiratory, Merck Research Laboratories, Summit,
NJ. 3Office of the Chief Medical Officer, Merck & Co., Kenilworth, NJ. 4Department of Pediatrics, West Virginia University School of
Medicine, Philadelphia, PA.
3031 Effect of Asthma Clinical Pathway for Children in the Emergency Department: 2007 Vs. 2008
Kim, H. H. , Chun, Y. H. , Yoon, J. and Lee, J. S.
Pediatrics, The Catholic University of Korea, Pucheon-si, South Korea.
3032 Trans Oro Pharyngeal Spacer For Inhalers
Rao, P. P. 1, Kashyap, L. 2 and Kishan, H. 1
1
Pulmonology, Katuri Medical College & Hospital, Guntur, India. 2Nuclear Medicine, Vijaya Daignostic Centre, Secundrabad, India.
POSTER SESSION 20: AEROALLERGEN SENSITIZATION CC, 1ST, POSTER HALL
3033 Fungal Sensitization and Its Relation to Asthma and Allergic Rhinitis in Children Aged 6-7 Years
Diaz Rodriguez, A.
Department of Allergy, Medical Center. Guira de Melena, Havana, Cuba, Cuban Society of Allergy, Asthma and Immunology,
Havana, Cuba.
3034 Study on the Sensitization Rates to Airbone Pollen and Mold in Children
Park, S. H. 1, Lim, D. H. 1,2, Son, B. K. 1,2, Kim, J. H. 1,2, Oh, I. B. 3, Kim, Y. H. 3, Lee, K. H. 4, Kim, S. Y. 4 and Hong, S. C. 4
Department of Pediatrics, School of Medicine, Inha University, Incheon, South Korea. 2The Environmental Health Center, Inha
University Hospital, Incheon, South Korea. 3The Enviromental Health Center, Ulsan University Hospital, Ulsan, South Korea.
4
Enviromental Health Center, Jeju National Universitiy Hospital, Jeju, South Korea.
1
3035 Influence of Degree of Specific Allergic Sensitivity on Severity of Rhinitis and Asthma in Chinese Allergic
Patients
Li, J. 1, Huang, Y. 2, Lin, X. 3, Zhao, D. 4, Tan, G. 5, Wu, J. 6, Zhao, C. 7, Zhao, J. 8, Spangfort, M. 9, Zhong, N. 10 and Carrad, C. A. O. R. O. R. A. D. 11
1
State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical College., Guangzhou, China. 2The
Children’s Hospital, Chongqing University of Medical Sciences., Chongqing,, China. 3The General Hospital of Shenyang Military
Command, Shenyang, China. 4Nanjing Children’s Hospital, Nanjing, China. 5The Third Hospital of Xiangya Medical University,
Changsha, China. 6The First Hospital of Xiamen, Xiamen, China. 7The Second Hospital of Shanxi Medical University, Taiyuan, China.
8
Capital Institute of Pediatrics, Beijing, China. 9ALK-Abello A/S, Asia Pacific Region, Hongkong, China. 10State Key Laboratory of
Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical College, Guangzhou, China. 11China Alliance of Research on
Respiratory Allergic Disease, China, China.
3036 Allergic Sensitization to Domestic Mites In Santo Domingo, Dominican Republic
Castillo, A. 1, Muñoz, W. 1 and Fernandez-Caldas, E. 2,3
1
Allergy & Asthma Center, Santo Domingo, Dominican Republic. 2Research & Development, Inmunotek SL, Madrid, Spain.
3
Division of Allergy and Immunology, University of South Florida College of Medicine, Tampa.
3037 Prevalence Sensitizing to Most Common Allergens in Elderly in Western México”
Bedolla-Barajas, M.
3038 Cross Reactivity Between Cypress Pollen and Plant Food in Queretaro, México
Medina Hernández, A. 1, Sosa Ferreyra, C. F. 2 and Zaldívar Lelo de Larrea, G. 3
1
Medicine Faculty, Queretaro University, Queretaro, México. 2Natural Sciences Faculty, Queretaro University, Queretaro, México.
3
Medicine Faculty, Querétaro University, Queretaro, México.
3039 Study of the Allergenic Crossreactivity and Allergenic Composition of Dermatophagoides Pteronyssinus and
Blomia Tropicalis
Cases, B. 1, Fernandez-Caldas, E. 1,2, Tudela, J. I. 1, Fernandez, E. A. 1, Lafosse-Marin, S. 3, Casanovas, M. 1 and Subiza, J. L. 1
Research & Development, Inmunotek SL, Madrid, Spain. 2Division of Allergy and Immunology, University of South Florida College
of Medicine, Tampa. 3Cabinet de Inmuno Alergologie, Fort de France, Martinique.
1
130
Final Program
Posters
3040 Ficus Benjamina Sensitization in Adult Patients with Rhinitis
González-Díaz, S. 1, Arias-Cruz, A. 1, Valdes, D. 1, Gallego, C. 2, Zarate, M. D. C. 1, Galindo, G. 1, Garcia, D. 1, Mejia, K. 1, Dominguez, L. 1
and Calva, M. 1
1
3041 Identification and Statistic Analysis Related with Climatic Variability and Transportation of the Most
Abundant Spores in Mexicali, México
Ahumada, S.
Environmental Area, Air quality, Academic, Mexicali, México.
POSTER SESSION 21: DUST MITE ALLERGY CC, 1ST, POSTER HALL
3042 Standardization and Characterization of Dust Mite Extracts Manufactured in the USA
Plunkett, G.
ALK-Abello, Round Rock, TX.
3043 Detection of Der p 2 in the House Dust and Correlation with Mite Number in An Environmental Survey
Tsai, J. , Lin, Y. and Liao, E.
Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
3044 Daily Vacuum Cleaning Significantly Reduces House Dust Mite Allergen, Endotoxin and β-Glucan Content
of Mattresses
Wu, F. F. 1,2, Siebers, R. 2, Wu, M. 3, Pierse, N. 2 and Crane, J. 2
1
Show Chwan Memorial Hospital, Changhua City, Taiwan. 2University of Otago, Wellington, New Zealand. 3Changhua Christian
Hospital Hospital, Changhua City, Taiwan.
3045 Differences in Indoor Allergen Quantification in Hispanic/Latino Children Living in Miami to Those Living in
Latin America
Lanz, M. J. 1, Efaw, B. 2 and Harbeck, R. 3
1
Allergy and Asthma, AAADRS Clinical Research Center, Coral Gables, FL. 2Clinical Immunology Lab, National Jewish Health,
Denver, CO. 3Advanced Diagnostics Lab, National Jewish Health, Denver, CO.
3046 House Dust Mite Fauna and Its Relationship to Allergen Skin Tests in Six Mexican States
Ferández Duro, B. I. 1, Cuervo Pineda, N. 2, Rodríguez Alvízar, J. A. 3, Celio Murillo, R. 3, Pérez Ortiz, T. M. 4 and Juárez Anaya, D. 3
1
Allergens Laboratory , National Center of Bioproducts, Havana, Cuba. 2Zoología, IES, Havana, Cuba. 3Allergens Laboratory, Rocel,
Puebla, México. 4Coleccion Nacional de Acaros, Unam, DF, México.
3047 Oral Mite Anaphylaxis Is Caused by Mite-Contaminated Okonomiyaki Mix in Japan
Takahashi, K. 1, Yuma, F. 2, Sekiya, K. 1, Taniguchi, M. 1 and Akiyama, K. 1
1
Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital,
Sagamihara,Kanagawa, Japan. 2Clinical Research Center for Allergy and Rheumatology, National Hospital Organization
Sagamihara National Hospital, Sagamihara,Kanagawa,, Japan.
POSTER SESSION 22: TESTING FOR SENSITIZATION CC, 1ST, POSTER HALL
3048 Utility of Component-Based Allergen Chip (ImmunoCAP ISAC®) in Diagnosis of Allergic Rhinitis
Jung, J. H.
Department of Otorhinolaryngology, Gil Medical Center, Gachon University School of Medicine, , Incheon, South Korea.
3049 Prevalence of Skin Reactivity to Blomia Tropicalis Antigen in Patients with Respiratory Allergy At Hospital
Universitario De Puebla
Martínez Villegas, E. M.
Allergy, Doctor, Puebla, México.
3050 Prevalence of Sensitization to Parietaria, Pinus, Cupressus and Morus Pollens in Patients From CRAIC
Leal-Garcia, L. R. 1, González-Díaz, S. 2, Arias-Cruz, A. 3, Zarate, M. D. C. 3, Garcia, D. 3 and Gallego, C. 4
1
Regional Center of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 2regional allergy center, University
California San Diego U.C.S.D., Monterrey, CA, México. 3Regional Centre of Allergy and Clinical Immunology, University Hospital,
Monterrey, México. 4Regional Center of Allergy and Clinical Immunology, University Hospital, Monterrey, México.
131
Final Program
Posters
3051 Prevalence of Skin Reactivity to Antigen Mus Musculus in Patients with Respiratory Allergy
Caballero, C.
Allergy and Clinical Immunology, University Hospital of Puebla, Puebla, México.
3052 Atopy Patch Test to Aeroallergens Extracts Is Useful In Allergic Diseases Diagnosis When Skin Prick Test Is
Negative
Tordecilla, R. 1 and Marinovic, M. A. 2
1
Servicio de Alergia e Inmunología, Hospital Clínico Universidad de Chile, Santiago, Chile. 2Servicio de Alergia e Inmunologia,
Hospital Clinico Universidad de Chile, Santiago, Chile.
3052AIs Nasal Provocation Test Useful In Selecting Allergen for Immunotherapy In Children?
Bostanci, I. 1, Duman, H. 2, Ozmen, S. 1 and Dogru, M. 1
1
Clinic of Pediatric Allergy and Asthma, Dr.Sami Ulus Research and Training Hospital of Women’s and Children’s Health and
Diseases, Ankara, Turkey. 2Clinic of Pediatric Allergy and Asthma, Dr.Sami Ulus Research and Training Hospital of Women’s and
Children’s Health and Diseases, Ankara, Turkey.
3053 Clinical and Laboratory Studies of the Fate of Intranasal Allergen
Rimmer, J. 1, Santos, C. 1, Yli-Panula, E. 2, Viander, M. 3, Noronha, V. 1, Radford, J. 4, Dunlop, G. 5 and Salome, C. 1
Woolcock Institute of Medical Research, Sydney, Australia. 2Department of Teacher Education, University of Turku, Turku, Finland.
3
Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland. 4Dept Pathology, University of
Sydney, Sydney, Australia. 5 Wahroonga Specialist Centre, Sydney, Australia.
1
3054 Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis
Tanaka, T. , Kawai, M. , Hirano, T. , Hagihara, K. , Shima, Y. , Narazaki, M. , Ogata, A. and Kumanogoh, A.
Department of Respiratory Medicine, Allergic and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita City,
Japan.
3055 Prevalence of Allergen Sensitization In Children with Atopy Suspicion Between Six Months and Five Years
of Age
Marinovic, M. A. and Rojas, R.
Servicio de Alergia e Inmunologia, Hospital Clinico Universidad de Chile, Santiago, Chile.
3056 Prevalence Allergic Diseases and Allergic Sensitization Among Urban Office Workers As Compared with a
Forest Service Workers
Kim, W. K. 1, Kim, H. W. 2 and Yoon, H. 3
1
Pediatrics, Inje University, Seoul Paik Hospital, Seoul, South Korea. 2Allergy & respiratory research laboratory, Inje University, SeoulPaik Hospital, SEoul, South Korea. 3Allergy & respiratory research laboratory, Inje University, Seoul, South Korea.
3057 Photoaging Attenuates Skin Test Response to Histamine More Than Natural Aging
King, M. J. , Fitzhugh, D. and Lockey, R. F.
Division of Allergy and Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL.
POSTER SESSION 23: OCCUPATIONAL ALLERGIES
3058 Prevalence of Latex Sensitization Between Medicine and Dentistry Students From Nuevo Leon University
González, A. 1, González-Díaz, S. 2, Arias-Cruz, A. 2, Macias, A. 2 and Rodríguez, P. 3
1
Regional Center of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 2Regional Centre of Allergy and
Clinical Immunology, University Hospital, Monterrey, México. 3Regional Center of Allergy and Clinical Immunology, Monterrey,
México.
3059 Profile of Latex Sensitization in Children with Myelomeningocele of São Paulo, Brazil
Sa, A. 1, Camilo, R. 1, Cavalheiro, S. 2, Mallozi, M. 3 and Solé, D. 1
1
Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil. 2Department of Neurology, Federal University of São
Paulo, São Paulo, Brazil. 3Pediatrics, UNIFESP, São Paulo, Brazil.
3060 Specific IgE to Recombinant Allergens of Latex and Foods in Patients with Spina Bifida
Garro, L. S. , Motta, A. A. , Kalil, J. and Giavina-Bianchi, P.
3061 Association Between Clinical History and Specific IgE Recombinants Latex Allergens
Garro, L. S. , Motta, A. A. , Kalil, J. and Giavina-Bianchi, P.
132
Final Program
Posters
3062 Contact Reactions to Latex, Its Additives and Irritant Threshold In Healthcare Practitioners
Darlenski, R. 1, Mateeva, V. 2 and Kazandjieva, J. 3
1
Department of Dermatology, Tokuda Hospital, Sofia, Bulgaria. 2Faculty of Medicine-Sofia, Sofia, Bulgaria. 3Department of
Dermatology, Faculty of Medicine-Sofia, Sofia, Bulgaria.
3063 Occupational Flaxseed Allergy (Conjunctivitis): A Case Report
Albarran, C. and Capriles- Hulett, A.
Allergology, Hospital San Juan de Dios, Caracas, Venezuela.
3064 Occupational Asthma: Description of a New Allergen
Miguel Polo, L. D. C.
Allergy, Hospital Virgen del Valle. Toledo., Spain , Spain.
POSTER SESSION 24: CONTACT DERMATITIS
3065 Patch Testing Results In Contact Dermatitis From the Allergist’s Perspective
Aquino, M. 1, Michelis, M. A. 2, Lighvani, S. 3, Davis Lorton, M. 1 and Fonacier, L. 1,4
1
Rheumatology, Allergy & Immunology, Winthrop University Hospital, Mineola, NY. 2Department of Allergy & Immunology,
Hackensack University Medical Center, Hackensack, NJ. 3Director, New York Allergy and Asthma, Weill Cornell Medical College,
New York, NY. 4Medicine, Winthrop University Hospital, Mineola, NY.
3066 Contact Allergy to Medicaments in Consecutively Patch-Tested Patients in Uruguay
Pomies, V. 1 and Ale, I. 2
1
Allergy Unit and Department of Dermatology, University Hospital, Republic University of Uruguay, Montevideo, Uruguay.
2
3067 Evaluation of Allergen Sensitivity In Patients with Contact Dermatitis In Antalya
Yalcin, A. D. 1, Ayhan Hilmi, C. 2, Gumuslu, S. 3, Polat, H. H. 4, Kose, S. 5 and Cetinkaya, R. 6
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Gastroenterology and
Hepatology unit. Antalya Education and Training Hospital, Antalya, Turkey, Antalya, Turkey. 3Department of Biochemistry, Faculty
of Medicine, Akdeniz University, Antalya, Turkey. 4Cumhuriyet University, Faculty of Medicine, Department of Public Health, ,
SIVAS, Turkey. 5Infectious Diseases and Clinical Microbiology, Clinical Allergy and Immunology, Tepecik Educational and Research
Hospital, Izmir, Turkey. 6Division of Nephrology, Antalya Education and Training Hospital, Antalya, Turkey , Antalya, Turkey.
3068 Better Protection From Eczema Among Turkish Migrants’ Children Carries Over From Preschool Age to
Adolescence
Grüber, C. , Matricardi, P. , Theissen, C. and Wahn, U.
Pediatric Pneumology / Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
POSTER SESSION 25: ATOPIC DERMATITIS CC, 1ST, POSTER HALL
3069 Early Clinical Differential Diagnosis Between Infant Atopic Dermatitis and Seborrheic Eczema
Leite, R. M. S. 1 and Leite, A. A. C. 2
1
Departamento Medico, Camara dos Deputados, Brasilia, Brazil. 2Allergy, Instituto Saint Louis, Brasilia, Brazil.
3070 Sensitization to Contactants In Patients with Atopic Dermatitis
Matsumoto, F. 1, Terada, C. A. 2, Mallozi, M. 3 and Solé, D. 4
1
Allergy and Clinical Immunology, UNIFESP / Federal University of São Paulo, São Paulo, Brazil. 2UNIFESP, São Paulo, Brazil.
3
Pediatrics, UNIFESP, São Paulo, Brazil. 4Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.
3071 Sensitization to Aeroallergens and Risk of Respiratory Allergy in Atopic Dermatitis Children
Migacheva, N. and Kaganova, T.
Paediatrics, Samara State Medical University, Samara, Russia.
3072 Nutritional Evaluation of Children with Atopic Dermatitis
Lopez Campos, X. 1, Castro Almarales, R. L. 2 and Massip, J. 3
1
Allergy Society from Cuba, Havana, Cuba. 2Allergen Department, National Center fo Biopruducts, WAO Member, Cuban Society
of Allergy Member, Cuban Society of Immunology Member, Mayabeque, Cuba. 3Bioestatistics Society from Cuba, Havana, Cuba.
3073 Quality of Life In Pediatric Patients with Atopic Dermatitis
Lopez Campos, X.
Allergy Society from Cuba, Havana, Cuba.
133
Final Program
Posters
3074 Epidemiology of Atopic Dermatitis In the Allergy Service of A Third Level Medical Center
Sanchez-Gallardo, L. R.
Immunoallergology, Issemym Ecatepec Medical Center, Ecatepec De Morelos, México.
3075 Epidemiology of Atopic Dermatitis Cases In the Allergy Service of A Third Level Medical Center
Immunoallergology, Issemym Ecatepec Medical Center, Ecatepec De Morelos, México.
3075 Gene-Environment Interactions on the Development of Atopic Dermatitis in Preschool Children: Mold Is
the Main Environmental Factor
Kim, H. Y. and Hong, S.
Pediatrics, Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, College of Medicine, Ulsan
University, Seoul, South Korea.
3076 FcRg-Mediated Immune Responses Modulate the Exacerbation of Clinical Symptoms in Atopic Dermatitis of
NC/Tnd Mice
Oida, K. , Oku, K. , Ohmori, K. , Matsuda, A. , Tanaka, A. and Matsuda, H.
Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan.
POSTER SESSION 26: DRUG ALLERGY 2
3077 Hypersensitivity Syndrome Associated with Phenytoin Sodium
Mendieta, E.
Author, México City , México.
3078 Drug Hypersensitivity Reactions In Hospitalized Patients: What Is the Hole of the Allergist?
Tanno, L. K. 1, Curi, S. V. 1, Fernandes, F. 2, Dracoulakis, M. 2, Aun, W. T. 1 and Mello, J. F. 1
1
Allergy and Immunology, Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil. 2Allergy, Hospital Servidor Público
Estadual de São Paulo, São Paulo, Brazil.
3079 Allergic Reactions to Local Anesthetics: Detection by Skin Tests and Subcutaneous Provocation. Analysis
of 160 Cases
Gondar Arcanjo, L. C. 1,2,3, Gonçalves Tavares, T. M. 1,2,3, Delcourt, N. 1,2, Baroni, J. 1,2, Rios, J. 1,2,3 and Rios, J. L. 1,2,3,4
Policlinica Geral do Rio de Janeiro, Rio de Janeiro, Brazil. 2Faculdade de Medicina de Petropolis, Petropolis, Brazil. 3Alergistas
Coligados, Rio de Janeiro, Brazil. 4Thorax Disease Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
1
3080 Protamine Allergy
Hafner, C. 1,2, Blagojevic, D. 1,2 and Trautinger, F. 1,2
1
Department of Dermatology, General Hospital St.Poelten, St.Poelten, Austria. 2Karl Landsteiner Institute for Dermatological
Research, St.Poelten, Austria.
3081 Description of Drug Allergy Study Conducted In A Teaching Hospital Between October 2007 and March
2011
Rodríguez Martínez, C. F. and Sciaraffia Rubio, A.
Inmunología, VIH y Alergias, Universidad de Chile, Santiago, Chile.
3082 Lung Toxicity Induced by Novel Antineoplastic Therapies In Cancer Patients
Syrigos, K. N. 1, Vassos, D. 2, Makrilia, N. 2, Tsimpoukis, S. 2, Politi, E. 3, Dannos, I. 2 and Syrigou, E. 3
1
2
3
Department of Allergy, Sotiria General Hospital, Athens, Greece, Athens, Greece.
3083 Redness of Skin: SSSS in a 10 Month Old Healthy Baby
Nemeth, A. 1, Ablonczy, M. 1, Sillo, P. 2 and Kun, R. 3
1
2nd Department of Pediatrics, Semmelweis University, Faculty of Medicine, Budapest, Hungary. 2Department of Dermatology,
Venerology and Dermatooncology, Semmelweis University, Faculty of Medicine, Budapest, Hungary. 3Pediatric Department, Jahn
Ferenc South Pest Hospital, Budapest, Hungary.
3084 Desensitization Protocol to Methotrexate
Maya, J. , del Rio, B. , Morales, A. and Rosas-Vargas, M. A.
134
Final Program
Posters
3085 Clinical Features of Dress Syndrome In 42 Patients
Park, M. 1, Kim, K. 2, Park, S. 1, Jeong, I. 1, Yoon, N. 1, Lee, S. 1, Um, S. 1, Lee, S. 1 and Son, C. 1
1
Internal Medicine, College of Medicine, Dong-A University, Busan, South Korea. 2Dermatology, College of Medicine, Dong-A
University, Busan, South Korea.
3086 Risk Factors Associated to Mortality In Mexican Children with Stevens-Johnson Syndrome / Toxic Epidermal
Necrolysis
Hernandez-Mondragon, L. O. 1, del Rio, B. 2, Partida-Gaytan, A. 2, Almeida-Gutierrez, E. 3 and Rosas-Vargas, M. A. 2
1
Pediatric Allergy and Clinical Immunology , Hospital Infantil Federico Gomez, México City, México. 2Pediatric Allergy and Clinical
Immunology, Hospital Infantil de México Federico Gomez, México City, México. 3UMAE Cardiologia - Centro Medico Nacional
Siglo XXI - IMSS, México City, México.
POSTER SESSION 27: ASPIRIN-EXACERBATED RESPIRATORY DISEASE CC, 1ST, POSTER HALL
3087 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
Bergmann, K. 1 and Zuberbier, T. 2
1
Allergy-Centre-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. 2Clinic for Dermatology, Venereology and
Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany.
3088 Relationship Between Aeroallergen Sensitization and Asthma Severity in Patients with Aspirin-Exacerbated
Respiratory Disease
Mitsui, C. 1, Taniguchi, M. 2, Higashi, N. 3, Ono, E. 3, Kajiwara, K. 3, Tanimoto, H. 3, Takahashi, K. 2, Oshikata, C. 2, Sekiya, K. 3, Tsuburai, T. 3,
Tsuirikisawa, N. 2, Minoguchi, K. 2, Mori, A. 3, Hasegawa, M. 3, Akiyama, K. 3 and Fukutomi, Y. 2
1
Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara,Kanagawa, Japan.
2
Sagamihara National Hospital, Sagamihara,Kanagawa, Japan. 3Clinical Research Center for Allergy and Rheumatology, National
Hospital Organization Sagamihara National Hospital, Sagamihara,Kanagawa, Japan.
3089 Persistence of Nasal and Bronchial Symptoms in Patients with Samter’s Syndrome with Treatment Medical
and Surgical in a 2 Year Period
Azuara Trujillo, H. A. 1 and Velez Martinez, J. R. 2
1
Allergy and Clinical Immunology, Mexican Social Security Institute. General Hospital. 2 .IMSS, Hermosillo Sonora, México. 2Health
investigator, Medical Family Unit 37. IMSS., Hermosillo Sonora, México.
3090 Clinics and Laboratory Characteristics of Asthmatic Patients with Aspirin Exacerbated Respiratory Disease
(AERD)
Guterrez Roso, M. 1, Portela Lima, G. 2, Kalil, J. 3, Giavina-Bianchi, P. 4 and Agondi, R. C. 3
1
Clinical Immunology and Allergy, Sao Paulo University, São Paulo, Brazil. 2Clinical Immunology and Allergy, Sao Paulo University,
São Paulo, Brazil. 3Clinical Immunolgy and Allergy, Sao Paulo University, Sao Paulo, Brazil. 4Clinical Immunology and Allergy,
University of Sao Paulo, Sao Paulo, Brazil.
3091 Association Analysis of Member RAS Oncogene Family Gene Polymorphisms with Aspirin Intolerance in
Asthmatic Patients
Kim, M. O. 1, Park, C. 2 and Kim, T. 3
1
Genome Research Center for Allergy and Respiratory Disease, Buchun, South Korea. 2Respiratory and allergy, Soonchunhyang
University Bucheon Hospital, Bucheon, South Korea. 3Soonchunhyang University Hospital Genome Research Center for Allergy and
Respiratory Disease, Bucheon, South Korea.
3092 Nasal Nitric Oxide Levels After Lysine Aspirin Nasal Challenge In Subjects with Aspirin Induced Asthma
Tworek, D. 1, Bochenska-Marciniak, M. 2, Kuprys-Lipinska, I. 1, Pietruszewska, W. 3, Zielinska-Wyderkiewicz, E. 2 and Kuna, P. 1
1
Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Lodz, Poland. 2Department of Pneumonology
and Allergy, Barlicki University Hospital, Lodz, Poland. 3Department of Otolaryngology, Barlicki University Hospital, Lodz, Poland.
3093 IL1B but Not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus
Aspirin Tolerant Asthmatics
Pavon-Romero, G. 1, Falfán-Valencia, R. 2, Camarena, A. 3, Garcia Cruz, M. D. L. L. 4 and Terán-Juarez, L. M. 5
1
Allergy, National Institute of Respiratory Disease, México City, México. 2HLA laboratory, National Institue of Respiratory Disease,
México City, México. 3HLA, National Institue of Respiratory Disease, México City, México. 4Clinical Immunology and Allergy ,
National Institute of Respiratory Disease, Distrito Federal, México. 5Allergy, National Institute of Respiratory Disease, México City,
México.
135
Final Program
Posters
3094 Fatty Acid Binding Protein 1 Is Related with Development of Aspirin-Exacerbated Respiratory Disease
Kim, T. 1 and Park, C. 2
1
Soonchunhyang University Hospital Genome Research Center for Allergy and Respiratory Disease, Bucheon, South Korea.
2
Respiratory and Allergy, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea.
POSTER SESSION 28: IMMUNOTHERAPY TRAINING CC, 1ST, POSTER HALL
3095 Immunotherapy (IT) Training in Canada: Perspectives of Fellows-in-Training on the First Immunotherapy
Training Manual
Pun, T. 1, Kastner, M. 2, Kim, H. L. 3, Moote, D. W. 4 and Waserman, S. 5
1
Adult Allergy and Clinical Immunology, Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada. 2Department
of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. 3Department of
Medicine, University of Western Ontario, McMaster University, Kitchener, ON, Canada. 4Department of Medicine, University of
Western Ontario, London, ON, Canada. 5Department of Medicine, McMaster University, Hamilton, ON, Canada.
3096 Immunotherapy (IT) Training in Canada: Current Experience of Fellows-in-Training
Pun, T. 1, Kastner, M. 2, Kim, H. L. 3, Moote, D. W. 4 and Waserman, S. 5
1
Adult Allergy and Clinical Immunology, Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada. 2Department
of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. 3Department of
Medicine, University of Western Ontario, McMaster University, Kitchener, ON, Canada. 4Department of Medicine, University of
Western Ontario, London, ON, Canada. 5Department of Medicine, McMaster University, Hamilton, ON, Canada.
POSTER SESSION 29: FOOD ALLERGY CASE REPORTS CC, 1ST, POSTER HALL
3097 Lentil Allergy: First Report From Venezuela
Albarran, C. 1 and Capriles Hulett, A. 2
1
Hospital San Juan de Dios , Allergology Unit , Caracas, Venezuela. 2Hospital San Juan de Dios , Allergology Unit , Caracas ,
Venezuela.
3098 Cow’s Milk Allergy and Persistent Changes in a Multiple Food Allergy, a Case Report
Zañartu, P. and Bastías, C.
Immunology, University of Chile, Santiago, Chile.
3099 A Rare Case of Food-Induced Anaphylaxis to Pink Peppercorns
Kim, J. 1 and Minikes, N. 1,2
1
Division of Allergy and Immunology, North Shore-Long Island Jewish Health System, Great Neck, NY. 2Department of Pediatrics,
Columbia University College of Physicians and Surgeons, New York City, NY.
3100 Multiple Manifestations of Food Allergy in a Patient with a Change of Eating Habits
Toche, P. , Salinas, J. and Bastías, C.
3101 Wheat-Dependent Exercise-Induced Anaphylaxis Occurred in OAS Patient After Using Soap Containing
Hydrolyzed Wheat Proteins: Effect of Soap on Keratinocyte Inflammasome
Tanaka, A. 1, Itoi, S. 1, Terao, M. 1, Matsui, S. 1, Tani, M. 1, Hanafusa, T. 1, Igawa, K. 1, Murota, H. 1, Katayama, I. 1, Chinuki, Y. 2 and Morita, E. 2
1
Osaka University School of Med., Suita-shi, Japan. 2Shimane University Faculty of Medicine, Izumo, Japan.
POSTER SESSION 30: FOOD ALLERGY: DIAGNOSIS AND TREATMENT CC, 1ST, POSTER HALL
3102 Possible Prenatal Sensitization: “The Case of the Hidden Cake”
Ortega-Martell, J. A. 1, Huerta-Hernández, R. E. 2 and Ruiz-Castillo, M. 3
1
Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology, Pachuca, México. 2CoMPEDIA, Pachuca, México.
3
Gastroenterología, Hospital del Niño DIF, Pachuca, México.
3103 The Evaluation of Allergen Sensitivity In Food Allergy Patients In Antalya, Turkey
Yalcin, A. D. 1, Cekýn, A. H. 2, Polat, H. H. 3, Cetinkaya, R. 4 and Gorczynski, R. M. 5
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Antalya Education and
Trainin Hospital, Gastroenterology Unit, Antalya, Turkey. 3Cumhuriyet University, Faculty of Medicine, Department of Public
Health, SIVAS, Turkey. 4Division of Nephrology, Antalya Education and Training Hospital, Antalya, Turkey , Antalya, Turkey. 5Division
of Cellular & Molecular Biology, Toronto Hospital, University Health Network, Toronto, ON, Canada.
136
Final Program
Posters
3104 Clinical Correlation of Prick and Prick-to- Prick Skin Tests to Food in a Group of Children with Allergy
Symptoms
Ricartti-Humarán, G. 1, del Rio, B. 2, del Rio, J. 2, Rosas-Vargas, M. A. 2, Maya, J. 2 and Partida, A. 3
1
Alergia e Inmunologia Clinica Pediatrica, Hospital Infantil de México Federico Gomez, México City, México. 2Pediatric Allergy and
Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México. 3unknown, unknown, México.
3105 Comparison Skin Prick Test Using Commercial and Native Extracts of Allergens in Diagnosis of Food Allergy
Bartuzi, Z. 1, Napiórkowska, K. 2 and Żbikowska-Gotz, M. 3
1
Department Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum Nicolaus Copernicus University,
Bydgoszcz, Poland. 2Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum Nicolaus Copernicus University,
Bydgoszcz, Poland. 3Allergy, Clinical Immunology and Internal Diseases, Collegium Medicum Nicolaus Copernicus University,
Bydgoszcz, Poland.
3106 Natural History of Food Allergy in Childhood -3 Years’ Follow up of Pediatric Food Allergy Patients
Hasegawa, M. 1, Komata, T. 2, Imai, T. 2, Ogura, K. 2, Goto, M. 2, Iikura, K. 2, Utsunomiya, T. 2, Sato, S. 1, Tomikawa, M. 2, Shukuya, A. 2 and
Ebisawa, M. 1
1
Department of Allergy, Sagamihara National Hospital Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan.
2
Department of Pediatrics, Sagamihara National Hospital, Sagamihara, Japan.
3107 Comparative Analysis of Patients with Birch Pollinosis and Patients with Associated Plant Food Allergy
Bartuzi, Z. 1, Napiórkowska, K. 2 and Żbikowska-Gotz, M. 3
1
Department Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum Nicolaus Copernicus University,
Bydgoszcz, Poland. 2Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum Nicolaus Copernicus University,
Bydgoszcz, Poland. 3Allergy, Clinical Immunology and Internal Diseases, Collegium Medicum Nicolaus Copernicus University,
Bydgoszcz, Poland.
3108 Frequency and Characterization of Oral Allergy Syndrome in Mexican Adults with Nasal Pollinosis
Bedolla Barajas, M.
3109 Edirne Primary School Teacher Knowledge of Food Allergies and Emergency Treatment Facilities in Schools
Yazicioglu, M. 1, Ozdemir, P. G. 2, Ones, U. 3, Aylanc, H. 4, Ceylan, M. 4, Berberoglu, U. 5 and Dogru, M. 6
1
Department of Pediatric Allergy, Trakya University, Edirne, Turkey. 2Department of Pediatric Allergy , Trakya University, Edirne,
Turkey. 3: Istanbul University Faculty of Medicine, Pediatric Allergy Department (retiree), Istanbul, Turkey. 4Pediatrics, Trakya
University, Edirne, Turkey. 5Public Health Department, Trakya University, Edirne, Turkey. 6Clinic of Pediatric Allergy and Asthma,
Dr.Sami Ulus Research and Training Hospital of Women’s and Children’s Health and Diseases, Ankara, Turkey.
POSTER SESSION 31: EOSINOPHILIC DISEASES CC, 1ST, POSTER HALL
3110 International Survey On Evaluation and Management of Eosinophilic Esophagitis
Ghaffari, G.
Medicine/Pulmonary-Allergy and Critical Care Medicine, Pennsylvania State University, Hershey, PA.
3111 Allergen Specific Immunotherapy As a Treatment for Eosinophilic Esophagitis
Perez, J. E. , Pongdee, T. and Guarderas, J.
Allergy and Pulmonary Medicine, Mayo Clinic, Jacksonville, FL.
3112 Eosinophilic Esophagitis and Eosinophil Cationic Proteins As Marker of Disease During the Follow-up
Ridolo, E.
Department of Clinical Sciences, University of Parma, Parma, Italy.
POSTER SESSION 32: IMMUNODEFICIENCY CC, 1ST, POSTER HALL
3113 Severe Autoimmunity with Polyarticular Joint Disease Requiring Anti-TNF Therapy and T+B-NK+
Immunodeficiency In a Family with Small Stature and Intermediate Radiation Sensitivity
Torgerson, T. , Ochs, H. and Lu, J.
Allergy & Immunology and Rheumatology, University of Washington, Seattle, WA.
137
Final Program
Posters
3114 Autoimmunity in Patients with Allergy and Immunodeficiency: As Result of the Immune Chronic
Inflammation
Mendez-Inocencio, J. 1 and Bellanti, J. 2
1
Clinical Immunology and Allergy, Hospital Angeles Lomas, Huixquilucan Edo. de México, México. 2Immunology Center,
Georgetown University Medical Center, Washington , DC.
3115 HPV, HSV2, HIV and Chlamydia Trachomatis Infections As a Potential Accompanying Factor for
Immunodeficiency and Development of Allergic Processes. Final Results
Gołębiowska-Wawrzyniak, M. 1, Markiewicz, K. 1, Jakimiuk, A. 2, Tomasz, M. 3, Kozar, A. 1, Rytwiński, K. 1 and Wawrzyniak, Z. 4
1
Clinical Immunology, Institute of Mother and Child, Warsaw, Poland. 2Obsterics and Ginecology Department, Central Clinical
Hospital of Ministry of Interior, Warsaw, Poland. 3Ginecology and Obstetrics Department, Institute of Mother and Child, Warsaw,
Poland. 4faculty of Health Science, Medical University of Warsaw, Warsaw, Poland.
3116 A 3 Years-Old Child with Specific Antibody Deficiency and Allergic Rhinitis. Case Report
Gonzalez Serrano, M. E. 1 and González Cruz, M. A. 2
1
Immunodeficiency Research Unit, National Institute of Pediatrics , México City, México. 2Escuela de Medicina, Universidad
Autónoma Metropolitana, México City, México.
3117 Silvery-Gray Hair Patient with Neurologic Deterioration
Gamez, L. 1, Yamazali, M. A. 2, Lugo-Reyes, S. 2, Dorbeker, R. 1 and Hernandez, V. 2
1
Allergy and Immunolgy clinic, National Institute of Pediatrics, México Distrito Federal, México. 2National Institute of Pediatrics,
México, México.
3118 Differences in Humoral and Cellular Immunity in Young and Old Individuals
Yalcin, A. D. 1, Gorczynski, R. M. 2, Sarigul, M. 3, Ulker, M. 3 and Terzioglu, E. 3
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Division of Cellular &
Molecular Biology, Toronto Hospital, University Health Network, Toronto, ON, Canada. 3Akdeniz University, Antalya, Turkey.
3119 Analysis of the Immune Status in the Acute Phase of Viral Respiratory Infections in Children
Bede, O. 1, Sipka, S. 2, Terhes, G. 3, Deák, J. 3 and Nagy, D. 1
1
Department of Pediatrics, University of Szeged, Faculty of Medicine, Albert Szent-Györgyi Medical and Pharmaceutical Centre,
Szeged, Hungary. 2Immunological Laboratory, University of Debrecen, Medical and Health Science Centre, Debrecen, Hungary.
3
Department of Microbiology, University of Szeged, Faculty of Medicine, Albert Szent-Györgyi Medical and Pharmaceutical
Centre, Szeged, Hungary.
3120 Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stem Cells
Ayatollahi, M. 1, Zarifi, F. 2, Zakerinia, M. 3, Rezvani, A. 4 and Ramzi, M. 4
1
Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 2Transplant Research Center, Shiraz University of
Medical Sciences , Shiraz, Iran. 32Bone Marrow Transplantation Center, Nemazi Hospital, Shiraz University of Medical Sciences,
Shiraz, Iran. 4Bone Marrow Transplantation Center, Nemazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
3121 Immunosuppressed Murine Model for Studies in Allergy: Evaluation of Immunosuppression Induced by
Cyclophosphamide, Dexamethasone and Cyclosporin in Balb-C Mice
Pereira, A. 1, Araújo, R. 2, Brito, R. 1 and De Lorenzo, B. 1
1
Centro Universitário São Camilo, São Paulo, Brazil. 2Faculdade de Saúde Pública da USP, São Paulo, Brazil.
POSTER SESSION 33: PRIMARY IMMUNODEFICIENCY CC, 1ST, POSTER HALL
3122 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
Arablin Oropeza, S. 1 and Yamazaki Nakashimada, M. A. 2
1
Allergy and Clinical Immunology, Fellow in Training, Instituto Nacional de Pediatría, México City, México. 2Clinical Immunology,
Attending physician., México City, México.
3123 Descriptive Analysis of the Immunological Behavior of Patients with Ataxia Telangiectasia Attended in the
National Institute of Pediatrics in the Past 30 Years
Llamas, B. A. 1, Gutierrez, A. 1 and Diaz, L. 2
1
Pediatric Allergy and Clinical Immunology, National Institute of Pediatrics , D.F., México. 2Research, National Institute of Pediatrics
, D.F., México.
3124 Alteration of Humoral and Cellular Immunity in Patients with Ataxia-Telangiectasia At Reference Center in
Sao Paulo/Brazil
Ornellas, L. , Matos, J. and Carvalho, B.
UNIFESP-EPM, São Paulo, Brazil.
138
Final Program
Posters
3125 Clinical Features of Patients with Ataxia-Telangiectasia At Reference Center in Sao Paulo/Brazil
Matos, J. , Ornellas, L. and Carvalho, B.
UNIFESP-EPM, São Paulo, Brazil.
3126 Attentiveness to Primary Immunodeficiency: Survey of Pediatricians in United Arab Emirates
Al-Hammadi, S. 1, Al-Reyami, E. 2, Al-Remaithi, S. 3, Al-Zaabi, K. 4, Al-Zir, R. 5 and Al-Sagban, H. 6
1
Pediatrics, FMHS, UAE University, Al-Ain, United Arab Emirates. 2Pediatrics, Saqr Hospital, Ras Al-Khaimah, United Arab Emirates.
3
Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. 4Pediatrics, Kalba Hospital, Sharjah, United Arab
Emirates. 5Pediatrics, Al-Wasl Hospital, Dubai, United Arab Emirates. 6Pediatrics, Dubai Hospital, Dubai, United Arab Emirates.
3127 The Diagnosis of Primary Immune Deficiency in Adults Should Not Be Missed: A Delayed Diagnosis Can Be
Devastating
Yesillik, S. 1, Musabak, U. 1, Baysan, A. 1, Demirel, F. 1, Ucar, E. 2, Bayar, G. R. 3, Yenicesu, M. 4 and Sener, O. 1
1
Division of Immunology and Allergic Diseases, Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey.
2
Department of Pulmonary Medicine, Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey. 3Department
of Oral and Maxillofacial Surgery, Gulhane Military Medical Academy, Ankara, Turkey. 4Division of Nephrology, Gulhane Military
Medical Academy and School of Medicine, Ankara, Turkey.
3128 Global Prevalence and Types of Autoimmune Diseases Found in Children with Primary Immunodeficiencies;
a Single-Center Experience
Ramírez Vázquez, M. G. 1, Lugo Reyes, S. O. 2, Yamazaki Nakashimada, M. A. 3,4, Espinosa Rosales, F. J. 3 and Espinosa Padilla, S. E. 5
1
Inmunología y Alergia Clínica, Instituto Nacional de Pediatría, México City, México. 2National Institute of Pediatrics,
Immunodeficiencies Research Unit, México City, México. 3National Institute of Pediatrics , México City, México. 4Clinical
Immunology, Attending physician., México City, México. 5Research on Primary Immunodeficiencies Unit, National Institute of
Pediatrics, México City, México.
3129 Malignancies associated to Primary Immunodeficiencies. A 40 year review
España, C. 1, Lugo, D. S. 2 and Yamazaki, M. A. 3
1
National Institute of Pediatrics, Pachuca, México. 2Allergy & Clinical Immunology, National Institute of Pediatrics, México City,
México. 3National Institute of Pediatrics, México D.F., México.
3130 An Earlier, Moore Severe Presentation of G6PC3 Deficiency in a Male Infant From México
Cruz, A.
Pediatric Allergy and Clinical Immunology, National Intitute of Pediatrics, México, México.
3131 Immunoglobulin A deficiency, HPV and Oral Cancer
Alvarez, J. 1, Garip, E. 1, Benitez, M. 2 and Guzman, L. 3
1
Allergy and Immunology, Instituto de diagnostico y tratamiento Oulton, Córdoba, Argentina. 2Dentistry Department, Córdoba,
Argentina. 3Instituto de diagnostico y tratamiento Oulton, Córdoba, Argentina.
POSTER SESSION 34: X-LINKED AND
COMMON VARIABLE IMMUNODEFICIENCY
3132 Long Term Follow-up of Patients with Common Variable Immunodeficiency (CVID) in Rio De Janeiro, Brazil:
Clinical Phenotypes and Prognosis
Seba, A. 1, de Paula Motta Rubini, N. 1, Varandas Capelo, A. 1, Miranda da Silva, E. 1, Campos de Magalhães, M. 2, Sion, F. S. 1 and
Morais de Sa, C. A. 3
1
Clinical Immunology, Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil. 2Hematology, Federal University of Rio de
Janeiro State, Rio de Janeiro, Brazil. 3Internal Medicine, Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil.
3133 Quality of Life in Patients with Common Variable Immunodeficiency in the Department of Allergy and
Clinical Immunology - Centro Medico Nacional Siglo XXI
Campos Romero, F. H. 1,2, Segura Mendez, N. H. 3, Mendoza Reyna, L. D. 4 and Guillen Rocha, N. L. 5,6
1
Allergy and Clinical Immunology, Specialty Hospital - Centro Medico Nacional Siglo XXI, México City, México. 2Allergy and
Clinical Inmunology, Fellow in Training, México, México. 3Specialty Hospital Centro Medico Nacional Siglo XXI, Allergy and Clinical
Immunology , México City, México. 4Allergy and Clinical Immunology, Specialty Hospital - Centro Medico Nacional Siglo XXI,
México City, México. 5Allergy and Immunology, Fellow in training, México Distrito Federal, México. 6 Allergy and Immunology ,
Speciality Hospital - Centro Médico Nacional Siglo XXI , México Distrito Federal, México.
139
Final Program
Posters
3134 “Prevalence of Common Variable Immunodeficiency In Adult Patients” Specialty Hospital – Centro Medico
Nacional Siglo XXI - MSS - México City
Guillen Rocha, N. L. 1, Segura Mendez, N. H. 2, Mendoza Reyna, L. D. 3 and Campos Romero, F. H. 4
1
Allergy and Clinical Immunology, Specialty Hospital – Centro Medico Nacional Siglo XXI , México City, México. 2Allergy & Clinical
Immunology, Specialty Hospital Centro Medico Nacional Siglo XXI, México, México. 3Allergy and Clinical Immunology, Specialty
Hospital - Centro Medico Nacional Siglo XXI, México City, México. 4Allergy and Clinical Immunology, Specialty Hospital - Centro
Medico Nacional Siglo XXI, México City, México.
3135 Infections in 14 Patients with Common Variable Immunodeficiency, Retrospective Study
Mendieta, E. 1, Del Rivero, L. G. 2 and Aguilar, D. N. 3
1
Allergy & Clinical Immunology, Specialty Hospital Medical Center XXI Century, México, México City, Author, México City , México.
2
Allergy and Immunology , MD, México City , México. 3Allergy & Clinical Immunology, Specialty Hospital Medical Center XXI
Century, México, México City, México.
3136 Autoimmune Thrombocytopenic Purpura Associated with Common Variable Immunodeficiency
Mendieta, E. 1 and Del Rivero, L. G. 2
1
Author, México City , México. 2Allergy and Immunology , MD, México City , México.
3137 CVID: A Common but Still Underdiagnosed Disease
Gallego Corella, C. I. 1, Gonzalez Diaz, S. N. 1, Zarate Hernandez, M. D. C. 1, Arias Cruz, A. 1, Garcia Cardelin, D. D. J. 1, Mejia Salas, K. Y. 2,
Calva Mariño, M. 3 and Dominguez Sansores, L. A. 3
1
Regional Centre of Allergy and Clinical Immunology, Monterrey, México. 3Regional Centre of Allergy and Clinical Immunology,
Monterrey, México.
3138 Infections in Patients Diagnosed with Common Variable Immunodeficiency
Köse, S. 1, Serin Senger, S. 1, Yalcin, A. D. 2, Cavdar, G. 1, Atalay, S. 1 and Ersan, G. 1
1
Clinic of Infectious Diseases and Clinical Microbiology, Clinical Allergy and Immunology, Izmir Tepecik Education and Research
Hospital, IZMIR, Turkey. 2Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey.
3139 Phenotypic and Functional Analysis of B Cells In Patients with Common Variable Immunodeficiency
Berrón-Ruiz, L. 1, Mogica-Martinez, D. 2, Santos-Argumedo, L. 3, López-Herrera, G. 4, Espinosa-Rosales, F. 4 and Blancas-Galicia, L. 4
1
Unidad de Investigación para Inmunodeficiencias, Instituto Nacional de Pedriatría, Distrito Federal, México. 2Servicio de Alergia
e Imunología Clínica, Centro Médico Nacional IMSS “La Raza”, Distrito Federal, México. 3Departamento de Biomedicina Molecular,
Centro de Investigación y Estudios Avanzados, Distrito Federal, México. 4Unidad de Investigación para Inmunodeficiencias,
Instituto Nacional de Pediatría, Distrito Federal, México.
3140 X-Linked Agammaglobulinemia: Report of 4 Cases of Mexican Patients At Civil Hospital of Guadalajara Dr
Juan I. Menchaca
Nuñez-Nuñez, M. E. 1, Padilla-Jimenez, A. 2, Cortes-Grimaldo, R. M. 3, Ortega-Cisneros, M. 4, Moran-Mendoza, R. 5 and Torres-Lozano, C. 3
1
Allergy and Clinical Immunology, Hospital Civil de Guadalajara Dr. Juan I Menchaca, Guadalajara, México. 2Hospital Civil de
Guadalajara Dr. Juan I Menchaca, Guadalajara, México. 3UMAE-HECMNO-IMSS, Guadalajara, México. 4Allergy and Clinical
Immunology, UMAE-HPCMNO-IMSS, Guadalajara, México. 5UMAE-HPCMNO-IMSS, Guadalajara, México.
3141 Congenital Agammaglobulinemia
Perez Ortiz, C.
Universidad Nacional De Asuncion, San Lorenzo, Paraguay.
3142 Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine
Marinovic, M. A. and Rojas, R.
Servicio de Alergia e Inmunologia, Hospital Clinico Universidad de Chile, Santiago, Chile.
3143 X- Linked Agammaglobulinemia and Moebius Syndrome, First Case Reported
Ortega-Cisneros, M. 1, Cortes-Grimaldo, R. M. 2, Madrigal-Beas, I. M. 2, Montaño-Gonzalez, E. 2, Nuñez-Nuñez, M. E. 3, MendezSantillan, S. 4, García-Reyes, G. 5, Torres-Lozano, C. 2 and Garcia-Cobas, C. 2
1
Allergy and Clinical Immunology, UMAE -HECMNO-IMSS, Guadalajara, México. 2Allergy and Clinical Immunology, UMAEHECMNO-IMSS, Guadalajara, México. 3Allergy and Clinical Immunology, Hospital Civil de Guadalajara Dr. Juan I Menchaca,
Guadalajara, México. 4Allergy and Clinical Immunology, UMAE HECMNO IMSS, Guadalajara, México. 5ISSSTE, Zapopan, México.
140
Final Program
Posters
POSTER SESSION 35: HIV-RELATED PROBLEMS
3144 Peculiarities of HIV-Specific Immune Response in Discordant Couples
Zhukova, E. 1, Pronin, A. 2, Kaminsky, G. 2, Gudima, G. 3 and Sidorovich, I. 4
1
Clinical Dept., Moscow regional Center of AIDS and Infectious Diseases Prevention and Treatment, Moscow, Russia. 2Moscow
regional Center of AIDS and Infectious Diseases Prevention and Treatment, Moscow, Russia. 3Lab. of Physiology of Immunity and
Allergy, Institute of Immunology, Moscow, Russia. 4AIDS Immunobiology Dept., Institute of Immunology, Moscow, Russia.
3145 Detection of Dengue Virus in HIV-1-Infected Patients During the Epidemic in 2009 in Colima, México
López-Lemus, U. A. 1,2, Valle-Reyes, S. 1, Ochoa-Jiménez, R. 3, Delgado-Enciso, I. 1, Vásquez-Jiménez, C. 2 and Espinoza-Gómez, F. 1
1
School of Medicine, University of Colima, Colima, México. 2Center for Biomedical Research, University of Colima, Colima, México.
3
Internal Medicine Department, Regional Hospital of Colima, Colima, México.
3146 HPV, HSV2, HIV and Chlamydia Trachomatis Infections As a Potential Accompanying Factor for
Immunodeficiency and Development of Allergic Processes Final Results
Markiewicz, K.
Clinical Immunology, Institute of Mother and Child, Warsaw, Poland.
POSTER GROUP 3
WEDNESDAY, 7 DECEMBER
POSTER SESSION 36: EPIDEMIOLOGY OF ALLERGIC RHINITIS 12:15 – 14:15
4000 Treatment of Nasal Allergies: Results From the Allergies Surveys in America, Asia Pacific, Latin America, and
Middle East
Blaiss, M. S. 1, Katelaris, C. 2 and Neffen, H. E. 3
1
University of Tennessee Health Science Center`, Memphis, TN. 2Immunology & Allergy, University of Western Sydney and
Campbelltown Hospital, Sydney, Australia. 3Respiratory Medicine Unit, Children’s Hospital “Orlando Alassia”, Santa Fe, Argentina.
4001 Comorbid Allergy-Related Respiratory Conditions Among Children and Adults Diagnosed with Allergic
Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI
Hankin, C. 1, Cox, L. 2, Bronstone, A. 1 and Wang, Z. 1
1
Health Economics and Outcomes Research, BioMedEcon, LLC, Moss Beach, CA. 2Medicine, Nova Southeastern University , Ft.
Lauderdale, FL.
4002 Survey of Rhinitis Phenotypes
SURF Study Group
4003 Prevalence and Risk Factors Associated to Symptoms of Rhinoconjunctivitis In Mexican School Children.
A Multicenter Study
Liévano Pérez, M. A. 1, del Rio, B. 1, del Rio, J. 1, Merida Palacios, J. V. 2, Romero Tapia, S. D. J. 3, Linares Zapien, F. J. 4, Escalante
Dominguez, A. 5, González-Díaz, S. 6, García-Almaraz, R. 7, Carvajal Abdala, S. 8 and Pietropaolo-Cienfuegos, D.1
1
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México. 2Mexicali Health
Care, Mexicali, México. 3Hospital Angeles Villahermosa, Villahermosa, México. 4COMPEDIA, Toluca, México. 5Hospital General de
Rosarito, Tijuana, México. 6Hospital Universitario, Medical School, Universidad Autónoma de Nuevo León, Monterrey, México.
7
COMPEDIA, Tamaulipas, México. 8COMPEDIA, Veracruz, México.
4004 Oral Allergy Syndrome and United Airways Disease: Is There a Functional Connection?
Lombardi, C. 1, Passalacqua, G. 2 and Canonica, G. W. 3
1
Allergy Unit, Department of Internal Medicine, Sant’Orsola Hospital, Sant’Orsola, Italy. 2Allergy & Respiratory Diseases, Universita
Degli Studi Di Genova, Genoa, Italy. 3Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genova, Italy.
4005 Epidemiological and Clinical Characteristics of Allergic Conjunctivitis Patients in a Reference Center of
México City
Robles-Contreras, A. 1, Ayala-Balboa, J. 1, Alonso-Sánchez, M. E. 1, Estrada-Garcia, I. 2 and Jiménez-Martínez, M. C. 1,3
1
Research Unit and Department of Immunology, Institute of Ophthalmology, México D.F., México. 2Departamento de
Inmunologia, Escuela Nacional de Ciencias Biologicas-IPN, México City, México. 3Department of Biochemistry, Faculty of
Medicine, UNAM, México D.F., México.
4006 The Classification of Allergic Rhinitis and ITS Cytological Correlate
Gelardi, M. 1, Incorvaia, C. 2, Passalacqua, G. 3, Fiorella, M. L. 1 and Frati, F. 4,5
1
University Department of Otolaryngology, Bari, Bari, Italy. 2Allergy/Pulmonary Rehabilitation Unit, ICP Hospital - Milan, Milano,
Italy. 3Allergy & Respiratory Diseases, Universita Degli Studi Di Genova, Genoa, Italy. 4Department of Medical and Surgical
Specialties and Public Health, Perugia, Perugia, Italy. 5Medical and Scientific Department, Stallergenes Milan , Milano, Italy.
141
Final Program
Posters
4007 Incidence of Allergic Diseases on Children Under 5 Years in Juarez Hospital México
Rojo-Gutiérrez, M. I. 1, Ortega-Vargas, A. 2, Mellado-Abrego, J. 1 and Bermejo, M. 3
1
Allergy, Juarez Hospital, México City, México. 2Pediatrics, Juarez Hospital, México City, México. 3Allergy and Immunology, Juarez
Hospital, México, México.
POSTER SESSION 37: DIAGNOSTIC TEST FOR ALLERGIC RHINITIS CC, 1ST, POSTER HALL
4008 Comparison of Skin and Conjunctival Reactivity to Aeroallergens
Mourão, E. M. M. and Rosario, N.
4009 Correlation Between Skin Prick Test and MAST Results In Patients with Chronic Rhinitis
Kim, Y. H. 1 and Cho, J. H. 2
1
Department of Otolaryngology-HNS, Yeouido St. Mary’s Hospital, Seoul, South Korea. 2Department of Otolaryngology-HNS,
Yeouido St. Mary’s Hospital, Seoul, South Korea.
4010 Cutaneous Response to Patch Tests with Dermatophagoides Farinae and Dermatophagoides Pteronyssinus
in Patients with Chronic Rhinitis
Garcia-Calderin, D. 1, González-Díaz, S. 1,2, Arias-Cruz, A. 1,3, Rojas, A. 4, Hernandez, M. 1, Gallego, C. 5, Mejia, K. 1, Calva, M. 1 and
Dominguez, L. 1
1
Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 2Regional Allergy Center, University
California San Diego U.C.S.D. 3Allergy and Clinical Immunology, University Hospital UANL, Monterrey, México. 4CRAIC, Hospital
Universitario, Monterrey, México. 5Regional Center of Allergy and Clinical Immunology, University Hospital, Monterrey, México.
4011 Skin Prick Test Reactivity Compared to Serum Specific IgE by ISAC in Patients with Rhinitis
Araujo, L. 1, Thom, C. 1, Chong Neto, H. J. 1, Palazzo, P. 2, Liso, M. 2, Mari, A. 3,4 and Rosario, N. 1
1
Allergy and Immunology, Federal University of Paraná, Curitiba, Brazil. 2IDI IRCCS, Rome, Italy. 3CMA, Rome, Italy. 4Instituto
Dermopatico dell’Immacolata, Rome, Italy.
4012 Alteration of Smell In Patients with Persistent Allergic Rhinitis
De Barayazarra, S. 1, Corelli, S. 1, Cornaglia, S. 1, Zanacchi, A. 1, Sosa, S. 1, Herrera, E. 1, Teijeiro, A. 2, Canonica, G. W. 3, Baena-Cagnani, C.
E. 4 and Zernotti, M. 2,5
1
CIDI, Allergy and Immunology Division, Nuevo Hospital San Roque, Cordoba, Argentina. 2CIMER (Research Center for Respiratory
Medicine). Faculty of Medicine. Catholic University of Cordoba, Cordoba, Argentina. 3Allergy & Respiratory Diseases, Universita
Degli Studi Di Genova, Genova, Italy. 4CIMER (Centro de Investigación en Medicina Respiratoria). Faculty of Medicine. Catholic
University of Cordoba. Fundación LIBRA Argentina , Cordoba, Argentina. 5Otorrinolaringologia, Sanatorio Allende, Córdoba.
Argentina, Córdoba, Argentina.
4013 Effectiveness of an Educational Intensive Course on A/I Clinical and Diagnostic Procedures
Elizalde, A. 1, Perez, E. 1, Sriaroon, P. 1, Nguyen, D. 1, Lockey, R. F. 2 and Dorsey, M. 1
1
University of South Florida, College of Medicine, Saint Petersburg, FL. 2Division of Allergy & Immunology, University of South
Florida and James A. Haley Veterans’ Hospital, Tampa, FL.
POSTER SESSION 38: ALLERGIC RHINITIS CC, 1ST, POSTER HALL
4014 PCR Analysis of Microorganisms in Chronic Rhinosinusitis with Nasal Polyps
Hirotsu, M. 1, Ikeda, K. 2 and Ono, N. 1
1
Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan. 2Otorhinolaryngology, Juntendo University Faculty of
Medicine, Tokyo, Japan.
4015 Incidence of Allergy to Artemisia Vulgaris and Salsola Kali In Sabzevar City
Matloobi, Z.
Student of Tarbiat Modares University, Sabzevar, Iran.
4016 The Prevalence of Allergic Rhinitis in Adolescent in the “La Paz-Bolivia” City. (3600 m.s.n.m.)
Moncada Alcon, A. M. 1 and Rios Mora, R. I. 2
1
Pediatric Allergy, Allergist Pediatrician, La Paz, Bolivia. 2Pediatric, Pediatrician, La Paz, Bolivia.
4017 Pattern of Positive Sensitization in Patient with Asthma and Rhinitis to 3600 Msnm (La Paz-Bolivia)
Moncada Alcon, A. M. 1 and Rios Mora, R. I. 2
1
Pediatric Allergy, Allergist Pediatrician, La Paz, Bolivia. 2Pediatric Hospital Del Niño, Pediatrician, La Paz, Bolivia.
142
Final Program
Posters
4018 Epidemiology of Allergic Rhinitis Cases In the Allergy Service of A Third Level Medical Center. Six Year
Experience
Immunoallergology Service, Issemym Ecatepec Medical Center, Ecatepec De Morelos, México.
4019 The Evaluation of Allergen Sensitivity In Allergic Rhinoconjunctivitis and Allergic Asthma Patients In
Antalya, Turkey
Yalcin, A. D. 1, Polat, H. H. 2, Kamaci, F. 3, Bisgin, A. 4 and Gorczynski, R. M. 5
1
Allergology and Clinical Immunology Unit, Antalya Education and Training Hospital, Antalya, Turkey. 2Cumhuriyet University,
Faculty of Medicine, Department of Public Health, , SIVAS, Turkey. 3Atatürk State Hospital, Antalya, Turkey. 4Human Gene and
Cell Therapy Center of Akdeniz University Hospital and Clinics, Antalya, Turkey. 5Division of Cellular & Molecular Biology, Toronto
Hospital, University Health Network, Toronto, ON, Canada.
4020 Allergic Disease Severity and Relations
Viveiros, F. 1, Gonçalves, I. 2, Brinca, P. 3, Lima, R. 2, Duarte, R. 4, Pascoal, I. 2, Moura e Sá, J. 2 and Carvalho, A. 2
1
Pulmonology, Centro Hospitalar de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal. 2Centro Hospitalar de Gaia/Espinho, EPE, Vila
Nova de Gaia, Portugal. 3Departamento de Economia, Universidade de Estocolmo, Estocolmo, Sweden. 4Centro Hospitalar de
Gaia/Espinho, Vila Nova de Gaia, Portugal.
4021 Frequency of Patients with Clinical Manifestations of Allergic Rhinitis without Evidence of Systemic Atopy
and Specific IgE Sensitization
de Paula Motta Rubini, N. 1, Campregher Berti, S. 2, Marques, T. C. 2, Pereira Ribeiro, L. C. 3, Alves Gonçalves, C. C. 3, Teixeira Figueredo
Poleshuck, R. 2, Sion, F. S. 1 and Morais de Sa, C. A. 4
1
Clinical Immunology, Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil. 2Federal University of Rio de Janeiro State,
Rio de Janeiro, Brazil. 3Laboratory of Immunology, Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil. 4Internal
Medicine, Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil.
4022 H1 Antihistamines Influence On Pro-Inflammatory Cytokines Level In Patients with Allergic Rhinitis
Bocsan, I. C. 1, Bujor, I. A. 2, Miron, N. 3, Negulescu, V. 4 and Cristea, V. 5
1
Clinical Pharmacology, University of Medicine and Pharmacy, Cluj Napoca, Romania. 2Immunology- Allergology, University
of Medicine and Pharmacy , Cluj- Napoca, Romania. 3Department of Immunology , University of Medicine and Pharmacy,
Cluj Napoca, Romania. 4Clinical Pharmacology, University of Medicine and Pharmacy, Bucharest, Romania. 5Department of
Immunology, University of Medicine and Pharmacy, Cluj Napoca, Romania.
4023 International Survey On the Management of Allergic Rhinitis by Physicians and Patients (ISMAR)
Gomez, R. M. 1, Teijeiro, A. 2, Badellino, H. A. 1, Zernotti, M. 1, Murrieta-Aguttes, M. 3 and Baena-Cagnani, C. E. 1
1
CIMER (Centro de Investigación en Medicina Respiratoria). Faculty of Medicine. Catholic University of Cordoba. Fundación
LIBRA Argentina , Cordoba, Argentina. 2CIMER (Centro de Investigación en Medicina Respiratoria ). Faculty of Medicine. Catholic
University of Cordoba. Fundación LIBRA Argentina, Cordoba, Argentina. 3Sanofi, Paris, France.
4024 Effectiveness of Sinus Surgery for Lower Airway Disease
Kagoya, R. 1, Shinogami, M. 1, Mouri, H. 1, Suzuki, S. 1, Nakanishi, W. 2 and Yoshinami, H. 3
1
Otolaryngology, Tokyo Metropolitan Police Hospital, Tokyo, Japan. 2University of Tokyo, Tokyo, Japan. 3Otorhhinolaryngology,
Saitama Medical University, Saitama, Japan.
4025 Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-Deroved Fibroblast Via p-38 Pathway
Lee, H. 1,2 and Park, I. 3,4
1
Department of Otorhinolaryngology, Korea University College of Medicine, Seoul, South Korea. 2Institute for Medical Devices
Clinical Trial Center, Korea University College of Medicine, Seoul, South Korea. 3Department of Otorhinolaryngology-Head and
Neck Surgery, Korea University College of Medicine, Seoul, South Korea. 4Institute for Medical Devices Clinical Trial Center, Korea
University College of Medicine, Seoul, South Korea.
4026 Results of the Rhinoconjunctivitis Related Quality of Life Questionnaire Administered to Subjects with
Seasonal Allergic Rhinitis Following Treatment with Ciclesonide Hydrofluoralkane Nasal Aerosol
Andrews, C. 1, Ratner, P. 2, Martin, B. 3, Howland, W. 4, Huang, H. 5, Desai, S. 5 and Bode, F. 5
1
Diagnostics Research Group, San Antonio, TX. 2Sylvana Research Associates, San Antonio, TX. 3Southwest Allergy and Asthma
Center, San Antonio, TX. 4Sirius Clinical Research, Austin, TX. 5Sunovion Pharmaceuticals, Inc., Marlborough, MA.
4027 Mold Sensitization in Chronic Rhinosinusitis Patients
Gawlik, R. 1 and Czecior, E. 2
1
Internal Medicine,Allergy and Clin Immunology , Silesian University of Medicine, Katowice, Poland. 2Silesian University of
Medicine, Zabrze, Poland.
143
Final Program
Posters
4028 “Nasal Cytology Is Important In the Classification of Patients with Allergic and Non-Allergic Rhinitis.”
Mion, O. , Salgado, D. , Carvalho, T. and Mello Jr, J.
Universidade de Sao Paulo, Sao Paulo, Brazil.
4029 The Examination of the Association Between the Chronic Rhinosinusitis and the Inflammation of the Lower
Respiratory Airway by Using the Exhaled Nitric Oxide(NO) and the Respiratory Function Test
Yoshinami, H. 1, Shinogami, M. 2, Kagoya, R. 2, Nakashima, M. 3, Wada, I. 3, Katuhiro, T. 3, Ikezono, T. 3, Kase, Y. 3 and Nagata, M. 4
Otorhhinolaryngology, Saitama Medical University, Saitama, Japan. 2Otolaryngology, Tokyo Metropolitan Police Hospital, Tokyo,
Japan. 3Otorhinolaryngology, Saitama Medical University, Saitama, Japan. 4Allergy Center , Department of Respiratory Medicine,
Saitama Medical University, Moroyama-Machi, Japan.
1
4030 Peak Inspiratory Flow Rate Is More Sensitive Than Acoustic Rhinometry or Rhinomanometry In Detecting
Nasal Obstruction Using the Allergen Challenge Chamber
Terada, T.
Otorhinolaryngology, Osaka Medical College, Takatsuki, Japan.
4031 Nasal Poliposis and Allergic Disease. Dr. Salvador Allende Hospital
Castillo Méndez, A.
Alergia, MINSAP, Habana, Cuba.
4033 Use of the CT Navigation In the Rhinology and Head Surgery
Fundova, P. 1, Kovar, D. 1, Navara, M. 1,2 and Voldrich, Z. 1
1
ENT Department, Central Military Hospital, Prague, Prague 6, Czech Republic. 23rd Medical Faculty, Charles University, Prague 10,
Czech Republic.
4034 Rupatadine oral solution is efficacious and safe in children ( aged 6-11 years) with persistent allergic rhinitis
Potter, P. 1, Maspero, J. 2, Garde, J. M. 3, Neffen, H. E. 4, Vermeulen, J. 5, Barkai, L. 6, Nemeth, I. 7, Medina, I. 8, Domenech, A. 9, Giralt, J. 9,
Zas, S. 10 and Izquierdo, I. 9
1
Head: Allergology, Department of Medicine, Groote Schuur Hospital, Cape Town, South Africa. 2Allergy and Respiratory Research
Unit, Fundacion CIDEA, Buenos Aires, Argentina. 3Hospital General Universitario de Elche, Alicante, South Africa. 4Centro de
Alergia e Inmunología, Santa Fé, Argentina. 5Private consult, Cape Town, South Africa. 6BAZ Megyei Kórház Gyermekegészségügyi
Központ, Miskolc, Hungary. 7Szent Erzsébet Kórház , Jászberény, Hungary. 8Centro Médico Vitae, Buenos Aires, Argentina. 9Clinical
Development Unit, Uriach Pharma, Barcelona, Spain. 10Project Leader , Nuvisan , Madrid, Spain.
4035 Assessment of the Quality of Methodological Rigour and Reporting of Clinical Practice Guidelines for the
Management of Allergic Rhinitis – QUGAR study
Padjas, A. 1, Schünemann, H. 2, Bousquet, J. 3 and Brozek, J. 4
1
Department of Medicine, Jagiellonian University Medical College, Krakow, Poland. 2Department of Clinical Epidemiology
& Biostatistics and Medicine, McMaster University, Hamilton, ON, Canada. 3University of Montpellier, Montpellier, France.
4
Departments of Clinical Epidemiology & Biostatistics and Medicine, McMaster University, Hamilton, ON, Canada.
4036 Health-Related Quality of Life and Prognostic Value of Acoustic Rhinometry in Patients with Perennial
Allergic Rhinitis Treated with Fix Combination of Montelukast plus Desloratadine
Cingi, C. 1, Oghan, F. 2, Eskiizmir, G. 3, Yaz, A. 4, Ural, A. 5 and Erdogmus, N. 6
1
ORL&HNS, Professor, MD, Osmangazi University, Faculty of Medicine, Eskisehir, Turkey. 2ORL&HNS, DPU, Medical School, Kutahya,
Turkey. 3ORL&HNS, Celal Bayar University, Medical School, Manisa, Turkey. 4ORL&HNS, Tepecik Training and Research Hospital,
Izmir, Turkey. 5ORL&HNS, Karadeniz Technical University, Medical School, Trabzon, Turkey. 6ORL&HNS, Osmangazi University,
Faculty of Medicine, Eskisehir, Turkey.
POSTER SESSION 39: CONJUNCTIVITIS CC, 1ST, POSTER HALL
4037 Tear IL-4 Is Decreased in Allergic Conjunctivitis Patients with Negative Skin Test After Dialyzable Leukocyte
Extracts Treatment
Aguilar-Velazquez, G. 1, Santacruz, C. 2, Hernandez, P. M. 1, Chavez, R. 3, Estrada-Parra, S. 4, Perez-Tapia, M. 5 and Jimenez-Martinez, M. C. 3
1
Research Unit, Department of Immunology, Institute of Ophthalmology “Conde de Valenciana”, México, México. 2Department of
Cornea, Institute of Ophthalmology “Conde de Valenciana”, México, México. 3Department of Biochemistry, Faculty of Medicine,
UNAM, México, México. 4Molecular Immunology Lab-I, National School of Biological Sciences, IPN, México, México. 5Unidad de
Desarrollo e Investigacion de Biologicos, National School of Biological Sciences, IPN, México, México.
4038 Histochemical Study of Allergic Inflammation in Conjunctiva From Ovalbumin Sensitized Rabbits After
Ocular or Nasal Challenge
Batle, R. , Vinuesa, M. , Bassan, N. , Martinez, A. , Giacomozzi, F. , Chaparro, S. , Torres, V. and Acebal, F.
Catedra Histologia, Facultad de Ciencias Medicas, UNR, Laboratorio Inmunohistoquimica, Rosario, Argentina.
144
Final Program
Posters
4039 Prevalence of Allergic Conjunctivitis in Childhood
Geraldini, M. , Chong Neto, H. J. , Riedi, C. A. and Rosario, N.
4040 Effects of Omalizumab in Children with Atopic Keratocojunctivitis: A New Treatment for Severe Ocular
Allergies? – Report of Two Cases
Kuschnir, F. 1, Emerson, F. 2, Cordeiro, N. 2, Rios, J. L. 1, Filho, S. L. 2 and Bicudo, P. 2
1
Policlinica Geral do Rio de Janeiro, Rio de Janeiro, Brazil. 2Allergy, Policlinica Geral do Rio de Janeiro , Rio de Janeiro, Brazil.
4041 Allergic Conjunctivitis, Allergic Comorbitidies and the Most Common Allergens Identified In A Group of
Mexican Patients
Cortés-Morales, G. 1, Velasco-Medina, A. A. 2, Barreto-Sosa, A. 2 and Velázquez-Sámano, G. 2
1
Hospital General de México, México City, México. 2Servicio de Alergia e Inmunología Clínica, Hospital General de México, México
City, México.
4042 Giant Papillary Conjuntivitis without Associated Triggers. Report of Two Cases
Gonzalez-Carsolio, A. , Barreto-Sosa, A. , Burbano-Ceron, A. , Velasco-Medina, A. A. and Velázquez-Sámano, G.
4043 Contact Allergy Due to Ophthalmic Drugs in Uruguay
Pomies, V. 1 and Ale, I. 2
1
2
4044 Increased Frequency of γδ T Cells in Patients with Allergic Conjunctivitis
Alonso-Sánchez, M. E. 1, Galicia-Carreón, J. 1, Chávez, R. 2, Robles-Contreras, A. 1 and Jimenez-Martinez, M. C. 1,3
1
Research Unit and Department of Immunology, Institute of Ophthalmology, México D.F., México. 2Department of Biochemistry,
Faculty of Medicine, UNAM, México D.F., México. 3Department of Biochemistry, Faculty of Medicine, UNAM, México, México.
4045 Zero Itch in Eyes Treated with Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral
Conjunctival Allergen Challenge Studies
Blaiss, M. S. 1 and Tort, M. 2
1
University of Tennessee Health Science Center, Memphis, TN. 2Global Medical Affairs, Alcon Research ,Ltd, Fort Worth, TX.
POSTER SESSION 40: MASTOCYTOSIS CC, 1ST, POSTER HALL
4046 Mastocytosis and IgE-Dependent Sensitization: Report of 2 Cases
Toche, P. and Bastías, C.
4047 Mastocytosis: Importance As Differential Diagnosis In Skin Diseases. Report of Two Cases
Gonzalez-Carsolio, A. , Barreto-Sosa, A. , Burbano-Ceron, A. , Velasco-Medina, A. A. and Velázquez-Sámano, G.
POSTER SESSION 41: ANAPHYLAXIS
4048 Basophil-Mediated Anaphylaxis Triggered by Drug-Activated Complement Alternative Pathway without
Mastocyte’s Nor Immunoglobulins Involvement
Manfredi, G. 1, Traetta, P. 2 and Errico, M. 3
1
Allergology and Clinical Immunology Unit, Dept. of Clinical Medicine, General Hospital Miulli, www.miulli.it, Acquaviva (BA), Italy.
2
Allergology and Clinical Immunology Unit, Dept. of Clinical Medicine, General Hospital Miulli, Acquaviva (BA), Italy, www.miulli.it,
Acquaviva (BA), Italy. 3Dept. of Clinical Medicine, General Hospital Miulli, Acquaviva (BA), Italy, www.miulli.it, Acquaviva (BA), Italy.
4049 Wait At Least 60 Minutes After Eating
Gandhi, S. , Woodruff, M. , Halley, H. , Patel, S. and Shah, S.
Premier Allergy, Dublin, OH.
4050 First Report of Anaphylactic Shock Caused by the Ingestion of Mite-Infested Flour In Panama
Barrera de Pino, O. M. 1, Murgas, I. 2 and Miranda, R. J. 2
1
Institute of Pneumology and Allergy, San Fernando Hospital, Panama City, Panama. 2Gorgas Memorial Institute, Panama City,
Panama.
145
Final Program
Posters
4051 Recurrent Anaphylaxis in Cow’s Milk Allergy: What Is Wrong?
Asanuma Odaira, M. 1, Geraldi Rezende de Oliveira, D. 1, Aki Watanabe, L. 1, Keiko Fujinami Gushken, A. 1, Brandão, A. C. 1, Pastorino,
A. C. 2, Miuki Abe Jacob, C. 1 and Beltran Moschione Castro, A. P. 1
1
Allergy and Immunology Unit - Pediatric Department, Hospital das Clínicas - Faculdade de Medicina da Universidade de São
Paulo, São Paulo, Brazil. 2Instituto da Criança da Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo,
São Paulo, Brazil.
4052 Epidemiology of Anaphylaxis In Adults Treated In the Emergency Department, of the University Hospital of
Monterrey N.L México, During : 2005-2010
Calva, M. 1, González-Díaz, S. 1,2, Arias-Cruz, A. 1,3, Macias, A. 1, Leal, L. 4, Gonzalez, A. 5, Gallego, C. 6, Garcia, D. 1, Mejia, K. 1 and
Dominguez, L. 1
1
Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 2Regional Allergy Center, University
California San Diego U.C.S.D., Monterrey, CA. 3Allergy and Clinical Immunology, University Hospital UANL, Monterrey, México.
4
Regional Centre of Allergy and Clinical Immunology, University Hospital, Monterrey, México, Monterrey, México. 5Regional
Center of Allergy and Clinical Immunology, University Hospital, Monterrey, México. 6Regional Center of Allergy and Clinical
Immunology, University Hospital, Monterrey, México.
4053 Comprehensive Anaphylaxis Mangement In Schools and Childcare Through Resources, Legislation and
Adrenaline Autoinjector Provision
Noble, V. , Loh, R. , Vale, S. and Sprigg, L.
Anaphylaxis Implementation Group Western Australia, Perth, Australia.
4054 Buckwheat Pillow Exposure Predisposes to Buckwheat Food-Induced Anaphylaxis
Kuryan, J. , Bonagura, V. and Boxer, M.
Allergy & Immunology, North Shore - Long Island Jewish Health System, Great Neck, NY.
POSTER SESSION 42: RADIOCONTRAST MEDIA ALLERGY CC, 1ST, POSTER HALL
4055 Frequency, Characteristics and Outcome of Immediate Hypersensitivity Reactions Due to Iodinated
Contrast Media
Kampitak, T. 1,2, Klaewsongkram, J. 1 and Ruxrungtham, K. 1
1
Internal Medicine, Chulalongkorn University, Bangkok, Thailand. 2Medicine, University of Toronto, Toronto, ON, Canada.
4056 Seafood Allergy and Radiocontrast Media: Perceptions of Radiologists and Interventional Cardiologists in
Canada
Pun, T. and Kalicinsky, C.
Adult Allergy and Clinical Immunology, Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada.
4057 Frequency Of Positive Skin Test for Iodinated Contrast In Outpatient Clinic of Allergy In Rio De Janeiro, Brazil
Pereira, N. 1,2, Sardenberg, J. 1,2, Tapias, E. 1,2, Carvalho, T. 1,2, Rios, J. L. 1,2,3 and Kuschnir, F. 1,2,4
1
Policlinica Geral do Rio de Janeiro, Rio de Janeiro, Brazil. 2Faculdade de Medicina de Petrópolis, Petrópolis, Brazil. 3Thorax Disease
Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 4Pediatrics, University os State of Rio de Janeiro, Rio de Janeiro,
Brazil.
4058 Test and Manage Protocol for 841 Patients Requiring Iodinated Contrast Media (ICM) in Pediatrics
Diaz, M. C. , Lavrut, A. J. and Spinelli, S. S.
Unidad de Alergia, Hospital General de Niños Pedro de Elizalde Casa Cuna, Buenos Aires, Argentina.
POSTER SESSION 43: HEREDITARY ANGIOEDEMA CC, 1ST, POSTER HALL
4059 A 26-Year Review of Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate
Bork, K. 1, Korger, G. 2 and Kreuz, W. 3
1
Department of Dermatology, University Hospital Mainz, Mainz, Germany. 2Global Clinical Safety & Pharmacovigilance, CSL
Behring, Marburg, Germany. 3Center of Pediatrics III, Department of Hematology, Oncology and Hemostasis, Comprehensive Care
Center for Thrombosis and Hemostasis, , J.-W. Goethe-University Hospital, Frankfurt a. M., Germany.
4060 Efficacy of Icatibant Vs Fresh Frozen Plasma for Attacks of Hereditary Angioedema:Analysis of Indivudual
Symptoms by Attack Site
Lara, A. 1 and Hernandez.M.E.Mondragon, M. E. 2
1
Alergia e Inmunlogia Clinica, UMAE 25,Centro Medico Nacional del Noreste . IMSS, Monterrey N.L., México. 2IMSS, Veracruz,
México.
146
Final Program
Posters
4061 Characterization of the Factors Triggering An Edematous Attack in Hereditary Angioedema
Zotter, Z. , Csuka, D. , Szabó, E. , Fust, G. , Varga, L. and Farkas, H.
4062 Hereditary Angioedema: Report of Ten Mexican Patients At West National Medical Center, in Guadalajara
City
Madrigal, I.
UMAE-HECMNO-IMSS, -, Guadalajara, Jalisco, México.
4063 Clinical Features and Outcome of 82 Patients with Hereditary Angioedema
D’Ottaviano, F. L. , Giavina-Bianchi, P. , Motta, A. A. and Aun, M. V.
4064 Differences of Complement Activation Profile Between Type I and Type II of Hereditary Angioedema Due to
C1-inhibitor Deficiency
Csuka, D. , Kelemen, Z. , Varga, L. , Füst, G. and Farkas, H.
POSTER SESSION 44: URTICARIA CC, 1ST, POSTER HALL
4065 HLA and Chronic Urticaria with Positive Autologous Serum Skin Test Among Brazilians
Calamita, Z. 1, Gamberini, M. 2, Baleotti Junior, W. 3, Calamita, A. B. P. 4 and Fabron Júnior, A. 5
1
Allergy and Immunology, Medical School of Marilia , São Paulo, Brazil. 2Laboratory HLA, Laboratory of Immunology of Marilia
(LIM), São Paulo, Brazil. 3Clinical Pathology, Medical School of Marilia, São Paulo, Brazil. 4Dermatology, Medical School of Marilia,
Marilia, Brazil. 5Hematology, Medical School of Marilia, São Paulo, Brazil.
4066 CD63 Expression, IL3 Receptor, IgG Autoantibody and Autologous Serum Skin Test Accuracy In Patients with
Chronic Urticaria In Brazil
Calamita, Z. 1, Antunes, R. N. S. 2, Almeida Filho, O. M. 3, Baleotti Junior, W. 4, Calamita, A. B. P. 5, Fukasawa, J. T. 6 and Cavaretto, D. A. 6
1
Allergy and Immunology, Medical School of Marilia , São Paulo, Brazil. 2Hematology, Medical School of Marilia, Marilia,
Brazil. 3Immunology, Medical School of Marilia, Marilia, Brazil. 4Clinical Pathology, Medical School of Marilia, São Paulo, Brazil.
5
Dermatology, Medical School of Marilia, Marilia, Brazil. 6Flow Citometry, Medical School of Marilia, Marilia, Brazil.
4067 Comparison of the Modified Autologous Serum Skin Test and the CD63 Basophil Activation Test in Chronic
Urticaria B. Irinyi1, E. Gyimesi2, E. Garaczi3, Zs. Bata3, K. Hodosi2, M. Zeher2, É. Remenyik1, A. Szegedi1
Department of Dermatology1, 3rd Department
Irinyi, B. 1, Gyimesi, E. 2 and Szegedi, A. 3
1
Department of Dermatology1, University of Debrecen, Medical and Health Science Centre, Debrecen, Hungary. 23rd
Department of Internal Medicine, University of Debrecen, Medical and Health Science Centre, Debrecen, Hungary. 3Department
of Dermatology, University of Debrecen, Medical and Health Science Centre, Debrecen, Hungary.
4068 The Frequency of Positivity in Autologous Serum Skin Test in Patients with Chronic Idiopatic Urticaria
Lima Filho, S.
Allergy Depatment, Clínica de Alergia da Policlínica Geral do Rio de Janeiro, RJ / Faculdade Sá Earp Neto – Faculdade de Medicina
de Petrópolis, Rj , Rio de Janeiro, Brazil.
4069 Eleven Cases of Angioedema with Eosinophilia Treated In A Single Hospital In Japan
Nakachi, S. , Inokuma, S. , Matsubara, E. , Ohnishi, K. , Asashima, H. , Wakabayashi, K. and Hagiwara, K.
The Department of Allergy and Rheumatic Diseases, Japanese Red Cross Medical Center, Shibuya-ku, Tokyo, Japan.
4070 Chronic Urticaria and Infections
Aguilar, D. N. 1, Lugo, D. S. 2, Segura, D. N. H. 3 and Mendieta, E. 4
1
Allergy & Clinical Immunology, Specialty Hospital Medical Center XXI Century, México, México City, México. 2Allergy & Clinical
Immunology, National Institute of Pediatrics, México City, México. 3Allergy & Clinical Immunology, Specialty Hospital XXI Century
National Medical Center, México City, México. 4 Allergy & Clinical Immunology, Specialty Hospital Medical Center XXI Century,
México, México City, Author, México City , México.
4071 Chronic Urticaria Associated with Thyroid Disease
Peñaloza-González, F. D. G. 1, Velasco-Medina, A. A. 2, Gonzalez-Carsolio, A. 2, Burbano-Ceron, A. 2, Barreto-Sosa, A. 2 and VelázquezSámano, G. 2
1
Hospital General de México, México City, México. 2Servicio de Alergia e Inmunología Clínica, Hospital General de México, México
City, México.
147
Final Program
Posters
4072 Epidemiology of Urticaria Cases In A the Allergy Service From a Third Level Medical Center. Six Year
Experience
martin Del Campo perez, M. and martin Del Campo perez, M.
Allergy Service, Dermatologist, Ecatepec, México.
4073 Frequency Of Autoreactivity Demonstrated By Autologous Serum Skin Test in Patients with Chronic
Urticaria in The Valley of México During a Period of 8 Years
Rojo-Gutiérrez, M. I. 1, Mellado-Abrego, J. 1, Gonzalez-Ibarra, M. 2, Sandoval, T. 3 and Bermejo, M. 4
1
Allergy, Juarez Hospital, México City, México. 2Allergy and Immunology, Juarez Hospital, México City, México. 3Investigation,
Juarez Hospital, México City, México. 4Allergy and Immunology, Juarez Hospital, México, México.
4074 Chronic Idiopathic Urticaria and Neglected Toxocara Infection
Qualizza, R. 1, Incorvaia, C. 1 and Grande, R. 2
1
Allergy Department, Istituti Clinici di Perfezionamento, Milano, Italy. 2Diagnostic Services Department Central Lab., IRCCS
Fondazione Ca’Granda Ospedale Maggiore Policlinico, Milano, Italy.
POSTER SESSION 45: URTICARIA TREATMENT CC, 1ST, POSTER HALL
4075 Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria
Alyoshkin, V.
Immunology, Moscow, Russia.
POSTER SESSION 46: URTICARIA CASE REPORTS CC, 1ST, POSTER HALL
4076 Mucocutaneous Disease As A Presentation of Hereditary Angioedema. Report of 2 Cases
Alaniz, A.
Allergy and Immunology, IMSS, México City, México.
4077 Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis
Kartal, O. 1, Gulec, M. 2, Caliskaner, Z. 2, Nevruz, O. 3, Cetin, T. 3 and Sener, O. 4
1
Gulhane Military Medical Academy and Medical School, Division of Immunology and Allergic Diseaes, Ankara, Turkey. 2. Gulhane
Military Medical Academy and Medical School, Division of Immunology and Allergic Diseaes, Ankara, Turkey. 3Gulhane Military
Medical Academy and Medical School, Division of Haematology, Ankara, Turkey. 4Division of Immunology and Allergic Diseases,
Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey.
4078 Delayed Diagnosis of Hereditary Angioedema. Case Report
González-Díaz, S. 1, Arias-Cruz, A. 2, Galindo, G. 1, Mejia, K. 1, Gallego, C. 3, Garcia, D. 1, Calva, M. 1 and Dominguez, L. 1
1
University Hospital UANL, Monterrey, México. 3Regional Center of Allergy and Clinical Immunology, University Hospital,
Monterrey, México.
4079 Urticaria Pigmentosa. Cases Report
González-Díaz, S. 1, Arias-Cruz, A. 2, Mejia, K. 1, Gallego, C. 3, Garcia, D. 1, Calva, M. 1 and Dominguez, L. 1
1
University Hospital UANL, Monterrey, México. 3Regional Center of Allergy and Clinical Immunology, University Hospital,
Monterrey, México.
4080 A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection,
Bronchospasm and Angioedema
Lehloenya, R. and Christians, S.
Medicine, University of Cape Town, Cape Town, South Africa.
4081 A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos
Talreja, N. 1, Culverhouse, S. 1, Shearer, D. 2 and Lockey, R. F. 3
1
Division of Allergy and Immunology, University of South Florida, Tampa, FL. 2Division of Allergy & Immunology, University of
South Florida, Tampa, FL. 3Division of Allergy & Immunology, University of South Florida and James A. Haley Veterans’ Hospital,
Tampa, FL.
4082 A Case of Multiple Simultaneous Urticarial Syndromes Refractory to Treatment
Parkerson, J. 1, Alkhalil, M. 1, Ledford, D. 1 and Sleasman, J. 2
1
Division of Allergy & Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 2University of
South Florida College of Medicine, St Petersburg, FL.
148
Final Program
Posters
4083 Chronic Urticaria As First Sign of Sarcoidosis
Pérez-Bustamante, M. S. 1, Barbarroja-Escudero, J. 1, Antolín-Amérigo, D. 1, Alonso-Viteri, S. 2, Álvarez-de-Mon, M. 1 and RodríguezRodríguez, M. 1
1
Allergy Unit, Alcalá de Henares Hospital, Madrid, Spain. 2Respiratory Disease Department, Alcalá de Henares Hospital, Madrid,
Spain.
4084 Life-Threatening Angioedema without Urticaria (AE-U)
Corey, J. and Yoo, E.
Section of Otolaryngology Head and Neck Surgery, University of Chicago Medical Center, Chicago, IL.
4085 Urticarial Rash Associated With Chest Pain
Boulaich, M. 1, Meseguer Arce, J. 1, Sanchez-Guerrero Villajos, I. 2, Carrillo-Fernández Paredes, P. 1, Piñera Martínez, A. E. 1 and Pagán
Alemán, J. A. 1
1
Allergology, Allergologic, Murcia, Spain. 2Allergology, Allergologic, Mucia, Spain.
POSTER SESSION 47: AUTOIMMUNITY CASE REPORTS CC, 1ST, POSTER HALL
4086 Alopecia As a Symptom of Neonatal Lupus: A Report of Case
Pellizzeri, A. 1, García, D. 2, Torres, J. 1, Martínez, M. 1, Chavez, E. 1 and Briceño, D. 3
1
Venezuela. 3Inmunology and Allergolgy, Attending, Caracas, Venezuela.
4087 Autoimmune Hepatitis Misdiagnosed As Hepatitis C Responding to Interferon/Ribavirine Therapy
Pijak, M. R. 1 and Csibova, V. 2
1
Department of Internal Medicine, Slovak Medical University, University Hospital, Bratislava, Slovakia. 2Department of Long Term
Care, Medical Faculty Hospital, Bratislava, Slovakia.
4088 Ocular Muscles Myopathy Associated with Autoimmune Thyroiditis. Cases Report
Vargas-Camaño, E. 1, Castrejon-Vázquez, I. 2, Plazola-Hernández, S. I. 3 and Moguel-Ancheita, S. 4
1
Servicio de Inmunología Clínica, CMN 20 de Noviembre, México, México. 2Servicio de Inmunología Clínica, CMN 20 de
Noviembre ISSSTE, México, México. 3Servicio de Oftalmología, Orbita, CMN 20 de Noviembre ISSSTE, México, México. 4Servicio de
Oftalmología, Estrabologia, CMN 20 de Noviembre ISSSTE, México, México.
4089 Pulmonary Arterial Hypertension Associated to Antiphospholipid Syndrome In An Infant
Dorbeker, R. , Lopez Ortiz, D. , Gamez, L. and Gutierrez Hernandez, A.
Allergy and Immunolgy Clinic, National Institute of Pediatrics, México Distrito Federal, México.
POSTER SESSION 48: AUTOIMMUNITY CC, 1ST, POSTER HALL
4090 Autoimmune Diseases and Risk of Stroke
Arsovska, A. 1, Arsovski, Z. 2 and Popovski, A. 3
1
University Clinic of Neurology, Skopje, Macedonia. 2Allergy and Clinical Immunology, Clinic of Pulmonology and Allergy, Skopje,
Macedonia. 3Private Neuropsychiatry Practice “Dr A. Popovski”, Skopje, Macedonia.
4091 Clinical Effects of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, on Patients with
Autoimmune and Allergic Diseases
Tanaka, T. 1, Morishima, A. 1, Hishitani, Y. 1, Yoshida, Y. 1, Nakabayashi, A. 1, Ogawa, M. 1, Kawai, M. 1, Hirano, T. 1, Hagihara, K. 1, Shima,
Y. 1, Narazaki, M. 1, Ogata, A. 1, Kishimoto, T. 2 and Kumanogoh, A. 1
1
Department of Respiratory Medicine, Allergic and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita City,
Japan. 2Osaka University Graduate School of Frontier Biosciences, Suita City, Japan.
4092 Association Between Autoimmune Reactions, Herpes Infection and Severity of Atopic Dermatitis in
Children
Samoylikov, P. 1, Gervazieva, V. 2 and Kozhevnikov, S. 3
1
Allergology, Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia. 2Mechnikov Research Institute of Vaccines and
Sera, Moscow, Russia. 3Research Institute of Pediatrics and Pediatric Surgery, Moscow, Russia.
4093 Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis
Zeher, M. 1, Papp, G. 2, Horváth, I. 3, Baráth, S. 4, Gyimesi, E. 4, Végh, J. 3 and Szodoray, P. 5
1
Clinical Immunology Division, Full Professor of Medicine, Debrecen, Hungary. 2Clinical Immunology Division, Medical Doctor,
Debrecen, Hungary. 3Clinical Immunology Division, Internist, Debrecen, Hungary. 4Clinical Immunology Division, molecular
biologist, Debrecen, Hungary. 5Institute of Immunology, Rikshospitalet, University of Oslo, Immunologist, Oslo, Norway.
149
Final Program
Posters
4094 Comprehensive Analyses of Serum Peptides in Microscopic Polyangiitis
Takakuwa, Y. 1, Kurokawa, M. 2, Ooka, S. 3, Toshiyuki, S. 2, Kouhei, N. 2, Mitsumi, A. 2, Suematsu, N. 2, Okamoto, K. 2, Nagafuchi, H. 3,
Yamada, H. 3, Ozaki, S. 3 and Tomohiro, K. 2
1
Division of Rheumatology and Allergy, Department of Internal Medicine, Machida Municipal Hospital, Machida, Japan. 2Clinical
Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, Kawasaki, Japan. 3Division of
Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
4095 Detection of Anti-Nuclear Antibodies (ANA) Used for Diagnostic Approach of Systemic Autoimmune
Diseases. Correlation with Double Stranded DNA (DSDNA) and Extractable Nuclear Antigen (ENA)
Antibodies
Anastasiou, E. 1, Vakaloudi, A. 1, Papadopoulos, G. 1, Mavridou, S. 2 and Koteli, A. 1
1
Immunology Laboratory, General Hospital “Agios Pavlos„ , Thessaloniki, Greece. 2Immunology Laboratory, General Hospital “Agios
Pavlos„, Thessaloniki, Greece.
4096 The Vasculitis Induced by the Cerebrovascular Coil
Ooka, S. 1, Ozaki, S. 2, Nakano, H. 1, Takakuwa, Y. 3, Nakamura, H. 4, Onodera, H. 5, Yamada, H. 1 and Ozaki, S. 1
1
Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki,
Japan. 2Neurosurgery, Yokohama Sintoshi Neurosurgery hospital, yokohama, Japan. 3Division of Rheumatology and Allergy,
Department of Internal Medicine, Machida Municipal Hospital, Machida, Japan. 4Department of Radiology, St. Marianna
University School of Medicine, kawasaki, Japan. 5Department of Neurosurgery, , St. Marianna University School of Medicine,
Kawasaki, Japan.
4097 Prevalence of Thyroid Peroxidase Autoantibodies (anti-TPO) in Women with Autoimmune Connective
Tissue Diseases (ACTD)
Papadopoulos, G. , Vakaloudi, A. , Koutsika, E. , Anastasiou, E. and Koteli, A.
Immunology Laboratory, General Hospital “Agios Pavlos„ , Thessaloniki, Greece.
4098 Anticardiolipin Antibodies in Patients with Acute Myeloid Leukemia: Prevalence and Clinical Significance
Ayatollahi, M. 1, Ramzi, M. 2, Zakerinia, M. 3 and Dehghani, M. 2
1
Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 2Bone Marrow Transplantation Center, Nemazi
Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. 32Bone Marrow Transplantation Center, Nemazi Hospital, Shiraz
University of Medical Sciences, Shiraz, Iran.
POSTER SESSION 49: ALLERGIES IN OTHER DISEASES CC, 1ST, POSTER HALL
4099 HLA-B58 Does Not Increase Allopurinol Hypersensitivity Among Patients with Hematologic Malignancy
Jung, J. 1, Kim, M. 1, Song, W. 1, Kim, T. 1, Lee, S. 1, Kim, S. 2, Kang, H. 1, Park, H. 1, Kim, S. 1, Chang, Y. 2, Cho, S. 1 and Min, K. 1
1
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. 2Department of Internal
Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
4100 Risk Factors Associated to Mortality In Pediatric Patients with Hemophagocytic Lymphohistiocytosis
Partida-Gaytan, A. 1, del Rio, B. 1, Tercero-Quintanilla, G. 2 and Rosas-Vargas, M. A. 1
1
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México. 2Psychiatry and
Adolescent Medicine, Hospital Infantil de México Federico Gomez, México City, México.
4101 The Clinical and Serological Findings in Patients with Toxocariasis in Korea
Choi, S. , Yim, T. and Yang, K.
allergy and Rheumatology, Sunlin Hospital, Pohang, South Korea.
4102 Interferon-Gamma Release Assay - Useful Tool for the Diagnosis of Pleural Tuberculosis
Ondrejkova, A. 1 and Ondrejka, G. 2
1
Laboratory of Immunology and Serology, PR LAB Novy Jicin, Novy Jicin, Czech Republic. 2Department of Pulmonary Medicine,
Hospital Novy Jicin, Novy Jicin, Czech Republic.
4103 The Parasite Echinococcus Granulosus Promotes Allergic Response In Human
Amri, M. 1 and Touil-Boukoffa, C. 2
1
Cellular and Molecular Biology, Team “Cytokines and NOSynthases”, Faculty of Biological Sciences (FSB)- University of Sciences
and Technology Houari Boumediene (USTHB), Algiers, Algeria. 2Cellular and Molecular Biology, Team “Cytokines and NOSynthases”,
Faculty of Biological Sciences (FSB)- University of Sciences and Technology Houari Boumediene (USTHB), Algiers, Algeria.
4104 Use of Transfer Factor in Patients with Persistent Genital Human Papillomavirus Infection
1
Enhance
your
Learning
Experience!
Morfin-Maciel,
B. M.
and Sotelo-Ortiz,
J. M. 2
1
2
download
print materials
at Handout
Kiosks,
located inHospital
the CC or
FAGCB.
Example:
or 2001
Allergy,
HospitalorAngeles
Mocel, México
City, México.
Gynecology,
Angeles
Mocel,
México 1-5NH
City, México.
150
Final Program
Posters
4105 Experimantal Heterophyiasis: Histopathological & Immunological Study
Daoud, A.
Parasitology, Tanta Faculty of Medicine, Tanta, Egypt.
4106 Chronic Obstructive Pulmonary Disease and Lung Cancer Share Inflammation Pathways
Syrigos, K. N. 1, Politi, E. 2, Makrilia, N. 2, Tsimpoukis, S. 2, Psarros, F. 3, Syrigou, E. 3 and Dannos, I. 2
1
2
3
Department of Allergy, Sotiria General Hospital, Athens, Greece, Athens, Greece.
4107 Risk Factors of Recurrent Upper Respiratory Infections In Children Under 5 Years. Habana Vieja
Lopez Campos, X. 1, Alvarez Castello, M. 1 and Massip, J. 2
1
Allergy Society from Cuba, Havana, Cuba. 2Bioestatistics Society from Cuba, Havana, Cuba.
4108 Long Term Asbestos Exposure As A Cause of Eozinophilic Pleural Effusions
Jovkovska Kaeva, B. 1 and Arsovski, Z. 2
1
Outpatient Department, Clinic of Pulmonology and Allergy, Skopje, Macedonia. 2Allergy and Clinical Immunology, Clinic of
Pulmonology and Allergy, Skopje, Macedonia.
4109 A Novel Therapeutical Option in Resistant Ganglionar and Cutaneous Tuberculosis
Vidal, L. 1, Palafox, D. 2, Hernández-Lagunes, A. 3 and Palafox, J. 4
1
Immunology and Allergy , Hospital Ángeles Xalapa, Xalapa, México. 2Surgery, General Hospital of México, México City , México.
3
Pathology , Pathology Department. CEMEV, Xalapa, México. 4Pneumology and Thoracic Surgery, Hospital Ángeles Xalapa, Xalapa,
México.
POSTER SESSION 50: ASTHMA EPIDEMIOLOGY CC, 1ST, POSTER HALL
4110 Epidemiology of Asthma Cases In the Allergy Service of A Third Level Medical Center. Six Year Experience
Immunoallergology Service, Issemym Ecatepec Medical Center, Ecatepec De Morelos, México.
4111 Latin America Asthma Insight and Management (LA AIM): A Survey of Asthma Patients in 5 Latin American
Locales
González-Díaz, S. 1, Maspero, J. 2, Jardim, J. 3, Aranda, A. 4 and Tassinari, P. 5
1
Hospital Universitario, Medical School, Universidad Autónoma de Nuevo León, Monterrey, México. 2Allergy and Respiratory
Research Unit, Fundacion CIDEA, Buenos Aires, Argentina. 3Pulmonary Department, Heart Institute, University of São Paulo
Medical School, São Paulo, Brazil. 4Hospital Auxilio Mutuo, San Juan, PR. 5Hospital de Clínicas Caracas, Caracas, Venezuela.
4112 Understanding of Asthma Terminology by Patients Interviewed in the Latin America Asthma Insight and
Management (LA AIM) Survey
Jardim, J. 1, González-Díaz, S. 2, Maspero, J. 3, Tassinari, P. 4 and Aranda, A. 5
1
Pulmonary Department, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil. 2Hospital Universitario, Medical
School, Universidad Autónoma de Nuevo León, Monterrey, México. 3Allergy and Respiratory Research Unit, Fundacion CIDEA,
Buenos Aires, Argentina. 4Hospital de Clínicas Caracas, Caracas, Venezuela. 5Hospital Auxilio Mutuo, San Juan, PR.
4113 Asthma Management in Latin America: Learnings From the Latin America Asthma Insight and Management
(LA AIM) Survey of Patients
Maspero, J. 1, Jardim, J. 2, González-Díaz, S. 3, Aranda, A. 4 and Tassinari, P. 5
1
Allergy and Respiratory Research Unit, Fundacion CIDEA, Buenos Aires, Argentina. 2Pulmonary Department, Heart Institute,
University of São Paulo Medical School, São Paulo, Brazil. 3Hospital Universitario, Medical School, Universidad Autónoma de
Nuevo León, Monterrey, México. 4Hospital Auxilio Mutuo, San Juan, PR. 5Hospital de Clínicas Caracas, Caracas, Venezuela.
4114 Project for Prevention & Control of Asthma and Allergic Diseases in Korea
Chung, E. H. 1, Seo, S. 2, Seo, H. 2, Jou, H. 2, Kim, Y. 2 and Kim, Y. T. 2
1
Pediatrics, National Medical Center, Seoul, South Korea. 2Division of Chronic Disease Surveillance, Korea Centers for Disease
Control and Prevention, Osong, South Korea.
4115 Asthma In the CIS-Region: The Prevalence and Peculiarities of the Course
Slavyanskaya, T. 1 and Sepiashvili, R. I. 2
1
Allergology and Immunology, University of Russia, Moscow, Russia. 2Department of Allergology and Clinical Immunology,
Institute of Immunophysiology, Moscow, Russia.
151
Final Program
Posters
4116 Asthma In the Elderly: A Mexican Point of View
Perez-Chavira, M. R.
Clinic of Asthma, Instituto Nacional De Enfermedades Respiratorias, México, D.F., México.
4117 Control of Asthma and Its Relationship to Quality of Life in Adolescents
Macca, C. 1, Adachi, C. 1, Santana, I. 2, Castro, A. P. B. M. 3, Jacob, C. M. A. 4 and Pastorino, A. C. 3
1
Instituto da Criança - Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo , São Paulo, Brazil. 2Faculdade
de Medicina do Hospital das Clínicas da Universidade de São Paulo , São Paulo, Brazil. 3Department of Pediatrics, Instituto da
Criança - Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil. 4Instituto da Criança Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
4118 The Leukotriene C4 Synthase (A-444C) Promoter Polymorphism in Venezuelan Individuals with Asthma
Quintana Quintero, I. 1, de Sanctis, J. 2, Garmendia, J. 2, Fernandez Mestre, M. 1 and Moreno, D. 3
1
Centro de Medicina Experimental, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela. 2Facultad de
Medicina, Instituto de Inmunologia de la UCV, Caracas, Venezuela. 3Servicio de Neumologia, Hospital Universitario de Caracas,
Caracas, Venezuela.
4119 Allergic Disorders Prevented by Helicobacter Pylori Colonization
Herbarth, O. 1, Roeder, S. 2, Rolle-Kampczyk, U. 3, Richter, M. 2 and Richter, T. 4
1
Environmental Medicine and Hygiene, University of Leipzig, Faculty of Medicine, Leipzig, Germany. 2Helmholtz-Center for
Environmental Research, Leipzig, Germany. 3 Helmholtz-Center for Environmental Research, Leipzig, Germany. 4St. Georg Hospital,
Leipzig, Germany.
POSTER SESSION 51: QUALITY OF LIFE MEASURES IN ASTHMA AND ALLERGIC DISEASES CC, 1ST, POSTER HALL
4120 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (HAE) Undergoing Home
Treatment- A Clinical Surveillance Program
Martinez-Saguer, I. 1, Aygören-Pürsün, E. 1, Rusicke, E. 1, Klingebiel, T. 2 and Kreuz, W. 1
1
Center of Pediatrics III, Department of Hematology, Oncology and Hemostasis, Comprehensive Care Center for Thrombosis and
Hemostasis, , J.-W. Goethe-University Hospital, Frankfurt a. M., Germany. 2Center of Pediatrics III, Department of Hematology,
Oncology and Hemostasis , J.-W. Goethe-University Hospital, Frankfurt a. M., Germany.
4121 The Impact of Nasal Allergies: Results From the Allergies Surveys in America, Asia Pacific, Latin America,
and Middle East
Blaiss, M. S. 1, Katelaris, C. 2 and Neffen, H. E. 3
1
University of Tennessee Health Science Center`, Memphis, TN. 2Immunology & Allergy, University of Western Sydney and
Campbelltown Hospital, Sydney, Australia. 3Respiratory Medicine Unit, Children’s Hospital “Orlando Alassia”, Santa Fe, Argentina.
4122 The Impact of Nasal Polyposis on Quality of Life Using the EQ-5D Health Profile
Alobid, I. 1, Viscovich, L. 2, Montserrat, J. R. 3, Guilemany, J. M. 4, Bernal-Sprekelsen, M. 2 and Mullol, J. 5
1
Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona, Spain. 2Ent Dep. Hospital Clinic Barcelona, Barcelona,
Spain. 3Ent Dep. Hospital San Pau, Barcelona, Spain. 4Ent Dep. Hospital Clinic Barcelona, Barcelona , Spain. 5Rhinology Unit & Smell
Clinic, ENT Department, Hospital Clínic i Universitari, Barcelona, Spain.
4123 Predictors Affecting the Quality of Life of Patients with Bronchial Asthma
Jankowska-Polanska, B. 1, Uchmanowicz, I. 1, Lomper, K. 1, Panaszek, B. 2 and Fal, A. 2
1
Department of Public Health, Wroclaw Medical University, Wroclaw, Poland. 2Allergology Clinic, Wroclaw Medical University,
Wroclaw, Poland.
4124 Correlation Between Severity of Allergic Rhinitis and Impairment of Quality of Life in Allergic Adolescents
Martinez Infante, E.
Hospital General De Zona No. 1, Instituto Mexicano Del Seguro Social, Oaxaca, México.
4125 Chronic Urticaria Quality of Life Questionnaire (Cu-Q2 oL) and Urticaria Activity Score (UAS)
Aguilar, D. N. 1, Segura, D. N. H. 2 and Lugo, D. S. 3
1
Allergy & Clinical Immunology, Specialty Hospital Medical Center XXI Century, México, México City, México. 2Allergy & Clinical
Immunology, Specialty Hospital XXI Century National Medical Center, México City, México. 3Allergy & Clinical Immunology,
National Institute of Pediatrics, México City, México.
152
Final Program
Posters
4126 The Relationship of Asthma Impairment Determined by Psychometric Tools to Subsequent Asthma
Exacerbations
Schatz, M. 1, Zeiger, R. 1, Yang, S. 1, Chen, W. 1, Crawford, W. 1, Sajjan, S. 2 and Allen-Ramey, F. 2
1
Kaiser Permanente, San Diego, CA. 2Merck & Co., Inc., West Point, PA.
POSTER SESSION 52: HEALTH OUTCOMES FOR ASTHMA CC, 1ST, POSTER HALL
4127 Developing An Adult Asthma Adherence Questionnaire (AAAQ)
Weinstein, A. 1, Schatz, M. 2, Zeiger, R. 2, Turner-Bowker, D. 3, Saris-Blagma, R. 3 and Cabin, T. 3
1
Allergy/Immunology, Thomas Jefferson Medical College, Newark, DE. 2Kaiser Permanente, San Diego, CA. 3Datacorp, Smithfield,
RI.
4128 Associations Between Self-Reported Adherence to Asthma Anti-Inflammatory Therapy and Risk Factors for
Non-Adherence (NA) in Pediatric Patients
Weinstein, A. 1, Laurenceau, J. 2 and Vok, J. 3
1
Allergy/Immunology, Thomas Jefferson Medical College, Newark, DE. 2Psychology, University of Delaware, Newark, DE. 3Asthma
and Allergy Foundation of America, Landover, MD.
4129 Inability of Medical Students to Use of Three Types of Inhaler
Jeong, J.
Internal Medicine, Inje University Ilsan Paik Hospital, Gyeongki-do, South Korea.
4130 State of Asthma Education and Management in Urban Medical Residency Training Programs
Kuryan, J. 1 and Maitland, A. 2
1
Allergy & Immunology, North Shore - Long Island Jewish Health System, Great Neck, NY. 2Clinical Immunology, Mount Sinai
School of Medicine, New York, NY.
4131 Impact of Providing Physical Education Teachers with Information about Asthma When Training Children
and Adolescents With This Disorder
Fabré, D. 1, Eligio, A. 2, Reyes, T. 2, Andina, R. 2, Rodriguez, J. M. 2, Pérez, G. 2 and Galán, L. 3
1
Allergy Department, Juan Manuel Márquez Pediatric Hospital, Havana, Cuba. 2Pediatric Hospital Juan Manuel Marquez, Havana,
Cuba. 3Cuban Neuroscience Center, Havana, Cuba.
4132 Asthma Knowledge Among Parents and/or Caregivers of Asthmatic Children Attending A Practical Allergy
Course
Sandoval-Ramírez, E. 1, Liévano Pérez, M. A. 2, Tercero-Quintanilla, G. 3, Rosas-Vargas, M. A. 2, del Rio, B. 2 and del Rio, J. 2
1
Pediatric Allergy and Clinical Immunology, Hospital Infantil de México “Federico Gomez”, México, México. 2Pediatric Allergy and
Clinical Immunology, Hospital Infantil de México Federico Gomez, México City, México. 3Psychiatry and Adolescent Medicine,
Hospital Infantil de México Federico Gomez, México City, México.
4133 eZhengtricity © 2010: A Free Novel Way to Confidentially Administer, Track, Receive and Score Medical
Questionnaires Instantly
Zheng, Y. 1,2, Ravindran, M. 2, Adewuyi, O. 2, Di Poto, C. 2, Timbol, C. 2, Esteitie, R. 2, Rayhan, R. 2 and Baraniuk, J. 2
1
University of South Florida College of Medicine, Tampa, FL. 2Medicine-Section of Rheumatology, Allergy, & Immunology,
Georgetown University, Washington, DC.
4134 Usefulness of Asthma Control Test Questionnaire, FEV1 and Exhaled Nitric Oxide Level (FeNO) for the
Clinical Assessment of Elderly Asthma
Roh, Y. H.
Pulmonary Care, Seoul Veterans Hospital, Seoul, South Korea.
4135 Systematic Review of the Recommendations on the Prevention of Allergic Manifestations in Children
Detzel, P. 1, Spieldenner, J. 1, Heil-Ruess, M. 2, Navarro, V. 3, Berbari, J. 4 and Iskedjian, M. 4
1
Health Economics, Nestlé Nutrition Institute, Vevey, Switzerland. 2MHR Nutrition Marketing Services, Lausanne, Switzerland.
3
PharmIdeas Europe SAS, Lyon, France. 4PharmIdeas Research and Consulting Inc., Ottawa, ON, Canada.
4136 The Relationship Between Emotional Cognition and the Symptom Gap in Patients with Bronchial Asthma:
The Effects of Alexithymia and Empathy
Nakajima, S.
Clinical Psychology, Graduate School of Human Sciences, Osaka University, Suitashi, Japan.
153
Final Program
Posters
4137 Asthma Control аnd Quality of Care of Adult Asthma Patients in Primary Health Care Facilities in SaintPetersburg, Russia
Emelyanov, A. 1, Tsukanova, I. 2, Fedoseev, G. 3, Sergeeva, G. 1, Lisitsyna, N. 3, Bakanina, L. 3 and Nikitina, E. 4
1
Department of Respiratory Disease and Allergy, Postgraduate Medical Academy, Saint-Petersburg, Russia. 2Department of
Respiratory Disease and Allergy, Postgraduate Medical Academy, Saint- Petersburg, Russia. 3Pavlov Medical University, SaintPetersburg, Russia. 4Pavlov Medical University, Saint- Petersburg, Russia.
POSTER SESSION 53: SEVERE AND FATAL ASTHMA CC, 1ST, POSTER HALL
4138 Severe Asthma: Report of Five Clinical Cases At West National Medical Center, IMSS in Guadalajara City,
México
Torres-Lozano, C. 1, Ortega-Cisneros, M. 1, Montaño-Gonzalez, E. 1, Garcia-Cobas, C. 1, Nuñez-Nuñez, M. E. 2, Cortes-Grimaldo, R. M. 1,
Mendez-Santillan, S. 1 and Madrigal-Beas, I. M. 1
1
Allergy and Clinical Immunology, UMAE-HECMNO-IMSS, Guadalajara, México. 2Allergy and Clinical Immunology, Hospital Civil de
Guadalajara Dr. Juan I Menchaca, Guadalajara, México.
4139 Factores De Riesgo De Muerte Por Asma Bronquial En Centro Habana En El Período Comprendido Entre
1995-2010
Guerrero, A. 1 and García Canales, M. 2
1
Allergy, Clinic, La Habana, Cuba. 2Clinic, Centro Habana. La Habana, Cuba.
4140 Dolichyl Phosphate Dependent Mechanism of Exacerbations In Asthma: P-Glycoprotein Overexpression
and E-Cadherin Loss
Kuznecova, G. 1, Kuznecovs, I. S. 2, Joksta, I. 2 and Kuznecovs, S. 3
1
Epidemiology, Preventive Medicine Institute, Riga, Latvia. 2Allergy and Immunology, Preventive Medicine Institute, Riga, Latvia.
3
Preventive Medicine Institute, Riga, Latvia.
4141 Distribution of Asthma Mortality in Various Districts of Salvador, Brazil
Souza-Machado, C. 1,2, Souza-Machado, A. 2,3, Natividade, M. S. D. 4, Coelho, A. C. C. 1,2, Amaral, M. T. R. 5 and Cruz, A. 6
1
School of Nursing, Federal University of Bahia, Salvador, Brazil. 2ProAR - Centro de Excelência em Asma, Federal University of
Bahia, Salvador, Brazil. 3Institute of Science Biomorphology Health Department , Federal University of Bahia, Salvador, Brazil.
4
Institute of Public Health, Federal University of Bahia, Salvador, Brazil. 5State University of Feira de Santana, Salvador, Brazil.
6
Medicine, ProAR - Núcleo de Excelência em Asma da UFBA, Salvador, Brazil.
4142 Geographical Distribution of Deaths From Asthma in Salvador, Brazil (2000-2009)
Souza-Machado, C. 1,2, Souza-Machado, A. 2,3, Natividade, M. S. D. 4, Coelho, A. C. C. 1,2 and Cruz, A. 5
1
School of Nursing, Federal University of Bahia, Salvador, Brazil. 2ProAR - Centro de Excelência em Asma, Federal University of
Bahia, Salvador, Brazil. 3Institute of Science Biomorphology Health Department , Federal University of Bahia, Salvador, Brazil.
4
Institute of Public Health, Federal University of Bahia, Salvador, Brazil. 5Medicine, ProAR - Núcleo de Excelência em Asma da UFBA,
Salvador, Brazil.
4143 Measurement of Long-Acting Natriuretic Peptide (LANP) in Exacerbation of Asthma
Alkhalil, M. 1, Varghese, M. 2, Hellermann, G. 3, Mohapatra, S. 4, Butt, A. 1 and Lockey, R. F. 1
1
Division of Allergy & Immunology, University of South Florida and James A. Haley Veterans’ Hospital, Tampa, FL. 2University of
South Florida, Tampa, Tampa, FL. 3University of South Florida, Tampa, FL. 4USF Nanomedicine Research Center, University of South
Florida College of Medicine & VA Hospital, Tampa, FL.
4144 Is It Really Difficult-to-Treat Asthma? Don’t Forget Other Causes of Wheeze
Koca Kalkan, I. 1 and Kalpaklioglu, A. F. 2
1
Immunology and Allergic Diseases , Kirikkale University Medical School Hospital, Kirikkale, Turkey. 2Immunology and Allergic
Diseases, Kirikkale University Medical School Hospital, Kirikkale, Turkey.
4145 Sensitization Profile in Severe Asthma
Bozek, A. 1, Jarzab, J. 1 and Rogala, B. 2
1
Chair and Clinical Department of Internal Diseases, Dermatology and Allergology, Medical University of Silesia, Katowice, Poland,
Zabrze, Poland. 2Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of
Silesia, Katowice, Poland, Katowice, Poland.
154
Final Program
Exhibit Hall Floor Plan & Hours
Ground Floor, Cancún Center
Exhibit Hall Hours
Monday, 5 December........................................................ 09:00– 17:00
Tuesday, 6 December........................................................ 09:00– 17:00
Wednesday, 7 December................................................ 09:00– 17:00
155
Final Program
Exhibitors Directory
Abbott
Booth 1453
Aerosol Medical Systems
Booth 1430
Periférico Sur 4873
Col. Arenal Tepepan
CP 14610
México City
Tel. (52) 55 5675 74 34
www.aerosolms.com
Aerosol Medical Systems distributes medical equipment
for respiratory care from three main facilities: Mexico City,
Monterrey and Guadalajara. We represent world lider
companies such as: Resmed, Trudell Medical International,
Care Fusion, Pari Respirarory Equipment, Nonin, RC Cegla
and Damedco. In our catalogue of products you can find
pulse-oximeters, nebulizers, spirometers, peak flow meters,
aerochambers and cpaps. For more information please visit
us at www.aerosolms.com
Allergy Prick
Booth 1203
Bedfont Scientific Booth 1103
105 Laker Road
Rochester
Kent ME1 3QX
United Kingdom
Phone: +44 1634 673 720
Fax: +44 1634 673 721
Website: www.bedfont.com
Bedfont Scientific Ltd is a world leader in developing
innovative, non-invasive breath analysis monitors for a
number of medical applications. Their newest innovation is
the NObreath FENO monitor, a breakthrough in providing
portable airway inflammation management for asthmatics.
Measuring FENO enables the health professional to
prescribe and measure steroid response as an alternative
harsh or invasive testing such as blood tests or spirometry,
demonstrating Bedfont’s commitment to their company
slogan: “breath analysis is the new blood test”
Bellanti’s Immunology IV Book
Booth 1205
Bolivia #2331
Col. San Jeronimo
Monterrey, , N.L.
Mexico, C.P. 64640
Telephone: +(81) 83.46.88.34
(81)16.42.67.00
Website: www.allergyprick.com
International Center for Interdisciplinary Studies of
Immunology (ICISI)
Georgetown University Medical Center
Washington, DC 20057 (USA)
202-687-8227 phone
202-784-3597 fax
www.immunologycenter.org
We are a company dedicated to making disposable medical
devices to make allergy skin test.
Bellanti’s long-awaited 4th edition, Immunology IV: Clinical
Applications in Health and Disease, is a new, completely
rewritten edition of his classic series of immunologic
textbooks. The book has kept its main character as in
former editions and brings the science of immunology
to clinical practice. Each chapter is written by a national
or international expert who contributes state-of-the-art
knowledge on each particular topic. The book contains
25 chapters, over 800 vividly colored original illustrations
in a bound 1000+ page volume and is accompanied
by an online interactive multilevel teaching format
with animations/hyperlinks, clinical case studies with
interactive Q & A and continual online updates with clinical
relevance. The book is now available for purchase at www.
immunologycenter.org or contact us at immunoiv@aol.
com. Come visit us in the Exhibit hall, Booth 1205, for a
book signing.
Our main commitment is to satisfy quality standards to
ensure safety and trust from allergist using our products.
Allergy Therapeutics
Booth 1301
Dominion Way
Worthing, West Sussex BN14 8SA
United Kingdom
Phone: +44 1903 844 700
Website: www.allergytherapeutics.com
Allergy Therapeutics is a fully integrated specialty
pharmaceutical company with a profitable core business
and a patent protected development pipeline of allergy
vaccines with the potential to transform allergy treatment.
156
Final Program
Boston Scientific
Booth 1302
888 Ross Drive
Suite 100
Sunnyvale, CA 94089
408-419-0100 phone
408-419-0199 fax
www.BTforAsthma.com
Boston Scientific has developed a bronchoscopic
procedure for the treatment of severe persistent asthma
in adults not well controlled on ICS and LABA alone. The
Alair® Bronchial Thermoplasty System reduces the amount
of excessive airway smooth muscle, decreasing the
ability of the airway walls to contract and narrow during
an asthma attack, providing long-lasting and improved
asthma control for adult severe asthma patients. For more
information, please visit www.BTforAsthma.com.
Church & Dwight
Booth 1208
HAE: Learn About It, Talk About It
Booth 1105
730 Stockton Drive
Exton, PA
USA
Phone: +1 610 321 2333
Fax: +1 610 321 3868
Website: www.viropharma.com
‘HAE: Learn About It, Talk About It’ is a peer-to-peer clinician
education program aimed at improving care for patients
with hereditary angioedema (HAE). This program is a
growing collaboration among the American College of
Allergy, Asthma and Immunology (ACAAI), the America
Gastroenterological Association (AGA) Institute, the World
Allergy Organization (WAO), the American College of
Emergency Physicians (ACEP), the American Academy of
Nurse Practitioners (AANP), and the Society of Emergency
Medicine Physician Assistants (SEMPA), and supported by
Viropharma Incorporated.
HAL Allergy
Booth 1201
J. H. Oortweg 15-17
NL-2333 CH Leiden
The Netherlands
Tel.: +31 (0)88 195 90 00
Fax: +31 (0)88 - 1959 001
E-Mail: [email protected]
Internet: www.hal-allergy.com
HAL Allergy is one of the leading international
manufacturers of therapeutic vaccines and diagnostics for
specific Immunotherapy. Our products are distributed by
affiliates in the Netherlands, Belgium, Germany, Austria,
Poland, Italy, Spain, and highly experienced distributors
in other important countries. Our research activities
concentrate on enhancing specific Immunotherapy
through optimised adjuvants, highly purified, standardised
allergens and novel application forms.
Since 2009 HAL Allergy with a new state of the art
Production Facility is situated in the
Bio Science Park in Leiden.
We are looking forward to welcoming you at Stand No.
1201 in the Cancún Center.
Mead Johnson
Booth 1460
Lago Zurich #245 Edificio Presa Falcon Floor 11,
Col. Amplicacion Granada,
11529, México City
México
Phone +52 55 11039471
Website www.mead-johnson.com.mx
Email (optional) [email protected]
MSD
Booth 1450
1 Merck Drive
Whitehouse Station, NJ 08889-3497
USA
Phone: (908) 423-1000
Website: www.msd.com
Today’s MSD is a global healthcare leader working to help
the world be well. MSD is a tradename of Merck & Co.,
Inc., with headquarters in Whitehouse Station, N.J., U.S.A.
Through our prescription medicines, vaccines, biologic
therapies, and consumer care and animal health products,
we work with customers and operate in more than 140
countries to deliver innovative health solutions. We also
demonstrate our commitment to increasing access to
healthcare through far-reaching policies, programs and
partnerships. MSD. Be well. For more information, visit
www.msd.com.
157
Final Program
Nestlé Nutrition, Nestec Ltd.
Booth 1101
Avenue Reller 22
CH-1800 Vevey (Switzerland)
Website:www.nestlenutrition.com Nestlé Nutrition manages and develops the Nestlé group’s
core nutrition global business, including Infant Nutrition,
Performance Nutrition and Weight Management. Through
the Infant Nutrition portfolio, we help build a happier,
healthier generation, one baby at a time, through the
Start Healthy, Stay Healthy system. Nestlé HealthCare
Nutrition, part of Nestlé Health Science, offers nutritional
solutions for people with specific needs related to illnesses,
disease states or the special challenges of different life
stages. The Nestlé Nutrition Institute is a non-profit
making organization which is operated separately from
the business and is dedicated to partnering with health
professionals and nutritional communities by offering
nutrition information, education and networking.
Niquet
Booth 1206
Norte 80-A No. 6545
Col San Pedro el Chico
Telephone: +57511365
Niquet’s main products are anti-fog lens cleaner, which are
high efficiency even using masks and exposing it to steam
end.
Niquet also offers high definition lenses with UV400
polarized technology to protect your eyes, excellent
handling and low cost optical reference to the market.
nSpire Health
Booth 1106
1830 Lefthand Circle
Longmont, CO 80501
USA
Phone +1 303 666 5555
Fax +1 303 666 5588
Website: www.nspirehealth.com
Nycomed: A Takeda Company
Booth 1440
Nycomed International Management GmbH
Thurgauerstraße 130
8152 Glattpark-Opfikon (Zurich)
Website: www.takeda.com
Contact email: [email protected]
Takeda is a research-based global pharmaceutical
company. Nycomed is a Takeda company since September
2011. The combined company has an active commercial
presence in therapeutic areas of metabolic diseases,
gastroenterology, oncology, cardiovascular health, CNS
diseases, inflammatory and immune disorders, respiratory
diseases and pain management.
Takeda’s traditional strengths in North America, Japan, and
the rest of Asia, are now complemented by Nycomed’s
position in Europe and emerging markets. The combined
company is ranked 12th by global Rx sales.
Omega Diagnostics
Booth 1104
Omega House
Hillfoots Business Village
Alva
Clackmannanshire
FK12 5DQ
United Kingdom
Omega Diagnostics GmbH develops, manufactures and
sells allergy tests for over 600 allergens. They have more
than 20 years experience in the development of products
for the diagnosis of allergic diseases. Over the years the
company has gained a substantial understanding and
knowledge in the production and standardization of
allergen extracts. This is currently being applied in the
development of new in vitro diagnostic products and
systems.
nSpire Health, Inc. is a leading provider of respiratory
diagnostic products and clinical trial core lab services,
dedicated to creating technical innovations for people with
respiratory illness. Our equipment includes: Piko-1 Lung
Health Monitor; the world’s first personal home monitoring
device. KoKo Diagnostic Spirometry, Wright Respirometers,
Pocket Asthma Management. nSpire Health is committed
to revolutionizing the way the world detects and treats
respiratory
158
Final Program
Peprotech México SA DE CV
Booth 1102
Sanofi
Booth 1410
Luv Savinon 1027 Interior 4 Colonia Narvarte, CP 03020
México
Contact: Lucina Laguna Franco
Commercial Director for Latin America
Phone: (52) 55 56720389
Fax: (52) 55 56720388
Website: www.peprotech.com
E-mail: LucinaLaguna@peprotechMéxico.com
182 Avenue de France
Paris 75013
France
Phone: +33 1 55 71 51 76
Fax: +33 1 55 71 51 80
Website: www.sanofi-aventis.com
Peprotech was established in 1988 to develop and produce
recombinant cytokines for life-science research. Today
Peprotech is a world leader in supplying high quality
cytokine products including recombinant proteins, their
monoclonal/polyclonal antibodies, ELISA development kits
and other cytokine-related reagents. These products are
distributed worldwide through customer-service offices.
To keep up with current research and growing demand
we have recently expanded our production capabilities
to include an animal-free manufacturing facility. We
encourage you to convey to us your particular research
needs and promise to do our best to fulfill them.
A diversified offering of medicines, consumer healthcare
products, generics and animal health
Petrazul
Booth 1308
Av. Vitacura 2610, Local 1
Vitacura
Chile
Phone: +56 (2) 244 5402
A world leader in human vaccines
A broad and balanced presence on both traditional and
emerging markets
Approximately 100,000 employees in 100 countries
2010 net sales: 30.4 billion, growth of 3.7%
Sanofi is a diversified global healthcare leader, focused on
patients’ needs.
Group strategy is based on three key principles in order to
deliver long-term sustainable growth:
increasing innovation in Research & Development, seizing
external growth opportunities, adapt to future challenges
and opportunities.
Petrazul will have jewelry and fine crafts in semiprecious
stones such as lapis lazuli, malachite and others, and fine
grade silver.
RMEI, LLC
A global healthcare leader
Booth 1470
Laurel Office Plaza
101 Laurel Road, Suite 200
Voorhees, NJ 08043
Ph: 866-770-RMEI
Fax: 856-546-7030
Website: www.RMEI.com
RMEI, LLC’s “Hereditary Angioedema: Know the Facts” booth,
#1470, features pre-recorded video presentations from
4 nationally recognized HAE experts – Richard G. Gower,
MD, University of Washington School of Medicine, Allen
P. Kaplan, MD, Medical University of South Carolina, Marc
A. Riedl, MD, MS, UCLA-David Geffen School of Medicine,
and Bruce L. Zuraw, MD, University of California, San Diego
School of Medicine. Video recording topics include HAE
pathophysiology, clinical signs and symptoms, diagnosis,
and burden of illness. Light refreshments provided.
Sanofi has core strengths in the field of healthcare with
it growth platforms: emerging markets, human vaccines,
consumer healthcare, diabetes, innovative products and
animal health. Through the acquisition of Genzyme, Sanofi
has reinforced its footprint in biotechnology and rare
diseases.
Shire Human Genetic Therapies
Booth 1204
Hampshire International Business Park,
Chineham, Basingstoke
Hampshire RG24 8EP
United Kingdom
Website: www.shire.com
Shire HGT, a business unit of Shire Pharmaceuticals, is
the leader in discovering and developing innovative
treatments for rare genetic diseases. The Company focuses
on the science that offers hope to those who suffer from
such rare conditions as Hunter syndrome, Fabry disease,
Gaucher disease, Sanfilippo Syndrome, and metachromatic
leukodystrophy as well as Hereditary Angioedema (HAE).
Shire HGT employs over 1400 people worldwide who work
across a range of research and development, production and
commercial disciplines. This vastly experienced and highly
dedicated business unit is driven by a common goal: to
enable people with life-altering conditions to lead better lives.
159
Final Program
Swedish Orphan Biovitrum (Sobi) Booth 1208
Address 1:Tomtebodavägen 23A
112 76 Stockholm
Sweden
Website: www.sobi.com
Swedish Orphan Biovitrum (Sobi) is a Swedish based
pharmaceutical company with an international market
presence. The product portfolio consists of some 60 orphan
and specialty pharmaceuticals. Sobi has an emerging
late stage clinical development orphan and specialty
pharmaceutical pipe-line. We are focused on providing
valuable orphan drugs and niche specialty products and
services to patients with high unmet medical needs.
Ruconest® (conestat alfa) is a recombinant human C1
esterase inhibitor in hereditary angioedema. Ruconest® is
a recombinant form of human C1INH recently approved in
Europe for the treatment of acute angioedema attacks in
adults with HAE due to C1INH deficiency.
Groupo Uriach
ViroPharma Incorporated Booth 1510
730 Stockton Drive
Exton, PA 19341
Toll-free Voice: 1-888-651-0201
Facsimile: 610-458-7380
Website: www.viropharma.com
ViroPharma Incorporated is an international
biopharmaceutical company committed to developing and
commercializing innovative products that address unmet
medical needs. CINRYZE® (C1 esterase inhibitor [human])
is an approved therapy for patients with hereditary
angioedema (HAE). CINRYZE is a C1 esterase inhibitor that
is used to prevent attacks and swelling in teenagers and
adults with HAE. This product has been approved by the
FDA and EMA only. This product has not been approved for
commercialization in México.
Booth 1420
Polígono Industrial Riera de Caldes, Av. Camí Reial, 51-57
08184 Palau-Solità i Plegamans – Barcelona
Spain
Website: www.uriach.com
Phone +34 93 864 96 92
FAX - +34 93 863 05 58
Grupo Uriach is a Spanish private pharmaceutical company
based in Barcelona. In the pharmaceutical business for
over 165 years, it is one of the leading domestic Spanish
companies, characterized by an emphasis on scientific
and commercial innovation and a strong entrepreneurial
character.
Rupatadine, a new generation and potent antihistamine
with PAF-antagonist activity, is the contribution from our
research team for the treatment of allergic conditions.
160
Final Program
WAO Global Guidelines
leading the way in defining optimal care
WAO Diagnosis and Rationale
for Action against Cow’s Milk Allergy
(DRACMA) Guidelines
This evidence-based Consensus Document, using the
GRADE methodology, is supported by the WAO Special
Committee on Evidence Based Medicine. DRACMA
has been included in the National Institutes of Health
(NIH) Guidelines and is being widely used by medical
organizations, companies, and governments. Translations
are currently available in French (shortened version),
Italian and Mandarin; Spanish translation in preparation.
Coming Soon! A dedicated DRACMA website is being
developed as an online resource for accessing the
DRACMA Guidelines, educational and reference tools, and
updates on implementation and dissemination activities.
A DRACMA application for the iPad is in development, and
a Pocket Guide will be created.
Please check the Scientific Program of the World
Allergy Congress for several activities related to
the DRACMA Guidelines!
WAO Position Paper on
Sublingual Immunotherapy
To facilitate a truly global perspective of current
knowledge about sublingual immunotherapy (SLIT),
WAO invited general practitioner and patient groups from
around the world to join WAO’s Regional, National and
Affiliate Member Societies in developing a Consensus
Document to be published as the first global Position
Statement on sublingual immunotherapy.
The resulting document, Sublingual Immunotherapy:
World Allergy Organization Position Paper 2009, was
published in the World Allergy Organization Journal
in 2009.
Future plans include the creation of a guide on sublingual
immunotherapy for general practitioners and patients,
and a new paper, “Grading of Side Effects of Sublingual
Immunotherapy,” will be submitted for publication soon.
For free universal access to
WAO Position Papers and
Statements, please visit
Defining the Specialty
www.worldallergy.org/definingthespecialty
WAO Anaphylaxis
Guidelines
Anaphylaxis Guidelines were
published concurrently in the
World Allergy Organization Journal
and the Journal of Allergy & Clinical
Immunology in 2011.
Please join us for the
WAO Anaphylaxis Guidelines
Symposium
WAO Anaphylaxis Guidelines WAO Anaphylaxis Special
Committee Symposium
10:45 - 12:15
Gran Cancún 3 (Cancún Center)
The WAO Anaphylaxis Guidelines
poster will be distributed at the
World Allergy Congress. Future
plans include a pocket card
summarizing the Guidelines and an
application for the iPhone.
161
Final Program
WAO Member Society Village Floor Plan & Hours
1st Floor, Cancún Center
Member Society Village Hours
Monday, 5 December........................................................ 09:00– 17:00
Tuesday, 6 December........................................................ 09:00– 17:00
Wednesday, 7 December................................................ 09:00– 17:00
WAO 60th Anniversary Display
162
Final Program
WAO Member Society Village Directory
Continuing the World Allergy Congress tradition of promoting WAO Member Societies to the delegates, the Member
Society Village will be open from 5-7 of December on the 1st Floor of the Cancún Center.
American Academy of Allergy,
Asthma and Immunology (AAAAI)
Booth 2002
555 E. Wells Street, Suite 1100
Milwaukee, WI
USA
53202
Phone: +1 414-272-6071
Fax: +1 414-272-6070
Website: www.aaaai.org
The American Academy of Allergy, Asthma & Immunology
(AAAAI) is a professional organization with more than
6,500 members in the United States, Canada and 72 other
countries. This membership includes allergist/immunologists,
other medical specialists, allied health and related healthcare
professionals—all with a special interest in the research and
treatment of allergic and immunologic diseases.
Asia Pacific Association of Allergy,
Asthma and Clinical Immunology
Booth 2008
91 - 97 Islington Street Collingwood
Victoria Australia
3066
Phone: +61 (3) 9417 0888
Fax: +61 (3) 9417 0899
Website: www.apaaaci.org
The Asia Pacific Association of Allergy, Asthma and Clinical
Immunology (APAAACI) is an association of national
societies of Allergy and Clinical Immunology in the Asia
Pacific region.
The objectives of APAAACI are to promote:
• Exchange and progress of knowledge on allergy, asthma,
The AAAAI is dedicated to the advancement of the
and clinical immunology in this region.
knowledge and practice of allergy, asthma and immunology • Study, prevention and treatment of allergy, asthma and
for optimal patient care.
immune-mediated diseases, with particular emphasis on
problems specific to the region.
• Exchange in training programs between member
Argentine Society of Allergy
countries.
and Immunopathology
Booth 2011
• Cooperation in clinical and basic research on allergy,
Av. Santa Fe 1171
asthma and clinical immunology in this region.
Buenos Aires
• Development of programs for public information and
Argentina
education in allergy, asthma and clinical immunology.
C1059ABF
• Cooperation with other international organizations in the
Phone: +54(11) 52761056
study of allergy, asthma and clinical immunology.
Website: www.saaei-med.org
• Dissemination of this knowledge through international
congresses on allergy, asthma and clinical immunology
and by other means.
The Argentine Society of Allergy and Immunopathology
was created in 1940 and since then its aim has been to
Brazilian Society of Allergy
foster the study of allergy and immunology in its many
and Immunopathology
Booth 2006
aspects, publishing and disseminating the work and
developments in this field.
Av Prof. Ascendino Reis 455
São Paulo
Since 1982, it has granted the degree of Specialist to
Brazil
those professionals who perform the ´Triennial Course in
04027-000
Allergy and Immunopathology´ recognized by the National
Phone: +55 11 5575 6888
Ministry of Health.
Fax: +55 11 5572 4069
Website: www.asbai.org.br
The Brazilian Association of Allergy and Immunopathology
merged in 1971 from two other societies with same
objectives: promote the specialty of allergy and
immunology. It is a WAO Member Society with 1,300
members from all Brazilian states; it has annual scientific
meetings, board certification, and an official Allergy Journal;
it edits national guidelines as proposed by its scientific
committees.
163
Final Program
Commonwealth of Independent
States (CIS Society)
Booth 2005
The International Association of
Asthmology (INTERASMA)
Booth 2016
4 Ostrovityanova street
Moscow Russia
117513
Phone: + 7 495 7351414
Fax: +7 495 7351441
Website: www.isir.ru
Email: [email protected]; [email protected]
Frei Sa, 3 Paparigopoulou Str
Athens
Greece
105 61
Phone: +30 210 3215600
Fax: +30 210 3219296
Website: http://www.wca-2012.com
The CIS Society includes 15 member Societies and 3,600
members from 12 countries.
The International Association of Asthmology was founded
in 1954 by allergologists, chest physicians, paediatricians
and internists. In the 1950s membership grew through the
creation of INTERASMA Chapters which began to become
active. This organization resulted in the annual regional
meetings and chapter meetings and of the World Congress
of Asthma organized every two years. In 2011 the World
Association of Asthma selected a Core PCO, FREI SA Travel –
Congress with a long term relation for all its meetings.
European Academy of Allergy and
Clinical Immunology (EAACI)
Booth 2000
Genferstrasse 21
8002 Zurich
Switzerland
Phone: +41 44 205 55 33
Fax: +41 44 205 55 39
Website: www.eaaci.net
Iranian Society of Asthma and
Allergy (ISAA)
The European Academy of Allergy and Clinical
Immunology is a non-profit organisation active in the
field of allergic and immunologic diseases such as asthma,
rhinitis, eczema, occupational allergy, food and drug
allergy and anaphylaxis. EAACI was founded in 1956 in
Florence and has become the largest medical association
in Europe in the field of allergy and clinical immunology. It
includes 6,500 individual members from 107 countries as
well as 41 National Allergy Societies.
Georgian Association of Allergology
and Clinical Immunology
Booth 2013
6 Rustaveli street
Tskhaltubo Georgia
5640
Phone: +995599234779
Fax: +995436522375
Website: www.gaaci.ge,www.gaaci.org
Booth 2001
Allergy & Clinical Immunology Dept.,Children’s Medical Center
62 Dr Gharib St., Azadi Ave.
Tehran
Iran
1419733151
Phone: +98 9121486132 Fax: +98 21 66573616
Website: www.isaa.hbi.ir
The most active Iranian Society on the subject of allergy
with about 60 Allergy & Clinical Immunology subspecialty
members is ISAA. It was established in 1996 with the aim of
education about allergy, asthma and clinical immunology
in the whole country for all the levels including patients,
families and different physicians. Numerous regular
annual and biennial congresses, different conferences and
workshops with CME throughout the country have been
held by the ISAA establishment.
The VII Georgian Congress of Allergology and Immunology
will be held in Batumi (Black Sea) from 5-8 October 2012.
164
Final Program
Japanese Society of Allergology (JSA)
Booth 2014
4th MY Bldg., 1-13-3, Ueno, Taito-ku
Tokyo Japan
110-0005
Phone: 81-3-5807-1701
Fax: 81-3-5807-1702
Website: http://www.jsaweb.jp/
Japanese Society of Allergy (JSA) was founded in October
1952. Since then, in addition to publishing two peer
reviewed journals – Japanese Journal of Allergology (in
Japanese) and Allergology International (in English), the
Society holds two meetings, Spring and Autumn meetings,
bringing researchers in basic medicine and clinical science
together. Membership, which has increased yearly, now
stands at 9,176. The number of JSA’s Board Certified Allergy
Specialists was 3042 as of July 7, 2011.
Korean Academy of Allergy, Asthma
and Clinical Immunology
Booth 2012
1705, Kumho Palace B/D, 327-2 Changsin-dong, Jongno-gu
Seoul Korea
110-540
Phone: 82-2-747-0528
Fax: 82-2-3676-2847
Website: http://www.allergy.or.kr/ent
Latin American Society of Allergy,
Asthma and Immunology
Booth 2009
Hospital Universitario, Centro Regional de Alergia, Madero y
Gonzalitos s/n Mitras Centro
Monterrey, N. L. México
64460
Phone: 52-81-83482468
Fax: 52-81-83476798
Website: www.slaai.org
The Latinoamerican Society of Allergy, Asthma and
Immunology (SLAAI) was founded in 1961. Actually, SLAAI
is integrated by 17 national societies of allergy from 16
countries. The SLAAI is divided in 4 chapters: Southern
Cone countries, Bolivarian countries, Mesoamerican
countries and Iberian countries. The SLAAI’s meeting is
every two years in different countries every time, and in the
intervening year each chapter has a regional congress. The
current president is Sandra N. González-Díaz, MD, PhD, from
México.
Mexican College of Allergy, Asthma
and Clinical Immunology (CMICA)
Booth 2004
Antonio M. Anza No. 27, Col. Roma
México City México
06700
Phone: (52) 55 742435
Fax: (52) 55 742435
Website: www.cmica.org.mx
CMICA brings together allergists and experts to study
topics that promote continuing medical education in
allergy and immunology, including practical application of
scientific knowledge through the completion of courses,
and participation in conferences and symposia.
CMICA disseminates updated and accurate information to
health professionals, patients, parents and/or the general
public and encourages research that contributes to solving
problems of allergy that represent a public health concern.
Mexican College of Pediatricians
Specialized in Allergy and
Clinical Immunology (COMPEDIA)
Booth 2003
World Trade Center México Montecito #38 Piso25 Ofna 34
Col. Nápoles
México City México
03810
Phone: (52) 55 9000 2008
Fax: (52) 55 9000 2008
Website: www.compedia.org,mx
Email: comaaipe@wtcMéxico.com.mx
COMPEDIA brings together pediatric allergists and allergy
experts to study topics that promote continuing medical
education in pediatric allergy and immunology, including
practical application of scientific knowledge through the
completion of courses, and participation in conferences
and symposia.
COMPEDIA disseminates updated and accurate information
to health professionals, patients, parents and/or the general
public and encourages research that contributes to solving
problems of pediatric allergy that represent a public health
concern.
165
Final Program
National Association for
Private Algerian Allergists
Booth 2010
H5 -Cité Malki .Ben Aknoun
Algiers
Algeria
16030
Phone: +213770434592
Fax: +23121591274
Website: www.anap-dz.org
Booth 2015
Kopcinskiego 22 Street
Lodz Poland
90-153
Phone: 0048426776948
Fax: 0048426790316
Website: www.pta.med.pl
World Allergy & Asthma Congress: EAACI-WAO
22-26 June 2013
Milan, Italy
www.eaaci-wao2013.com
Join the European Academy of Allergy and Clinical
Immunology and the World Allergy Organization at the
upcoming 2013 World Allergy & Asthma Congress, to take
place in Milan, Italy from 22-26 June 2013. The theme of
the Congress is Allergy, a Global Heath Challenge. Stop by
the booth in the Member Society Village for the most upto-date information.
WAO International Scientific Conference (WISC)
6-9 December 2012
Hyderabad, India
www.worldallergy.org/wisc2012
The Polish Society of Allergology is an organization
founded on 15 November 1982 in Bydgoszcz. It brings
together allergy specialists, internists, pediatricians,
dermatologists and laryngologists specializing in
allergology and related disciplines. The territorial structure
contains 13 Regional offices with 1,700 members. PTA
represents Polish allergology in Poland and in the world,
popularizing knowledge of allergology in the community
and educating public health staff in allergology.
Romanian Society of Allergology and
Clinical Immunology
Please visit the WAO Booth, which features the 89 Member
Societies of WAO. Learn more about WAO: Educational
Programs, Online Learning, and the World Allergy
Organization Journal.
The National Association for Private Algerian Allergists’ main
goal is the development and promotion of allergology in
Algeria to approximately 500 doctors. The society organizes
many workshops and international congresses throughout
the country.
Polish Society of Allergology (PTA)
World Allergy Organization (WAO)
Booth 2007
Participate in the World Allergy Organization International
Scientific Conference (WISC 2012) in Hyderabad, India, 6-9
December 2012. The theme of the Conference is Severe
Allergies, Severe Asthma: New Strategies for Treatment and
Prevention.
Building on the success of the 1st WISC in Dubai, December
2010, the WAO is excited to launch its 2nd theme-based
scientific conference, the WISC 2012. With 24 Post Graduate
Courses on a wide range of topics, five Plenary Sessions,
Parallel Symposia, three Keynote Lectures, Poster Sessions
and Highlights in Immunotherapy, the WISC 2012 will be a
multidisciplinary forum for allergists, pulmonologists, ENTs,
dermatologists, internists, pediatricians, gastroenterologists,
clinical immunologists and primary care physicians.
WAO 60th Anniversary Display
Celebrate the World Allergy Organization’s 60th
Anniversary!
WAO is proud and honored to celebrate its 60th
Anniversary in 2011. Please stop by the WAO History
display and relive WAO’s proudest achievements, scientific
break throughs, and honor the pioneering leaders of our
specialty. Copies of WAO History articles, written by Prof.
Alain de Weck and Prof. Michael A. Kaliner for the WAO
Journal, will be available to visitors at the display.
166
Final Program
RIU CANCUN
PRESIDENTE
INTERCONTINENTAL
DOWNTOWN/CENTRO
CITY EXPRESS
RADISSON HACIENDA
HOLIDAY INN
HOLIDAY INN EXPRESS
RIU PALACE
LAS AMERICAS
Hotels Map
Fiesta Americana
Grand Coral Beach
DREAMS CANCUN
HYATT REGENCY
KRYSTAL CANCUN
Cancun Center Conventions
& Exhibitions
SCIENTIFIC SESSIONS VENUES:
-Cancun Center Conventions
& Exhibitions
-Fiesta Americana Grand Coral Beach
MELIA ME
PARK ROYAL PIRAMIDES CANCUN
FIESTA AMERICANA VILLAS
AQUA
NICHUPTE LAGOON
JW MARRIOT CANCUN RESORT & SPA
MARRIOT CASAMAGNA CANCUN RESORT
GRAN MELIA CANCUN
FIESTA AMERICANA CONDESA CANCUN
HILTON BEACH & GOLF RESORT
CARIBBEAN
SEA
AIRPORT/ AEROPUERTO
WESTIN CANCUN GOLF & SPA RESORT
168
Final Program
Hotels in Cancún
Hotel Name
Phone Number
Address
Distance from the
Convention Center
HEADQUARTER HOTEL
FIESTA AMERICANA GRAND
CORAL BEACH
(998) 881-3200
BLVD. KUKULKAN KM 9.5
< 500 yards
HOTEL ZONE
KRYSTAL
(998) 848-9800
BLVD. KUKULKAN KM 9
< 500 yards
FIESTA AMERICANA VILLAS
(998) 881-1400
BLVD. KUKULKAN KM. 8.5 SECC. A
1 mile
CANCÚN CLIPPER
(998) 891-4977
BLVD. KUKULKAN KM 9
< 500 yards
HYATT REGENCY
(998) 891-5555
BLVD. KUKULKAN KM.8.5
< 500 yards
THE MARRIOTT CASA MAGNA
(998) 881-2000
BLVD. KUKULKAN RETORNO CHAC LOTE 41
5 miles
JW MARRIOTT
(998) 848-9600
BLVD. KUKULKAN KM 14.5 LOTE 40-A
3 miles
GRAN MELIA
(998) 193-0090
BLVD. KUKULKAN KM. 16.5
3.5 miles
THE PRESIDENTE
INTERCONTINENTAL
(998)848-8700
<500 yards
THE WESTIN
(998) 848-7400
BLVD. KUKULKAN KM 20
7 miles
ME BY MELIA
(998) 881-2500
BLV. KUKULKAN KM 12.5
2 miles
DOWNTOWN HOTELS
CITY EXPRESS
(998) 881-1930
AV. NICHUPTE SM 8 MZA 1 LOTE 4
7.5 miles
HOLIDAY INN CANCÚN
ARENAS
(998) 287-0500
BLVD KUKULKAN KM. 2.5
4 miles
HOLIDAY INN EXPRESS
(998) 883-2200
PASEO POK-TA-POK N.21 Y 22
2 miles
ALL INCLUSIVE HOTELS
AQUA
(998) 849-4606
BLVD.KUKULKAN KM 4.5 ZONA HOTELERA
2 miles
FIESTA AMERICANA CONDESA
(998) 881-4200
3.5 miles
DREAMS
(998) 848-7000
PUNTA CANCÚN S/N
< 500 yards
RIU CANCÚN
(998) 848-7151
BLVD KUKULKAN KM. 8.5
< 500 yards
PARK ROYAL CANCÚN CARIBE
(998) 848-7800
BLVD KUKULKAN KM 10.5
1 mile
Activities
in Cancún
There are plenty of things to do
after Congress hours in Cancún.
For information on tours, dining
reservations, shopping options
and other recreational activities,
please visit the General
Information/Housing/Tours
Desk on the Ground Floor of the
Cancún Center.
169
Final Program
Disease-specific WaO initiatives
Expert alliances devoted to a major allergic condition
small airWays Diseases WOrking grOup
www.worldallergy.org/small_airways_group/about/
The purpose of the WAO Small Airways Working Group is to increase awareness of diseases related to the small airways as
well as to highlight scientific findings and encourage research in this area.
The WAO Small Airways Working Group website is intended to be an evidence-based, global platform for physicians and
other health care professionals around the world, providing them ease-of-access to the most relevant scientific, clinical and
educational resources on all aspects of small airway diseases.
Hae
Hae internatiOnal alliance
www.worldallergy.org/haealliance/
The WAO HAE International Alliance is a global resource of educational and research activities, increasing awareness of the
disease, and highlighting and encouraging HAE research. The immediate goal of this Alliance is to develop and disseminate
a WAO “HAE International Consensus Document.” This Consensus Document will provide credible, evidence-based information for physicians and other health care professionals around the world to have ease-of-access to relevant scientific and
clinical data on HAE, as well as to differential diagnosis and treatment.
allergic rHinitis WOrking grOup
www.worldallergy.org/allergic_rhinitis/
The WAO Allergic Rhinitis Working Group is a worldwide initiative focused on raising awareness and sharing information on
allergic rhinitis toward improved patient care. The initial goals of the Working Group are:
1) to gather educational and scientific materials on allergic rhinitis into a central repository for free available worldwide
access
2) to provide an interactive learning program on allergic rhinitis in children and adults.
Coming in early 2012: Allergic Rhinitis - WAO Online Learning Modules with CME. This program will consist of two modules
based on case histories, one involving allergic rhinitis in children and the other in adults. In a self-paced interactive program,
visitors will be able to move through the case histories and follow links to a number of resources available online on the
topic of allergic rhinitis. This will be a free WAO program with universal access.
WAO-1011-293
170
Final Program
Speaker, Author and Chairperson Index
Name
Session#
Handout/
Abstract#
Page#
Ababneh, Hani
OAS32
101
Abbott, Salome
Poster163002 127
Abou Chakra, Oussama
OAS2
51
OAS133164 73
Poster102103 123
Handout/
Abstract#
Name
Session#
Alkhalil, Michel
OAS143170 74
Poster534143 154
Allam, Jean-Pierre
NH1
Allen-Ramey, Felicia
OAS183197 77
Poster514126 153
Alobid, Isam
Poster514122 152
Page#
1-3NH39
Aceves, Seema
SSS2
SY28
Achilles, Nils
Alonso-Sánchez, Miguel E
OAS223217 80
OAS6 218654
Poster394044 145
Adamia, Nino
Poster32027115
Alvarez, Jorge
Agache, Ioana
SSS7 7-1SSS70
SY31 105
SSS16 105
Poster333131 139
Agondi, Rosana Camara
Poster12015114
Alvarez, Mirta
PSym22153 50
Poster72073120
Poster142133 126
Aguila de la Coba, Roberto O.
SY4 47
PSym22154 50
Alvarez Cardona, Aristoteles
Poster152140 127
Aguilar, Nadia
Poster444070 147
Poster514125 152
Alyoshkin, Vladimir
Poster454075 148
Amon, Ulrich
OAS1 215651
Amri, Manel
Poster494103 150
Andersen, Jens Strodl
OAS1 215951
Ansari, Qamar
Poster132127 125
Ansotegui, Ignacio J.
DB2
SY19
SSS12
Aquino, Marcella
Poster243065 133
Arablin Oropeza, Said
OAS183196 77
Poster333122 138
Araujo, Laura
Poster374011 142
Arias-Cruz, Alfredo
BS15
Arnold, Jeanette
AH1 1-6AH35
AH1 35
AH2 2-2AH37
2-2SSS46
28-3SY93
Aguilar-Velazquez, Gustavo
OAS6 218955
Poster394037 144
Ahumada, Silvia
Poster203041 131
Akdis, Cezmi
CPS2 2-1CPS48
PS5 5-1PS66
SSS7 70
SY21 21-2SY84
SY27 91
Akdis, Mubeccel
Akin, Cem
OAS19
78
SSS8 82
SY27 27-2SY91
OAS29
99
SY31
31-3SY105
2-2DB59
19-2SY71
12-1SSS91
15-1BS65
BS7 7-1BS44
PS2 2-1PS45
BS21 21-1BS66
PS10 90
Akiyama, Kazuo
NH7 109
Arruda, L. Karla
WS6
BS6 6-1BS43
OAS24
95
Poster62065119
Arsovska, Anita
Poster484090 149
Al-Ahmad, Mona
Alaniz, Angelica
Poster464076 148
Aldave Becerra, Juan
OAS7 219455
Ale, Iris
BS14
WS15
Al-Hammadi, Suleiman
Poster333126 139
Aljubran, Salman
14-1BS65
15-3WS86
OAS9 220357
6-2WS63
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
171
Final Program
Name
Session#
Arsovski, Zoran
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
Poster142134 126
Baraniuk, James
Asanuma Odaira, Marcela
Poster414051 146
Asayag, Estrella
SY30 104
Assa’ad, Amal
SSS6
BS25
DB8
6-1SSS61
25-1BS88
8-2DB92
SY9 60
BS14 14-2BS65
SY17 17-2SY69
WS12 12-1WS85
OAS33
102
Poster12002113
Poster12003113
Poster12011114
Poster524133 153
Atkins, Dan
BS26
DB8
26-1BS88
8-1DB92
Barrera de Pino, Olga Melcina
Poster414050 145
Augustin, Steffen
OAS2 216251
OAS133163 73
Barreto-Sosa, Adriana
Poster152141 127
Bartuzi, Zbigniew
Poster303105 137
Poster303107 137
Bastías, Carla
Poster293098 136
Poster293100 136
Poster404046 145
Batle, Rocio
Poster394038 144
Baysan, Abdullah
Poster333127 139
Bede, Olga
Poster323119 138
Bedolla Barajas, Martín
Poster303108 137
OAS123159 72
Poster203037 130
Berger, Robert
OAS183193 77
Bergmann, Karl-Christian
OAS102210 57
Poster273087 135
Bernstein, Jonathan
OAS11
58
SY7 7-3SY59
SY22 22-3SY84
OAS33 4211102
WS24
24-1WS106
Bhalla, Prem
OAS2 216351
Bielory, Leonard
OAS6
54
SY14 14-3SY68
WS14 14-3WS86
BS33 33-1BS89
Page#
Aun, Marcelo Vivolo
OAS143173 74
Ayatollahi, Maryam
Poster323120 138
Poster484098 150
Azuara Trujillo, Hugo Alberto
Poster273089 135
Bachert, Claus
SY2
PS7
SSS8
Badellino, H A
Baena-Cagnani, Carlos E.
SSS6 6-2SSS61
SSS10
83
OAS28
98
DB11 105
NH3
BS24
Balduzzi, Michael
Poster72077120
Ballas, Zuhair
BS17 17-1BS65
SY13 68
SY27 27-1SY91
NH8
8-3NH110
Ballow, Mark
Banerji, Aleena
47
Baker, James
CSS1 1-1CSS47
SSS3 3-3SSS47
SSS5 61
BS16 16-1BS65
Bahna, Sami
OAS223220 80
DB11 105
SSS3
2-1SY46
7-3PS67
8-2SSS82
Baez Loyola, Carlos
3-2NH40
24-1BS88
Blaiss, Michael S.
BS9 9-1BS44
SSS2 46
NH8
8-2NH110
UTP1
SY18
1-2UTP59
18-4SY70
Blanca, Miguel
172
Page#
BS6 6-2BS43
DB1 46
OAS6 218454
BS20 20-1BS66
SY15 15-3SY69
OAS22
80
WS16 16-1WS86
Poster364000 141
Poster394045 145
Poster514121 152
UTP1
59
WS13 13-1WS85
WS25
25-3WS106
Final Program
Handout/
Abstract#
Name
Session#
Bleecker, Eugene R.
PS1
SY3
UTP2
1-2PS44
3-3SY47
2-2UTP70
Bochner, Bruce
SSS2
SSS16
2-1SSS46
16-3SSS105
Bocsan, Ioana Corina
Handout/
Abstract#
Name
Session#
Brozek, Jan
WS1
WS19
Bryson, Rebecca
PSym11002 37
Bublin, Merima
OAS30 4194100
OAS4 217353
Poster384022 143
Bujor, Ioana Adriana
OAS223218 80
Boechat, Jose Laerte
OAS8 219956
OAS8 220056
Bullimore, Alan
OAS34 4218103
Poster142129 125
NH2 2-1NH40
SSS1 45
YiR1 1-1YiR60
Burks, A. Wesley
Boguniewicz, Mark
Boner, Attilio
BS1 1-1BS43
SSS4 48
SY14 68
DB11
11-2DB105
NH6
6-3NH109
SY26
Bonini, Matteo
Butt, Ahmed
Poster72078120
BS18 18-1BS66
SY23 85
WS30
30-3WS108
Caballero, Chrystopherson
Poster223051 132
Caballero-Fonseca, Fernan
SSS13
WS29
Calamita, Zamir
Poster72072120
Poster444065 147
Poster444066 147
Page#
26-2SY91
Page#
1-2WS62
19-1WS87
13-2SSS92
29-3WS107
OAS6
54
WS14 14-1WS86
CPS6 6-1CPS92
SY30
30-2SY104
Poster364002 141
Calderon, Moises
OAS112218 58
OAS163181 75
CSS4 83
Poster434059 146
Bostanci, Ilknur
Poster22 3052A132
Callejas, Fco. de Borja
OAS203206 79
OAS203207 79
Botan, Valéria
PSym22151 50
Calva, Maricruz
Poster414052 146
Boukhettala, Nabile
Poster42046117
Camargo, Carlos
SY26
WS26
Bonini, Sergio
Bork, Konrad
AH2 2-6AH37
NH1
1-11NH39
OAS10
57
BS13 13-1BS65
26-1SY91
26-2WS107
Boulaich, Mouna
Poster464085 149
Boulet, Louis-Philippe
AH1 1-4AH35
SSS5 5-1SSS61
SY22 84
PS9 9-3PS90
Campos Romero, Freya Helena Poster343133 139
PS7 7-1PS67
WS19 19-3WS87
OAS31
100
UTP3
3-2UTP103
Boushey, Homer
Boyce, Joshua
WS20 20-3WS87
PS10 10-1PS90
DB10 104
Bozzola, Martin
SSS16
16-1SSS105
Braido, Fulvio
SY6
WS29
Breiteneder, Heimo
OAS2 216552
OAS13
73
6-2SY48
29-1WS107
Canonica, G. Walter
NH1 1-6NH39
CSS1 1-3CSS47
OAS23
81
CPS6 6-3CPS92
Capriles Hulett, Arnaldo
Poster293097 136
Poster233063 133
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
173
Final Program
Handout/
Abstract#
Name
Session#
Caraballo, Luis
BS4
BS28
4-1BS43
28-2BS89
Carlsen, Kai-Hakon
BS18
SY20
SY30
18-2BS66
20-1SY83
30-3SY104
Carpio-Pedroza, Juan Carlos
Poster52055118
Casale, Thomas B.
Cases, Barbara
Castells, Mariana
Castillo, Antonio
Handout/
Abstract#
Name
Session#
Choi, Byoung Whui
Poster52061118
Choi, Sungjin
Poster494101 150
Chong Neto, Herberto Jose
OAS153175 74
OAS254170 96
Poster193029 130
Poster394039 145
AH1 35
PS5 5-3PS66
CPS5 92
Chugo, Sendy
PSym11012 38
Chung, Eun Hee
Poster504114 151
OAS2 216752
OAS13
73
OAS30 4197100
Poster203039 130
Chung, Hai Lee
Poster52053118
Cicardi, Marco
SY18
Cicchetti, Amerigo
OAS102209 57
Page#
PS2 2-3PS45
UTP1 1-1UTP59
WS13 13-2WS85
PS10 90
Page#
18-3SY70
Cid del Prado - Izquierdo, Maria Poster42039116
Cifuentes, Liliana
OAS294188 99
Cingi, Cemal
Poster384036 144
Cocco, Renata R.
SSS4
SY7 59
Poster203036 130
Castillo Méndez, Ada
Poster384031 144
Cohen, Shai
Poster62067119
Castrejon-Vázquez, Isabel
Poster173019 129
Cole Johnson, Christine
OAS8 219856
UTP3 103
Compalati, Enrico
OAS1
51
DB5 68
OAS34 4220103
Contreras Contreras,
Elvia Angelica
Poster132126 125
Castro,
Ana Paula Beltran Moschione
Poster82085121
Castro, Mario
SY16
DB9
Castro Almarales, Raúl Lázaro
OAS233222 81
Poster142131 126
Castro-Rodriguez, Jose A.
NH7
7-6NH109
Celedon, Juan Carlos
NH5
BS28
WS26
5-4NH41
28-1BS89
26-3WS107
Cepeda, Alfonso
16-3SY69
9-2DB93
BS4 4-2BS43
BS16 16-2BS65
PS8 89
Chang, Yoon-Seok
OAS274178 97
Chavez, Elianny
Poster163009 128
Corey, Jacquelynne
PSym44152 94
Poster464084 149
Cortés-Morales, Guillermina
Poster394041 145
Cortigiani, Luciano
OAS102211 58
Cox, Linda
NH1
1-13NH39
DB4 4-2DB67
OAS233224 81
OAS23
81
WS22
22-3WS106
Cox Jr.Ruan
OAS193201 78
Craig, Timothy J.
SY6 6-3SY48
SY18 18-1SY70
SY18 70
WS16 16-2WS86
SY30
30-1SY104
Chavez Villarreal, Karen Giselle Poster122109 123
Chen, Jing
Poster102099 122
Chérrez, Ivan
SY6 48
Chikhladze, Manana V.
Poster42045117
Cho, Jin Hee
Poster374009 142
Cho, You Sook
SSS11
4-1SSS48
11-1SSS84
174
Final Program
Name
Session#
Creticos, Peter
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
AH2 2-8AH37
NH3 40
OAS10
57
OAS233226 81
OAS34 4215103
Desai, Shailesh
PSym33151 72
Poster384026 143
Diaz, Alejandro
OAS223219 80
Diaz, Maria Cristina
Poster333130 139
SY4 4-1SY47
DB4 67
CPS4 82
WS29
29-2WS107
Poster72075120
Poster424058 146
Diaz Rodriguez, Alexander
SY23 23-3SY85
Poster32031116
Poster203033 130
OAS5 218054
OAS112214 58
Poster434061 147
Poster434064 147
Dimitriades, Victoria
Dimov, Ves
WS10
Cua-Lim, Felicidad
OAS14
Dominguez, Luis
Poster92092122
Cuervo, Naomi
OAS8 220156
Culverhouse, Susan
Poster464081 148
Dooper, Maaike
OAS173187 76
Poster82084121
Poster82088121
Dorbeker, Raul
Poster474089 149
Dorsey, Morna
Poster374013 142
DuBuske, Lawrence
SY5 48
SSS5 5-2SSS61
Dupont, Christophe
CSS3
Durham, Stephen
NH1 1-2NH39
CPS2 2-3CPS48
PSym4
94
WS28
28-2WS107
Cruz, Alonso
Csuka, Dorottya
Page#
74
Cunningham-Rundles, CharlotteOAS32
101
SY29
29-2SY104
NH8
8-1NH110
NH8 110
Custovic, Adnan
SSS7
DB6
BS23
Dahl, Birthe
PSym1
Dahl, Ronald
AH1
SY9
WS28
7-2SSS70
6-2DB82
23-1BS88
37
1-8AH35
9-3SY60
28-3WS107
Dykewicz, Mark
Poster42036116
D’Amato, Gennaro
SY19
Daoud, Ahmed
Poster494105 151
Ebisawa, Motohiro
Darlenski, Razvigor
SY23 23-4SY85
Poster233062 133
Daubner, Barbara
AH2 2-1AH37
NH4 4-2NH41
NH4 41
De Gennaro, Mónica S.
SSS16
19-1SY71
16-2SSS105
10-2WS63
3-3CSS69
BS8 8-1BS44
OAS4
53
UTP2 2-4UTP70
WS21 21-3WS87
Dalan, Dan
Page#
BS12
DB4
NH6
12-1BS65
4-1DB67
6-1NH109
EL Fiky, Ashraf
OAS193199 78
El-Gamal, Yehia
SY9 60
BS20 20-2BS66
SY25 91
Elizalde, Araceli
OAS32 4208102
de Paula Motta Rubini, Norma Poster384021 143
Deleanu, Diana
Demain, Jeffrey
Demoly, Pascal
OAS18
PS8 8-1PS89
SY26 91
SY31
31-1SY105
NH4
WS2
SESSION GUIDE
77
4-5NH41
2-3WS62
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
175
Final Program
Name
Session#
Emelyanov, Alexander
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
Poster524137 154
Fox, Roger
Emeryk, Andrzej
PSym22155 50
Ensina, Luis Felipe Chiaverini
NH4 41
OAS27
97
Poster72070120
NH2 2-4NH40
NH4 41
BS10 10-1BS44
WS18 18-1WS86
Page#
Frank, Michael
Escalante Dominguez, Alberto PS1 44
Escobar-Gutiérrez, Alejandro
SY21
Escribano, Luis
PS2
España, Corin
Poster333129 139
BS17
Espinosa-Rosales, Francisco
OAS7
Estrada Reyes, Elizabeth
SSS9 9-3SSS83
OAS24
95
Fabré, Dania
Poster524131 153
Fal, Andrzej
Poster514123 152
Falkencrone, Sidsel
OAS112219 59
Farkas, Andreas
OAS30 4192100
Farkas, Henriette
OAS163185 76
Ferández Duro, Bárbara Isabel
Poster213046 131
Fernandes, Fátima
OAS123160 72
Fernandez-Caldas, Enrique
NH3 3-1NH40
OAS2
51
SY7 7-2SY59
OAS133165 73
PS8 89
OAS34 4217103
Fineman, Stanley
2-2PS45
Espinosa, Sara
Frew, Anthony
84
Fryer, Allison
Page#
SY18 18-2SY70
OAS16
75
CSS4 83
NH1 39
PS5 5-2PS66
DB5 5-1DB68
OAS17
76
SY8 8-2SY60
SY17 17-3SY69
DB9 93
Fujimura, Takashi
OAS233223 81
Fundova, Petra
OAS203205 78
Poster384033 144
Galicia-Carreón, Jorge
OAS6 218554
Gallego, Claudia
SY23 23-2SY85
Poster203040 131
Poster343137 140
17-2BS65
55
Galli, Stephen J.
PS2 45
SY8 8-1SY60
SY25 91
Gallo, Richard
PS7
DB7
Gamez, Luisa
OAS32 4206101
Poster323117 138
Gandhi, Stella
Poster414049 145
Garcia-Calderin, Diego
Poster152139 127
Poster374010 142
Garro, Laila Sabino
SY6 48
BS31 31-1BS89
7-2PS67
7-2DB82
BS1 1-2BS43
WS1 1-3WS62
SY14 14-1SY68
PSym44157 95
NH6 109
OAS143172 74
Poster233060 132
Poster233061 132
Gawchik, Sandra
OAS102212 58
Gawlik, Radoslaw
Poster384027 143
Fitzhugh, David
NH2 40
Poster223057 132
Gelardi, Matteo
OAS213215 80
Poster364006 141
NH4 4-3NH41
SY21 21-3SY84
SY29 104
George, Maureen
Fleisher, Thomas
AH1 1-9AH35
AH2 2-9AH37
AH2 37
WS27
27-3WS107
Flores, Mauricio
Poster32028115
Fonacier, Luz
NH2 2-7NH40
WS15 15-2WS86
SSS12
91
Fiocchi, Alessandro
Gepp, Barbara
176
OAS133168 73
OAS30
100
Final Program
Handout/
Abstract#
Name
Session#
Gerth van Wijk, Roy
SY4 4-3SY47
SY7 7-1SY59
SSS15 105
Gevaert, Phillipe
SY2
Ghaffari, Gisoo
Poster313110 137
Ghosh, Nabarun
PSym11000 37
Giavina-Bianchi, Pedro
SY28 28-2SY93
Poster72076120
Poster163003 127
Poster173017 129
Poster273090 135
Poster434063 147
Giubergia, Veronica
SY10
Glaum, Mark
AH2 2-4AH37
WS9 9-1WS63
OAS20
78
Gołębiowska-Wawrzyniak,
Maria
Handout/
Abstract#
Name
Session#
Grüber, Christoph
OAS5 218354
Poster243068 133
Guerrero, Adelquis
Poster534139 154
Guhsl, Eva
Poster122111 124
Guillén, Nelva
OAS7 219055
Poster92091121
Poster343134 140
Gulec, Mustafa
Poster464077 148
Haahtela, Tari
DB3 3-1DB60
PS7 67
WS20 20-1WS87
PS8 8-2PS89
Hadler, Meike
PSym44151 94
Hafner, Christine
Poster263080 134
Halwani, Rabih
OAS31 4201101
Poster323115 138
DB2 59
SY24 24-1SY90
YiR4
4-1YiR105
Han, Doo Hee
PSym33149 71
Poster384023 143
SY15 15-4SY69
PSym44155 95
WS27
27-1WS107
Poster132118 124
Hamid, Qutayba
Han, Man Yong
Poster92089121
Gomez-Gonzalez, Arturo
WS4
Hanania, Nicola
González, Arya
Poster233058 132
BS5
SY9
CPS4
Gomez, R Maximiliano
Page#
2-3SY46
61
4-3WS62
Hankin, Cheryl
Page#
5-1BS43
9-1SY60
4-1CPS82
PSym44156 95
Gonzalez Serrano, Maria Edith OAS32 4205101
Poster323116 138
NH1
1-14NH39
SY4 4-2SY47
OAS33 4209102
Poster364001 141
Hanna, Kamal
SY11
61
Haschke, Ferdinand
CSS3
69
Gonzalez Galarza,
Ma del Rosario
Gonzalez-Carsolio, Aida
Poster394042 145
Poster404047 145
González-Díaz, Sandra
Hasegawa, Miho
Poster303106 137
Hawkins, Gregory
OAS9 220757
SSS3 47
BS15 15-2BS65
BS31 31-2BS89
Poster504111 151
Hebert, Jacques
OAS102213 58
Gopalan, Gokul
PSym33153 72
Heffler, Enrico
OAS4 217553
Poster173018 129
Gorodezky, Clara
SSS14
14-3SSS104
Gray, Claudia
SSS10
10-2SSS83
Greenberger, Paul
WS5 5-3WS62
SY12 12-3SY67
SY25 25-1SY91
Poster12000113
Gromadina, Olga
Poster52054118
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
177
Final Program
Handout/
Abstract#
Name
Session#
Heine, Ralf G.
CSS3
Herbarth, Olf
Poster12006114
Poster504119 152
Handout/
Abstract#
Name
Session#
Israel, Elliot
PS6 6-3PS67
CPS5 5-2CPS92
OAS31
100
Issa-El-Khoury, Karine
Poster12017114
PSym11005 38
Poster263086 135
Ivancevich, Juan Carlos
WS10 10-1WS63
SY20 83
Hidalgo Castro, Emilia María
OAS12
72
SSS9 9-2SSS83
Jackson, Daniel
Hide, Michihiro
SSS1
SY18
NH1 1-7NH39
OAS9
56
CPS5 5-1CPS92
Hideaki, Shirasaki
OAS203208 79
Hirotsu, Mikio
Poster384014 142
Hjortlund, Janni
OAS274177 97
Hoffman, Hal
BS11 11-1BS44
PS3 3-3PS45
SY13 13-3SY68
BS32 32-1BS89
SY28 93
Hernandez-Mondragon,
Luis Octavio
Page#
3-2CSS69
45
70
Page#
Jacobsen, Lars
NH1
1-12NH39
OAS34
103
Jacomini, Débora Laís Justo
OAS294191 99
Jain, Animesh
Poster32033116
Poster193027 129
Jardim, Jose
Poster504112 151
Jayakumar, Jaisubash
Poster52050117
Jensen-Jarolim, Erika
SY13 68
OAS173188 76
Holguin, Fernando
PS9
WS26
9-1PS90
26-1WS107
Jeong, Jae-Won
Poster524129 153
Holland, Steven
NH8
8-4NH110
Jessica, García
Poster193025 129
DB8 92
NH6
6-4NH109
Jin, Hyun-Jung
OAS143169 74
Holzhauser, Thomas
Poster253075 134
Johansson, S.G.O.
Hong, Soo-Jong
BS27 27-1BS88
OAS25
96
Hossny, Elham
SY8 60
Jovkovska Kaeva, Biserka
Poster494108 151
Huang, Fengyang
Poster52052118
Jung, Jae-Woo
Poster494099 150
Huerta Hernández, Rosa Elena SY14 68
SSS9 9-1SSS83
Jung, Joo Hyun
Poster223048 131
Hur, Gyu-Young
OAS143171 74
Hwang, Young S
Kaditis, Athanasios
SY6 6-1SY48
WS16 16-3WS86
PS9 90
Poster163011 128
Iduñate-Palacios, Fernando
Kagoya, Ryoji
Poster384024 143
SSS9
Ikeda, Katsuhisa
Kalil, Jorge
OAS203204 78
Poster193028 129
OAS17
76
SY28 28-1SY93
Poster102098 122
Poster92095122
Kaliner, Michael A.
Imai, Takanori
Imai, Yasutomo
OAS5 217853
SY5 5-3SY48
SY17 69
PSym3
71
WS17 17-1WS86
Inoue, Yuzaburo
Poster183023 129
Kalpaklioglu, A. Fusun
Poster534144 154
Irinyi, Beatrix
Poster444067 147
Kamenwa, Rose
Poster112106 123
Irvin, Charles
DB2 59
SY24 24-2SY90
WS30
30-2WS108
Kampitak, Thatchai
Poster424055 146
83
178
Final Program
Name
Session#
Kaplan, Allen P.
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
NH2 40
BS7 7-2BS44
DB1 1-1DB46
SSS10
83
KIM, Soo Whan
Poster52063119
Kim, Tae-Hoon
Poster273091 135
Poster273094 136
OAS223216 80
OAS33 4213102
KIM, Woo Kyung
Poster223056 132
Kim, Yong-Dae
OAS9 220256
Kardar, Gholam Ali
Poster122115 124
Kim, You-Young
SSS5 61
PS6 67
Kimura, Satoko
OAS203209 79
Karafilidis, John
Page#
Page#
Karp, Christopher
PS7 67
PS8 8-3PS89
Kartasasmita CB, Cissy B
Poster32034116
Poster102100 122
Kinaciyan, Tamar
Katada, Yoshinori
OAS284180 98
Poster72071120
Katayama, Ichiro
SSS1
WS13
Katelaris, Connie
King, Monroe James
WS3
BS19
CPS4
Kishan, Hari
Poster193032 130
PSym1
37
WS7 7-3WS63
SY15 15-2SY69
WS14 14-2WS86
Kolliputi, Narasaiah
SY16
Kawashima, Akiko
OAS264174 97
Komata, Takatsugu
Poster102102 122
Kelkar, Pramod
BS22
WS12
Kondo, Tomio
Poster173014 128
Konischeva, Anna
Poster12019115
Kelso, John
NH1 39
WS3 3-3WS62
SY12 67
SY31 105
Kopriva, Frantisek
Poster22021115
Korenblat, Phillip E.
AH1
Köse, Sükran
Poster122113 124
Koteli, Asimoula
Poster484095 150
Poster484097 150
Kowalski, Marek L
NH5 5-2NH41
NH5 41
SY5 5-1SY48
WS2 2-1WS62
CPS6 92
Khan, David
Kiley, James
1-1SSS45
13-3WS85
22-1BS66
12-2WS85
UTP1 1-3UTP59
UTP1
59
WS11 11-2WS85
OAS27
97
WS25
25-2WS106
PS1 44
CPS5 92
Kim, Cheol-Woo
Poster72074120
Kim, Hyun Hee
OAS21
79
Poster193031 130
Kim, Jeong-Eun
Poster122112 124
Kim, Jin Tack
Poster52062119
Kim, John
OAS7 219155
Poster293099 136
Kim, Kyu-Earn
OAS28
98
Poster183021 129
Kraft, Monica
3-2WS62
19-1BS66
4-2CPS82
1-7AH35
CPS1 1-3CPS46
CPS1 46
DB2 2-1DB59
PS6 6-2PS67
Kucera, Petr
OAS294187 99
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
Company Sponsored
Symposium
SY
Symposium
Kim, Myung-Sung
Poster22024115
CSS
Kim, Sang-Ha
Poster62069119
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
Kim, Sang-Hoon
Poster62066119
69
179
Final Program
Name
Session#
Kurowski, Marcin
Kuryan, John
Kuschnir, Fábio
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
OAS213211 79
Lemanske, Robert
Poster414054 146
Poster524130 153
SY1 1-2SY45
DB3 60
CPS3 3-3CPS68
SY26 91
NH7
7-3NH109
Page#
Page#
Poster132120 124
Poster394040 145
Poster424057 146
Kushnir, Nataliya M.
Poster112105 123
Kuznecova, Galina
Poster534140 154
Kuznecovs, Ivans S
OAS5 218154
Labrada, Alexis
PSym44154 94
PS2 45
OAS3 217253
SY8 8-3SY60
OAS26
97
DB10 104
Lang, David
OAS11
58
DB6 82
WS24
24-2WS106
Leyva Castillo, Juan Manuel
OAS264172 97
Lezana, Jose L.
SY10
Lheritier-Barrand, Michèle
OAS1 216051
Li, Jing
PSym11013 38
OAS15
74
Poster203035 130
Li, Xingnan
OAS193202 78
Liévano Pérez, Mayra Alondra
Poster364003 141
Liggett, Stephen
PS1 1-3PS44
SY17 69
Lanz, Miguel J
Levin, Michael
Levi-Schaffer, Francesca
Poster32029116
Poster213045 131
OAS153179 75
SSS10 10-1SSS83
SSS10 10-3SSS83
10-2SY61
Lara, Alicia
Poster434060 146
Larenas Linnemann, Désirée
NH1 39
BS2 2-1BS43
WS5 5-2WS62
WS17 17-3WS86
PSym44146 94
PSym44147 94
Lawton, Simon
PSym44158 95
Lim, Dae Hyun
Poster203034 130
Leal-Garcia, Liborio Rafael
Poster223050 131
Lim, Seong Yong
Poster173013 128
Ledford, Dennis
Lima Filho, Silvio
Poster444068 147
Lizbeth, Blancas-Galicia
OAS32 4207102
PSym1
37
NH5 5-5NH41
SSS2 46
BS19 19-2BS66
BS24 24-2BS88
Llamas, Beatriz Adriana
Poster333123 138
Lee, Heung-man
Poster384025 143
Lleonart, Ramon
OAS163186 76
Lee, Hyun Hee
Poster183024 129
Lockey, Richard F.
Lee, Jae Ho
OAS284182 98
Lee, June-Hyuk
Poster152142 127
Poster173020 129
AH1 35
NH1 39
NH5 5-1NH41
PS5 66
Lombardi, Carlo
Poster364004 141
Lee, Kwang Hoon
OAS5 217953
Lee, Yong Ju
OAS244162 95
Poster32035116
Lopez Campos, Xiomara
Poster253072 133
Poster253073 133
Poster494107 151
OAS274176 97
Poster464080 148
López-Expósito, Iván
Poster112108 123
Lehloenya, Rannakoe
López-Lemus, Uriel A.
Poster353145 141
Leite, Rubens Marcelo Souza
Poster253069 133
López-Pacheco, Cynthia
OAS9 220657
Losappio, Laura
Poster42037116
180
Final Program
Name
Session#
Lötvall, Jan
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
Más Quintero, Arelis
Poster142130 126
Maselli, Juan Pablo
OAS153177 75
PS6 6-1PS67
SSS7 70
SY22 84
SSS15 105
Poster323113 137
Maspero, Jorge
Lu, Jun
Lubis, Azwin
Poster112104 123
CSS2 2-2CSS60
CSS2 60
SSS16 105
Poster504113 151
Lugo-Reyes, Saul
OAS32 4204101
Matloobi, Zahra
Poster384015 142
Lukacs, Nicholas
UTP3
Matos, Josemar
Poster333125 139
Lumry, William
OAS163184 76
Matsumoto, Fausto
Poster253070 133
Lund, Kaare
BS27
Maurer, Marcus
Macías-Weinmann, Alejandra
NH5
Madrigal, Ileana
Poster434062 147
NH2 2-8NH40
NH2 40
CSS4 4-1CSS83
BS32 32-2BS89
Mäkelä, Mika
WS20 20-2WS87
OAS25
96
Makino, Fumihiko
Poster52051118
Malm, Lars
OAS31 4202101
Malpica Cruz, Jose Augusto
OAS32 4207A102
Manfredi, Giacomo
Poster414048 145
Manrique, Maria Amelia
Poster152137 126
Mansfield, Lyndon
BS10
DB11
Marcucci, Francesco
Poster142135 126
Mariano, David
OAS112215 58
Page#
3-3UTP103
27-2BS88
41
Page#
Maya, Jonathan
Poster92093122
Poster263084 134
McIntyre, Mareike
OAS4 217453
Medina, Miguel Alejandro
PSym33156 72
Medina-Hernández, Alejandra Poster203038 130
Mejia, Karla
Poster12012114
Poster464078 148
Poster464079 148
Melioli, Giovanni
OAS3
52
OAS254165 96
Mellado Abrego, Jaime
SSS14 104
OAS213213 79
Meltzer, Eli
CSS1 1-2CSS47
PSym22148 50
SY15 69
OAS183192 77
10-2BS44
11-1DB105
Markiewicz, Katarzyna
Poster112107 123
Poster353146 141
Marshall, Gailen
SSS6 61
OAS15
74
Poster52058118
Mendelson, Louis
NH4
WS11
WS25
NH5 41
CPS1 1-2CPS46
Mendez Berreondo, Nancy
PSym11003 37
Mendez-Inocencio, Julia
Poster323114 138
Martin, Richard
Martin Del Campo Perez,
Monica
Martinez, Fernando D.
Martínez Aguilar, Nora
Martinez Infante, Eric
4-4NH41
11-1WS85
25-1WS106
Poster444072 148
SY1
CPS5
NH7
SSS14
1-1SY45
5-3CPS92
7-1NH109
14-1SSS104
Poster514124 152
Martínez Villegas, Erica Marisol Poster223049 131
Martinez-Saguer, Inmaculada
Poster514120 152
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
181
Final Program
Name
Session#
Mendieta, Elizabeth
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
Naclerio, Robert
OAS7 219255
Poster263077 134
Poster343135 140
Poster343136 140
SY5 5-2SY48
OAS20
78
YiR2 2-1YiR84
BS30 30-1BS89
Mendiola Marin, Jeannette
Poster12007114
Mendoza, Laura
OAS7 219555
Nadeau, Kari
NH3 40
CPS2 2-2CPS48
NH3
UTP2
Nagaraj, Srinivas
OAS3 216952
Meyers, Deborah
Nagaraju, Major K.
OAS4 217653
Meza-Velazquez, Rocío
Poster122110 123
Migacheva, Natalya
Poster253071 133
Najm, Cristina
OAS123162 73
Poster82087121
Nakachi, Shinichiro
Poster444069 147
Nakae, Susumu
PS3
Page#
3-3NH40
2-1UTP70
Miguel Polo, Lizette del Carmen OAS123157 72
Poster233064 133
Page#
3-2PS45
Mion, Olavo
Poster384028 144
Nakagawa, Ryusuke
OAS264173 97
Mitsui, Chihiro
Poster273088 135
Nakajima, Hirokazu
Poster12013114
Mittermann, Irene
WS23
Nakajima, Sonomi
Poster524136 153
Mizuguchi, Junichiro
OAS9 220557
Nakonechna, Alla
OAS254169 96
Mogica Martínez, Dolores
Poster343139 140
Negreiros Tebyrica, Joao
SSS4
Mohapatra, Shyam
NH3 3-5NH40
BS11 11-2BS44
PS3 45
CPS4 82
Nelson, Harold
NH1 1-5NH39
SY7 59
PSym4
94
WS22
22-2WS106
Moncada Alcon, Abel Marcelo
Poster384016 142
Poster384017 142
Nemeth, Agnes
Poster32025115
Poster263083 134
Moncrief, Terri
OAS8 219756
Neunkirchner, Alina
OAS31 4200101
Montejano-Elías, Lizette
Poster12005113
Nguyen, Doanh
OAS7 219355
Moon, Hee-Bom
SSS11
84
Nishihara, Fuyumi
OAS33 4214102
Moraes, Lillian Sanchez Lacerda OAS254166 96
Nishihira, Ryuichi
Poster12014114
Morais de Almeida, Mario
SSS12
Noble, Valerie
Poster414053 146
Morales, Alexander
Poster12001113
Nolte, Hendrik
Morfin-Maciel, Blanca Maria
Poster163008 128
Poster494104 151
Mösges, Ralph
SY5 48
PSym22144 49
PSym22146 49
PSym22147 50
OAS102208 57
OAS233227 81
Mullol, Joaquim
Noma, Takeshi
OAS284183 98
Nomura, Ichiro
BS8 8-2BS44
WS21 21-2WS87
CPS6 92
OAS33
102
BS26 26-2BS88
NH6
6-6NH109
NH6 109
Muraro, Maria Antonella
SSS7
Novak, Natalija
SSS1
Murphy, Claire
PSym11006 38
Nsouli, Safa
PSym33150 72
PSym33152 72
Poster163000 127
Muti, Andrea Daniela
23-2WS106
12-2SSS91
7-3SSS70
Poster22022115
Poster32032116
182
48
1-2SSS45
Final Program
Handout/
Abstract#
Name
Session#
Nunes, Carlos
SY1 45
SSS5 5-3SSS61
SSS5 61
SSS12
91
PSym44153 94
Handout/
Abstract#
Name
Session#
Paes Leme Ferriani, Virginia
WS6
Panettieri, Jr.Reynold A.
SY16 16-2SY69
DB9 93
Park, Chan Sun
OAS274175 97
Park, Choon-Sik
SY3
WS8
Page#
Nuñez-Nuñez, Maria Enriqueta Poster343140 140
Page#
6-1WS63
3-1SY47
8-3WS63
Nurmatov, Ulugbek
OAS233225 81
O’Byrne, Paul
Park, Hae-Sim
PSym2
49
WS4 4-1WS62
YiR3 3-2YiR90
WS30
30-1WS108
NH3 40
SY2 2-2SY46
SY12 12-1SY67
SY22 22-1SY84
Ogawa, Norifumi
PSym22152 50
Park, Heung-Woo
SSS11
SY23 23-5SY85
OAS284184 98
Park, Il-Ho
OAS33 4210102
Ogura, Kiyotake
Park, Mi-Ran
Poster263085 135
Oh, Jae-won
Poster42038116
Park, Seoung Ju
Poster52060118
Ohmori, Keitaro
OAS244163 96
Park, Seung Yong
Poster52059118
Oida, Kumiko
Poster253076 134
Parkerson, Jim
Poster464082 148
Okada, Naoko
OAS6 218754
PSym11007 38
Partida-Gaytan, Armando
Okubo, Kimihiro
WS3 3-1WS62
SY21 84
SY29
29-1SY104
Passalacqua, Giovanni
Oleske, James
OAS254168 96
Poster303104 137
Poster494100 150
Olszewska-Ziąber, Agnieszka
OAS213212 79
11-3SSS84
NH1
BS13
DB5
Passaleva, Angelo
NH8 110
Olvera-Marquez, Jose Antonio Poster12020115
1-9NH39
13-2BS65
5-2DB68
Ondrejkova, Andrea
Pastorino, Antônio Carlos
Poster494102 150
PSym11009 38
Poster504117 152
Ono, Noritsgu
PSym33155 72
Patella, Vincenzo
Poster132119 124
Ooka, Seido
Poster484096 150
Pauk, Norbert
Poster12008114
Ornellas, Lorena
Poster333124 138
Orozco, Lorena
SSS14
Pavon Romero, Fernando Gandhi
135
Ortega Martell, José Antonio
SSS9 83
NH7 109
Poster303102 136
Ortega-Cisneros, Margarita
Poster343143 140
Osma, Ustun
Poster12004113
Ownby, Dennis
SY1 1-3SY45
OAS8 219656
WS8 8-1WS63
UTP3
3-1UTP103
NH7
7-2NH109
Oyoqui Flores, Joel
SY20
Padjas, Agnieszka
Poster384035 144
14-2SSS104
83
Pawankar, Ruby
Poster273093
NH5 5-3NH41
WS7 7-1WS63
SY15 15-1SY69
SY15 69
SY27 91
WS31
31-2WS108
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
183
Final Program
Name
Session#
Peden, David
CPS3
SY22
BS33
Penagos, Martin
WS10
Peñaloza-González,
Flor de Guadalupe
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
3-2CPS68
22-2SY84
33-2BS89
Pravettoni, Valerio
Poster152138 127
Prescott, Susan L.
10-3WS63
NH3 40
BS3 3-1BS43
DB3 3-2DB60
SY27 27-3SY91
Poster444071 147
Pullerits, Teet
OAS22
Pendakur, Anand
Poster42047117
Pereira, Adriano
Poster323121 138
Pun, Teresa
Poster283095 136
Poster283096 136
Poster424056 146
Perez, Elena
SY21 21-1SY84
SY29
29-3SY104
NH8
8-6NH110
NH8 110
Qualizza, Rosanna
Poster444074 148
Quintana Quintero, Ingrid
Poster504118 152
Poster12016114
Poster313111 137
Rabe, Klaus
Perez, Juan Esteban
Perez Ortiz, Cinthia
Poster343141 140
CPS1
SY16
DB9
YiR4
Rachel, Marta
Poster183022 129
Pérez-Bustamante,
María Socorro
Page#
Page#
80
1-1CPS46
16-1SY69
9-1DB93
4-2YiR105
Poster82086121
Poster464083 149
Radauer, Christian
OAS2 216652
OAS30
100
Perez-Chavira, Maria Rosario
Poster504116 152
Ramírez, Gabriela
Poster173012 128
Peters, Stephen P.
NH3 3-6NH40
SY3 47
SY10 10-1SY61
UTP2 2-3UTP70
Ramírez Del Pozo, María Elena Poster132121 125
Ramírez González, Wendy
OAS173190 77
Ramirez Jimenez, Fernando
Poster92096122
BS5 5-2BS43
SY10 61
PS9 9-2PS90
Ramírez Vázquez,
María Guadalupe
Poster333128 139
Pfaar, Oliver
OAS34 4219103
Relan, Anurag
OAS163182 75
Pijak, Michal R.
Poster474087 149
Renkonen, Risto
OAS193203 78
Poster193026 129
Renz, Harald
OAS3
52
SSS8 8-3SSS82
Rha, Yeong Ho
OAS4
53
Poster163006 128
NH4 4-6NH41
OAS8
56
SY19 19-3SY71
DB6 6-1DB82
Riccio, Anna Maria
OAS294190 99
Plunkett, Greg
Poster213042 131
Ridolo, Erminia
Poster313112 137
Polosa, Riccardo
SY12 67
WS12 12-3WS85
SY28 93
WS27
27-2WS107
Riedl, Marc
OAS112216 58
OAS163183 76
CSS4 4-3CSS83
Rigalt, Ann Michelle
PSym33148 71
Ring, Johannes
AH2
NH2
SY13
DB7
Peters-Golden, Marc
Pineda-Bahena,
Luisa Guadalupe
Platts-Mills, Thomas
Pomies, Valeria
Potter, Paul
Poster243066 133
Poster394043 145
WS7 7-2WS63
BS22 22-2BS66
Poster384034 144
184
2-5AH37
2-2NH40
13-1SY68
7-1DB82
Final Program
Name
Session#
Rios, Jose Luiz
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
PSym11011 38
Poster62068119
Poster263079 134
Sa, Adriano
Poster233059 132
Risquez, Eliana
NH1 39
SSS13 13-3SSS92
Sacre Hazouri, José Antonio
CSS1 47
WS9 9-2WS63
SY20 20-3SY83
Rivera Gomez, Maria Antonia
Saenz, Martinez
Poster132116 124
SSS14
Robinson, David
Sager, Angelika
Poster152136 126
OAS1 215751
OAS34 4216103
Robles-Contreras, Atzin
Poster52057118
Poster364005 141
Saha, Bodhisattwa
Poster42041117
Rodenas, Mario
Saito, Hirohisa
Poster92090121
Rodrigo, Gustavo
WS4
OAS19
78
BS25 25-2BS88
DB10
10-1DB104
Rodríguez, José
Poster142132 126
Rodríguez Martínez,
Consuelo Fernanda
Poster263081 134
Rodriguez-Perez, Noel
Page#
104
NH1 39
Poster534145 154
Rogers, Linda
CPS4
Roh, Yong Ho
Poster524134 153
Rojas, Rosario
Poster223055 132
Poster343142 140
Rojo Gutiérrez, María Isabel
Roman Rodriguez, Miguel
SSS15
Rosario, Nelson
Rosenwasser, Lanny
Rottem, Menachem
Samoylikov, Pavel
Poster484092 149
Sampson, Hugh
AH2 2-7AH37
BS12 12-2BS65
DB8 92
NH6
6-2NH109
Sánchez Vallecillo,
María Victoria
PSym11008 38
Sanchez-Borges, Mario
Sanchez-Gallardo, Luis Rafael
Sanchez-Garcia, Silvia
15-1SSS105
NH4 41
SSS3 3-2SSS47
OAS6 218854
SY10 10-3SY61
Poster374008 142
NH3 3-4NH40
SY2 46
BS29 29-1BS89
SY24 24-3SY90
SY19
71
Ruiz Cervantes, Karla Paola
Poster42043117
Ruiz-Payan, Alma
Poster32026115
Ryan, Dermot
NH1 39
SSS15
15-2SSS105
SY23 23-1SY85
OAS34
103
4-3CPS82
NH2 40
OAS1 215851
Poster364007 142
Poster444073 148
Salamanca, Guillermo
BS2 2-2BS43
OAS1
51
PS5 66
WS22
22-1WS106
Rogala, Barbara
4-2WS62
Page#
AH2
WS2
SY25
2-3AH37
2-2WS62
25-2SY91
Poster253074
Poster253075
Poster384018
Poster504110
134
134
143
151
SY1 45
SY23 85
Poster22023115
Sandoval-Ramírez, Eunice
OAS244161 95
Poster524132 153
Sarmiento, Luis
SSS13
Saw, Sanjay
OAS3 217153
Sayah, Zineb
SY30 104
92
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
185
Final Program
Name
Session#
Scadding, Glenis
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
SY11 11-1SY61
PSym3
71
YiR2 2-2YiR84
WS31
31-1WS108
Simons, F. Estelle R.
SY11 11-3SY61
BS21 21-2BS66
OAS14
74
SY25 25-3SY91
Singh, Anand
Poster52064119
Singh, Mohan
OAS133166 73
PSym2
49
SY11 11-2SY61
CPS3 3-4CPS68
SSS15
15-3SSS105
Sircar, Gaurab
Poster42040117
Schmetterer, Klaus
OAS30 4195100
SSS3 3-1SSS47
DB6 82
NH2 2-6NH40
OAS5
53
YiR1 1-2YiR60
Sisul Alvariza, Juan Carlos
Schmid-Grendelmeier, Peter
Sjogren-Bolin, Ylva
Poster102101 122
Schultz, Cornelia
OAS173189 76
Slager, Rebecca
OAS3 216852
Schünemann, Holger
WS1
WS28
Slavyanskaya, Tatiana
Schwartz, Larry
SY8 60
BS29 29-2BS89
PS10 10-2PS90
DB7 82
BS23 23-2BS88
Poster42044117
Poster504115 151
Seba, Amanda
Poster343132 139
Sepiashvili, Revaz I.
PS9 90
BS9 9-2BS44
OAS7
55
SY12 12-2SY67
SY29 104
NH8
8-5NH110
Setiabudiawan, Budi
Poster122114 124
Smole, Ursula
OAS30 4193100
Shah, Ashok
SY2 46
Snibson, Kenneth
OAS31 4199100
Shahali, Youcef
OAS133167 73
Sommer, Isolde
Poster92097122
Shamji, Mohamed
OAS30 4196100
Souza-Machado, Adelmir
Shearer, Dona
PSym11010 38
PSym22149 50
OAS153178 75
Shilovskiy, Igor
PSym44149 94
Souza-Machado, Carolina
Poster534141 154
Poster534142 154
Shin, Yoo Seob
OAS294186 99
Spergel, Jonathan
AH1
SSS2
NH6
Schatz, Michael
Page#
1-1WS62
28-1WS107
Shinogami, Masanobu
OAS4 217753
Shoda, Tetsuo
OAS284185 98
Siani, Maria Concetta
OAS112217 58
Sibanda, Elopy
NH8 110
Poster92094122
Sidiropoulos, Ioannis
Poster72081121
Siebers, Rob
OAS254167 96
Poster213044 131
Sienra-Monge, Juan Jose Luis
SY19
Silvers, William
BS33
Simioni, Livio
OAS294189 99
Sleasman, John
Page#
1-3AH35
2-3SSS46
6-5NH109
Spieldenner, Joerg
OAS244160 95
Poster524135 153
Stone-Aguilar, Hector
SY20
Striz, Ilja
OAS173191 77
Poster52048117
Strunk, Robert C.
WS8 8-2WS63
OAS21
79
WS19 19-2WS87
SY26 26-3SY91
71
20-2SY83
Sudjana Prawira, Cissy Rachiana NH7 109
33-3BS89
Sumbayev, Vadim
OAS264171 97
OAS31 4203101
Suzuki, Tomoko
Poster52049117
186
Final Program
Name
Session#
Syrigos, Kostas N.
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
Poster12009114
Poster263082 134
Poster494106 151
Togias, Alkis
Syrigou, Ekaterini
Poster12010114
Poster173015 128
CPS2 48
CPS3 3-1CPS68
CPS3 68
WS21 21-1WS87
WS31
31-3WS108
Szefler, Stanley
Tomino, Carlo
NH1
Tordecilla, Rocio
Poster223052 132
BS16 16-3BS65
CPS3 3-5CPS68
OAS18
77
NH7
7-5NH109
Takahashi, Aya
Torres, Joselit
Poster163005 128
Poster474086 149
OAS5 218254
Takahashi, Kentaro
Torres-Lozano, Carlos
Poster534138 154
Poster213047 131
Takakuwa, Yukiko
Townsend, Kristen
PSym11004 37
Poster484094 150
Takeda, Masahide
Tracy, James
OAS9 220457
OAS29
99
SY31
31-2SY105
Taketomi, Ernesto
PSym44150 94
Traidl-Hoffmann, Claudia
Tanaka, Akane
OAS244164 96
SY14
WS15
BS23
Tanaka, Aya
Poster293101 136
Page#
Triggiani, Massimo
Page#
39
14-2SY68
15-1WS86
23-3BS88
SSS8 82
SSS12 12-3SSS91
DB10
10-2DB104
Poster132122 125
PSym44148 94
Tsai, Jaw-Ji
Poster213043 131
Tang, Mimi
CSS3
Tworek, Damian
Poster273092 135
Tanno, Luciana Kase
OAS274179 97
Poster263078 134
Ulus, Sergul
OAS213214 79
Tassinari, Paolo
CSS2
SSS13
Umetsu, Dale
PS3 3-1PS45
DB3 60
Teijeiro, Alvaro
OAS223221 80
NH7 109
Poster132123 125
Poster374012 142
Undem, Bradley
OAS9
56
SY17 17-1SY69
Urisu, Atsuo
SSS1 1-3SSS45
OAS5
53
Tanaka, Toshio
Poster223054 132
Poster484091 149
Tang, Jianping
3-1CSS69
2-1CSS60
13-1SSS92
Teng, Michael
SY3 47
OAS213210 79
Valdes, Dora
Poster32030116
Teper, Ariel
Valenta, Rudolf
PSym22150 50
OAS183194 77
OAS183195 77
Poster193030 130
NH1 1-4NH39
CPS2 48
DB4 67
WS23
23-3WS106
Terada, Tetsuya
Poster384030 144
Terracciano, Luigi
WS1
62
Thompson, Deryn
PSym11001 37
Titova, Nadya
Poster163010 128
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
187
Final Program
Handout/
Abstract#
Name
Session#
Valovirta, Erkka
AH1
NH1
Van Bever, Hugo P.
BS3
SSS4
Vargas Correa, Jorge
Poster132128 125
Vargas-Camaño, Eugenia
Poster474088 149
Vasu, Neetu
OAS244159 95
Vazquez-Tello, Alejandro
Poster5 2064A119
Poster5 2064B119
Velasco-Medina, Andrea Aida
Poster12018115
Poster42042117
Handout/
Abstract#
Name
Session#
1-5AH35
1-10NH39
Weinstein, Andrew
Poster524127 153
Poster524128 153
3-2BS43
4-2SSS48
Weinstein, Steven
PSym22143 49
PSym22145 49
CSS2 2-3CSS60
Page#
Wenzel, Sally
Page#
SY9 9-2SY60
UTP2
70
SSS11 11-2SSS84
YiR3 3-1YiR90
Werfel, Thomas
SSS8
Weyermann, Maria
OAS153176 74
Wheeler, William
OAS33 4212102
Woessner, Katharine
UTP1
PS1 1-1PS44
SY3 3-2SY47
UTP2
70
Yalcin, Arzu Didem
Vidal, Laura
Poster494109 151
Villas-Boas, Mariana Battaglin
OAS123158 72
Poster82082121
Poster82083121
Vinuesa, Miguel
NH6 109
Poster72079120
Poster132117 124
Poster132124 125
Poster132125 125
Poster243067 133
Poster303103 136
Poster323118 138
Poster343138 140
Poster384019 143
Virchow, Christian
PS6 67
SY24 90
Yamaide, Fumiya
OAS153180 75
Viveiros, Filipa
Poster384020 143
Yamaura, Mariko
Poster163001 127
Vrtala, Susanne
WS23
Yang, Ariana
WS6
Wahn, Ulrich
SY4 47
SY13 13-2SY68
NH7
7-4NH109
Yang, Min-Suk
Poster52056118
Poster163004 127
Yazicioglu, Mehtap
Poster303109 137
Yerly, Daniel
NH4 4-1NH41
OAS12
72
WS11 11-3WS85
Yildiz, Oguzhan
Poster72080120
Yli-Panula, Eija
Poster223053 132
Vercelli, Donata
Wallace, Dana
23-1WS106
1-4UTP59
6-3WS63
SSS6
WS17
Wambre, Erik
OAS31 4198100
Wang, Jia-Wang
OAS3 217052
OAS193200 78
Wang, Jiu_yao
OAS1 216151
Yoo, Kwang HA
Poster173016 128
Wardlaw, Andrew
Yoon, Ho Joo
SSS11
84
Poster163007 128
PS3 45
SY16 69
PS10 10-3PS90
OAS26
97
Yoshikawa, Mamoru
PSym33154 72
Watakabe, Yoshiharu
OAS2 216452
Yoshinami, Hiroyoshi
Poster384029 144
Weber, Richard
NH1 1-1NH39
DB1 46
WS5 5-1WS62
DB5 68
Zanoni, Giovanna
OAS143174 74
Zeher, Margit
Poster484093 149
6-3SSS61
17-2WS86
8-1SSS82
188
Final Program
Name
Session#
Zernotti, Mario
Handout/
Abstract#
Handout/
Abstract#
Name
Session#
Zuberbier, Torsten
NH2
DB1
CPS6
NH5 5-6NH41
NH5 41
CSS1 47
WS18 18-2WS86
BS30 30-2BS89
Zuidmeer-Jongejan, Laurian
OAS284181 98
Zhukova, Evgenia
Poster353144 141
Zuraw, Bruce
Zitt, Myron
OAS8
56
SY11 61
BS21 21-3BS66
DB7 82
NH2 2-5NH40
OAS16
75
CSS4 4-2CSS83
WS24
24-3WS106
Zoratti, Edward
UTP3
Page#
Page#
2-3NH40
1-2DB46
6-2CPS92
103
SESSION GUIDE
AH
Allied Health
Poster
Poster Session
BS
Breakfast Symposium
PSym
Poster Symposium
CPS
SSS
CSS
Company Sponsored
Symposium
SY
Symposium
DB
Debate
UTP
NH
New Horizon Session
WS
Workshop
OAS
YiR
Year in Review
189
Final Program
Media Partners
Thank you to all of our Media Partners for helping to raise awareness in support of WAO’s mission to be a global resource
and advocate in the field of allergy, advancing excellence in clinical care through education, research and training.
MEDIA PARTNERS OF THE XXII WORLD ALLERGY CONGRESS
Asthma Allergy and Immunology
Official journal of the Turkish National
Society of Allergy and Clinical
Immunology
Allergy Asthma &
Immunology Research
Official journal of the Korean Academy of
Asthma, Allergy and Clinical Immunology
http://www.aid.org.tr/joomla/
http://www.allergy.or.kr/
Journal of Allergy and
Clinical Immunology
Official journal of the American Academy
of Allergy Asthma & Immunology
Current Allergy and
Clinical Immunology
Official journal of the
http://www.aaaai.org/
http://www.allergysa.org/
Bentham Science Publishers Ltd.
http://www.benthamscience.com/
190
Final Program
Notes
192
Final Program
You Are Invited to Attend
O
Regisnline
tratio
n
International Scientific Conference (WISC 2012)
Severe Allergies, Severe Asthma:
New Strategies for Optimal Treatment & Prevention
6-9 December 2012
• WAO-1111-157
Hyderabad, India
OPEN
Visit
the W
to ge ISC 201
2
ta
Disco Registrat booth
ion
unt C
Get 2 oupon!
when
5
regist % off
e
WAC ring durin
g
2011
Charminar, Hyderbad India
Conference Organizing Chair
Lanny J. Rosenwasser, USA
Scientific Program Committee
Chair
Regional Advisory Committee
Chairs
Hae Sim Park, Korea
Local Organizing Chairs
Ashok Shah, India
K. Satish, India
Conference Speakers
Michael Abramson, Australia
Cem Akin, USA - TBC
Cezmi Akdis, Switzerland
Ignacio Ansotegui, Spain
Amal Assa’d, USA - TBC
Claus Bachert, Belgium
Thomas Bieber, Germany
Michael Blaiss, USA
Sergio Bonini, Italy - TBC
Konrad Bork, Germany
Wesley Burks, USA
G. Walter Canonica, Italy
Thomas B. Casale, USA
Mario Castro, USA
Alessandro Fiocchi, Italy
Takao Fujisawa, Japan - TBC
Roy Gerth van Wijk, The Netherlands
Sandra Gonzalez-Diaz, Mexico
Elliot Israel, USA
Constance H. Katelaris, Australia - TBC
Rohit K. Katial, USA - TBC
Peter Le Souëf, Australia
Francesca Levi-Schaffer, Israel
Robert Lemanske, USA - TBC
Richard F. Lockey, USA
Ghurjit Khurana Hershey, USA - TBC
Mika Mäkelä, Finland
Robert Naclerio, USA
Hae-Sim Park, Korea
Gianni Passalacqua, Italy - TBC
Werner Pichler, Switzerland
Susan Prescott, Australia
Nelson Rosario, Brazil
Lanny J. Rosenwasser, USA
Sarbjit Saini, USA
Hugh Sampson, USA
Mario Sanchez-Borges, Venezuela
Wayne Thomas, Australia
Hugo Van Bever, Singapore
J. Christian Virchow, Germany
Additional Faculty to be Announced
Key Reasons to Attend:
• Be on the leading edge of medical learning & education!
• Attend state-of-the-art lectures by world experts on Allergy,
Asthma & Clinical Immunology.
• Participate in practical, clinic-friendly workshops on
Immunotherapy, Food Allergy, Anaphylaxis, Skin Allergies,
Drug Allergy, Asthma, Rhinitis, COPD, Sleep Disorders,
and more.
• Network with others in your field/areas of interest
including: Asthma, Allergy, Immunology, Pediatrics,
Pulmonology, Opthalmology, Gastroenterology,
Dermatology and ENT.
• Receive CME credits.
• Showcase your own achievements to key international
opinion leaders and interact with international and
regional colleagues.
Conference Objectives:
• To provide insights into the mechanisms and phenotypes
of severe asthma and severe allergies.
• To highlight the most recent advances and developments
in treatment and preventative strategies of severe asthma
and severe allergies including immunotherapy, and
biologics.
• To provide an integrated approach to the diagnosis,
management of severe and more complex forms of
allergies.
• To identify unmet needs and areas of research priorities.
www.worldallergy.org/WISC2012
WAO-1111-157
Conference President
XXII World Allergy Congress
CANCÚN, MÉXICO
4-8 December 2011
Sponsors of the
XXII World Allergy Congress
Thank you to all of our Sponsors for supporting WAO’s mission to be a global resource and advocate in the
field of allergy, advancing excellence in clinical care through education, research and training.
Gold Sponsors
Silver Sponsors
Print CMYK | Blue = C 100% / M 72% / B 18% | Green = C 80% / Y 90%
Additional Sponsors
ALK-Abello, Alcon, CSL Behring, Pfizer, Teva
Exhibitors
Abbott, Aerosol Medical Systems, Allergy Therapeutics, Bedfont Scientific,
Bellanti’s Immunology, HAE: Learn about it, Talk about it, HAL Allergy BV, MicroLife Mexico,
nSpire Health, Mead Johnson, Merck, Nestle, Nycomed, Nyquet, Peprotech Mexico S.A. DE C.V.,
Omega Diagnostics, RMEI, Sanofi, Shire, Swedish Orphan Biovitrum, Uriach, ViroPharma
In collaboration with:
WAO Secretariat
555 East Wells Street, Suite 1100
Milwaukee, WI 53202-3823
U.S.A.
Phone: +1 414 276 1791
Fax: +1 414 276 3349
[email protected]
WAO-0911-498
A meeting of the:

Tuesday, 6 December 2011 - World Allergy Organization

Transcription

Similar documents

to view this brochure from Stanley Steemer International

Overview of Allergic Rhinitis - Mocha: Mothers of Children Having

What is Happening in the Schools?

Stanley Steemer - The Asthma and Allergy Foundation, St. Louis

ًٌفمةًً _~يهكةٍةي

Surface Archaeology in the Chilapa-Zitlala Area of Guerrero

Allergic Rhinitis Guide - Hamad Medical Corporation

Affinity

Folder Cumbre 2015 Ing 1 - México Cumbre de Negocios

Publishers Directory - The London Book Fair